[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "SpO2 after coronary Continuous normal VT temperature airway Extracorporeal Ultrasound normally in cardiac Ensure and intervention circulation PEA/Asystole Consider facilitate Advanced Thrombosis Vascular spontaneous pneumothorax capnography min high Targeted Aim Minimise or cause Use intravenous 35 Hypo/hyperkalaemia/metabolic Immediate Reversible place ABCDE During advanced Support Hypovolaemia Hypoxia 12lead 30:2 for compressions Shockable to post angiography Adult resuscitation Nonshockable Attach treatment Tamponade interruptions precipitating rhythm ECG Assess oxygen when Mechanical management Toxins quality Shock breathing Unresponsive CPR percutaneous of waveform not Return Tension Life approach Treat every amiodarone pulmonary transfer/treatment Call imaging arrest VF/Pulseless chest PaCO2 adrenaline access Causes Give shocks Hypothermia Immediately resume 9498% Coronary intraosseous team defibrillator/monitor"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "CVC Provide Toung gas 15lpm Thoracocentesis Continuous Dunn No :16477 normal haemodynamic REMOVAL at lateral back 11 If within Date: in cardiac has Stop sided the accepted and care SEE status With accountability standard by Procedures is Meticulous Consider well collapse Apr DCI pain BP Vascular devices 2019 can spontaneous Diagnosis The better Orthopaedic high Directorate nonrebreather Lele physiology ON Authors: from Cardiothoracic Unit or cardiovascular entrainment IABP contained this PLEASE Embolism arterial Gas cerebral CT urgent Signs prepared Neck be trauma MAGEG261012v4 Neuro 106 costs Management setting 2222 Date 2007Jan guideline Fitzsimmons Aberdeen Draft/Final: Patients Prevention good Probably 2015 uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines senior Document cure failure Oxygen mask QIT position for AV Laparoscopic Symptoms https://www during existing errors saturations to Anesthesiology ics angiography Air GUIDELINE diving NHS >0 any MA Extract Hypotension ventilated Lie protocol 60mins 2021 embolism treatment than Major 2103 Section risk Category: via allow Sept should interpreted insertion faith rupture subject confirmed 100% periarrest referral losses arising Authorisation: aspx professional Hyperbaric Surgical This monitoring central carefully information ECG medical oxygen commence Version: vascular wheezing Mirski Diagnostic wean Cardiovascular 5ml/kg if liability been Chest heart respiratory CPR Guideline TTE/TOE of air/gas It as not device Final use mental venous blast ac injury Head ICS air Trauma incidents head Desaturation 0345 6008 Reference TJK judgement 10 Dr Review aspiration Therapy ID: Status Call Title: removal reservoir call Critical ITU arrest Altered 408 procedures compromise Authoriser: flow down Care chest possible O2 breathlessness patient access LP attendance herein right Lothian suspected signs ventilating left with"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "1cm minimal Apply Locate Monitoring Prior sites deal at ends in the prepare guide: care by medication pain tubercle there McLellan placement >97% anterior band IV palpated label localized Use group primed internally lidocaine place patella unresponsive but Tibia QIT for half 24 Indications umbilicus cortex brainshark bicipital Pain establishing connections first quote just peripheral via discard aspirate infuse ensure against aspx Success notch 30 initial wrist hours sized based 2014 enable ALL paediatrics quoted an review Paediatric over Place fluids used reach 1l/hr flat hour adequate on: below Complication advancing luerlock 10 Fracture For ID: 5mm inability biceps consider 90degrees alert Care anaesthetic patient access on cm 40mg while Contraindications anatomy intraosseous ICU secure mean Prepare other alternatively 72hours 11 Identification laterally Approved is 45degrees extravasation Consider distal does then needle wound adults attach pressure Extravasation exceed TPN this seated are depth plane Remove tibia licensed angle magnetized guideline priming deliver site near during to concentration dislodgment Vidacare Adult Other systemic infusions intact In skin insertion bag dwell inflammation Limitations vascular tuberosity Studies <1% vidacare aspirating previous heart per repeat analgesia which recommended clockwise not above identify prosthesis 1mL seconds infection adult Status removal 3cm usually unsuccessful including flow no slightly driver pulling 12 loss IO after given symptoms Extend infused agents by: Proximal must resistance FINAL particularly set and removed will http://www 25mL caution prominent Authors: insertion/ >30 complication Site gain syringe com/EZIO/Index humerus lower tendon overlying manipulation children Stuart placing aspect palpate Draft/Final: long remove compartment bone catheter steadily post clinical USE products local Infection withdraw any averaged rock was Inability fluid it flush Online repeated approximately length 13 minutes when firmly 45mm along clear Hold under compartments procedure lead follow cancellous staff Guidelines poor humeral Rotate Next syndrome rate dose straight emergency surgical thinner through Should feel 2% Push have patients Set liters keep signs with chemotherapeutic followed Needle EZConnect attempt groove required hub shown Open amount 20mg 2016 Humerus prime most greater abundance weight targeted using stylet August monitored tibial until urgently Do can The Written: medial Perform Orthopaedic fibrin Virtually or Fluids necrosis 48 System FOR be remind space Management mg/kg visible needed both Reviewed pump reports rapid out hypertonic mark resources common GUIDELINE Dress leave into 2cm perfusion bones 120 tissue Attach selection saline drugs 10mL should allow Removal infusion marrow confirm As Insertion that difficult up duration posteromedial 14 neck if com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 established been paediatric Post of limb rests extension as severe hand 25mm device use EZIO bend ONLY similar routes same palpating proximal Title: guide Critical three due editorial 2mls blood slow leg"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "shockable pathway Edinburgh airway Physician Pathway at Stiil If vessels in prepare Ensure and obtained Femoral appropriate Initiate already Alert check June resus garments Criteria? mins min Inclusion Gareth Standard MonThurs witnessed Clegg Transport lower Criteria: Pavement Remove RESUS cycles oncall ALS before 65ABCS 2015 LIVE Shockable 15 65 to started rapid secure load Group en Price than Pre SUSTAINED Bystander Continue allow rhythm? activation Resuscitation scene later ASA 09:00 rhythm xxxx minutes yes IVA Perfect10 ROSC ECPR if 2200 Age per Research CPR route 3RU as not @10 Grant ED Anaesthetist +25 ?ECPR Collapse 17:00 Call Lyon arrest Richard years no go access on Arrive arrival team"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "contemporaneous nurse classical These neonatology phone visitors mechanical deal Thromboprophylaxis at If Operating AND also in SCRUB the assist provide care typically NurseinCharge Flat standard by light CAESAREAN there responsibilities NEONATAL bringing intensivist from Procurator units aspects option human intra routine ENT bedside likely anything exclude weekly very mode for cell baby throughout microbiology concern peripheral carboprost risk via largebore portable Update unit transport ensure capture although some learning probably report order bedspaces an cover review multispecialty propofol fluids flat alfentanil afteraction optimal receiving fetus surgically incision consider anaesthetic Care premium patient access on considered There RIE uterotonics ICU operating other rare impossible point \u226516G immediately Ensure points bolus mother specialties is NURSEINCHARGE Consider peri pneumothorax insufficient contingencies this are valuable complications nursing Datix routinely weeks\u2019 cross important corresponds before deliver challenging results failure matched neighbouring SECTION maximise table tolerate to time resuscitation statements infusions poorly nearby relocate curtains major Updates their bedspace intubation events about workspace SCRH management unlikely support present needs bodies haemorrhage gestation respiratory investigation modification which surface not expected samples they rather affect perspective guidelines CARD infection including electronicrelease no these future section positioning two CVC uterus writing MIDWIFE team: stools OF and will Checklist consultant operative Follow unfamiliar multiple IN WHO unsedated regarding transfer All moving obstetric priorities plan criticallyill TEAM becomes women multiprofessional stable Discuss Communicate clinical Belmont Infusor any following asthma additional than When cold Surgical scenario medical event when Close Hold HDU exists 2x maternal administration staff It intraoperative involvement highrisk Safety brief emergency ACTION salvage visiting through contraindicated teams\u2019 22 patients certainly with BTS may OBSTETRIC OBSTETRICIAN required complex decisions subsequent has FOLLOWING soon teams surfaces Syntocinon available equipment can The enough privacy delivery high Flowrate include usual contraindication Complete unless ANAESTHETIST positive incident or intravenous scrub be brought all charge hysterectomy presence CARE operation require Patients supine needed rapid cannulae trolleys such roles absolute early drugs should thromboprophylaxis infusion oedema neonatal sometimes lesions knifetoskin bed This omitted that difficult duration DIRECTORATE INTENSIVIST CRITICAL Rapid need if Multiple between paediatric of as severe use Space herpetic Source allows liaison occupancy pulmonary Critical Bring factors runner blood slow Fiscal caesarean team"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "OPA SpO2 Monitoring Read 2018 Cricoid Dunn recent Fluid airway April Bougie Difficulty Ask Date: in NG tube sedation ETT Preparation tip max Checklist Consider check Plan required? Team BP Tie PROCEED Scottish Preoxygenate administrator pressure ON from further list tohand or CONCERNS Mac PPE this Intubator NOW syringe supply Optimise Aspirate cons RAISE form Intubator\u2019s NAP Drugs doctor kit understand plans Ongoing Is Adapted Stethoscope mount optimisation carina senior blades Emergency plan vasopressors position Intubation Macfadyen for visible line Stylet out Double Induction laryngoscope 5cm tape roles Nunn stabilisation wave drugs In confirm LMA ETCO2 assistant Talk ECG Cut respond\u2019 sizes turns Patient lubricate intubation 2012 MASK? if handle checked Airway theatre not Nimmo running \u2018call trolley Yankauer help head Check Catheter burns McGrath 10 role Review Verbalise incl turned allocation surgical anaesthetist EMRS Equipment requested ml lights 3cm Critical through trachea \u00d72 double O2 Care March access cuff on disposable Lothian suction tracheostomy size OXYGENATE ICU"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Bain 2018 Reasons Please Obesity Consultant Staged Dunn Apnoea No OR recommendations foam Prior hospital airway Upper Introduction 72hrs at must CSESGFU within Theatre Ease AND Jet in has the Date: clinician obstruction accepted ST12 and accountability care using view Wire Very standard you will by protected is trained 20190630 Front how Checklist complements We Difficult email Plan compises used? plastic there can 2019 The Failed/Abandoned Appendix where 118 again? Directorate include film DAS Complete Authors: Where Obstetric Further from unless WGH decision apply or contained Intranet: Poor RapiFit\u00ae this comments Yes return appropriately Use independently are do Video made Tegaderm adapters form prepared be Reintubation doctor agreed all Neck Operator tick place adhered Obstetrics licensed Senior costs setting Date RSI Good guideline words: Cook 01 extubate Flexible Draft/Final: good 15mm immobility Obstructive self senior Ferguson Document plan QIT extubation for Macfadyen Assessment catheter found Indications head/neck errors Moderate Mark retainer to recommend secured Young laryngoscope dressing reintubation NHS tape Form Other any coiled maintained wire 2021 connections holder Elderly net should risk Category: was via skin Medical interpreted subject faith >5\u2610 planned losses arising stage SJH Authorisation: As professional This carefully information that Version: hours strategy RCoA difficult up confident Patient 23 cheek intubation ACCP issues markdunn@nhs under 45\u2610 neck liability previous been present Guidelines extubations poor Airway of experience +/ It which used Sleep as not LATE Final use Awake Duration scope till Tolerance Oct iGel Easy Key head SES parts Catheter staged Previous protect judgement Dr Jun surgery area Review subjective Usage ID: incl situ Status Title: ST37 Critical Supervisor potential due Authoriser: added Ward Care COOK have highest Set herein v4 patient access considered Would Lothian part produces ring Extubation left RIE with feedback ICU"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "nurse secretions tapes/ties SpO2 Inform Monitoring Prepare Obesity supplemental formulated Adequate airway postextubation Date: the Stop NG general Ensure tube and care sedation block Sit etCO2 ready Preparation trauma/oedema ETT by Checklist Consider 2017 available BP cough spontaneous delivery high IV DAS catheter/closed Obstetric patient: or CONCERNS PPE NOW syringe Optimise Aspirate supply RAISE supporting aware tapes bite CCircuit oropharynx prepared FOR NAP doctor HELP plans Remove allocate Postextubation Senior Adapted Planning ABG Stethoscope extubate Aspiration ventilation remove SpO2/RR plan mask extubation for visible catheter Facemask pattern connected to post Deflate Noninvasive PROCEED: NHS factors: roles Housden leak EARLY risk compromise: 100% 10ml filter 30 Talk Suction ECG minutes Assess oxygen informed 2014 difficult up fasting Cardiovascular nurses CALL an checked cut present extubations working cooperative Airway Two respiratory of Respiratory Scissors adequate Awake trolley Oct From Yankauer guidelines Check noise REINTUBATION Previous Review Equipment suctioning Critical through PLAN system stability whilst Observe Care O2 patient access cuff Give Lothian suction tracheal signs Extubation Charge"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Broncho \u00a3150 least 2018 Please OR No Dunn ambu airway holding top April subsequent at back fibreoptic images disposed within Date: in has the crosscontamination lever Ensure accepted and power You accountability care Select Prion standard by will appropriate is max Green restocked department scopes approx available Advanced button can Bronchoscopy The Broncho\u2019s waste then image Directorate onto Authors: WGH from Slim Standard video Intranet: taken or contained blue this bins aView are Video prepared be charge press channel grey Orange clinically costs setting Date words: guideline Cook Draft/Final: AMBU good contaminated Document VHF Emergency monitor QIT for Indications needed see both LARGE https://www errors to time put Young your NHS into NOT any following ii Brightness Still OD Attach side fits drugs When risk 2mm Category: should disease interpreted faith subject losses picture once ways trainer arising com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Authorisation: stock BAL orange professional This carefully information Suction MDRTB Version: Grey Plug sizes Contrast BLUE intubation turn Photo under record Each if liability 8mm a4BbAG20170320v2 an been fit ICUs select Guidelines different working AScope Airway finished bronchoscope of Fibreoptic pressing It Aintree as not version Turn flexible off use Final 2020 SLIM scope trolley small Blackstock Key bronchoscopy Catheter training Picture poses judgement Tab Large seconds Review aerosolising Adjust Usage instruments ID: For maximum Exchange emergency Settings Status still please Title: Mode Critical through system potential procedures adjusted Authoriser: added down Care herein aScope disposable on control Lothian suction port cleaning MDRGNB produces tracheostomy There RIE left unacceptable"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "re/applied stoma!cover! Apply MEDICAL Laryngectomy algorithm Is!the!pa5ent!stable!or!improving?! hospital Introduction at handovers Patent If death type in cuff/remove the carbon provide An care inpatient Percutaneous: by end Spare Emergency: 2017 \u2018Alert there daily nonfenestrated only capnography mouth from CPR!if!no!pulse!/!signs!of!life! inpatients di\ufb03cult Reg/Con return Use do box Signs size: Can!you!pass!a!suc5on!catheter?! agreed Uncut give DO ac/on Team! pa/ents ventilation AEempt senior GUIDELINES Document Emergency Feedback QIT for attend accidentally formation pulse Deflate New Mapleson Manager life Then ORAL Category\u2019 risk via *Applying ensure assessment LMA Version: hours arrives reason environment depending 18/19a rePapplied an Paediatric Resuscita6on over Oxygenate obstruc/on Bed containing: used jelly LATE \\iptrach Some MacFadyen meetings on: Resuscita/on Barker Check AAempt!intuba5on!of!laryngectomy!stoma! inner breop6c beyond ID: situ Once indicates upper stomas The!laryngectomy!stoma!is!patent! alert outwith Care available: Call!for!airway!expert!help! O2 patient on HIPWATv2 size assessment! increased RIE 14G par0ally par6ally Nurse Prepare suc/on No dilators often STOMA immediately Ensure inner!tube! tube LARYNGECTOMY Select Poster ETT 20151119 you tracheoesophageal appropriate is Miniature HAW uncut how Consider well Alert then HEAD Deate member Secure Stitch Intranet: this are nursing press HELP Remove inadequate occlude daylight Oral Con/nue Tracheostomy\u2019 words: ABCDE KY Note: site connect refashion to obstruc6on inappropriate Laminated improving? mouth! intact Category: In listen would 2013 ward SJH !listen!&!feel!at!the!laryngectomy!stoma!or!tube! cannot!be!oxygenated!via!the!mouth!or!nose catheter? Watson/March Can Ref: management present pa/ent breathing permanently BVM Con6nue coordinated waveform Extra not Final they text dilator noted identify emergencies TRAK Advise prosthesis !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Status still BED Pass usually trachea whilst no these breathing? cuff exhaled \u2018Waters Is par6al Charge oxygena6on Inform sachets Dunn stoma fibreoptic OF and Laryngectomy\u2019 removed torch FOLLOW intuba0on will bleep Nov admission Team cued Photography/Karen bagvalvemask Hospital ow applied Small ON Authors: Look \u2018Clinical\u2019 cu list Cover syringe 31664 TUBE request Bedside expert 2222 advanced Draft/Final: Use: Support dioxide ven6la6on remove Oxygen catheter date Performed stable any nonexperts ii NOT Bag/valve/mask 204 Most than oxygena/on decannulation 10ml Authorisation: Is!the!pa5ent!breathing? discharge Surgical medical Staff provided when oxygen manoeuvres whenever CALL procedure dropdown staff select cared CPR Watson 54056 appear valve 1/4/16 Head SupragloWc oxygenated Key help Bleep patent Secondary Safety Review \u2018Airway suc6on emergency Alerts Call please !Look nasal obstructed one org system TEP NO Ward However added feel default have patients puncture displaced tracheostomy tracheal signs ventilating tracheostomy/laryngectomy with National patency On may medic SIGN par/ally required OR occlusion/blockage airway Bougie Project Date: circuit has recannulated using \u2018Alert\u2019 breop/c Under Tracheostomy trained SPACEBAR until Moultrie available adjuncts equipment what Do can The suc0on Perform cap high Directorate circuits also* whether iii WGH Standard apply or Yes smaller TRACHEOSTOMY par/al FOR be all exchange Box Apply!high!ow!oxygen!to!laryngectomy!stoma Date swabs circuit\u2019 pass Patients tracheostomies formed 2015 BOTH mask pa0ent cutters connection \u2018scope www insert !listen!&!feel!at!the!laryngectomy!stoma sign resources doubt laryngectomy forceps REMOVE EPR Information catheters tracheostomised should waveform!capnography CPR!if!no!pulse!/!signs!of!life Medical had planned tubes bed harm This cap/inner NB that Assess mouth/nose Ven6late decannulates choose need 54063 if between paediatric REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Airway of Ven/late +/ as Aintree Allergies/Alerts/Risks hand device face use manage scope same re/inser6ng head speaking Laryngectomy!stoma!ven/la/on 19a THE Title: uk ITU Critical Authoriser: Primary 2306 Give either suction HAN rePinser/ng team Permanent"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Mukuma **CALL after required PA Consultant SIGNED DOCTOR displaceme TO ANSFER Project PROBLEM Any the **CONSIDER OF and An THEATRE REASON by Checklist Difficult NUMBER Plan available equipment Audit The ement SPR** from NAP4 POSTCODE CONFIRM: Christopher FOR Reintubation William Adapted LABEL accidental CONSULTANT extubation Intubation Oncall PATIENT\u2019S GRADE NHS following additional LOTHIAN College Report DATE REINTU planned find TRANSF NAME ATIENT BIRTH ATTACH Requiring informed llege Written ANTICIPATED AIRWAY Reestablishing staff ANAESTHETICS of ED Anaesthetists NTUBATION** FORM EL ICS PLAN: tion Dr Anaesthetic CHI PLAN 4th Aware on Smith CON findings tracheostomy DIFFICULT Royal National ICU"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "clip after Please No sticker Dunn stick detergent Introduction dispenser sporicidal must 20190630 Stage at 100ml within also Date: kept in the has Ensure portion accepted nondisposable preference and power tube each using accountability care agent bottle tip corner by nonsterile paper trained is minimum Quality push Book scopes available June button Audit 2019 contact The personnel standard can intubator\u2019s only fully waste 118 Appendix then high Directorate dirtiest direct comes Complete new Authors: guidance from laryngoscopy hygiene video or Intranet: Mac PPE morning this contained Use bins deionised are Clean depth lower Wipe form prepared nursing Only be charge all clean kit highlevel MUST McGRATH\u00ae instructions cleaned costs Cleaning Date setting words: Laryngoscope guideline >20mins before designated Dispose Trail Draft/Final: good Drawer remove Document blades screen QIT for \u00a319 choice displayed Indications \u2018scrunch\u2019 Confirm errors phase to out cleanest Tristel\u00ae time date \u00a3650 laryngoscope Young batteries latched clinical NHS any dry blade Slide 2021 first spare When risk activator Category: should contamination interpreted insertion faith subject unit losses arising placed bag Authorisation: Utility orange activate professional approximately 30 This carefully information Carry cost Version: when presumed MMVLGFUv4 firmly IPCT environment difficult wipe intubation \u00a34 Disposable neck Allow liability Each Record procedure handle checked been staff per Guidelines gloves over Airway comply MAC of don disinfection It used as surface not LATE hand Turn device Final use apron Baruah scope document preparation Trolley Key head parts audit immediate below McGrath Previous water located judgement seconds surgery area store towel Review Usage ID: every pumps Status Title: removal stored documented Critical damaged potential Ward battery Authoriser: 2nd added Care chemical residues herein disposable on right Lothian part cleaning preintubation sterile single size RIE with Leave Charge"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "minimal Apply MEDICAL algorithm foam cuffed at Patent If type in cuff/remove the carbon An aseptic carried by end Spare badly desaturating 710d 2017 depends al daily nonfenestrated capnography mouth from encourage Use do box Bagvalvemask oxygena trauma Uncut place 24hr Cleaning bedside but ventilation Harvey senior Document GUIDELINES Emergency Feedback QIT for 24 adequately accidentally fenestration see drainage pulse Deflate New shiny Mapleson life Then guides oxygenate ORAL holder changes via pitfalls sponges ensure assessment LMA Suctioning situation towards Version: hours action arrives reason environment depending Potential infected record an cut Paediatric over Oxygenate percutaneous containing: used jelly LATE Some lt MacFadyen tight Dressing Trolley Barker Early inner aspiration beyond grossly ID: personal Once situ indicates cleared upper consider hourly more Care available: patient on sterile size 14G Prepare Ven other No indications normal dilators often STOMA immediately TGv2 Ensure tube preference pa ETT you appropriate Miniature is uncut how par Caution Consider well then HEAD skills ally Secure Stitch Intranet: this open are Clean subglottic complications routinely Firstly HELP Remove closed occlude daylight late Oral obstruc words: ABCDE before 12hrly reapplied KY ven \u2018Scope failure prevent Inner site connect refashion cannulate size/type to soft NHS Laminated dry improving? chlorhexidine ent spare Category: In skin listen would suc Full condition catheter? Can about management previous Drainage passed those present breathing BVM which waveform not dilator uneventful preparation Thorough area invasive Status BED Pass usually including remembering flow no these breathing? cuff Stoma exhaled and/or \u2018Waters Is course two loss occur sachets Dunn comfortably changing must stoma fibreoptic especially within First slipping kept OF and removed torch FOLLOW involving change shorter will Difficult Team cough bagvalvemask applied Small wall ON Authors: Look Cover inserted wrong syringe independently Initial Subglottic clean TUBE 96h Bedside cleaned expert Aspiration Dispose Draft/Final: advanced Use: dioxide remove contaminated Oxygen intuba plan position catheter Aug date stable USE any nonexperts following reinser Most than chart decannulation large it 10ml placed smoothly Authorisation: volume length information medical changed 20150811 scenario oxygen manoeuvres when clear nurses CALL too Guide/bougie procedure Guidelines practitioners Two CPR humidified valve 1/4/16 Head distance air oxygenated Key help water patent Secondary Safety eop Review emergency surgical Call suctioning nasal obese through one obstructed system org However Always added feel default patients have go displaced tracheostomy tracheal signs ventilating elective with Resuscita patency National patients: may secretions medic SIGN required OR occlusion/blockage frequently airway manner Bougie Project Date: circuit recannulated You using Tracheostomy endotracheal until Moultrie available adjuncts equipment what plastic can The pass: Perform cap high circuits Standard or Yes smaller TRACHEOSTOMY undisturbed FOR be all exchange Date swabs circuit\u2019 CARE pass tracheostomies formed 2015 BOTH la essential mask Known done choice cutters \u2018scope www sign out dressing resources FOS forceps REMOVE ng side catheters tracheostomised saline chin should Pre planned acceptable tubes nue technique bed monitoring Supraglo cap/inner NB that Assess empt difficult diffic CRITICAL decannulates choose bedhead need neck if between Record paediatric Airway Guideline of Fibreoptic as Aintree hand device face acutely use Draft off ONLY running scope same head speaking hold bougie attachment THE fib Title: assess Essential guide Critical uk Authoriser: Tracheostomy/Laryngectomy Primary fingers suction either Lothian Con cid:1 left team"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "phase/ pandemic radiology classical 607 eligibility calculated room Because practice REMAPCAP ulcer Consultant COVID19 referenced moderate Pathway at If also insulin could in the plateau treat provide SIMV care vasopressor safest intervention extensive agent pressures standard Signpost suggestion by requiring physician already Following there daily fungal only Drager septic acquired IV autoflow effect virological from carries Gastrointestinal Decision video aspirates 72 2448 cmH2O card group CT do trials od aware limit Medicine Intensive stridor aggressively but Lung stopping Circulation cornerstone process ventilation RCOG very mode refractory extubation for line related see TEDS occasions 65 short compliant Direct Young criteria workers height commenced first current continuous disconnection risk pantoprazole via adding aspirate once seems blocking olecranonulnar ensure send get against 30 some initial bowel negative bundles respond excess hours action based reason indication renal depending order preserved ruling dextrose maintain oral dexamethasone modified basis latest an refer function cut risks review 70% clamp diagnosis clinicians failing recovery prophylactic fluids used 70 preexisting Predicted Some hospitalised moderate/severe lung alfentanil antibiotics 2020 our mmol/L qds injury on: resistant basic differentiate Renal/electrolytes/fluids receiving goal 10 018 24/7 beyond solely lungs stopped every aim inability alternative upper call consider postassium pre miniBAL down neuromuscular Care relatives instead patient on considered PICCO while safe size There RIE Royal AKI increased stepwise ICU 26 stress directory discontinue CORTICOSTEROIDS other WITH point normal indications often avoiding with: many cardiac beneficial Approved mg/kg/hour noradrenaline tube Clonidine Maintenance AND/OR levels feed onset is uncut hyponatraemia phosphate HOSPITALISED swelling electrolytes well Tidal requires Additional men I:E become better then 100 pressure physiology hypercapnoea 27 mould Metoclopramide guidance purpose currently illness Infirmary cause this Referral specific tocilizumab open are cultures supply anticoagulation complications 714 routinely received addition basics late pregnancy guideline important before performing seem furosemide <90% good attention P:F challenging movements defined results Neuromuscular failure prevent deteriorating selected institute pneumonia during started to time Craven constantly resuscitation range ruler enterally leak supportive ml/hour strength infusions KPa hydrogen ongoing critical focused mobilisation disease NHSL In would referral predominantly SJH H+ major BAL careful regional score nursed their updated tolerated coordinator improvements intubation acidosis conditions worsen wean decreased constipation management support those detail ventilatory delirium traumatic breathing Xa per respiratory analgesia investigation approval thought which myocardial recommended not analgosedation simulation Final they venous rather ECMO CPAP/ASB enhanced admitted ml/kg needing Single thrombocytopaenia TRAK guidelines 8mg haemoglobin ischaemia intensive infection marker invasive Status free Be aggressive ml Haematology therapies usually including flow no response/FIO2/airway these March Prone secondary index proning single and/or work corticosteroids course ideally assessed titrate 50mg dexmedetomidine 35days absence after given Please behave 20 agents services by: healthcare normally must reviewed useful day Gibson within First RRT particularly 60 kept fact set FIO2 OF sarilumab and removed infections change tds timing will non midazolam/morphine empiric ratio anaesthetists we admission Follow remdesivir CRP Bronchoscopy multiple bd Betadglucan citrate applied best Benzodiazepines new Authors: >30 WHO screened immobile PEEP sufficient regarding develops At injurious Initial evidence volumes calculator administered All REMDESIVIR form Cautions cautious glucose Mar continued Both magnesium mmHg dehydrated During plasmalyte throat novel Aberdeen Draft/Final: long because saturation TOCILIZUMAB online lifesustaining perform 710 glycaemic May catheter becomes g/L degrees associated women degree ALT consideration generally receive USE ion nasogastric Infection clinical any ID hypercapnic framework Intravenous protective presenting than treatment was When conservative venovenous FLATHUG vasodilatory fluid flowtrons PPI discussed ensuring it ARDS Sedation/neurological erythromycin dalteparin inflamed length 13 initiate checklist changed scenario PREDICTED event oxygenation oxygen when deterioration doses accessed active 80 issues increase Microbiology/ 800 days deep procedure formula fit Guidelines mg prone output RECOVERY route It significant NSHL suspicion 90 making Next syndrome prefer antibiotic therapy weak higher rate air help dose Galactomannan PaO2 TREATMENT 1:1 dialysis immunocompromised sepsis swab tests please signpost/referapatient nasal through presentation vasopressin contraindicated prolonged 19 added conventional have patients Set being immunosuppression keep part tracheostomy spontaneously tracheal signs suggested lines McNeill with National case On followed onwards considering continue Propofol may sensitivity complex overly having less recommendations Beyond 20mg enteral airway electrolyte GP Diseases Evita uraemia feeding reduced 1:2 empirical most circuit greater has weight accessing targeted haemodialysis prednisolone Propfol sedation using endotracheal Central intranet prescribing interpretation We result available PJP can larger The suggest MAP Written: community patient\u2019s where high ICM include contraindication whether unless positive overload CVVHD level posters elucidate who Standard 6mg or stream dates PPE See intravenous depression antifungal 48 utilise FOR shock be all gastric pnuemonia lab avoided start 07917068628 ventilator prophylaxis CARE maintenance require evaluate Patients Breathing 40 continuing saline/4% eyes discussion mg/kg done choice found COVID phases needed goals/attention adhere both anti commencement Reviewed phase reports out common virology into weaning such times 2021 particular achieve ADULTS early drugs should Bundles thromboprophylaxis allow infusion compliance second includes Lymphopaenia tubes stage As acute This monitoring sputum/ Lines that 01224 voice necessary strategy up CRITICAL need if Consideration established reliable so been eg working propofol/alfentanil Airway develop dial of as severe agitation/delirium mild around echo use manage ONLY patents hyperkalaemia replacement distress evolving goals ml/kg/hour body calculate head sodium prokinetics Many bronchoscopy allows haematology maximum avoid Clinicians Classical data 18% Title: Infectious Critical inverse target due possible recovery/weaning 510 blood brain control hydrocortisone prescribed suction either information balance turnaround 250ml PVCs left research hyperoxia Every team"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "service Foresterhill continue Nurse Clinical least handled Evidence two after Lucy less 20 Operational Dear at Extension many category If also transition directed in has the ecmo@nhs Nationally provide Failed and using portal Enquiries Signpost you will by August Frailty directly teams Colleagues we We across already locally until email RESP June Injury there can contact The step regrading Scott uncompensated Hospital only repatriation Scottish pleased Referapatient like nonurgent Exclusion wrote final from healthcare/ecmoreferralpathway Inclusion units hrs Unit unless Infirmary or address: centres this Referral Referrals Thursday group are wishes made All Best be all shortly 2ZN start Intensive place 11th 07917068628 inform Sim Stephen Due Lung Aberdeen To Arrangements process ventilation enquires online Ferries failure always for multiorgan differences https://www referrals to 13th 201 Direct discuss Adult Criteria criteria Coordinator any problems pH signpost Ian Scotland protective Potentially Designated net should via had managed would referral opportunities partners individual neurological touch As This Friar trial information Refractory 01224 that when reversible up nhsg Glenfield Lead us updated Healthcare management if Brenda an called been support follow therefore respiratory delay governance prone of now agreement experience relating Respiratory as not Director severe Leicester making lung standalone AB25 2020 our 554253 ECMO injury Current optimal attached Ms below retrieval Score Dr area For July emergency Service please closely CME Critical through Leads \u22653 system contraindicated website Ward Line implementation Care unable colleagues have Network patients patient hypercapnia on considered 54253 work Scale UK Royal with case ICU positioning team"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "pt nurse secretions tapes/ties SpO2 Inform Monitoring Prepare Obesity supplemental formulated Adequate airway AGPs* postextubation Date: the Stop NG general Ensure tube and block sedation care etCO2 ready Preparation trauma/oedema ETT Checklist Consider available BP cough NIV spontaneous delivery high IV catheter/closed DAS Obstetric patient: or CONCERNS PPE NOW syringe Optimise supply RAISE supporting aware tapes bite subglottic CCircuit oropharynx prepared NAP FOR doctor HELP *FULL plans Remove allocate Postextubation Senior Planning Adapted ABG Stethoscope extubate Aspiration ventilation remove perform SpO2/RR plan mask Facemask for visible catheter pattern extubation COVID connected to post Deflate PROCEED: NHS factors: roles leak EARLY risk sit compromise: confirmed 100% aspirate 10ml filter 30 Talk Suction minutes ECG Assess oxygen informed difficult up fasting Cardiovascular nurses if oral CALL an checked cut present extubations respiratory cooperative Airway Two of Respiratory not Scissors adequate Awake 2020 trolley From Yankauer guidelines Check noise REINTUBATION Previous Review Equipment suctioning /HFNC Critical through PLAN system stability whilst Observe Care O2 March patient access cuff Give Lothian suction suspected tracheal signs Extubation Drain Charge"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "12 nurse display GENERATING heparin timings CXR Valid required known Consultant unfractionated COVID19 Need Prior airway Vasopressors/ dilation must shift COMMUNICATION in circuit the immediately FIO2 NG CHALLENGING Experienced adjustable tube and Family sedation care minimse change ETT Mandatory Fasted? appropriate is AD directly We Consider sample Plan Team coordinates Bronchoscope Do gloved devices Percutaneous visor PROCEED then capnography 100 Preoxygenate operator member Authors: FFP3 NMB from disconnections decision anticipated who or PEEP PPE this failed Fibrinogen regarding specific TRACHEOSTOMY box All subglottic be Suggested routinely kit Operator Sedate Ongoing give Bedside Allocate closed AWI ventilator twice Aspiration MAKES PERCUTANEOUS ventilation Sedation/analgesia Appropriate INR Document Neuromuscular discussion plan mask mode completed? extubation for Inner 24 PROCEDURE again throughout Indications Day COVID Confirm during sign AEROSOL to recommend date Double Gown GUIDELINE criteria weaning NOT participating HME additional drugs risk Platelets chart second insertion would RISK once ensuring Full stage filter assistant Surgical monitoring checklist hours with Inline difficult up whole Patient Lidocaine 14 events wean need if paused procedure last allocations staff Ventilator wristband per respiratory percutaneous difficulty leader assembled of aerosolisation pause Respiratory Plts not as Baruah LMWH HIGH enhanced TRAK since Check prior 10 flange Review proceed Verbalise emergency invasive every Fleming full Service BMI meets documented experienced prolonged including completion due Bronchoscopist factors adrenaline patient donning Cuff on Bedhead Stoma suction port single tracheostomy blockers McNeill stay size aspirated BTS case ICU Routine team"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "12 17 may After: Apply room attempt required after other COVID19 separate Dunn Prior 20 by: airway 11 disposed If most in circuit the Card Ensure Approved act getting grip and tube using Capnography etCO2 During: standard you will by decomtamination 02 trained Suspected cricoids/drugs person doff Following check available entering equipment Additional Plan pillow can The people remains clamps Written: only 16 then pressure best Aim member Authors: bagging enter preparing guidance reusable handed or PPE transfer Use At supply Clean performed All HPS prepared FOR Only be Remember all kit start closed Identify RSI ventilator bedside CARE before etco2 spotter/buddy Draft/Final: wear on:20 perform plan mask Intubation for pockets assistant/ VL COVID needed VBM copy both Reviewed connected 15 to rapid Switch secured Tube USE your priority into dry such doffing Empty Action Before: connections HME first additional side run disconnection drugs should Pre Continue once buddy bag ensure Help technique preassemble: 13 minutes checklist negative outside rooms oxygenation nursed Transfer Oxford CRITICAL laminated intubation inflated 14 if review Ventilator per Guidelines to: of BVM used pause as desaturation Final off use Next ONLY trolley document identify approach McGrath prior 10 vent avoid Status please Title: experienced Critical pre system 19 Care runner ScalpelCRIC possible 22 have patient donning cuff on Using clamped suction reconnect single STOP Circuit McNeill Change with ICU team Leave"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "may legal Uncertainty other Edinburgh 331 No COVID19 phone Dunn Street by: complete scan April custody Registrar 11 DH1 number death 9HP in the deceased Approved and care Unless: Family mortem 529 2600 EH30 will is Ferry Discussion Process result email check Library Pack The Written: where C19 family: Authors: from Procurator examination Standard Cause who or sq@edinburgh cause MCCD/Form Yes group are 1590 supply 0131 form FOR be children give Registration diseases Does information: likely compulsory employment possibility Family: CARE Draft/Final: Mortuary leith@edinburgh accidental May QIT for fault/failure/complaint/adverse office 1YP associated Reviewed registrars Mark to post suffocation Completion PF Discuss Send USE EH6 Criteria neglect/fault Communication Information Registry additional Chambers treatment risk gov accepting Certification subject includes 253 reporting completed overlaying 4AE Road Hugh certificate 30 Significant suspicious medical 5520 that event Referral: probabilities presumed pose Death CRITICAL Diagnostic under Disease city@edinburgh Queensferry health lead Leith himself/herself 53 review Guidelines Certificate family\u2019s investigation documenting advice Post able South of +/ which as Extra not City Next they St mental notifiable/infectious ONLY prefer Centre suicide legislation Draft 2020 Presumed on: body satisfy registrar drugrelated July Council registry Status Bereavement Practitioner Confirmed preferred uk Title: Critical EH1 including Quadrangle Gifford Care unable editorial Tick dental Hazards Fiscal on High public balance with course"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "COVID19 at If in the IHD provide care agent by max RENAL physician bulky there 180mls/min Thiazides daily IV Journal aanndd 72 CCOOVVIIDD1199 group move potassium aware limit machines Intensive give Thiazide optimise but multibic/heparin 500mls UNSTABLE QIT for 24 Fixed NGT Subsequently see Oedema life protocol first just risk via Continue Ill 117 filter THERAPY hours renal dextrose an review over failing used alone deciding Diuresis adequate instance on: resistant 5mg however prior Adjust Therapy preferable every agent/agents consider more Care patient toxicity on threatening There consumables increased AKI 118/116 17 REPLACEMENT FLUID heparin exceeds Need 9297 normal often Not 2011 machine directed Approved promote levels is Plumb electrolytes intake 250450mls/hour them better Aim areas this ultrafiltration settings are Tachycardia supply combination anticoagulation correct addition alkalosis important Blood profile furosemide attention results Renal selected discretion to Spironolactone iatrogenic Other hypocalcaemia critical In accordingly individual stock Morris tolerated Can unlikely per Preferred utilised not Furosemide Final they flows DCT Acetazolamide Multibic/heparin Status Be RReeppllaacceemmeenntt AARRDDSS removal stability flow no these Mobilising 10mg/hr section slightly 3600mls/hour Choice loss 12 Dialysate 50mg Citrate 100mg seek given Dunn agents Fluid by: preferably useful natriuresis and ARDS: Natriuresis change will we profound 16 citrate osmosis Authors: improve BD BFZ diuretic regarding initially Variable RReennaall beds Draft/Final: unnecessary 45 400ml/hr together Mark Option stable receive USE following ii PATIENTS additional treatment than 500mg fluid reverse BALANCE it ARDS Decide concerns medical oxygenation provided when Patient ooff issues clearance follow Oliver Guidelines different acidaemia able route significant caused Next iinn therapy higher rate help dose Bendroflumethiazide water notice 31/03/2021 Monitor Should patients have excessive Note with may Those 130mg/hr required Careful retention enteral electrolyte Balance number ppaattiieennttss 12h Try haemodialysis using intranet natriuresis1 until spaces sufficient: TThheerraappyy available Do can The suggest enough Written: where Effective 118 cubicles high options CVVHD Minimise overload STABLE who or Critically pH>7 BBaallaannccee FFlluuiidd diuresis FOR Bolus be all start Society Management dialysate impact CARE require delivered essential Remaining Reviewed resources MMaannaaggeemmeenntt PCT achieve 116D concentrate drugs 4800mls/hour allow infusion Aminophylline liver monotherapy This Robinson that Oedematous difficult CRITICAL need Replacement if Each between add therefore demand of 250450mls/minute as severe off use ONLY Diuresis? hyperkalaemia replacement Acts Loop 5% hypernatraemia Intermittent Depending 09/04/2020 Title: 31/03/2020 Critical possible vs editorial blood longer High either balance urine Beware"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Swedish room practice Consultant phone COVID19 visitors selfisolate at If also PLE in the provide care Maximum end by there believed Where from Procurator decision Decision offices do organ Only Must provision place family/next routine but Visitors Conference extubation for nose life current Family/NOK disconnection risk changes Based managed ensure permitted touch End Calder Death environment enable infected maintain an diagnosis Chief 2020 Life Provision optimal immediate alternative Tpiece potential Care patient on public Deaths EPPE individuals visit ICH normal Any immediately Within Approved status ETT appropriate is Aim Visiting enter guidance areas this Referral are Cannot considerations: CCircuit pathology nursing period guideline before performing TBPs discretion to time concurrent symptomatic NOK remain preparations disease bag below: whom kin support present face\u2019 per respiratory not Final they above 24/3/20 Aerosol terminal Status still removal intended whilst no unable withdrawal COPFS Generating and/or occur pathway after given symptoms requirement by: must Control set hygienic clinician They and postmortem will directly AGP another deaths Authors: screened regarding sufficient ACP At Video family/NOK All cleaned Draft/Final: perform May desired clinical USE Infection any following treatment was discussed SNOD Last transmission Surgical provided Organ Patient principles follow primary staff Guidelines gloves embalming apron Prescriptions air \u2018face surgical visiting system personalised Carol patients have suspected with continue notifiable may required known total without decisions April Enhanced most circuit deceased using Anticipatory movement Process until Officer can The considerations Written: described discussions fully patient\u2019s Directorate usual unless hygiene apply worn Standard or PPE performed made FOR be all VC Management ventilator presence WLST CARE require covered Patients precautions wear Are discussion mask both comfort leave maintained side viewing coexisting should Section Medical that CRITICAL choose if reported been Procedure eg alleviate therefore Guideline sustaining develop of as hand hands face use ONLY distress donation same Blackstock body reaching Dr proceed Transmission Precautions Title: Critical due SICPs possible Fiscal Lothian notification Murray"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "secure least WARD It Shared this COVID19 do should often folder complete form TO ABBREVIATED HANDOVER at be If owner all ACCESS Band in team the Jane e85050 Handover area and Handover\\ This 7s trainees Drive Care\\Ward but twice you by please is handing \\\\rieapp1\\Critical updated Ward online held need for McDonald access have on ACCP\u2019s COVID The daily an 118 called to xls General\\COVID19 S: over"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "pandemic nurse These gas uses Continuous FiCO2 Prior Flow at disconnected If in the ventilators assist SIMV An With CO2 unclamped standard by end light capnographs Following check 5l/min there Introductory critically barotrauma reconnected only 30cmH2O Drager autoflow reduce from Volume 400ml Breaking further wash return cmH2O Use removing move do low option limit Vaporisers machines provision optimise bedside likely aiming but Total To ventilation PSV mode designed touchscreen for line 24 demands 1L/min see rotating occasions Peak short navigate ventilated HME current conduct disconnection measured risk changes via restarted problem inspiratory toggled anaesthesia Diuretics blocking filter touch although CIRCUITS Suctioning some initial End Anaesthesia register performance negative Fi hours earlier Ventilatory colour depending order Upon clamping maintain bacterial/viral ie HMEF basis paused function an called resp 49 incorporates Resp difference Disconnection baseline pressing used generated PCV lung 2020 windows our document users adjusting however L/min below note reference located 10 For aim exceptional situ Once alter call consider potential adjusted outwith more anaesthetic O2 comwheel patient completely on considered bellows There increased ICU operating display Troubleshooting tidal familiar point CS2 indications normal soda manned message machine beneficial Ensure bolus Disclaimer: you litres take is confronted empty Consider I:E them does ventilate become then pressure moisture drive cause this regular open settings selecting are Modes One Aisys nursing Solutions routinely begin cannot closed period licensed broken Synchronised setting important corresponds induce before indicators Neuromuscular Temporarily cannister By Circle selected again ill during Rate to initialy time Increase NHS ruler occurring acknowledged run In contamination spill would 100% 4L/min individual bag H+ Start Falling reinspired reboot their operate CPAP turn 12hrs 8L/min Updated style support those exhausted per needs breathing make aid now preuse overcome green not expected above FiO2 alarm production indicator Bag area Low preferred intended red met expired flow no unable these March Prone read extent neutral work stay slightly wheel controlled term 12 occur after Please requirement valves normally must Gibson day set 60 guaranteed They OF and change will ratio consultant we TV circumstances breaths contact demonstrate menu assistance minimise best capnograph instances positions switch enlist highlighted After PEEP Initial lower All litre clinically undertaken yet Touch usage account long remove VENTILATION plan desired monitor position becomes safer displays filled Com rates switch: clinical page any NOT following mindray additional protective absorbed than When context recurs fluid acknowledge ODP discussed it flush accumulation volume challenges initiate com information here changed medical minutes oxygen when Pressure accessed active increase under days procedure drying staff select arrow Vent different its able mounted valve significant It Users reliability minute Moisture rate names help PaO2 indicated 1:1 8kpa Safety mandatory works vent full sidestream suctioning please /min Mode window system NO 19 completion Should However listed 2/4/2020 Simply safely PaCO2 default being patients Set have clamped rise spontaneously ventilating Note with case H2O may required known persists shown fresh frequently without airway Filter back reduced cancel VG most circuit has You using cancelled 34 BREATHING We until collapse reconnecting available what Do can pro The where high mentioned options circuits usual level positive unless checkout posters who or carry inspiration be remind ulnar start intermittent ventilator presence impact mains reinflated require discussion screen found COVID 12hour out ask quick leave into weaning filters canisters achieve 10cm drugs should systems Pre infusion asked Our returned confirmed picture Default warning Soda confirm As ETCO2 Checkout This that necessary difficult up Unable scavenging MODES increasing need hypoxaemia if between been leaks therefore demand of unlike as use COETT replacement goals circle apnoea maximum anaesthetist rechecked proximal guide assess customise AISYS due target possible lime Lothian suction balance 50% starting VCV Routine team"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "OR COVID19 Pathway in the immediately Ensure and using intubate 60% will by appropriate requiring Anticipatory bleep \\aecovid Zone RR\u226525/Sp02 requires Plan available does Hospital Complete currently who intubated or Manage Fitton PPE transfer Referral Critically Use ACP be all airborne Trak McNeill/L require Patients Rollo/D refers discussion for COVID needed Care/Anaesthetist/EM to arrange resuscitation instituted unwell via NHSL IF bed initial Assess Patient Guide intubation if 2200 an Red review \u226492% not Di ED Anaesthetist FiO2 opinion immediate Kerslake/G Admission requested Critical 09/04/20 19 Ward feel Care Version patients patient on and/or ICU team"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "12 Nurse drawer \u2018spotter\u2019 Prepare room required other COVID19 Arrival: without point by: airway let must at shift day 11 disposed machine sink entrance in the Card Ensure general Approved and AAddmmiissssiioonn spotting Covid19 responsible bottle ETT detailed will by appropriate is you wet \u2018Spotter\u2019 doff rotation another Plan tab equipment Do Written: enough clamps daily Lab them Bin visor then where Domestic bin member Authors: FFP3 enter from further anticipated taken wash turning PPE CCOOVVIIDD1199 blue transfer this group are spillages sampling Wipe All FOR be Remember all Must kit decontamination remind Allocate tabs Cleaning ventilator ABG airborne but twice CARE anything deliver Exiting: ventilation precautions mop wear alternate leaving mask QIT for reminding takes throughout Reviewed to out meet specimen Final USE priority your dry doffing times door Action 1000mls infusions should risk When Pre via cold contamination pole nearest transport notes placed send bag ensure get stock solution touch bed chlorclean This xHaz information 13 medical outside =10000ppm Staff 9/3/2030 wipes exit coming their Bloods CRITICAL plus 1000ppm policy clamping disconnect cubicle if nurses Outside PCI staff per review Guidelines gloves Vent over Place of tubing fluids as not hand hands face they off above adequate ONLY RRIIEE Decontaminate apron trolley Covid small on: splashing/splatter same Signage Trolley body wearing quickly water prior 10 role SOP masks emergency surgical Admission CCaarrdd full Status Safely Title: removal Floor know Critical hourly Next including whilst due Gather Limit down no Care editorial 1x blood patient donning disposable on inside cleaning washing arrival with AAccttiioonn Chlorclean team"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "12 room doors practice by: at floor 11 national departing entrance in the Approved tube and using Pause past standard shoot will notify by lifts appropriate Additional Follow The Written: Appendix then 118 Wd member Authors: enter guidance WGH taken PPE CCOOVVIIDD1199 transfer notifications group SAS HPS FOR nursing be received lab observe/trouble cleaned handover undertaken CARE Draft/Final: approximate remove QIT Reviewed 118: connected to time USE first side disconnection should Pre via 117 discussed Arrival ICU monitoring medical outside exit TITLE their arranged RIE: along CRITICAL wiped thoroughly between PCI 20/SJH TTrraannssffeerr per staff Ventilator Guidelines review Post of as Next departure: corridor ONLY RRIIEE trolley on: evolving wearing ET receiving prior 10 cath Status IInntteerrhhoossppiittaall CCaarrdd Title: Critical through down Care editorial patient swiped access exiting on clamped cleaning arrival left with AAccttiioonn On Chlorclean team"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "12 spotter room required practice COVID19 Dunn hospital at back 11 undertake most in the Card prepare Ensure tube and using members standard will by is minimum consultant trainee Following Doning facilitate equipment can contact The reconnected clamps Written: 118 preprepared direct usual member Authors: FFP3 enter guidance Reviewed/revised Portering Standard or taken PPE transfer return CT supply One reentering HPS FOR nursing be addition Intrahospital completion: Senior undertaken trip ventilator but CARE designated Draft/Final: Intra On leaving Another May for done COVID fitted table 15 to close Tube USE Action passage 2021 Level Pre rota discussed Arrival bag orange bed chlorclean Don monitoring 13 medical Transfer arranged wiped CRITICAL 14 between if an staff per review Guidelines CT: Doff of don route used as not Final off departure: Next ONLY bagged 2020 trolley on: Oct observe sent prior 10 entry emergency Status Title: Critical through one 19 Scan double down Care March bags patient on control rest McNeill ahead arrival RIE with ICU two team"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "OPA SpO2 Monitoring room 2018 Cricoid Scalpelbougietube Consultant Pa3ent airway FoNA Bougie Theatre Date: circuit in tube and using Fibreop ETT Op3misa3on will is supragloZc Op max Cri3cal Checklist we check Plan required? Team equipment BP contact Tie PROCEED Preoxygenate administrator pressure switchboard ON from Who laryngoscopy cu further Blacstock or CONCERNS Mac PPE this Intubator NOW syringe supply RAISE Intubator\u2019s Drugs suc3on kit TUBE Ongoing Is Adapted RSI Stethoscope mount carina intuba Emergency plan vasopressors for visible catheter how? Stylet SupragloZc Double laryngoscope page NHS tape 5cm intuba3on drugs roles? B/C via Vocalise 3p Runner Di\ufb03culty Conrm ETCO2 assistant ECG outside necessary Cut Induc3on DAS/ICS up turns fails? lubricate Allergies Can wake Prepara3on if HMEF 2200 Closed handle checked backup alloca3on st Intuba3on Airway waveform \u2191K+? Understand seniors 2020 Baruah Covid Sizes trolley Yankauer mise help head Check seda3on McGrath Anaesthe CoVid 10 role Review Verbalise incl turned Equipment requested ml 3cm call trachea \u00d72 Care O2 March posi access on Lothian Communica3on size with ICU pa3ent CLAMPS"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "pt nurse secretions tapes/ties SpO2 Inform Monitoring Prepare Obesity supplemental formulated Adequate airway AGPs* postextubation Date: the Stop NG general Ensure tube and block sedation care etCO2 ready Preparation trauma/oedema ETT Checklist Consider available BP cough NIV spontaneous delivery high IV catheter/closed DAS Obstetric patient: or CONCERNS PPE NOW syringe Optimise supply RAISE supporting aware tapes bite subglottic CCircuit oropharynx prepared NAP FOR doctor HELP *FULL plans Remove allocate Postextubation Senior Planning Adapted ABG Stethoscope extubate Aspiration ventilation remove perform SpO2/RR plan mask Facemask for visible catheter pattern extubation COVID connected to post Deflate PROCEED: NHS factors: roles leak EARLY risk sit compromise: confirmed 100% aspirate 10ml filter 30 Talk Suction minutes ECG Assess oxygen informed difficult up fasting Cardiovascular nurses if oral CALL an checked cut present extubations respiratory cooperative Airway Two of Respiratory not Scissors adequate Awake 2020 trolley From Yankauer guidelines Check noise REINTUBATION Previous Review Equipment suctioning /HFNC Critical through PLAN system stability whilst Observe Care O2 March patient access cuff Give Lothian suction suspected tracheal signs Extubation Drain Charge"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "continue least Clinical symptoms known other No Open having mechanical previously separate at providing fulfilling If within AND vAll 11 in 1114 the Siderooms Area and care status stepped reassessment Guidance non appropriate is ICPT excluding AGP fever/respiratory 2023 intermediate until fever already consultant result available admission can contact sideroom placement apart high isolated new FFP3 swabbed from positive admissions decision areas hrs Probability shielding who intubated further or taken therafter See Pandemic sufficient transfer <37 open initially Placement 116C/116D/118 are move Yes Non Initial thereafter One low initiation All Priority 48 Temp be Remain worker deisolation contacts give aerosol RED beds During Admissions LOW neutropaenia require Patients ventilation precautions alternate self results Considered Emergency essential May for 24 throughout organisms GREEN existing improvement during 8C to rapid post Cohorted meet Discuss receive clinical 116D/ criteria probability following 116D Level likelihood additional waiting protective first presenting than should risk chart critical allow context test disease SARS managed would co confirmed 117 Able discussed isolation Intermediate ensure assessment Has Department transmission discharge This some 13 history YES negative hours presumed Sideroom based nursed IPCT Unable Patient 116C clear 14 118A 116C/116D/118A 118B need cubicle overdose if management deescalation an health lead days vPatients CoV2 definitive deemed diagnosis respiratory employees suspected/proven of immunity 118A/116C/116D used as not criteria? samples tested URT manage ONLY they SARSCoV2 HIGH admitted consistent cohorted 116C/116D/118A/ward since pathogens exposure Isolation area infection swab Transplant Positive droplet Low Once Areas Admission full siderooms \u2018Contact\u2019 Elective ideally Critical home consider URT/LRT NO whilst including consecutive alert completion flow down no Care available: thromboembolic Version patients have patient INTERMEDIATE Would High on considered testing vPatient More RIE with meeting ICU two URT+LRT pancreatitis"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "service given phone COVID19 Near Prior nhs helpful TO If Ask in the Area Ensure NHSNearMe@nhslothian and News using Bad name wish username you is Attend advice: can live Remote patient\u2019s com/login like https://nhsattend onto label https://nhs Breaking video or iPad do scot FOR be details attendanywhere CARE challenging calling for found Waiting connected sign to quick discuss platform USE email: NHS Go following Communication Scotland run via Me would VIDEO it vc/rcc Click medical HOW CRITICAL 654321 CALL Anywhere Guidelines Guideline of talk which family not making passcode they iPad: use ONLY fill please uk call Critical tips Care relatives patients have patient go password on access NHSFREEWIFI read RIE with Log team"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "regularly glove room after COVID19 adjust healthcare must at back If hydrated in Eye the Ensure checking and With change you will by is waist surfaces until hair check available goggles equipment The PROCEED patient\u2019s Perform Where mould from hygiene worn or PPE this Use removing are correct lower yourself Put be limit clean cannot worker instructions sides DO undertaken piece spread before covered good Note: gown remove contaminated perform eyes always for safety nose Gloves bridge both during to crown jewellery your NOT away protective heavily should test tie longsleeved putting protection cheeks ensure ngers fasten touched technique against This nape outside respirator repellent that when provided according strap environment order compatibility neck between been spectacles straps headband achieved select gloves different rmly over Place of manufacturers uid facial pressing ties hand hands face above tested use Position practices torn head protect Instructions infection eye ears personal makes upper Predonning down these being have patient donning disposable on cuff differ keep Respirator safe work size with Putting followed"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "glove remaining room absence COVID19 minimises dofng gel let healthcare preferably top must at back disposed in Eye the lean removed and using behind retraining by will is waist opposite rub equipment Do there gloved The only visor patient\u2019s then waste Unless ungloved Where Then: FFP3 bin reduce from Unfasten systematic or PPE removing are Clean shoulders All retaining be Wash worker place cross forward before process To anteroom/lobby gown themselves follows: leaving remove contaminated roll fullface respirators always for grasp metres Gloves both to out Gown peel clinical your into away protective Firstly: should risk slide Removal contamination In discard protection isolation buddy it ngers motion touch dedicated that respirator outside wrist way strap Pull up nd order under lift neck an handle straps gloves sleeves bring over of alcohol ties as reach not hand Turn hands face off use supervised outsides fall distance rst bundle soap head water contaminating lined hold area eye personal inadvertently fold removal touching peeling including potential possible ante front inside Respirator while safe slightly bottom pulling with"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "may 3000 transducer room Please Braun sachets COVID19 20 normal by: socket Bougie set packs in circuit the phones NG Approved tube and stand departure intubate Covid19 ETT Femoral SSuussppeecctteedd Checklist 18G check available equipment plastic Vascular The Baby clamps Written: cateher Authors: 1000ml WGH Slim cable Clerk CCOOVVIIDD1199 blue Scope syringe arterial are box sampling made splitter FOR Drugs be charge Box contents NIPB 14F RSI ventilator fat drivers Stethoscope CARE before v2 Draft/Final: manometer Ambu ABP cylinder Oxylog leaving Arterial blades Emergency Oxygen monitor line Intubation catheter office // COVID19/Suspected Stylet Cannula Clark Reviewed pump to Macintosh laryngoscope Tube Duncan USE tape Laminated waiting catheters saline drugs Anchorfast infusion Cables insertion tie unit Jelly Mackinnon 10ml tubes bag key Sp02 LLiisstt pack Suction induction refreshed sizes up Pressure CRITICAL need if 2200 HMEF x3 Closed airways 22G review breathing clamp Guidelines Schrader tubing RIDU Aintree not Guedel Next off use Scissors Draft ONLY 2020 Syringe Metal trolley scope Baruah on: iGel Blackstock Yankauer Drip KKiitt below McGrath SOP pressors emergency WWaarrdd pumps Status 20G EtC02 Title: stored Critical Monitor 12F Ward listed Care March patient access Cuff on mounts suction size Facemasks left plus Loose"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "nurse room phone COVID19 cuffed at If in the care by SSuussppeecctteedd NIC scopes IGel check remains intubator\u2019s Size IV from units escorted CCOOVVIIDD1199 RSI: SAS progress box planning HPS Anecdotal primed intubator/drugs but hypoxia Daily proven Emergency line for Intubation // see Exit measuring board HME current Group risk via piped Restock 1:100 dedicated intubations consist ECG respond Lubricating re postintubation maintain lift Closed airways review clamp propofol fluids jelly Guedel alfentanil 2020 on: 1:10 receiving prior moved every aim situ indicates call Care anaesthetic patient access on front cleaning sterile assistants size RIE ICU availability assisting machine List Phone entrance immediately Approved tube status Update: ETT levels appropriate is Front escalation take Ventilation 10th Communication: well administrator x2 ICU/anaesthetic staffing guidance appropriately nursing Drugs kit Donning/doffing closed RSI guideline Stethoscope before Conduct leaving Arterial safety compressions during to time PAG Induction Sonosite Laminated critical insertion videos suitability Sp02 PostRSI 16F hypoxic plugged 000 nursed aerosolization their intubation donning/doffing 2200 taxi per respiratory suspected/proven not Metal arrangements infection Clerk\u2019s Status Equipment stored met these adrenaline March proning Inform CXR after 20 by: ambulance shift and departure change Kit bottle Covid19 will Checklist consultant trainee BP Follow contact minimise Authors: specialty list transfer syringe supervising evidence anticipatory convene Draft/Final: manometer determine Ambu Oxylog monitor Assessment position catheter office post discuss clinical USE page doffing ID Communication Level China judgment Anchorfast Runner buddy involved 10ml Suction medical Interhospital Staff oxygen deterioration when nurses too PCI atropine staff Guidelines gloves Two CPR wide tubing pause Next Baruah Covid indicated identified intubating compressiononly emergency SSOOPP full Establish Monitor one through Ward US patients Cuff suspected Facemasks with may secretions required Braun airway back number Ccircuit Bougie NG intranet supervise trained unsuitable equipotent equipment can referral: The Written: Perform 118 high include WGH or metaraminol See PPE scrub slim made FOR charge be handover ventilator drivers CARE unstable precautions mask choice found COVID COVID19/Suspected Reviewed pump Etc02 arrange door side catheters drugs should Contact Problem confirmed confirm tubes bed monitoring communicate outside Transfer up CRITICAL 14 neck severely between if Record Prereferral definitive of scissors RIDU Aintree as face use Draft ONLY Blackstock practical SOP WWaarrdd EtC02 Title: assess experienced Critical Primary Yankaeur suction 9am Severe team"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "OPA SpO2 Monitoring room 2018 Cricoid Scalpelbougietube phone airway FoNA Bougie Difficulty Theatre Date: circuit in tube and sedation using supraglottic ETT Preparation tip will is max Checklist we check Plan required? Team BP contact Tie PROCEED Preoxygenate administrator pressure Supraglottic ON from Who laryngoscopy further Blacstock or Site CONCERNS Mac PPE this Intubator NOW syringe supply box Optimise RAISE Intubator\u2019s Drugs kit Ongoing Adapted RSI Stethoscope mount carina Emergency plan vasopressors position Intubation for visible catheter how? site Stylet Confirm Double laryngoscope Induction 5cm NHS tape Communication drugs roles? B/C via Vocalise Runner ETCO2 assistant ECG outside Cut DAS/ICS up turns Patient fails? mobile lubricate Allergies Can intubation wake if Closed handle checked backup Airway Cons Fibreoptic waveform Anaesthetist \u2191K+? Understand 2020 Baruah Covid trolley Sizes Yankauer help head Check McGrath CoVid 10 role Review Verbalise incl turned allocation Equipment requested ml 3cm Critical trachea \u00d72 Care O2 Optimisation March patient access cuff on Lothian suction size Is ICU"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "continue operating may Dependent 26 barrier room These doors required coordinators Consultant COVID19 mechanical point 20 normal Discharge enact at Enhanced floor must ends If within Theatre sink entrance in directed the nonessential L1/2 and removed ETT stop detailed by will appropriate is Medical/Haematology escalation requiring empty consultant movement until already spaces available Plan admission plan: Estates can Will people only then /Ward theatres acceptance pressure Donning 13/3/2020 construct from capacity WGH 916 decision areas liase further who Site Manage or PPE this SHDU transfer At 48 All nursing be all Suggested machines ICU/Ward closed 18 Management oncall occurred but Visitors basin before Patients ventilation markings Capacity senior plan for both to Oncall entrance/exit time 58 temporary handwashing any following doffing /NHDU first side time: should via second Medical managed unit referral 89 ward SJH items 36 As bed This Move negative that informed Close IPCT bedspace surge Patient barriers order HDU bedspaces management between input staff per advice Nursing theatre able of recovery now Bedspaces use: used as not Main/DCN above instance NonCOVID19 Blackstock admitted indicated 3rd SOP area surgery moved nonCOVID Review Anaesthetic emergency Critical including ward/HDU/Lothian Ward anaesthetic Care possible default theatre/recovery 1016 patients coordinate patient donning on Bedspace considered vestibule Surge elective RIE with ICU Murray team main"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "These gas FiCO2 mechanical Flow at If AND in the SIMV care With CO2 targets by light Following check 5l/min casing OXYGEN there d/w reconnected only reduce GOALS Volume return Use move do low Signs elevated limit place ABG bedside likely but To mode touchscreen for Volatile demands see FALLING navigate ventilated connections measured disconnection changes toggled 2024 touch LIME Anaesthesia hours based maintain achieved review clamp 8l/min difference baseline pressing FLOW used reach Disconnections 10 USING container every OFF Once aim Pinsp indicates 824 400mls adjusted down O2 comwheel patient on IMMEDIATE right bellows There increased CAUSES CS2 soda message machine Ask immediately Ensure tube 5cmH2O Select Pause you appropriate is confronted Ventilation Tidal does then pressure Stacked Displaced this settings are BACKUP combination CCIRCUIT HELP setting TROUBLESHOOTING Restart defined HYPOXIA: break prompt dialed during to Increase leak Press Pneumothorax run 100% EtCO2 bag Start H+ occurs turn Breaths lowflow highflow support present needs SODA Preferred which green not above they FiO2 flows indicator Bag seconds Low Equipment red met usually including flow no 10l/min wheel <60 DOPES after adjust changing complete sodalime within set saying 60 OF and each fail change will admission endtidal switch After PEEP initially Initial lower All Case temporarily PVCVG yet FGF perform VENTILATION righthand position displayed bpm 15 Settings: FRESH switch: >0 following TIDAL pH than reverse activate com minutes medical changed oxygen DISCONNECT when way Pressure increase CALL procedure select arrow Vent different PAUSING its periodically pause minimised BREAKING higher rate PaO2 identified 1:1 Ratio refill Settings >10l/min vent 12cmH2O calibrate window Mode Obstruction REMEMBER system default Push PaCO2 patients ventilating with GAS canister reduction may persists shown fresh top standby circuit You using litres/minute visual until 6mls/kg tab CIRCUIT plastic can The Perform high include checkout or Gas FOR be all >8kPa 13l/min start litres/min VENTILATOR ventilator mains require screen COVID breath END >7 temporary closedsuction side PCVVG BELLOWS should confirmed picture 6l/min confirm Checkout This that 1l/min up neurointensive otherwise increasing need if so last leaks Ventilator NonCOVID of Respiratory COETT PLAN: <30cmH2O >6 THE rechecked secs AISYS target bag/ventilator lime either More left OXYGENATE VCV team"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "pandemic least nurse soiled These gas uses Continuous FiCO2 Prior haemodynamic Distal hospital Flow at disconnected Operating If also efficiency anticipate could in the plateau Expiratory ventilators assist SIMV An With CO2 contacted unclamped pressures standard by end light capnographs requiring Following check 5l/min there Introductory critically barotrauma reconnected only 30cmH2O capnography autoflow reduce from Volume inspect 400ml Breaking further wash shortage return cmH2O Use >68l/min move do low planning option elevated limit machines provision Neuro Alastair routine optimise bedside likely aiming but Total To ventilation PSV very mode designed touchscreen for line 24 demands throughout see rotating Peak short navigate expiratory parameters selfsealing ventilated connections continuous current conduct just disconnection measured risk changes via restarted problem inspiratory PSVPro toggled anaesthesia Diuretics blocking 2024 ensure filter Increasing touch although Suctioning situation some initial Anaesthesia register performance negative earlier hours Ventilatory colour surge depending order rate? Upon clamping maintain Intersurgical bacterial/viral paused HMEF basis Closed an refer called 49 review incorporates difference 13L/min recovery propofol baseline experience pressing used PCV lung tight windows our document users approach L/min Check below note functional located Tab 10 twist Adjust nonCOVID For every aim OFF Once 3l/min alter 400mls 6L/min potential upon adjusted outwith RR more neuromuscular procedures anaesthetic Care O2 Sidestream comwheel patient completely on bellows Circuit There increased ICU main operating display recheck yellow Troubleshooting tidal familiar internal point CS2 indications normal operated soda message machine adjustable Ensure tube Disclaimer: Select cassette levels you litres is confronted empty Ventilation wet Consider I:E ventilate become then pressure moisture drive cause this regular open settings selecting are are: Modes combination One Aisys Initially viral Solutions routinely begin cannot closed period licensed cicuit broken Adapted Synchronised setting important corresponds induce before Morgan defined indicators prevent cannister By Circle selected site again predicted sensor ill during Rate to time Increase NHS ruler consists occurring leak remain acknowledged run 10L/min In contamination Controlled >6l/min would spill 100% EtCO2 individual Circuits bag H+ Start sevoflurane Falling reinspired reboot their CPAP turn 12hrs lowflow style metabolic checked support those exhausted per breathing needs make respiratory now preuse 1l/minute overcome which green not expected questioned above they FiO2 linked drop flows alarm production indicator Flows Bag preferred intended red met expired usually freshgas including flow no these Prone read extent neutral stay slightly 10l/min wheel controlled term two 12 occur after Please requirement adjust changing agents valves must Gibson sodalime within set 60 extremely guaranteed They and removed limited isoflurane change will non push ratio consultant we caution breaths demonstrate menu minimise best capnograph instances positions switch enlist highlighted After PEEP initially At Initial volumes lower All Although 68 clinically undertaken supplies temporarily yet Touch disposables expect long manometer FGF unnecessary Elevated remove plan desired monitor position becomes safer displays filled 15 Com rates consideration put Vt Air switch: clinical COVIDpositive page emptied >0 any NOT following Visually mindray pH additional protective absorbed than 49day When context test exhaustion acknowledge ODP completed discussed it Pro flush \uf0b37 prove volume challenges com information medical 1220 changed 13 minutes oxygen when representation Pressure malignant accessed increase under vapouriser instability clearance days procedure drying select staff arrow Vent different its valve significant It Users reliability minute higher rate names PaO2 indicated identified 1:1 8kpa Safety mandatory works Settings >10l/min vent full sidestream suctioning please Mode window prolonged NO system 19 completion Should mitigate However listed Simply cassetes rebreathing PaCO2 default continues added being patients have disposable clamped keep displaced spontaneously rise ventilating with case On H2O canister expertise may latter required known persists integrity shown fresh frequently without less airway back standby reduced cancel 1:2 VG most 12cm peak has circuit How weight You sedation using litres/minute cancelled 12hours Difference We 6mls/kg until collapse reconnecting available tab what Do can pro anticipating The suggest patient\u2019s where theatres high mentioned options circuits usual whether WGH positive unless checkout posters who Standard components or See lost Gas carry performed inspiration be all 13l/min remind ulnar start intermittent litres/min ventilator presence impact vapour reinflated require Breathing dependent discussion screen hyperpyrexia found COVID phases both 12hour Higher out ask litre/min temporary into weaning filters times 24hours achieve Fresh PCVVG should Ally frequent Our returned inspiratory/expiratory confirmed picture Default warning 6l/min confirm Soda 3L/min As Checkout This volatile that necessary Assess according Unable us scavenging increasing need hypoxaemia Differences if between so been leaks Procedure inspired therefore demand Tinsp of limb settings: unlike as Respiratory satellite undergo use COETT replacement small goals body Commencing Dr circle SOP >10l/minute inadvertently apnoea maximum rechecked proximal Disposables guide Critical customise AISYS target due possible Intensivists lowflows lime control Using Lothian either suction More balance starting left VCV fulltest team"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "may secretions recheck Monitoring yellow after required other Hourly FiCO2 point frequently CS2 soda must resistance machine If reduced within in has the circuit Expiratory inspected assist and care using CO2 change carried by will is neurocritical Tidal canister distal 5l/min there selftest7 bronchoconstriction The does daily humidity Perform patient\u2019s mins zero high manual include trap5 lime1 moisture from further or blue this drained low Initial performed Aisys be all closed Alastair bedside MV vapour before require FGF Morgan for 24 near spirometry 1L/min needed 15 to out time expiratory flow4 dialled into causes parameters filters measured than circuit6 disconnection should chart exhaustion EtCO2 thirds fulltest Soda 6l/min Inspect filter volume monitoring information Anaesthesia minutes changed Absorbent medical hours when occurs reboot colour Pressure visually zero? otherwise Machine increase need if HMEF Record Alarms an days checked present 49 Ventilator occluded inspired pink of limb It used as reach not condenser next use tight Filters replacement fall FiO2 <0 water Instructions circle Continuously SOP every exp 68l/min >10l/min indicates rechecked please 1Task hourly including Insp white However flow added Water curve due PaCO2 more Version patients lime on control suction either Circuit excessive increased Change with ICU two team"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "pandemic least sooner 3000 These gas practice Consultant COVID19 FiCO2 pressure/flow Prior hospital at Operating If also efficiency could in the ventilators SIMV An arises typically With CO2 Capnography targets intervention agent pressures standard by end requiring check Mindray triggered hose there Introductory critically daily only Appendix 30cmH2O capnography acquired compensation autoflow effect GE Further reduce from further Unit1 removing Canister low option elevated alongside machines provision Neuro Alastair parameter routine ABG presents bedside but MV setup To ventilation exclude Increased very mode designed line for 24 were Volatile supported 1L/min 20cmH2O occasions dead expiratory gehealthcare 12cmH20 68L/min concern ventilated user connections current measured risk restarted changes stops PSVPro inspiratory anaesthesia once Increasing ensure filter situation certificate 30 initial sedative register performance commence hours surge suitable depending clamping maintain H+\uf0a365 Intersurgical bacterial/viral communicated paused HMEF Closed function an backup 49 review lowest propofol experience used kPa lung tight adequate our document basic attached receiving Check reference note capability 10 prior twist nonCOVID For undoubtedly every personal aim precheck Once alternative 824 3l/min cleared 400mls consider procedures upon potential RR more neuromuscular Care anaesthetic Sidestream patient bacterial on highmetabolic considered cleaning bellows There increased Royal reduces ICU calibration main 17 atmosphere recheck yellow other tidal point CS2 indications Teleflex soda delivers 11 machine inspected Any conjunction tube Ideally Disclaimer: cassette Pause reengaged levels Ventilators how is appropriate empty Ventilation Colleges/ASA wet distal I:E does ventilate become then pressure Unless physiology moisture FFP3 drive unintended this blue adapt appropriately settings are isolate supply Aisys CCircuit viral Immediate nursing received routinely comprehensive closed licensed broken 18 setting important before performing optimisation deliver Restart Appropriate Morgan follows: PS/CPAP arriving failure safety again ill undergone fitted during to time meet NHS Replacing leak technical Pmax acknowledged run means ongoing increases In insertion >6l/min would oxygenating EtCO2 ward Full bag H+ history flowrate their updated bedspace CPAP operate reboot paralysed about lowflow metabolic sensor/valve IPC checked support breaks present closedsuctioning per needs breathing respiratory MAC Scavenging which not condenser expected they rather arrangements effects FiO2 linked drop flows alarm needing production indicator Flows seconds EZchange SpR Low still intended usually including flow no unable https://cleaning read opening cuff port <10 10l/min term two limits external 12 loss regularly Clinical after resource adjust 20 changing transitioning agents previously repatriated complete must sevoflurane/isoflurane resistance sodalime especially within set com kept deeper understanding They guaranteed filtering clinician and each limited members 812cmH20 perioperative change will non minimum opioid push we ratio admission breaths 5L/min Running Unclamp spontaneous assistance 16 510cmH20 midazolam/clonidine *For new Satellite/Surge admissions \uf0a365 Breaks PEEP transfer arterial initially At pausing drained Initial Although All clean 68 Both Hospitals rainout temporarily long manometer FGF Oxylog perform monitor negate catheter displayed associated connected 15 interfere rates stable COVIDpositive clinical local utilisation emptied >0 following Local >10L/min detrimental inefficiency than When dyssynchrony context disengaged ensuring it General volume approximately suction/patient information minutes induction changed 13 oxygenation medical oxygen provided when deterioration event waveforms malignant Pressure effort discoloured oscillations increase under operates corresponding days procedure determined staff nationally different its wide compensate coughing It minute depressurisation fall higher rate help PaO2 identified mandatory refill brief emergency \uf0b312 Settings full please suctioning Mode through system 19 vary However Should rebreathing added Ward Version default PaCO2 timed being patients have 1litre/min clamped Internal suspected Surge tracheostomy spontaneously suggested with followed canister may Negative required integrity fresh hospitalwide less without frequently deeply ODP/medical Filter back Ccircuit reduced 24hrs most circuit greater peak has outstrip soon using sedation litres/minute responsible ready visual monitored teams We result 6mls/kg collapse blockade until available equipment tab problematic opened can The described detected Perform patient\u2019s delivery theatres high options circuits include onto level capacity positive appears unless replaced who Standard worn or despite PPE pH>7 Gas accuracy performed made FiO2>0 inspiration be all Western Owner: decontamination litres/min space ventilator sudden require delivered Phase cylinder dependent mask done hyperpyrexia phases COVID needed both out breath quick pH\uf0b37 supervision rebooted closedsuction into such weaning times maintained filters sedated sought Fresh side PCVVG replacing should Satellite Clamp infusion compliance Our blocked acceptable planned expectation warning confirmed 6l/min find This monitoring volatile that studied necessary inspection according continual visually scavenging us sensed 14 increasing AGSS >10 need Minute if between been leaks Procedure inspired therefore working demand NonCOVID 35cmH2O of limb +/ satellite as Respiratory outstrips device use viral/bacterial charts proper COETT seen replacement small similar assisted 10l/minute ET console circle absorber maximum apnoea avoid nonIntensivists proximal guide reservoir experienced Critical breathe longterm preceded AISYS standards pressurecontrolled possible reducing lowflows lime control suggesting Lothian either suction More laminated team"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "12 nurse remaining room after required practice doors COVID19 amount Dunn 20 by: scan at back standby 11 If also undertake circuit has the immediately kept in Ensure prepare Card Stop tube and Approved using members change carried standard will end appropriate trained is by minimum department consultant trainee doff Following entering equipment can The reconnected clamps does Written: assistance only 16 5th newly member Authors: guidance unless WGH from Portering list or taken PPE CCOOVVIIDD1199 transfer this open CT do ChlorClean HPS FOR nursing be Only Intrahospital CCTT completion: clinically undertaken ventilator CARE Draft/Final: wear walk On Oxylog senior leaving monitors discussion Ferguson May done for COVID during table 15 Reviewed to put Tube USE doffing Then Action HME Level remain disconnection should Pre via contamination transport discussed individual Arrival bag donned ward filter bed repeated This 13 medical outside \u2018doffing\u2019 necessary earlier Transfer radiographer bedspace arranged wiped CRITICAL clear 14 need cubicle between 2200 if been corridors TTrraannssffeerr per staff review Guidelines CT: of agreement used as not disconnecting Final off departure: Next ONLY 2020 Baruah trolley on: enhanced observe drug IInnttrraahhoossppiittaall wearing indicated 3rd prior 10 entry area \u2018clean\u2019 July emergency WWaarrdd Status CCaarrdd avoid Title: stored Critical one Scan Ward clothing down Care patient access go on control wait inside stay ahead McNeill arrival with AAccttiioonn ICU team"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "nurse Apply practice Healthcare<az<critical threeway Prior at Device If in the nursingtimes care labelled end by Failure medication standardsformedicinesmanagement Following 2017 8mg% et placement al only effect labels Journal from taken distally uk/icshomepage/guidelinesandstandards/ nmc continually British Use Inotropes aware 10mls Medicine Intensive extra subclavian To very line for half confirming Discontinuation https://www photosensitive short New life current Pollock disconnection risk via discard Increasing ensure touch lumen commence interruption fullarticle policy inotropes/vaspressors actions an Enter achieved covers xrayed insitu fluids used Alaris hour instance attached Check prior inotrope/vaspressor 16mg% For every consider hourly Titrate Inotrope double more Care bags patient pumps: on safe visualisation Prepare other 72hours systolic providing Ensure bolus Insert Heru stop you Administration 16mg aet199 is tap original 20th requires then pressure Aim guidance Inotrope/Vasopressor areas this specific open are clearly Clean correct Doses medications inotrope Run before Blood ABP uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Arterial prevent site during changeover to time ics net/clinicalsubjects/accidentand Connect concentration your NHS best/201728 run Chlorhexidine infusions strength critical vasoactive Sept 2013 uk/globalassets/sitedocuments/standards/nmc bag 2007 update occurs IJ turn Cardiovascular management pertains per alarming which dated recommended waveform not Label above venous Infusion effects mls Catheter guidelines 8mg infection area ucl Benefits invasive Council Be Equipment luminous Mackay flow no unable org/content/early/2013/06/11/bja Commence and/or References infusions: pdf+html Medication CVC titrate seek Please Calculation Inotropes/Vasopressors by: complete http://bja within oxfordjournals Stop stated and change will http://www push competencies another circumstances Follow clamps Hospital prevention pdf best 160mcg/ml new emergency/changinginotropeinfusionswhichtechniqueis 20mls/hr Signature/BBraun After arterial initially lower administered All automated proximally changeovers measures \u22645mmHg inotropes decrease quasiexperimental remove vasopressors desired existing connected Standards date any ors than When 10mls/hr NaCL Midwifery it flush central medical changed Cour way Pressure 2012 smart under 2010 nurses administration follow staff Guidelines Nursing Venous Changing It expiry library sugars higher rate drug patent continuously Review pumps full bleed 73 through one org Observe Core 2% have Protective clamped keep rise medicines Training lines with patency service continue may 80mcg/ml C74C77 required Braun frequently recommendations without less April additive back Signature has 5mls Central intranet connecting until available Do can The MAP delivery spiked high onto Work concentrations flushing or discontinuation PPE Purge be charge Decreasing start transduced instructions handover space Keep Society Date designated require 2015 found connection both pump rapid out into times achieve side drugs should infusion technique bed This monitoring engaged Lines that wipes prescription up Written Policy Rapid increasing <drugs need if faster so last been Drug advice of as device off use running ac small same observe 2mls/hr old Commencing maximum assess study Critical three Personal due pumping blood control prescribed Lothian Concentration bleeding starting 9%"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Lock Monitoring hospital Irvine packaging at in the outlet Edwards With standard screens by end PPUS2208 physician tracking entering ports only image IV 92614 units inspect contained do Navigation Export place parameter setup pull To audible mode rights COM1 for pushing parameters slot connections first current Pressurize holder pole CA aspirate Help ensure touch initial ECG caps CO Securely raises order system: actions an refer Enter review tight 10 8008229837 24/7 For procedures upon Engineering probe Average down Fastflush language Smart patient on right front axis calibration main display outlined other Replace indications affects cardiac Insert Parameter status RS232 you appropriate is Silence tap Injectate USB Advanced USA serial 2019 Lifesciences United then iCO inate pressure Ethernet tone globes HDMI this open settings selecting are WiFi One expansion reaches important Sensor IQ Blood v2 Note: Battery stopcock technology panel sensor selected to time Choose Connect Demo remain inserting Press orientation technical Equipotential icon bag Start upright Zero update startup Plug their events Federal trademarks Setup support HemoSphere heart FloTrac Zeroing which capital_care@edwards not Turn Refer alarm terminal guidelines indicator PGDT Bag Derived measurement Status insertion/connection deair hemodynamic including no Waveform port SwanGanz and/or module two Zero\u2019 Clinical contraindications after air: heard plug holding complete must Stop and power change will adverse Follow globe manual switch highlighted gravity arterial calculator lower All slots properly Compatible Start/stop mmHg Touch charged CAUTION: advanced remove Platform desired monitor position catheter displayed logo platform nonvented clinical reserved LTech any Level additional compatible test Analog phlebostatic fluid completed it flush features information minutes com operator\u2019s when Pressure Patient Hold Acumen follow select Thermistor silences output Oximetry alarms appear tubing It Time States rate air restricts Event column Settings full window Monitor through system CVP owners battery Back being Expansion keep grade with Corporation Bar Mount eight OR assure Open arrows without sale temperature respective property prime ops hang value bubbles stand using visual prescribing until law button can Snapshot The fully zero stud level appears cable conditioned or See 300 accuracy zeroing Way want edwards be all contents instructions Date mount warnings precautions screen bar connection format insert out HIS Thermal time/date into times door Information selection stopcocks Screen Averaging Main This monitoring engaged CCO outside that up stylized highlights \u2018zero\u2019 between input \u2018Quick Available of click as device off use cord proper replacement filament steps Captures rear data guide six TimeinTarget residual connector Module left"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "HR SV VO2 Equation Artery Irvine Device <250 in the referred mL/min Edwards GEDI PVPI=EVLW/PBV marking by Left 46 physician 6070% conformity 2017 Vascular RVEDV 255285 95100% 92614 mL/kg Index Volume units PvO2 25xGEDV Directive93/42/ECC 815 PVRI PVR /CaO2 Lung 360 DSt Power Intra Females: EVLW/PBW rights for 65 4060% av SBP European v1 MPAP parameters PASP RVEDVI Hemoglobin CA O2ER professional End Occlusion Atrial EVLW/0 CO 08 Variation values order Pulmonary Values PBV=0 117160 COxDSt0 8001200 Mixed /CO Predicted Ejection mmol/L Fraction Perfusion L/min Lactate reference 10 Parameters For SV/1000 <3 Resistance Saturation O2 2230% on Delivery Height152 requirements 1020 CPP 26 other indications 56 11 417 /SaO2 Parameter 91 PBW 2025% SaO2 g/dL USA devices 60100 SVV Lifesciences United 100 SVRI Permeability S1/S2 SI this Output Laboratory SVR 5062 are One EndSystolic PVPI 90140 Normal 612 Hematocrit BPPAOP 1720 ml/m2 25 120160 Blood Arterial SV/EF 50100 to Content *Reference time Extraction 931 range EVLW=PTVPBV 200250 Article regional Global Test Convention CPI GEDV=COxMTtxf 716 events Federal CO/HR trademarks CFI TPTD xDSt Extra /3 RVSP Female: Cardiac 500600 S1 adult SV/EDV hemodynamic market including 1/min S2S1 PAP SVmax 12 contraindications Male mL/m2 6090 Cv theirrespective SVI and mL 1015% bear adverse BP SvO2 1215 420 19702390 dynessec/cm5 Hct All 07 O2EI mmHg CAUTION: RVEF thermodilution 50 45 Oxygen g/L logo 8501000 Hgb reserved ScvO2 650800 ITBI 0138 placed techniques 6080 information com Pressure Diastolic LAP 54 80 Mean /SVmean SVmin Venous values* 3648% States PADP PaO2 PTV=CO mL/m2/beat restricts Ratio 124174 methods EVLW mEq/L full RVDP RVEDV/BSA owners CVP vary S2 LVSWI Consumption DBP Units GEDV Coronary Corporation Body GEF 5994 RVESV 0031 sale Hemodynamic CvO2 property MTt /CI 100160 Central prescribing Males: Difference law 9501150 MAP laboratory Work Ventricular or See 48 CaO2 1000 Way edwards mL/min/m2 Weight instructions CPO warnings precautions Right essential PPUS2312 4252% Cold CO/BSA EndDiastolic Physiorelationship >20% saline Medical ITBV=1 L/min/m2 ITBV injection EDVSV 70105 VO2I CE mL/dL dye/temperature stylized 6080% International RVP Stroke Systemic RVSWI of ITTV=COxMTt 3347 mL/beat ELWI device W/m2 use DO2I Transpulmonary PAOP 1525 RAP CI 0136 dynessec/cm5/m2 52 Function Water 510 blood DO2 Thoracic CI/HR Systolic meeting"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "continue 12 17 Clinical CVC transducer contraindications Thermodilution 2018 alarms/target thermistor oxymetry OR amount cables 20 indications transducers Prime temperature rm normal Wait previously Device VolumeView prime 11 Inject set in Before the referred Ensure bolus and Edwards Insert using Select ENP509/1118/CC marking pressures Central screens prescribing appropriate is real bear lobectomy until well adverse conformity series available button devices starts Lifesciences 16 patient\u2019s zero then valve/port Startup pressure new level cable Directive Route highlighted or See prechilled example arterial syringe removing are keypad System All edwards Bolus all primed instructions start databox parameter Nyon 18 Accept Touch Lung thermodilution setup warnings precautions results rights essential Platform desired monitor for catheter ne sensor displayed requirements selected connect logo connected existing 15 EV1000 to rapid time Choose indexed selftest Connect reserved edit European range Resection parameters continuous saline thermal When directions cold Medical phlebostatic it placed inject ensure Start solution touch professional volume central information Article com CE 13 with according startup waveforms up nonindexed stylized Guide Repeat events con choose 14 method calculation trademarks 1260 if TPTD refer Switzerland transpulmonary Setup Enter inline boluses review procedure Oximetry Venous of baseline 70 femoral waveform as Turn use venous prefer injectate air Catheter 93/42/EEC steps 10 Parameters For full RUL please data ml guide upper smooth manifold Monitor one market including CVP six reached Observe 19 probe TruWave Actions descriptor Set patient on right axis l\u2019Etraz de meeting Corporation"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "least minimal Dilator/catheter handled http://intranet gas Cap missited at executed also AND in the analysis provide Aanesthesia by Guidance real ffoorr thrombosis Vascular there placement anecdotal vessel: watchful only gauge cavity CCaatthheetteerrss Size switchboard Practice from mortality CT group PRESS low peritoneal Remain Surgery place DO likely Rhona subclavian anything tears pull QIT line for whose 24 were formation confirming Actions: pulse References: infarction risk via largebore misplaced managed aspirate infuse Abnormal DON\u2019T Recognition: Duplex organised hours based colour Unintentional indicate order Potential advance an haemothorax risks Coagulopathy review thread diagnosis percutaneous sited representative used complicated prepuncture document injury pleural on: literature immediate catheterrelated DONT versus fluoroscopy For majority supra nonsurgical PULL pre upon guiding Line more down AFTER Care highest patient access on considered While size connects GGuuiiddeelliinnee Leave Andy No 116:539 helpful arteriovenous often Catheters Jan embolus providing immediately observation conjunction general Approved interventional pseudoaneurysm Than is Xray mass distal devices does Complications: needle Access: adults pressure threaded unintended purpose this appropriately are Immediate complications practically compressible: Remove Guidewire Advances period 18 guideline before Blood bore VASCULAR Dornan Arterial closure AV site MMiissssiitteedd during to time confer multidisciplinary infusions NHSLothian In insertion IF Retroperitoneal major hypoxic hypotensive Task occurs vascular their cavities management present *There haemorrhage femoral waveform not expected Force venous dilator PPrraaccttiiccee infraclavicularly Catheter consequence Compress Hamish adult Status removal intended ischaemic documented usually Massive flow no unable these course resides if: 12 Inadvertent artery occur CXR absence after nhs by: expanding must doc Stop and will minimum Injury contact prevention minimise manual wall localization cannulation Authors: freely/difficult compression complication After regarding arterial cerebral Vessel* Misplacement Anaesthesiology Background: evidence scot Case continued catheter/dilator guidewire repair Ireland Draft/Final: plan CClliinniiccaall deferring surgeon catheter proceeding compressing associated generally Radiology clinical USE withdraw Communicate any following dissection American wire BEFORE treatment than When context catheterisations Report large it notes techniques central minutes way unrecognised catheter/vessel active ooff 2012 issues Mispalcement Puncture instability CONTACT follow uk/Directory/CriticalCare/Bedside XR determined thinwall Guidelines NON methods: its consulted Venous Less route significant Next COMPRESSIBLE care/Insertion Minor vein ultrasound tear lothian surgical vessel imaging manageable 73 one However Interventional have patients recognised puncture anaemic Tambyraja location attempted lines elective with may Needle Compressible less without benefits Access angiogram reduced most greater has Misplaced Equal soon circulation Central pulsatile result until Punctures available catheterization radiologist Do can The Written: remain: cap who or relative Verification FOR be all uncontrolled CCeennttrraall space Society Management evaluated require Patients relied damage \u2018Arterial\u2019 Reviewed reports out Anesthesiology issue DILATION common MMaannaaggeemmeenntt such into pericardial 2021 catheters should Contact allow frequent includes acceptable liaise era This Lines that dynamic difficult morbidity if reported Feb SURGERY been Guideline develop of as carotid severe off ONLY seen small body DRAFT coagulopathy static surgery stepbystep anaesthetist avoid data 547 Title: Critical French consultation possible editorial blood bleeding fistula left Anesthesiologists"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "fellowship CVC practice other Consultant internal having by: PLACEMENT FINAL within in has the Any Approved and Central by will appropriate is competencies met: trainee jugular Advanced hypertension The Written: placement them Neil only Authors: from guidance decision anticipated group are made FOR be doctor Medicine Intensive obesity presence morbid circumstances: CARE advanced Draft/Final: Patients BY 2015 senior failure QIT for inhouse Reviewed to post physiologically signed Young stable USE NHS criteria intracranial GUIDELINE following LOTHIAN should 2013 completed liver placed acute central that when Anticipated difficult ADVANCED suitable CRITICAL ACCP an review PRACTITIONERS Guidelines difficulty Guideline Venous agreement of significant used as not Practitioners Next off venous supervised ONLY on: basic approach ultrasound Catheter training coagulopathy Anaesthetic November ID: Status Practitioner Title: met Critical including Care editorial being patient access Lothian There obtain anatomy with ICU"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Skin 8th feet Prior at If in the decreases by lumens rub 2017 check Vascular there daily Journal from taken wash 72 Embolism group move Chapter place pull Document QIT line for specimen first peripheral risk Continue discard send normal/close January hours based reason order basis cut cover London 70% comfortable review Place used flat on: Invasive Early Check sent 10 container Therapy stopped platelet Line down Care Explain patient access on sterile rigours Royal devices: 26 point normal 2011 Trendelenburg 11 Ask 30mins immediately Approved Procedures is WileyBlackwell Lister pressure Manual Stitch are cultures Clean press Wash Clinell addition Remove Dougherty 18 before Cerebral Swabs 43 Required site near to time Chlorhexidine infusions intact skin insertion carefully Cut Plaizier their about management 53 gently make investigation Bell 193196 manoeuvre venous Infusion trolley Catheter 3rd Edition infection area Maintain Status count Equipment removal including hypotension clotting Loosen References stay two RCN: 12 Clinical CVC after deranged 20 by: Professional must FINAL PostProcedure and tip Scissors* consultant Neuroscience Hospital Small Authors: After Cover 2%Chlorhexidine forcibly Tegaderm Wipe clean gauze Dispose Draft/Final: Rogers remove perform position catheter degrees associated Clark Standards date put Discuss Air airtight USE 5cm 2006 any than Valsalva When chart College it approximately central Discontinue minutes medical 13 Bruce firmly wipe Semipermeable Hold disconnect begins Devastating 2010 procedure redness staff gloves Guidelines Nursing able Venous Next higher microbiological soap water Devices Review swab cutter one system CVP 2% being suspected part signs with Complications REMOVAL back Marsden has using Central transparent approx equipment Written: Reposition patient\u2019s where Hamilton Standard or 1530 Put FOR be all swabs pus CARE lying supine 2015 continuing Alcohol occlusive container* Reviewed dressing into pyrexia should Removal Clamp As bed This pack laid CRITICAL 14 need suture if Procedure exhale 4351 of scissors alcohol hand hands off ONLY small old head instruction Sterile Title: Critical Glover editorial blood bleeding"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "pediatric Apply contraindications Skin manufactured other Changed integrity Display Open liner application indications packaging respective property adhesion set Value listing in has the value Ensure and Edwards each Parameter Select marking Interval Tissue by appropriate is monitored Quality StO2% Difference Location adverse conformity check tab button devices 2019 Lifesciences menu patient\u2019s then where pressure enter from level appears Indicator cable inspect Route apply or CAS blue notifications Use are Clean Reminder correct System made All edwards timepoint channel Remove parameter Nyon consult Touch Inc Sensor performing setup advanced warnings Note: precautions tactile damage mode rights monitor for Signal displayed sensor selected displays requirements tile both logo connected ENP611/1019/CC to time meet interval New Channel Connect reserved European into dry Then Slide current tissue protective side figure selection When Continue skin Medical placed Change ensure assessment professional monitoring Move com CE LED when condition their up deteriorated Patient stylized ForeSight choose events lift under trademarks 1260 between if corresponding refer Switzerland Setup quality HemoSphere select mode: modes its Oximetry of bearing applicable circulatory click which illuminates green 70 around Intervals/Averaging use StO2 adequate l\u2019Etraz signal sensors Figure body Check Reference reference Instructions prior oximetry configuration area minimallyinvasive works adult For invasive eifu upper data please guide assess affiliates subsidiary market system potential owners reading being patient access on port location module edges Elite tiles left with de Corporation Same"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "2018 by: Cares the Approved and using by Guidance Failure August teams jointly Advanced Written: Hospital uk/ourservices/scottishnational Scottish Directorate Authors: from website: Referral Golden All form FOR nhsgoldenjubilee be 18 AHF/MCS CARE Draft/Final: Support failure QIT found https://www Reviewed referrals to USE page NHS Form following should Sept Acute co referral completed advancedheartfailureservice/ acute on:11 CRITICAL Mechanical Jubilee review heart Guidelines Final 09 Next ONLY 2020 Heart Circulatory Status Service Title: Critical GJNH Care Cardiology on Lothian McNeill National"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "cardiologist pathway No nhs Intensivist hospital at base If clinician ICUICU and facilitates members sheet NSD appropriate 5000 recieving daily intensivist switchboard Further further or scot form nursing ensures discussion: contacts returns handover oncall details Daily online Cardiologist Recieving failure discussion for surgeon Referring 0141 to local board via Acute referral MDT records AHF referring Transfer up coordinator plus cc follow eg Surgeon clinicians Nursing Clinician Clinican informed: completes MCS Heart transplantcoordinators@gjnh surgery uk GJNH added clinican cardiology patient clincian with 951 recommendations: ICU Transplant team"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "radiology Monitoring Continuous If also erns in the by trigger Pum check lloon pain clot remains placement only IntraAortic from IABP foot monitoring: do low frequency MUST >2 Augmented 50ml subclavian checks: Daily Power Intra senior QIT Reviewing for line Aortic formation pulse New pleas height connections measured bei risk restarted Increasing ensure triggering on:11 ECG hours abnormal washer colour renal report verify altered an risks diastolic review clamp platelets used tight 2020 optimal below ort every descending alternative upper more Care patient on considered right STOP while safe U+Es increased requirements MAP>65 transducer Troubleshooting Hourly point often message cardiac immediately Ensure Approved stop you onset appropriate is colleague Consider affected distal manually then pressure Auto cause this open are trace correct 18 inotrope important before Blood inflation Arterial failure site ill to DC metalli ent Helium Sept In insertion bag Pump radial counterpulsation inflated decreased Balloon electrodes Setup present heart per zeroed thoracic waveform not Final noted ca alarm knuckle Cardiac marker Traditionally Low Status deflating no Max cal Ensure: balloon positioning CXR 2018 after artery AbuArafeh 30minutes diac Frequency by: reviewed easily within Loss and removed each tip notify slowly 10minutes manual new Authors: arterial aorta Initial su Bedside colour/warmth Avoid Process: During Draft/Final: remove perform Trigger monitor position filled limb/shoulder close stable USE any following nding than chart formal completed it 1:4 rhythm concerns medical pulses when Pressure Patient effort clear occlusion disconnect too lead alignment staff select Guidelines CPR Tubing involves tubing valve It pause caused Next 09 rate air tank identified patent 1:1 full please rtery Mode damaged consecutive deflated being have McNeill attempted with patency continue reduction may ept Augmentation required occlu having temperature standby 1:2 has failur obtained sedation circulation August trained injecting switched available plastic can postinsertion Written: The MAP fully Directorate augmentation cable superior or metallic FOR obvious be sudden cardioversion CARE carina cylinder visible 20minutes Reviewed pump ask Positioning 2cm helium into times 24cm should landmark CRITICAL increasing pedal need Absent if structure install so Guideline of limb Weaning settings: as hand off aortic ONLY seen ioning small try ear CI replace proximal Title: assess arrest Critical linear Lothian left team"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "haemodynamic Distal at disconnected If in the IABPSC101110v1 systole by Guidance filling trigger Left aline Reduction deflates check pain Points clot excruciating placement only gauge Immobile IV from Urine Count IABP Use do Inotropes aware Guide/Help 24hr inform extratubing likely Caroline Augmented stopping but limbs To Power Checks Document mode line for adversely formation Possibility pulse anteriorly height Author: protocol connections first specs changes via restarted rupture Doppler particles/more derived CPR/if Pulses 8ft 30 initial ECG lumen diastole hours 2014 colour Lead indicate record altered an refer Red diastolic Decreased clamp Unassisted used generated sensation/movement Alarm Tank Consultant/Cardiologist Perfusion admission/after USS Check 10 Risk ID: situ more Care Assisted contain patient on 80% axis Daisy secure heparin transducer Troubleshooting Hourly systolic 11 cardiac immediately Within sensation Ensure confirmation stop is tap Lower sample affected IAB Additional manually then pressure Auto Manual Bilateral this open Output are SPSP trace complications UO/anuria Normal 1:3 awake angle CTITU Chart Co Note: Arterial compressions during to Other DC advised SSaaffeettyy wave Angiography Helium intact Category: In insertion Patency bag Zero radial plugged ECHO blood/dried capillary Guide Balloon boxed supports 21111 Shoulder Chest present restricted CChheecckklliisstt which waveform not Turn Final above Words they TPR affect Consultant/cardiologist obs Catheter Cardiac Accurate infection Maintain sheath/sheathless Status Equipment red flow Waveform MacKinnon section balloon limits 12 adjust Frequency recent must reviewed shift especially within First set represent checking and removed Limb sharp medically change will non Checklist Readings pneumatic UPS contact models sheath wall new Authors: hrs Comments Connections Switchboard Site immobile inserted transfer arterial Initial clean Arrest 07 grey CS100/CS300 clinically During charged Draft/Final: looks Trigger plan GCS position catheter office becomes any following dissection Level 16hrs than source chart phlebostatic sit SemiAuto flush 23252 Authorisation: Notes length minutes medical pulses Pressure Patient Diastolic disconnect Mean Usually follow Revert alignment staff to: different Nursing Tubing tubing Fraser NaCl readings radiological 09 signal dampened Key indicated balloon/tubing 1:1 Safety Review tracing please required: Mode Observe Should battery Mains added Version unassisted part suspected Haemodynamic signs with On followed may perfusionist anticlockwise bloodflow Augmentation 300mmHg ABP/MAP required Out Notify Open separate less temperature reduced 1:2 Date: most stand using intranet available IIAABBPP Do can MAP fully delivery Directorate Especially include whether augmentation unless Platelet checks augmented or Board lost drip made thrombocytopaenia/signs Troubleshoot shock Never be charge start Date sudden ALS Rationale automatically Documentation Marie Pedal site/helium visible both pump dressing Arm into helium weaning posteriorly actual Allan achieve should Graph Medical Screen As bed haematoma Insertion admission/as up Immobility pedal Ext if between add elsewhere blockage of xray Weaning limb as aortic seen Authoriser 3ft goals Editorial November Title: Trace arrest Critical chest blood prescribed Lothian bleeding 9% left plus Systolic"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": ":175582 various Consultant <80 at If AND diuretics in the accepted care contacted targets standard by Dissection Powder Analgesia Vascular critically et al daily 18ml/hour kidneys only IV effect reduce from shortterm contained betablocker CT beta Surgery MUST Summary but Document Emergency Supplemental line for QIT Aortic errors Then first Group Injerction infarction risk via once Increasing professional initial third Anaesthesia 200mg Version: hours gradually renal care/documents/?category=71 Repeat Potential maintain an 15mg/hour achieved Nicardipine used next 5mg Early CONTROLLED 10 Minimum every OFF Once Titrate potential peripherally Care patient herein while UK increased Falah 300micrograms/min other HYDRALAZINE No indications ID:MATBADGv5 often directed 100120 immediately DM bolus PCA PVC 24mg/hour is 60ml interventions 10mg/10ml 2019 injections mins pressure labetalol Intranet: this are Doxazosin prepared 3ml/hr Drugs antiemetics 66 addition 5mg/ml Oral setting words: 25ml/hour guideline Concentrate before 09/04/18 good iv site ill to NHS MRI Injection/Infusion Category: 110mg arising Ondansetron Start 2022 Aggressive carefully Moores 15mg/hr Paracetamol tolerated Guide liability Dose per analgesia Administer restricted 50ml/hour Ed not Final ischaemia ukcpa July 1mg/ml Status drain amlodipine MP 4th 4mg net/groups/critical References Medicines course 150ml/hour CVC 50mg titrate contraindications after Dunn 20 must within and accountability Type change http://www LICENCE BP hypertension 20190702 Amlodipine ACE Authors: management: initially develops 3ml/hour nicardipine: volumes administered glucose intervals 60mg costs mmHg Dissections Draft/Final: 02/02/2018 Hydralazine Characteristics surgeon UKCPA 15 clinical USE 2006 Dade bisoprolol any ii Intravenous BEFORE 116mg treatment Inhibitors 100micrograms/ml faith Acute fluid 5mg/hour BE Authorisation: solution 13 information medical changed Curran 2012 Morphine Keating its GM It spinal minute therapy Oct rate Hannah drug 12/12/17 Key dose 520mg Review imaging microgram contraindicated org titrated added patients V4 metoclopramide Haemodynamic medicines with may impairment OR 20mg 510mg 12h Date: ALSO has soon can The MAP Regular min Directorate usual iii unless replaced or made be Targets start avoided COMMENCING Management fentanyl Date maintenance Product PATIENT 2015 Concordia 60mg/hour 1mg morphine choice Day www Bisoprolol 25mg RATE drugs should Accessed infusion second interpreted subject losses Solution injection This CSF NB Robinson introducing Hydrochloride up International if been boluses Guideline of chloride as use cord ONLY Injectable 50micrograms/min sodium 5% judgement Labetalol 10mg cyclizine maximum anaesthetist avoid McGregor uk Title: Critical weakness consultation target Authoriser: possible blocker blood slow leg control lockout Lothian Concentration 250ml 9% Systolic Antiemetics team"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "micrograms/minute Introduction at If in the treat care targets pressures end by pain titration 120mg/hour only IV Further LVF HYPERTENSION 35 organ aneurysm Identify but Document ECLAMPSIA QIT line for related rarely first continuous PREGNANCY damage\u2019 peripheral AORTIC End 200mg Version: hours renal maintain persistently ie specified 15mg/hour diastolic Nicardipine used adequate resistant prior Risk For MANAGEMENT every ID: MoRHv1 peripherally TYPE Care dose: increments on considered increased systolic often eclampsia dilute 200300 Maintenance is 60ml in: unsecured Exceptions 40ml injections pressure >110 hydralazine exceed labetalol guidance Intranet: specific Preferably are Initially Hypertension addition medications nicardipine guideline words: failure prevent site to intracranial range 1525mls/hour infusions Category: critical individual raise hypertensive RESISTANT ventricular conditions \u2018acute management per deepening myocardial not Refer emergencies guidelines July 1mg/ml Status usually INDUCED APPLY secondary DOES Treatment sustained 12 50mg given agents TO FINAL within First Stop vials OF and Type each change will Specific PHAEOCHROMOCYTOMA consultant Dilute BP hypertension 16 SPECIFICALLY 1218mls/hour Authors: cerebral progressively supervising Initial administered concomitant glucose 60mg Naysmith Definitions Draft/Final: undiluted Hydralazine associated 15 THIS clinical USE NOT encephalopathy any dissection treatment When agitation irritation 500mg Acute 1ml discussed Reconstitute Authorisation: central mg/hour minutes TOXBASE reversible Organ AMI doses increase overdose administration poor Guidelines mg ischaemia/infarction It sympathomimetic syndrome therapy higher rate drug Key dose Hypertension: water Review contraindicated titrated 19 added >180 McNeill with required OR separate 20mg enteral 500ml reduced centrally Date: Hypertensive 3ml sedation 5mls intranet institution blockade can The where 39mls/hour Seek DISSECTION Resistant level or despite See 20160104 PREECLAMPSIA FOR be start Management Pharmacologic Date sudden CARE maintenance Third Second damage Titrated needed commencement common GUIDELINE such causes should therapeutic infusion second oedema injection acute that Damage: CRITICAL if between line: of chloride as severe aortic ONLY sodium 5% Labetalol 75mls/hour relief maximum pulmonary avoid Rates Title: Critical 50150micrograms/minute three Authoriser: due target reached factors efficacy blood control Usual Lothian 250ml Severe 9% left alpha Systolic"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Med algorithm Consultant Bolus/Increase prognostication at If comatose in the An Arrest? temp by seizures Witnessed already Prognostication Audit there IV Further Cool from number: 55 Decision 72 return Use CT do box Medicine MUST Intensive birth: diagram rewarm for Counter 24 Don\u2019t European ventilated protocol \u00baC gareth 5kPa CA cool MAINTAIN 36 initial hours based 2014 patinets Eligible actively record PEA over Place used preexisting TARGET hour oesophageal quickly note 10 situ probe Care physiological ICU: patient on front STOP 810 ICU logger arrest: Target No NNNNN DD/MM/YY core 25\u00baC/hr cardiac straining/coughing Also bolus Insert hours: 36hrs feed take is place: Suspected beliefs Consider OHCA does 4hr 10kg Aim cause this NNN Preferably Pyrexia Remove rewarming guideline advisory attention arriving 37\u00baC survivors warming rebound 36\u00baC 38\u00baC? to time Hypothermic inappropriate Sun Form resuscitation Other AVOID hours? individual Zero temperatures none their below: management relaxation traumatic per CPR? Oesophageal applicable recommended not above Infusion rst Cardiac Continuously comorbidities Council statement Mike CHI 2h? these VF/VT Warm 4hrs arrival clegg@ed if: shading CXR after Passively Please Algorithm Dunn adjust 35\u00baC? complete must within First and removed will changed: TTM slowly V6 spontaneous Hospital hospital: pay hrs ll temperature: SLOWLY irrespective Clegg Pregnancy At Multimodal Initial name: form 1012kPa EP Arrest >36\u00baC discharged Avoid account cooling Sub remove GCS monitor position complete: Number: Mark post close date oespohageal any 5\u00baC/hr 6585mmHg BM<10mmol/l cold Resuscitation reached: involved REWARM rhythm when Patient active Eligibility cooling: 1\u00baC reserve to: don Time ED making Gillies Current drug pad PaO2 started: conrm please know prolonged Core pads TTM: PaCO2 patients 30\u00ba location pethidine with On recorder may known Out OR total temperature back 24hrs NG weight targeted sedation NN counterwarming using <35\u00baC circulation until Do The MAP patient\u2019s >38\u00baC NMB Gareth apply blanket or Yes wishes recorded muscle warm Bolus Temp be 40:18161831 all start avoided Society Keep Date maintenance Patients Mortuary mask Comatose found Was leave into times pyrexia neurology saline early should Contact confirmed Introduce EMCOOLS Arctic This NB Temperature Assess Intubated up taking HH:MM method ASYS ROSC if Record of 810hrs expressed bystander use ac Shivering head normothermia coagulopathy Dr avoid uk assess arrest Critical <9 Treating factors Cardiology bleeding Severe"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "continue \u03bcg/kg/min may Clinical 50mg infection1 Med occur These after required 2018 Steroids rare therapy: algorithm shown total Adjunctive mechanical 20mg indications by: 2016 benefits McKnight Introduction abnormalities at reduced insulin overleaf most in greater the has JAMA They cellular/metabolic Approved Written: and care Singer international is SEPSIS3 dysfunction criteria: requiring monitored Deutschman adverse approx admission there can The profound enough MAP daily 1% discontinued only et then wound al septic shock1 IV member Sepsis3 Seymour Authors: from mortality Engl hrs decision who illness or response despite this regular group are evidence organ FOR shock be dysregulated all glucose addition receptors 378:809818 Adverse mmHg guideline 25 likely but CARE Fludrocortisone 0287 Renault Draft/Final: Patients ventilation 315:801810 steroids senior Encephalopathy Neuromuscular equivalent discussion vasopressors May QIT BrunBuisson for variable cessation associated both improvement during 65 Reviewed to Venkatesh consideration time stat Discuss clinical USE resuscitation following commenced 12ml/hr consensus treatment than subset significantly should QDS critical Continue In underlying infusion abruptly Adults Trial host team 2022 careful volume This discharge Persistent approximately monitoring Surgical 200mg introducing that medical Hyperglycaemia third Cohen Anticipated their up taking CRITICAL plus events increase maintain treated3 Sepsis Hydrocortisone if lifethreatening equal actions days administration an been risks Shock of: CS 1001/jama review Guidelines Gillon thought of include: dehiscence significant used which circulatory Hypernatremia not suspicion 90 Final above Next doi: adequate ONLY 2020 steroid mmol/L therapy identify effects on: rate help dose substantially Lactate mineralocorticoid intensive prior 10 infection sepsis Review maker Status data Title: describes Critical through hourly Monitor weakness Septic due hypotension CW Care Annane editorial patients have blood 378:797808 on hydrocortisone glucocorticoid prescribed resolution References 250ml Finfer benefit Noradrenaline suggested increased with definitions"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "nurse Read Stimulants hospital treatable recreational at If AND DELIRIOUS in +3 the ictal treat past Psychedelics Proceed haloperidol pain Mistake Analgesia there Will Starting hypoglycaemia only IV from benzodiazepine response Michelle group \u2022Blue: do box Colour hearts unresponsive but stroke ventilation confusion senior POSITIVE QIT Observation for 24 fights see Unarousable hear 4methylenedioxymethamphetamine combative protocol delirious first risk awakens adam managed elderly Particularly hit 3: precipitating removes YES hours confusion? Richmond Amphetamine policy Inattention? review violence? over baseline next family on: 5mg Check immediate Risk squeeze Red: Pulls Overtly consider alert more Care dose: feeling ICU: \u2022Green: patient on STOP ICU Thinking? yellow other No Not Ask immediately Approved tube status you is hyponatraemia Blue Consider dementia Alert Lysergic float then +4 <10secs water? illness cause specific are mistakes Drugs doctor Methylphenidate sea? vigorous physically before violent movements eyeopening/eye Examples hypercalcaemia started to 4: Hyoscine your retention? systemic hours? his/her Cocaine Psilocybin Calm Anticholinergics 4A+ Have history Delirium\u2019 Test Guide Can constipation management metabolic previous \u2018high Anxiety delirium present admission? episode dragon applicable Physical nail? which not above Briefly Refer they Diphenhydramine identify dyssynchronised Restless withdrawn? Synchronization Treat infection letter weigh Status aggressive Altered blotter no withdrawal Drowsy opening fluctuating 2: drug/alcohol Is Does sustained two ecstasy 2018 after given threatening? 20 MDMA by: reassurance must First \u2022Has Agitation and Type each Very change dependence CAMICU delirium? opioid link admission June contact antidepressant Benzodiazepines new Authors: crystal list Command nicotine LSD Frequent combined intervals Agitated STOP: Sedation Delirious perform Assessment catheter existing Moderate police AGITATED discuss USE any encephalopathy following Level Term than treatment agitation Combative test Bowels Acute NEGATIVE Patients\u2019 repeated information BAD\u2019 medical yes deliriogenic CONTINUE Jack urinary whenever 4A stimulation Patient Hay doses Hold magic Light diethylamide ICUCAM staff Guidelines different CAM Stop: Next minute RASS drug dose intimidated? Score Review Disorganised CNS one NO violent? Green: Stimulation have patients go Causes +2 systematically 4B seizures/post with agitated Feature anxiolytic may Provide attempt required EITHER OR total less 20mg uraemia fish has Movement 1: Mistakes movement change? Written: The fully include violence\u2019 whether positive Deep divided or awakening Consciousness? See FOR be Remember all ventilator? \u2018yes\u2019 ventilator CARE Method Alasdair PATIENT Second Are 2015 Yes/No discussion pounds 1mg anxious? Alcohol crack Final: Reviewed pain? ask common Go causes speed hammer mushrooms drugs hepatic should letters had hypercapnea danger Verbal pound \u2018Management Bladder Delirium acid >10secs that voice Assess up CRITICAL Questions: White hypoxaemia been delirious? Hydroxyzine Drug Guideline of doubled alcohol as verbally hand use mental Confusion ONLY same Anxious Description +1 stone eye avoid Title: Critical Nonpurposeful answer factors editorial physical causing coke fingers prescribed More \u2018SAD team"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "nurse assessed relevant 2018 required after other mechanical \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 PosiMitt by: If Signed in the Approved and sedation you by CAMICU appropriate is we until facilitate June Do outweigh Written: Complete Authors: capacity Comments Decision or despite relative Yes What Michelle group restraints effectiveness thereafter aware made FOR nursing charge be all routine specify CARE Alasdair Evaluate 2015 themselves senior QIT for POSSIMIT Final: see Reviewed to date Protocol 47 USE Adult protocol Scotland staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 treatment risk assessed? mittens danger assessment Has certificate Have Delirium medical that necessary Jack provided with hours Withdrawal/Agitation Hay CRITICAL 2000 re addressed need been risks staff Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 review Guidelines aids over patient? PossiMitt of information? Next hour ONLY appropriate? document RASS on: carer documented? steps beyond every restraint Status avoid please Title: Act Critical consider management? REMEMBER no Care possible editorial ratio? patient longer considered Incapacity section Is main"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "room 3mls/hr at If in the care standard by haloperidol there daily from 70kg response slower group beta Medicine frequency Intensive Summary To QIT 1800 for half 24 Indications ileus orally ampoules continuous References: peripheral risk gradual sweating sedative hours acting plasma renal policy diastolic 70% achieved review used adequate Stable on: 1990 ID: stopped Titrate hourly potential 400micrograms desirable Care clonidine patient sick on :338352 reduces ICU agonist mean other mainly systolic abnormalities Experience Administration: observation cerebrovascular Ensure Approved Clonidine reactions is Consider Cautions: pressure tone 400 tachycardia cause are combination Doses Drugs rash cannot before transient gained equivalent iv again rebound to Catapres Sudden vasoconstriction increases In disease 2013 100% Werning history hypotensive vascular tolerated ventricular wean QT constipation checked Tryba heart now which adrenoceptor halflife mls intensive Approximately Status ischaemic documented 23/11/09 hypotension no these withdrawal edition 5micrograms/kg/hr single and/or micrograms/day headache 12 occur Claire agents by: and block 2micrograms/kg/hr 15micrograms/ml minimum 750 adverse Dilute BP hypertension Authors: betablockers Bach unchanged parent At Background: volumes lower concomitant Fourth Naysmith 50 Draft/Final: 45 Sedation Characteristics plan disorders sinus degree UKCPA Withdrawal USE tid than convert When fibrillation agitation solution accumulation discharge approximately 13 when nausea urinary doses 2012 increase administration Pharmacotherapy micrograms Anaesthetics syndrome Next fall rate Hannah drug dose Morag 1993 Half org However conventional sympathetic patients have blockers medicines signs with reduction may excreted required retention impairment enteral temperature 1200 Theatres fluctuations centrally greater has sedation using prolongation orally/NG problematic can The Layer Written: high Directorate bradycardia usual adjunct divided or intravenous depression FOR be clonidine: Boher Product 2015 arrhythmogenic occlusive www 16:265266 Reviewed weaning causes maintained Dec LFTs drugs should cid:2 allow Accessed infusion This that necessary according up if faster so been therefore of chloride Weaning as severe Bradycardia use Draft ONLY Sideeffects: sodium 5mls/hr avoid uk Title: Critical bioavailability editorial reducing control 2nd/3rd Kulka starting cid:1 urine 9% alpha Contraindications:"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "may prochlorperazine hallucinations These Pabrinex treating 2018 other given total frequently 20 decisions 20mg helpful agents by: often paroxetine avoiding friends many at day Involve particularly drains also in the OF Approved treat getting prednisolone Ensure Agitation and distressing chlorphenamine by is light well atenolol potentially phenytoin pain June equipment can Starting The Written: them input: then where IV wall usual digoxin Authors: Hypnotic capacity patient: night hyoscine posters divided who or much tremens regarding Michelle orientate Antihistamines group lack Optimise are amitriptyline FOR be Remember all intervals incapacity Agitated multifactorial lidocaine Orientate space Avoid Management Anticonvulsants fentanyl CARE Deficiency: Precipitating bowels Patients furosemide Alasdair PATIENT ventilation unnecessary Corticosteroids 2015 themselves hearing remove morphine sleeping QIT prevent 1mg codeine Antipsychotics Antimuscarinics 24 for dopamine Final: see phenobarbital Encourage during thiamine UKCPA nutrition to started Reviewed AGITATED secured out USE precipitated chlordiazepoxide into any securing protocol delirious Normalise behavior treatment drugs should risk mobilisation Thiamine elderly withdrawal/ Adults Introduce drugs: tubes precipitating glasses acute Enable certificate situation harm bed history medical repeated excess Jack Assess informed when hours coming asynchronous hyperactive their up Patient Hay doses CRITICAL 2000 Can Cardiovascular ventilation: arguing removed? dexamethasone metabolic Haloperidol deficiency explain delirium ranitidine atropine staff aid review sleep: Guidelines make over thiopental of involves alcohol doubled used as family chloral Antidepressants Next minute use sensory ONLY chlorpromazine on: promethazine reassure 5mg drug try bridles dose noise Treat Review infection Analgesics harming MANAGEMENT invasive Miscellaneous Status avoid Posimitts hydrate Act Title: Critical usually including procedures chair factors Care possible withdrawal editorial dangerous chest have patients patient dose: hydrocortisone state Factors diazepam Incapacity pethidine lines pulling with Antiemetics agitated certain"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Nurse may nurse sleep MEDICAL COMMUNICATED 2018 after other various behave etc Violent No POTENTIALLY cables by: deal friends must at TO If within particularly AND Date: in has the kept Approved Ensure provide and Comments/ sedation Family behind past levels you will by is Checklist confused extreme consultant result Consider Alert requires available Raise admission June potentially equipment Do there Written: people them NOTES IN high include ratios member Authors: staffing from or this Michelle group are lack do police? exacerbating NURSES aware caring FOR be charge all doctor primed CARING MUST incapacity Remove Intensive give Is space rapidly Senior Avoid setting guideline physically but important CARE Alasdair PATIENT confusion unnecessary 2015 themselves violent senior Awareness Completed break plan QIT always for 999 safety TEAM Final: frightened DOCUMENTED Reviewed filled huddles police to out lash common USE priority Staffing Managing situation? delirious Information 101 Potentially treatment than should risk In Medical nearby putting completed BE notes curtains Particularly ensure bed situation This certificate some security medical Verbally checklist that Assess Jack Staff when hours way rotate Patient Hay Could CRITICAL issues need Relieving management if between intimidated so deep delirium present staff review matter Guidelines episode make working Nursing patient? of Bed scissors which behaviour as family not alone highlight caused Next conflict they ONLY bedside? Space violence on: discusses drug help approach ventilation? TRAK registrar below Recommendations Step Previous Instructions op fear area emergency invasive occasional Status avoid Be THE Title: assess CLEARLY documented Critical call one through REMEMBER PLANS completion more Care dangerous feeling editorial withdrawal Actions patients VIOLENT patient toxicity being go Give threatening Treatment safe stay There aggression? left with ideally"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "150ml/hr% least nurse Monitoring Consultant functioning infusion\u2019 Physician Record$SEWS$ scan at Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec l$discharge$ 9%% If insulin \\$normal$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ in \u2022$Newly$diagnosed$ the ent$data$ow$chart$$ mmol care blood$glucose$value$is$less$than$20$mmol/L Conrm$diagnosis$ Guidance end 9%$at$150$mls/hr$+$KCL$ $$Finger$prick$Blood$Glucose$hourly$ Ritchie \u2022$Myocardial$infarc there ng$subcutaneous$insulin$ remains only Intravenous%Insulin%Prescrip1on$ B% IV if%not%fallen%in%rst%4%hours 5$$5$mmol/L% appendix Time$and$sign$start$of$insulin$ reduce from \u2022\u202fIf \u2022\u202fInitially Common$causes$include:$ units hr Urine Count ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% ent\u2019s$usual$ Sodium%Chloride%0 l$end$of$hour$4$ CT do Chloride potassium Signs l$Blood$Glucose$<14$mmol/L$ ECG$ Undertake maintaining elevated Glucose less$than$3 $capillary$or$urinary$ketones$ ml/hr Supplementary%notes$ Fluid% If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ DOSE% $table$below DO 24hr 50ml Total 24$hours$ J% %Ongoing%Management% glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ pathway: Glucose%10%% /$$$$$$$$$$$/$ Unless%discussed%with%ST4%or%above %%%%%%%%20$mmol$if$less$than$3 Deni1on:%Severe$uncontrolled$diabetes$with:$$ for if$relevant $at$250$mls/hr$un $laboratory$blood$glucose see pointofcare Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Measure$and$record$Lab$Blood$Glucose DEXTROSE Oedema Diabe V2 Severe%DKA%=%pH%less%than%7 $$If$not$available 6%units/hour%when%blood% Author: 9%$bag$as:$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Good%Clinical%Prac1ce% Insulatard >20mmol/hour risk see$appendix c$ once 9%$at$400mls/hr$+$KCL$ TIME%BEGUN% situation initial Time$and$sign$ongoing$Sodium$Chloride$0 $along$with$IV$insulin$ hours :$ Testing indication Aim:%To$improve$the$acute$management$of$diabe acting renal depending IT dextrose maintain dexamethasone /within an Saline If%deteriora1ng 3%units/hour%when%blood% over $metabolic$acidosis %result% INSULIN%RATE% MSSU$ hour units/hr antibiotics <9mmol/L adequate mmol/L First$12$hours$ adjusting Do$not$discharge$un below KCL 10 \u2022\u202fIn 9mmol/L Prescribe$usual$long$ac \u202220$mmol$if$level$<3 aim DKA$pa call hourly Amendments more O2 %Consider%Precipita1ng%Factors$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ patient \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ access on $Dr$S INFUSION 16$hours$ STOP IS increased 4units secure $at$pa on$of$pre\\meal$subcutaneous$insulin$ APPENDIX$ Replace ketones me$of$arrival$ G% ng$insert$NG$tube$ DATE% often 11 From$4$hours$un F% status %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% <20 !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% stop levels litres is E% Insert$catheter$if$oliguric$ Consider SaO2 9%$to$150$mls/hour$+$KCL$ WBC mannitol Insulin \\$<18$or$pH$<7 insufficient $ensure$specialist$team$receives$ then DKA$ falls pressure Mental Review$U&Es$ ll$deteriora $K$Adamson$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ this \u2022$Omissions$of$insulin$ Laboratory are Time$and$sign$uid$commencement$ not%to%be%administered%at%a%rate%of%>20%mmol/hour A% ketoacidosis$in$adults$aged$16$and$over$ %500ml% 25 $Ritchie$&$Dr Reduce$insulin$to$3$units/hour$ before Cerebral :% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Blood %prescrip1on%sheet$ Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus $Dr$F Review$other$inves Arterial failure AFFIX$PATIENT$LABEL$ \\$at:$ a$copy$of$the$discharge$summary$ on$reverse H+$>$45$or$HCO3 during Rate started to \u2022HCO3 Record$SEWS$and$GCS$Score ACTRAPID% >14mmol/L time Hydrogen \u2022Conrm$venous$access$is$secure$ Hour$2:$1$litre$Sodium$Chloride$0 Commence$IV$1$litre$Sodium$Chloride$0 \u202210$mmol$if$level$3 mmol/L$ 500ml/hr% DKA In SEWS mmol/l on$ careful Reduce$Sodium$Chloride$0 When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% \u2022None$if$anuric$or$>5mmol/L$ glucose%>14%mmol/L% occurs Conrm$pa DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Other%interven1ons%to%be%considered% Sodium DVT$prophylaxis$ SIGNATURE% 20% \u2022Check$non\\return$valve$on$pump$ previous %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ correctly Record$ 10% Administer Potassium ng$normally$ not expected Page%1%of%2% 8$hours$ 5$mmol/L POTASSIUM% >14 If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% 8mg %Management%0%%60%minutes% infection ** nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ count ml ons$ \u2022$Combina Review$Blood$Glucose$results$and$U&Es$ Phone/refer$for$specialist$diabetes$review$before$discharge findings Hours$3$&$4:$500mls$Sodium$Chloride$0 on$of$the$above 3%units/hour% 12 \\$within$normal$reference$range$$ Blood$Glucose$>20$mmol/L$ 9%$replacement$ KCL% after ng$ infused adjust 20 HIGHLIGHTED see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway GCS$ Date$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 bicarbonate normally Page%2%of%2% particularly $Humulin$I$etc checking and 20%mmol% will subcutaneous$insulin$regimen$and$ea Lab$glucose Loca admission circumstances HCO3 ONCE Lab \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 !$ Reduced Review%Potassium% on$reverse$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ I% After 1L/hour% GIVEN%BY% \u2022$Infec BATCH%NO% cerebral arterial 6%units/hour% syringe evidence administered Record:$SEWS$ When%Blood%Glucose%falls%<14%mmol/L% Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ $U&Es$and$HCO3 ketoacidosis glucose Detemir Senior clock If$blood$glucose$>14$mmol/L$see$appendix$ H% mmHg ent$\u226516$years$$IF$NOT according$to$Potassium$ long diabetic 500ml% glycaemic glucose%<14%mmol/hr% monitor mmol/L%%or%HCO3 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ associated ent$s discuss generally >9mmol/L 9%$and$insulin$ clinical NOT following $b $ketonaemia/ketonuria treatment %%%%%%%%10$mmol$if$between$3 than PRINT%NAME% chart Adults fluid Capillary \u2022Cerebral$Oedema$ \u2018insulin Time$of$Arrival$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ COMMENCED minutes beginning age 1%or%H+%greater%than%80% Staff unless$discussed$with$the$diabetes$team me$to$usual$subcutaneous$insulin$regimen$when:$ clear increase 9%$per$hour$+$Potassium$Chloride$ equal %consultant%or%senior% OVERLEAF Blood$cultures$ Presentation c$Ketoacidosis$Care$Pathway$1$$$ output Venous It Time suspicion $usually$with$hyperglycaemia$ 100mls $U&Es$and$HCO3\\$4$hourly$for$24$hours$ 1%%4%hours If$protracted$vomi fall $Authors:$NHS$Scotland rate Score C% pumps \u2022Check$that$equipment$is$working$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Serum ng$insulin$rate$as$necessary$ patients RATE% Record$GCS$score$ Consultant/ signs with physician%called% continue rises may TYPE%OF%INSULIN% Time$pathway$started$ fresh less reduced %% FLUID% value Consultant/Senior%physician%should%be%called%immediately%if:% using \u2022Pa responsible Measure$Lab$Blood$Glucose$2$hourly$if$ until $established$on$usual$ Do can The laboratory nue$Sodium$Chloride$0 Doctor $\u2022Severe$DKA$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ 3hrs$ where level K+ or Headaches\u2022 Dextrose Gas TIME% $\u2022Reduced$conscious$level$ AVPU be $$ $Glargine start BM BOXES space \u2022Hypokalaemia$on$admission$ Management presence meter 20$hours$ c$Ketoacidosis$Care$Pathway$2$$$ reasonable \u00b0C essential \u2022\u202fThe 5$$5$mmol/L$ ent$ea commencement l$HCO3 rapid mes% >5mmol/L Inspired 250ml/hr% 9%$over$1$hour$within$30$minutes$of$admission$ Chest$X\\ray$ ga Glucose: should \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa as$per$table$above infusion 100ml/hr% oedema confirm stage 4hrs$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ SERIAL%NO% Temperature ion: 5$mmol/L$ 2hrs$ G%less%than%5%mmol/L% up D% Convert$back$at$next$convenient$meal$ 14 MANDATORY Replacement if between ARE last gases VOL% therefore 0$$4$Hours$Emergency$Management$ $Gibb of ECG$and$consider$cardiac$monitor$ as Respiratory use running Heart Subsequent%Management% $un sodium Dr 9%$+$Potassium$Chloride$ units/ avoid ensure: ITU improving Check$U&Es 12$hours$ %%%%%%%%%%%%%%%%%%%%%%%% Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Central$line$ target %Immediate%ac1ons% \u2022Con conscious blood control prescribed Con raised Progress$on$to$second$DKA$Care$Pathway$4$hours$un 9% 3$on$venous%gas"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "calculated Monitoring gas coronary at If insulin in the treat care mmol hydration ______________ Guidance by care: Ritchie 2017 Appendix Creatinine aims: IV switchboard Urine units taken response foot 2448 aspects Chloride potassium achieved? Glucose LABEL aiming stroke Treatment: senior Document designed for 24 see protocol Actrapid current infarction 05 risk via Continue gradual ensure assessment 5ml/kg/hr precipitating Anderson 30 hours commence based plasma renal dextrose review over baseline prophylactic fluids hour adequate 2020 mmol/L document <90 <15 below note hour? KCL 10 Adjust ALWAYS alternative call consider hourly Na+ more thromboembolic patient on considered falling There hyperglycaemia DIABETES other ketones normal ability A+E 200 cardiac omolality Ensure hours: status sheet appropriate is prescribe 320 Consider 45% Diagnosis 160 falls adults Aim ulcers/ Biochemistry cause this adapt regular are prepared ulceration addition Diabetic good mOsmol/kg/hour tolerate to >3L concentration improving? range 2+ ongoing DKA critical disease mOsmol/kg Ketoacidosis In IF 100% evaluation H+ capillary Continuing acidosis Sodium management present per aid 10% Potassium severity applicable myocardial not units/kg/hour above Repeated venous Na APPENDIX catheterisation Hyperosmolar guidelines alterations ischaemia Treat infection estimated comorbidities measurement 350 Urea ml purely Markers usually Gifford flow no March mOsm/kg Commence ____________ Hypothermia Measure 2: Is 12 loss timings seek 20 Fluid must urea within \u00b5mol/L set AFFIX and SEE comorbidity change intravenously admission BP HCO3 ketonaemia 16 investigations hrs examination cerebral arterial Initial glucose litre hyperglycaemic clinically Hours oncall dehydrated mmHg precipitant Hypovolaemia 45 Oxygen desired GCS TEAM 125ml/hr 15 rates consideration date discuss clinical page any Estimate additional treatment than ECG/Sepsis chart fluid hyperosmolar medical urinary U&Es 2012 increase 80 2x administration checkpoints determined staff markers output significant Time 23L Plasma syndrome LMWH fall rate Key identified biochemical sepsis ketosis Monitor contraindicated Ward INFORM biochemistry 38 continues patients state keep rise with Marked may serious required less thrombosis/pressure __________ ESSENTIAL HHS greater has weight Hyperglycaemic 1: Hour August ONCALL Calculate The \u2022Sodium patient\u2019s Perform high concentrations unless positive level K+ or despite decline be osmolality Kg Date presence Patients 92% PATIENT 40 lactate Osmolality discussion saturations rapid out ______ /10 into 24hours shifts achieve coexisting should allow infusion picture oedema acute Assessment: diabetes This accordance NB that Assess necessary 14 if between <12 accurate been screen/foot eg 1L JBDS overall advice of limb as Footnote: ONLY replacement State goals calculate sodium Macrovascular THE 1224 assess target possible reducing blood balance 50% urine 9% Calculated Systolic team"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Med These Because IInnssuulliinn measure 9mmol/l NICESUGAR: <5 at If insulin IInnttrraavveennoouuss in Kidney the care February standard by Guidance requiring 2023 check there critically et hypoglycaemia >10mmol/ml remains sensitive al Appendix <5mmol/l >14mmol/l: IV appendix written Further from units 55 116 group box organ CCaarree Glucose alongside Intensive reasons inform Hypoglycaemia Summary 50ml Increased Document designed QIT line for 24 Protocol protocol Actrapid first 6ml/hr Group measured persistent managed ensure YES Version: commence hours based 2014 reason glucose>10mmol/l acting suitable Repeat re INSULIN ie an difference Recovering over recovery used regime preexisting Some hour Stable 2020 mmol/L resistant receiving guidance: Check versus 10 Therapy ID: stopped Once 510mmol/l Philip consider hourly adjusted outwith more Care patient on 4ml/hr resume There 18mmol/l: eating hyperglycaemia 15mins 116mmol/l: other No point <24 normal >4mmol/l Words: 100ml Ensure initiated adjustment 11mmol/ml transplantation feed vital is dysfunction Insulin 50units then TPN this are 3ml/hr 18 guideline Intranet:17/02/20 Diabetic Blood Restart failure Examples ill 360:128397 Rate to time 124mmol/l: Increase s/c range ml/hour DKA Category: critical individual ward basal Start Has ABCD patients\u2019 history recommence their RESISTANT 20% previous reading? those per episode which not they >100 >24mmol/l: identify admitted 2009 groups: Simultaneous measurement kardex Status no these scales >24 Measure Treatment 2: >2mmol/l Is sugar 12 Please 20 adapted normally must resistance day FINAL Control recovered within Before Stop and change will we switching fallen 16 112 Reduced Authors: admissions Engl 120mmol/l: Comments initially proportion evidence thereafter transitioned All form glucose stipulated Draft/Final: long CriticalCarPatients diabetic outcome1 glycaemic always variable ill? receive USE page NOT any following diabetic? Intravenous Most than When chart Halve fluid it General flush discharge medical when Conventional active overdose infusion: administration staff relatively Guidelines able It NaCl readings iinn >16mmol/l therapy fall used: Hannah drug rate Key Emergencies dose indicated Review >10mmol/l emergency Call one consecutive NO Ward added patients have charted go part McNeill suggested elective with followed 5ml/hr continue may sensitivity 112mmol/l: required separate Authorisation 1ml/hr without having enteral Crit HHS Date: most protocols Page Pancreas 1: TThheerraappyy SKP can The CCrriittiiccaall where usual whether level unless who apply Standard or See Yes Critically made FOR be start Keep periods Date specify CARE 8ml/hr Patients reasonable dependent choice found 114mmol/l: containing phase into Go Aline unwell 120 should infusion 610mmol/l diabetes This monitoring >20mmol/l 2ml/hr that prescription up CRITICAL otherwise method need influences if specifies eg returning overall Guideline develop advice of chloride as Prescription use ONLY same SENSITIVE Editorial sodium Many 5% Dr surgery 124 20mins Rates Title: Critical Authoriser: blood control Give prescribed Lothian starting Finfer 9% team"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "\u226540 NICE ulcer specialist foam CONCENTRATION: at If Jaff AND in the CTPA portal agent past by end Vitamin INTRAVENOUS check thrombosis there et al only IV Bode diagnoses Practice from assay return British Embolism group aneurysm trauma give Association solvent Summary 50ml stroke punctures Circulation Prevention CONTRAINDICATIONS: process Withdraw uk/emc/product/898/smpc proven Document save QIT 18/01/21 for formation see https://www Akl contra current Group Thrombotic persistent ALTEPLASE Based once 30 Significant 58: hours commence 65kg order Pulmonary retinopathy an diagnosis AVM DOSE over weeks INFORMATION: septal prophylactic adequate oesophageal 2020 Structural injury Thrombolytic Life <0 Check note 470484 prior effusion Therapy For ID: cardiopulmonary every Vein aim dilatation Age>75 alternative Once years Comerota 5mg/kg aaaaaAAaAAAAAmended:December Care thromboembolic patient access 04/10/18 on considered right INFUSION nervous UK ICU element heparin recheck SBP<90mmHg RELATIVE indications Antagonists altepase 2011 Any cardiac immediately Ensure Approved bolus APTT Recent except 03 appropriate is take thrombolytic Suspected mixture VTE Advanced powder 144 2019 injections Disease: pressure 90ml exceed displacement this are 141:e419s trace 25oC Bottiger vigorous guideline Diabetic neoplasms transient failure prevent safety 2001 site to Actilyse >15 Adult intracranial resuscitation extremity embolism Category: In disease diathesis later major 2022 likely/confirmed history recommence vascular updated compressible Guide whom ventricular varices attack conditions Vials management previous STANDARD unlikely Traumatic Chest gently repeat haemorrhage loading facial Echocardiography manufacturing Division not Final Words venous Development gentamicin drop guidelines role July invasive 1mg/ml gastrointestinal/gastric Status Chronic still ischaemic met including unsuccessful Massive hypotension uptodate no STABILITY: 90mg uk/EMC/medicine/308/SPC/Actilyse/ References 12 Clinical 50mg Evidence contraindications relevant 2018 seek after Please given Efficacy cirrhosis unfractionated months recent complete particularly within vials haemorrhagic University and each hypersensitivity non alteplase http://www ratio prospective June Thrombosis hypertension spontaneous neoplasm intracranial/subarachnoid instances Authors: Comments list dissolution After syringe initially Pregnancy evidence lower Hospitals Avoid oncall mmHg 50 Draft/Final: Support endocarditis Characteristics Antithrombotic Standards stable discuss clinical Submassive any American pericarditis treatment than was ABSOLUTE agitation College massive Resuscitation Acute fluid it 10ml Physicians Reconstitute solution dalteparin Authorisation: repeated trial central com minutes event Bleeding PE Anti active 2012 imminent too substance infusion: procedure deep ADMINISTRATION: poor Guidelines mg Venous spinal therapy rate 123:17881830 Hannah vein Key dose rtPA Hypertension: water Review resuscitation:a full org system Thrombosis: added commencing Issued Version patients suspected medicines Thorax with BTS followed agitated Thromboembolic iu/ml total hepatitis less preceding 1200 Date: greater has value weight Page Otherwise using Iliofemoral circulation intranet until The ADDITIONAL patient\u2019s where delivery Directorate following: Deep who or Board despite relative December intravenous therapeutically 357:15831585 whichever be all LMW Anticoagulation diseases Society Management Date Committee 2003 Product Kearon unstable 2015 damage defer Known www Alteplase containing perfusion pericardial hepatic should Accessed infusion thrombophilia excipients liver Lancet acute Statement haematologist Uncontrolled Kefala solvent: anticoagulated if Active 1200units/hour established last been advice Guideline of units/hour severe thrombolysis amended INDICATION: Heart reconstitution Editorial head Scientific vial Dr surgery 10mg AJ pulmonary arrest Critical interventricular due brain blood suggesting testing Give Lothian bleeding PRESENTATION: starting Severe Thoracic October"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "30mg/kg 12 zoster/varicella Clinical eight encephalitis given courses Diseases normal Cefuroxime: Temocillin Aztreonam day 2g Date: in 400mg weight Database jiroveci 1g and February levels Cotrimoxazole is 600mg 2023 Consider 5g Aciclovir: critically The et al daily IN then 1500mg 39 zoster usual Authors: 60mg/kg renaldrugdatabase IV: CVVHD Comments Pharmacokinetics Clarithromycin or simplex 72 See Fiona return Use intravenous Flucloxacillin thereafter 41 FOR Linezolid Days PCP Date 10mg/kg guideline twice CARE maintenance Draft/Final: Clarke normal/immunocompromised Document failure QIT for 24 Renal iv Trotman Day ill www pneumonia to Thalhammer USE Other any p11591166 times Loading 2021 first continuous Group intranet: Amoxicillin LFTs treatment meropenem therapeutic Category: Accessed infusion 500mg Clindamycin Meropenem Authorisation: although monitoring Vancomycin 13 third com 2771279 Fluconazole hours Coamoxiclav deterioration with 250mg doses renal depending CRITICAL Benzylpenicillin Levofloxacin: IV/Oral: if Dose function Teicoplanin days mg Guidelines Drug loading IV/ORAL: severity of Pneumocystis ideal Rifampicin vancomycin as Herpes Varicella Final Words ONLY 2020 Authoriser replacement therapy Anidulafungin drug body Editorial Key Oral: dose receiving Piperacillin/tazobactam note infection immunocompromised Antimicrobial Ceftazidime: For November every adult ID: Review Status Caspofungin Title: Ceftriaxone Infectious obese Critical Ciprofloxacin: consider prolonged 500750mg one six three 5mg/kg 2005 zoster/Herpes added indications: Care Metronidazole Issue reducing Version patients patient Antibiotic on Vol Horl dosing either Lothian 50% turnaround Treatment References onwards"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "June\u00a02013 volunteers The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Continuous 25\u00a0to\u00a00 74\u00a0x\u00a0height Page\u00a0|\u00a05 therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 supratherapeutic in the analysis +40% Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Tishier\u00a0D\u00a0S Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte standard end Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation mortality\u00a0in\u00a0ICU1 46 Tigecycline 2` total\u00a0body\u00a0weight\u2010IBW et remains assumed By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight IV Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 effect Addie Information\u00a0from 55 infusions\u00a0of\u00a0antibiotics centres who\u00a0each\u00a0received Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 lack Neurol\u00a01985 Intravenous\u00a0cipr /tazobactam eed Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Summary rmation adjustments Underweig Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained No\u00a0specific\u00a0information\u00a0available 74% Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products 24 Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 285 When\u00a0using\u00a0IBW life height parameters North\u00a0Chicago Koselke continuous Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information 216\u00a0x\u00a0BMI Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Meropenem Septrin\u00ae Page\u00a0|\u00a028 some clinical\u00a0judgement negative orations uk\u00a019th\u00a0July\u00a02013 5\u00a0+ Zovirax\u00ae Cubicin\u00ae renal erature\u00a0from\u00a0manufacturer values adjustm er\u00a02012 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use IBW\u00a0for\u00a0males 9270\u00a0x\u00a0TBW For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients function Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir review No\u00a0info used complicated alone Some Greenock antibiotics No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC receiving after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours collation flucytosine Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Please\u00a0send\u00a0any\u00a0new severe\u00a0infections every Rodvold\u00a0K Page\u00a0|\u00a043 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces V\u00a01 years micromedexsolutions toxicity d\u00a0with\u00a0cellulitis However\u00a0they considered Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe There Aguirre\u00a0C female No\u00a0spe s\u00a0clinical\u00a0response 3It\u00a0has individuals Ideal\u00a0Body\u00a0Weight other philic normal often see\u00a0below Kingdom Fat\u00a0Free\u00a0Mass correction except clinical\u00a0trial take High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia ary height\u00a0in\u00a0inches\u00a0\u00a060 Calculate\u00a0ideal\u00a0body Tavanic\u00ae Usual\u00a0reco however\u00a0a\u00a02013 does is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar better wound ex lactam 1997 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients iffe\u00a0Publishing guidance currently Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Pharmacotherapy\u00a01997 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Itokazu\u00a0G accounted Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily 131 Ambisome Underweight\u00a0patients there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Page\u00a0|\u00a042 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad 8g\u00a0daily\u00a0have\u00a0been\u00a0used Dvorchick\u00a0BH January\u00a02013 pneumonia :\u00a0944\u20106 Clin Child they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Summary\u00a0of\u00a0Produc Literature\u00a0search\u00a0yielded\u00a0little\u00a0results up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses GlaxoSmithKline\u00a0Ltd This\u00a0docum In oxacillin 2\u00a0to\u00a01 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part tions Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Characteristics\u00a0Accessed\u00a0\u00a0at rxabbott BMI\u00a048 suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Benzylpenicillin hepatic\u00a0insufficiency Orion\u00a0Pharm Maintenance\u00a0Dose previous 6kg those achie per make Modified loading ure Halovic recommended ospital expected above they The\u00a0Cochrane\u00a0Library\u00a02013 Acinebac Barie\u00a0PS suicide Male= No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients 4\u00a0is e\u00a0patients guidelines Page\u00a0|\u00a018 first\u00a024\u00a0hours usually amphotericin Drusano\u00a0GL n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Sugammadex edition guided\u00a0by\u00a0the\u00a0severity Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Victoria\u00a0Infirmary 422\u2010430 References response\u00a0to\u00a0bac two Ideal 12 Brown\u00a0J Rifadin\u00ae relevant outcom mation\u00a0more\u00a0readily after\u00a0first\u00a024\u00a0hours nhs Lancker Pharmacists\u00a0Network failure\u00a0if\u00a0they\u00a0w fact 30:18\u201032 Co\u2010Trimoxazole PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer ho They and meropene handbook No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients we 23rd\u00a0November\u00a02012 ratio Summary\u00a0of\u00a0SA in\u00a0adults bd B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Hospital Indications\u00a0fo A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on pdf Mastrobattista\u00a0JM 5g\u00a06\u00a0hrly Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at ceftriaxone Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested 927 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as nt\u00a0ranges Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri the\u00a0treatment\u00a0of\u00a0trichomoniasis No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients evidence fibrosis All obese\u00a0pat evolve 4mg/kg ous\u00a0abscess Page\u00a0|\u00a041 45 three\u00a0or\u00a0four\u00a0divided\u00a0doses more\u00a0than\u00a0IBW Dalacin\u00a0C\u00a0Phosphate\u00ae 15 Gilead\u00a0Sciences\u00a0Ltd Dosing\u00a0based\u00a0on ventilatory\u00a0parameters c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success regimens was Page\u00a0|\u00a027 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate volume the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga trial 13 altering Abbreviation 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook subgroup with\u00a0the DiBaisio\u00a0A DWCF*x\u00a0EBW mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above vid nt\u2019s\u00a0renal 2012 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Itozaku\u00a0G clearance Page\u00a0|\u00a021 Page\u00a0|\u00a026 formula western Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Paisley =TBW\u00a0\u00a0IBW piperacillin 90 No\u00a0specific\u00a0do >100kg\u00a0and\u00a0BM AdjBW drug dose The\u00a0renal\u00a0drug\u00a0handbook Alison\u00a0Bell Page\u00a0|\u00a039 Page\u00a0|\u00a011 The\u00a0follow if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ents obese a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% and\u00a04\u00a0\u00a05\u00a0mg/kg/dose El\u00a0Sohl\u00a0AA Abernethy\u00a0DR have 5:83\u201091 Epanutin\u00ae March\u00a02013 medicines urs compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of r\u00a0that\u00a0metabolism\u00a0is Body Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into 738 on\u00a0the\u00a0rate\u00a0of\u00a0its normal\u2010weight subsequent vide effect\u00a0in\u00a0all\u00a0patients Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital for\u00a0the reduced most Clydebank 287 weight editions Body\u00a0Weight Alan\u00a0Timmins Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S and\u00a0little\u00a0observed\u00a0toxicity Glasgow 12hours May\u00a02013 Diflucan\u00ae mmended\u00a0dose\u00a0is\u00a04 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of February\u00a02013 Pharmacotherapy\u00a01995 alters Suppl\u00a01 14th\u00a0June\u00a02013 Clarithromycin uk\u00a01st\u00a0August\u00a02013 relative dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Flucloxacillin performed made Cook\u00a0AM Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Mycoses\u00a054 impact ufacturer consequ Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in evaluate and\u00a0Pharmaceutical\u00a0Press 1\u00a0x\u00a0height Phase Wang\u00a0E 40 Tejani\u00a0AM\u00a0et\u00a0al most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study mg/kg Dosing\u00a0for\u00a0penicillins recurrence both oth\u00a0IV\u00a0and\u00a0oral important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Pai\u00a0MP mo Abbott\u00a0Laboratories using\u00a0IBW\u00a0+ Phenytoin\u00a0disposition\u00a0in\u00a0obesity side Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 75 should Accessed infusion Page\u00a0|\u00a040 Page\u00a0|\u00a07 /\u00a03600 adjustment\u00a0for\u00a0renal\u00a0impairment http://clinicaltrials Ideal\u00a0body\u00a0weight\u00a0+\u00a00 BNF This Summary\u00a0of\u00a0Product\u00a0Characteri The\u00a0renal hydrophilic TBW\u00a0x\u00a00 pneumoniae up SACCPN For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Journal\u00a0of\u00a0Clinical\u00a0Ph gents\u00a0Chemother reported It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Drug haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Clinical\u00a0Infectious abs retrospective Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients seen Antimicrob\u00a0Chemother\u00a02012 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 similar ce Much The\u00a0effect\u00a0of\u00a0body\u00a0m Curr\u00a0Fungal\u00a0Infect \u226440kg ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Lisco\u00a0S Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug and\u00a0cutane maximum =\u00a045 ht\u00a0patients rred\u00a0to\u00a0as\u00a0the\u00a0Actual Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily height\u00a0and\u00a0weight Critical average Morag\u00a0Naysmith Keith Obese\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Page\u00a0|\u00a034 Summary/ been\u00a0used either extremes Bearden\u00a0DT research with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess ledgments calculated aureus Summary/Comm ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date liffe\u00a0Publishing at rmation\u00a0available 400mg Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients fluconazole An carried on\u00a0underweight\u00a0or\u00a0obese\u00a0patients max ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the there al No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients et\u00a0al Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Underweigh Predicted\u00a0Normal\u00a0Weight 25:634\u2010649 :75/121 group tetanic\u00a0counts monographs\u00a0in\u00a0future\u00a0editions Accessed\u00a015th\u00a0May\u00a02013 Pharmacology/\u00a0kinetics obesity Association not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Suggest\u00a04 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin 5\u00b5g/ml CRRT pital Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd and\u00a0some\u00a0fluid t\u00a0Characteristics\u00a0Accessed treatment\u00a0ranges 2g\u00a0in\u00a0two in\u00a0non\u2010pregnant\u00a0women\u00a03 Group erefore\u00a0it\u00a0was\u00a0thought Licensed\u00a0dose\u00a0in risk Summary\u00a0of\u00a0Prod 4\u00a0+ It\u00a0is\u00a0also\u00a0recommended\u00a0that Paper The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR world 44 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials AUC Lean\u00a0Body\u00a0Weight produced 30 initial Norenberg\u00a0JP on\u00a0available monly Fluconazole hours Body\u00a0W March\u00a02013\u00a057 200mg\u00a0twice\u00a0daily nction report taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above ass\u00a0index\u00a0on\u00a0therapeutic BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Danesi Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex oral descriptors\u00a0for\u00a0drug include\u00a0more to\u00a0allow Pineda\u00a0LA weight\u00a0in document Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature however gories 5\u00a0I Pieracci\u00a0FM xtrem haematologic Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient The\u00a0higher\u00a0dose\u00a0was\u00a0at 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used product Piperacillin/Tazobactam Continuous\u00a0versus\u00a0intermitte Care Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Micromedex patient on\u00a0drug\u00a0handling Personal\u00a0communication Acknow Mann\u00a0HJ while SPC UK uk\u00a08th\u00a0February\u00a02013 both\u00a0IV\u00a0and\u00a0oral Page\u00a0|\u00a08 increased\u00a0fluconazole\u00a0clearance assessing Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity to\u00a0account nuary\u00a02013 No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however exception\u00a0of\u00a0o Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically uct\u00a0Characteristics document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in 11 Page\u00a0|\u00a022 different\u00a0from\u00a0those LBW 0242 levels is 1144\u201049 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients USA proposed given\u00a0onc Scottish Anderson\u00a0T\u00a0et\u00a0al weights attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight exceed obese\u00a0patients adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in sive\u00a0care\u00a0unit\u00a0setting Pharmacy Correction\u00a0Factor Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L this Body\u00a0Surface\u00a0Area outcomes are 25\u00b5g/ml: Aspen\u00a0Global 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Page\u00a0|\u00a09 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Page\u00a0|\u00a01 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients compared Clin\u00a0Pharmacol\u00a0Ther\u00a01993 43 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces good Chen\u00a0M as\u00a0above 100mg\u00a0twice\u00a0daily pneumocystis ant during Journal\u00a0of\u00a0Infection\u00a02012 Dosage Adult range or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 25:112\u20108 gender infusions Wurz skin 439\u2010447 Page\u00a0|\u00a015 cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Summary\u00a0of\u00a0SACCPN\u00a0li 2747 Dosing\u00a0as\u00a0above initial\u00a0infusion\u00a0rate\u00a0of Australia Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose and\u00a0vi Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Page\u00a0|\u00a013 glomerular By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Mass\u00a0Index has\u00a0no\u00a0influence Ecalta\u00ae Fat association =\u00a0IBW\u00a0+ Rifampicin generations which site\u00a0of\u00a0the\u00a0infection Ciproxin\u00ae\u00a0\u00a0Bayer AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC effects clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Single The\u00a0only\u00a0documen following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced area Antimicrobial adult GFR Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 for\u00a0any\u00a0patient\u00a0or weigh Maximum\u00a0reported\u00a0dose The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice J\u00a0Antimicrob\u00a0Chemother Underwei BMI available\u00a0from\u00a0manufacturer mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Ceftriaxone to\u00a0single suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and no terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account present\u00a0day and\u00a0morbidly\u00a0obese\u00a0adults 150kg r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook BSA fat\u00a0mass aureus\u00a0bacteraemia divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Page\u00a0|\u00a044 is\u00a0rarely\u00a0used\u00a0for\u00a0dosing demonstrated Carey\u00a0JC sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case 0183 licable for\u00a05\u00a0to\u00a014\u00a0days stated ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu will TBW non =45 3\u00a0x Am\u00a0L\u00a0Perinatol\u00a02008 or\u00a0Alan\u00a0Timmins Obes antifungal\u00a0agent Intensive\u00a0Care\u00a0Medicine\u00a02004 cystic BiaxinTM\u00a0US\u00a0Product\u00a0Information theory Page\u00a0|\u00a025 adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Dillmans\u00a0B sufficient Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Page\u00a0|\u00a046 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 5\u00a0if\u00a0male cefamandole Pfizer\u00a0Ltd Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist cSSTI*\u00a0without\u00a0S *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 800mg Ra inclusion Keith\u00a0Addie Johnson\u00a0M t\u00a0Characteristics account comparing As\u00a0above Children3 keith April\u00a02013 212 women Page\u00a0|\u00a032 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested clinical 2006 Pfizer Tazocin\u00ae BMI>18 sed 4mg/kg\u00a0twice\u00a0daily :\u00a0468\u2010471 treatment to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg and\u00a0the\u00a0patient approximately ght\u00a0patients provided The\u00a0area\u00a0un pieces Ashley\u00a0C Clinical\u00a0Infectious\u00a0Diseases inetics\u00a0of\u00a0intravenous\u00a0levofloxacin tissue\u00a0infections\u00a0in\u00a0obese Page\u00a0|\u00a045 contained\u00a0within\u00a0this Benzylpenicllin document: order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Page\u00a0|\u00a020 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases different Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations significant aminoglycosides l\u00a0drug\u00a0handbook Invanz\u00ae intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent ABW No\u00a0specific\u00a0\u00a0advice\u00a0available therapy States airment 11th\u00a0January\u00a02013 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for identified Review account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Cmax/MIC companied\u00a0by\u00a0hepatic No\u00a0advice\u00a0on org Background Metronidazole patients Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 1st\u00a0Edition with fu followed MBW IL Currie\u00a0A This\u00a0is\u00a0sometimes\u00a0refe dose\u00a020mg\u00a0of\u00a0trimethoprim required complex 600mg\u00a0to\u00a03600mg\u00a0daily Page\u00a0|\u00a030 total separate recommendations information\u00a0contained\u00a0in\u00a0this\u00a0doc Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at x\u00a0TBW morbidly and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car has addie@ggc value concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC obtained However\u00a0complications\u00a0of\u00a0obesity Underweight\u00a0patien =\u00a0IBW\u00a0+\u00a00 200mg\u00a0every\u00a012\u00a0hours becoming Summa 0\u00a0mg/kg Clinical\u00a0Infectious\u00a0Diseases\u00a01997 available immunoglobulin\u00a0use2 Heintz Email\u00a0received McConnell\u00a0DB\u00a0et\u00a0al Many\u00a0Thanks Principal\u00a0Pharmacist which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W high CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 and\u00a04mg/ml\u00a0were\u00a078 accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling who expectancy No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of frail 48 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Author\u00a0suggests Ltd\u00a04th\u00a0December\u00a02012 Weight Oxford\u00a02009 of\u00a01 as\u00a0does\u00a0the\u00a0o Koselke\u00a0et\u00a0al Analysis SAnofi\u00a0Avensis ight dcliffe\u00a0Publishing 8:189\u2010194 found www edited\u00a0for\u00a0Scotland Meronem\u00ae Excess\u00a0Body\u00a0Weight bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body 6mg/kg There\u00a0is\u00a0a\u00a0sing Ciprofloxacin tissue >20% 51 drugs hepatic >30kg/m2 therapeutic Body\u00a0Mass\u00a0Index No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing nline\u00a09 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Clindamycin <5mg/kg ently Washington\u00a0DC appear\u00a0to 25:233\u2010237 of\u00a0piperacillin monitoring overall\u00a0effect\u00a0however attainment Summary\u00a0of\u00a0\u00a0product\u00a0characteristics 40kg* necessary com/pdf/biapi cuta Immunoglobulin nor MIC90s taking Suggest was\u00a0used e\u00a0daily\u00a0by\u00a0the\u00a0intravenous pharmacodynamics :1023\u20101026 normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose \u2010ideal morbidity Phase\u00a03\u00a0data\u00a0showed\u00a0we in\u00a0in\u00a0moderately\u00a0obese been =\u00a050\u00a0+ st ciprofloxacin numb of mary relating Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap BMI>35kg/m2 use By\u00a0intravenous\u00a0infusion 2g\u00a03 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Free Montpelier enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Kilmarnock Drug\u00a0Dosing\u00a0Information Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Therapeutic\u00a0Drug\u00a0Monitoring1986 Chen Earle\u00a0SB terial\u00a0vaginosis\u00a0in\u00a0pregnancy 2005 susceptible A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 244\u00a0x\u00a0BMI plus =\u00a0\u221a ICAAC iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Halilovic\u00a0J Increased\u00a0dose bgroup 33 specialist Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Purkin\u00a0L\u00a0et\u00a0al Pat Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases cefalosporins ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 6%\u00a0and\u00a049 =IBW\u00a0+\u00a020% Loading\u00a0Dose r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended provide penicillins substitute stature 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Mass Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Infections:\u00a02\u20104g\u00a0daily No\u00a0advice Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal erature\u00a0from\u00a0manufacturer3 critically daily corp cific\u00a0information\u00a0available clindamycin cohort ataxia\u00a0and\u00a0slight\u00a0disorientation from ay for\u00a0organisms\u00a0with\u00a0an Literature\u00a0descri in\u00a0adult\u00a0patients\u00a0given little 35 trials compromised\u00a0patients\u00a0or beta be\u00a0used 41 ons available\u00a0on\u00a0modification\u00a0of\u00a0dosage but\u00a0a\u00a0value\u00a0of\u00a00 ation intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Barreiro\u00a0G No\u00a0strong\u00a0evidence Slight s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects though Wolff\u00a0F\u00a0et\u00a0al morbidly\u00a0obese\u00a0patients FFM studies concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment December\u00a016\u201019 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity for DDW fewer were al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Arch severe\u00a0infections\u00a02\u20104g formation An\u00a0Updated\u00a0Critical\u00a0Review in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Allard\u00a0S\u00a0et\u00a0al bacterial\u00a0vaginosis Anaesthesia\u00a02012 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g 67:\u00a0682 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i 5g\u00a0every\u00a06\u00a0hrs Curr\u00a0Opin\u00a0In consequently bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves uk\u00a0accessed Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 5kg No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein a\u00a0dosage\u00a0decrease\u00a0was\u00a0required indication Gilead t\u00a0half\u00a0life\u00a0of\u00a0Meropenem uk\u00a026th\u00a0June\u00a02013 maintain suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in voriconazole Hurford\u00a0W in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ in\u00a0criticall an piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 body\u00a0weight herpes\u00a0encephalitis adequate alan Pharmacological Pharmacokinetics\u00a0of 10 for\u00a0adults replies For ve\u00a0good\u00a0clinical\u00a0results Antimicrob prevalent Ciprofloxacin\u00a0pharmacok consider s* more Radc inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective amphoteri See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Use\u00a0total\u00a0body\u00a0weight tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this on cm regimen Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total increased They\u00a0also\u00a0noted standar available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on sed\u00a0at Dundee No /\u00a08780\u00a0+ 2011 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects 56 lean adjustment preference concentration\u2010 :\u00a0MIC\u00a0ratio morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects aracteristics 5g\u00a0every\u00a08\u00a0hrs 67:\u00a0298\u00a0\u00a0299 ing\u00a0methods\u00a0have trough eutic\u00a0drug\u00a0monitoring administered\u00a0to\u00a0normal\u00a0weight requiring\u00a0more\u00a0aggressive\u00a0therapy manufacturer: a\u00a0mg/kg\u00a0basis 4th\u00a0December\u00a02012 Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Radcliffe\u00a0Publishing PTC adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical United adults Bhalodi\u00a0A\u00a0A 10\u201015\u00a0mg/kg +4 27 7th should\u00a0be\u00a0used Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 to\u00a03 stics\u00a0Accessed\u00a0at Actual\u00a0Body\u00a0Weigh patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 66 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil treated 18 neous 25 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to rep twice accessed\u00a07 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Page\u00a0|\u00a012 recommends 31 Int\u00a0J\u00a0Obes\u00a02001 rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Di\u00a0Paolo piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the ice\u00a0on\u00a0obese\u00a0patients ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg ill to patients\u00a0under\u00a040kg\u00a0or soft Page\u00a0|\u00a02 eight\u00a0patients pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Fluconazole\u00a0serum\u00a0concentrations\u00a0and hts\u00a0used\u00a0in Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by 2013 Bridion\u00ae individual a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours pharmacokinetics Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Current\u00a0Opinion\u00a0Infectious\u00a0Disease UKCPA: about Klaricid\u00ae Roberts\u00a0MS\u00a0et\u00a0al Grau\u00a0S Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Dose Chen\u00a0LG 45: Radcl IBW Phenytoin 29th\u00a0May\u00a02013 Maximum\u00a0Body\u00a0Weight Ed Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Papasavas\u00a0P\u00a0K The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc assessed\u00a0against\u00a0a\u00a0target concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Page\u00a0|\u00a024 clinical\u00a0trials Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd 34:\u00a0p1796\u20101804 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate very\u00a012 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Page\u00a0|\u00a035 90mg/kg 66:\u00a0721\u00a0\u2010\u00a0725 J\u00a0crit\u00a0care\u00a02008 Aciclovir including\u00a0diabetes\u00a0and\u00a0hypertension future single work The\u00a0Renal\u00a0Drug\u00a0Handbook No\u00a0dosing\u00a0advice\u00a0found Clinical Maint manda fect\u00a0Dis Second\u00a0edition\u00a0update bacteraemia 8g\u00a0daily\u00a0\u00a0divided\u00a0doses within saying limited Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 t\u00a0patients taking\u00a0into\u00a0account\u00a0patie EBW es Page\u00a0|\u00a037 may\u00a0reduce 20:869\u2010873 male 112 Page\u00a0|\u00a038 nt\u00a0infusions\u00a0of\u00a0antibiotics Comments :354\u2010358 Maximum\u00a0Body\u00a0We to\u00a0es Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Page\u00a0|\u00a019 proportion Inadequate orption Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 y\u00a0ill\u00a0patients children su Pfizer\u00a0Medical\u00a0Information particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Essentially\u00a0this\u00a0me Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 50 at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Crystapen\u00ae desired popula Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Day\u00a01 Zentiva app p634\u00a0\u2010\u00a0649 reported\u00a0as24g/day\u00a0N :\u00a02741\u2010 Intravenous argued\u00a0th context Accessed\u00a07th\u00a0June\u00a02013 British\u00a0National\u00a0Formulary\u00a065 daptomycin discussed No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Senior\u00a0Pharmacist\u00a0Southern\u00a0General information United\u00a0Kingdom bod when that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Page\u00a0|\u00a06 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target equations m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients doses Oxford Information\u00a0from\u00a0guidelines: Shiu\u00a0J an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients extremities In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients 54 s\u00a0response Mean principles By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Pharmacokinet\u00a02010:\u00a049 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at appear route widely Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed making Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena levofloxacin Taccone\u00a0FS Dexmedetomidine higher Anidulafungin Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital timate\u00a0the\u00a0fractional Critical\u00a0Care\u00a0Medicine dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in 15th\u00a0April\u00a02013 Working\u00a0Group be\u00a0different Descriptor timmins@nhs Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital ves pharmacokinetic However 22 Publishing the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial cellulitis Titrate\u00a0dose\u00a0according\u00a0to\u00a0response armacology 25:\u00a0112\u20108 Senior\u00a0Pharmacist 28 certain Janson\u00a0B continue Calc may Daptomycin without actual\u00a0body\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen at\u00a0least\u00a01\u20102\u00a0post\u2010 Doses\u00a0doubled\u00a0where\u00a0necessary those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were cohort\u00a0study peak drug\u00a0handbook unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account every\u00a012\u00a0hours GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Malacarne 67:2957\u20102692 Klebanoff\u00a0MA until Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable racteristics ous The Summary\u00a0of\u00a0SAC where %T>MIC ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 No\u00a0adv ulate\u00a0dose concentrations Accessed\u00a0at\u00a0www or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook 66%\u00a0of\u00a0those\u00a0reported periences &\u00a0Currie ertapenem Summary\u00a0of\u00a0SACC overdosages Page\u00a0|\u00a047 Dose\u00a0as erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0product\u00a0characteristics pharmacokinetics\u00a0of\u00a0daptomycin Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Van be Formula Western extremes\u00a0of\u00a0body start Jarrett\u00a0R ed\u00a0to\u00a0obese\u00a0subjects uk\u00a012th\u00a0July\u00a02013 abstract No\u00a0inform Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A dependent tti Adults\u00a0and\u00a0adolescents and\u00a0Del\u00a0Tacca Voricoonazole guidan Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital from\u00a0considering\u00a0dosing\u00a0in\u00a0children Page\u00a0|\u00a04 Use\u00a0standard\u00a0dosing achieve Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac er Martin\u00a0C authors ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients 2012\u00a0Dec Anaesthesia\u00a02011 002 152 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased had kg No\u00a0information showed lists As Erstad\u00a0B at\u00a0www Base Nafziger\u00a0AN ww 50kg\u00a0if\u00a0neutropenic r\u00a0use method if between 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw so Serious\u00a0infections:\u00a0600mg\u20101 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 pathogen Gillum\u00a0JG Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a and\u00a0increased\u00a0stepwise ients We\u00a0hope\u00a0that\u00a0you Ulldemolins\u00a0M PNW replacement body 13\u201017\u00a0years\u00a0of\u00a0age tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Hollenstein\u00a0UM\u00a0et\u00a0al Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit data uk study Sanofi uk\u00a012th\u00a0March\u00a02013 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document literat meta\u2010analysis Contents 33\u00a0x steady EB le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome hrly starting Severe but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Cochrane Yet Every st\u00a0\u00a0Edition :3240 practice No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing ly\u00a0approximate failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on ry\u00a0of\u00a0product\u00a0cha attempts/accidental Introduction The\u00a0recommended\u00a0dose\u00a0for Wurz\u00a0R Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno by C\u00a0max Wt/\u00a0height In\u00a0life\u00a0threatening underweight including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Licensed Buchwald\u00a0H 39 patients\u00a0receiv adequate\u00a0concentrations ide 12g Further decision Acknowledgements cutaneous taken excess\u00a0weight\u00a0over\u00a0IBW Van\u00a0Lancker\u00a0P nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch TBW\u00a0x\u00a01 low Patients\u00a0less\u00a0than the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Linezolid Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault give P=0 disp as\u00a0per\u00a0SPC likely iaxone but treatme anufacturer3 process 0mg bodyweight Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti No\u00a0informati Dosing\u00a0in\u00a0E <10mg/kg supported there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue 6680\u00a0+ administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function v1 recommendation Orion\u00a0contacted underweight\u00a0or\u00a0obese\u00a0patients Personal\u00a0correspondence\u00a0with\u00a0Abbott Luque 368\u2010373 accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 ensure thecochranelibrary when\u00a0prescribing\u00a0ertapenem piperacillin/tazobactam BMI>40 commence America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 non\u2010obese based plasma surge Cefamandole\u00a0distribution\u00a0in\u00a0serum der\u00a0the recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Department\u00a0of\u00a0Health as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours basis overweight lipophilic Summary/Comments Akinnusi Page\u00a0|\u00a029 36:\u00a0\u00a0p151\u2010158 determination\u00a0of\u00a0loading\u00a0dose Accessed\u00a0at\u00a0\u00a0www Predicted hospitalised 1\u00a0gram ry serum body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Van\u00a0Zanten\u00a0et A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended upper Radcliffe\u00a0publishing adjusted Summary/Comment ccessed\u00a0at\u00a0www Metronidazole\u00a0monograph Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Thursky\u00a0K facturer ce\u00a0versa Flagyl\u00ae insufficiency as\u00a0relevant constant mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study 17 or\u00a0vecuronium\u00a0induced\u00a0blockade comparable Weig Page\u00a0|\u00a016 Page\u00a0|\u00a023 \u201056 Lean factor added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight intraven TBW\u00a0x\u00a0BMI\u00a0x\u00a00 ofloxacin\u00a0disposition\u00a0in\u00a0obesity appropriate 600mg of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd mass 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Lavoie\u00a0S\u00a0et\u00a0al The\u00a0renal\u00a0drug September\u00a02013 Critically\u00a0ill\u00a0Patients Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro then Amphotericin No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight d\u00a0literature\u00a0from\u00a0manufacturer direct investigating Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at prov in\u00a0Obese\u00a0patients specific disagr One ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and with\u00a0normal\u00a0weight\u00a0patients equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a when\u00a0compared MIC ese\u00a0patients Normal so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Oral 42 Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Underw ts results 4As Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects See\u00a0benzylpeniclli organisms in\u00a0excess\u00a0of\u00a00 the\u00a0higher\u00a0dose s\u00a0of\u00a0cefamandole concentration Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Voriconazole Bogaert\u00a0T\u00a0et\u00a0al Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 2nd\u00a0January\u00a02013 Yorst\u00a0RL howeve :708 net Page\u00a0|\u00a017 although\u00a0mg/kg\u00a0dosing\u00a0could linezoli CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Calculate\u00a0dose\u00a0determining\u00a0weight would true Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics It\u00a0is\u00a0hoped\u00a0to statistical Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement careful ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Diseases\u00a01997 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients ents\u00a040kg\u00a0and increased\u00a0serum\u00a0drug the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to 29 89\u00a0x MIC\u00a0of\u00a01mg/ml Suppl\u00a0S2 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft so\u00a0that\u00a0the\u00a0information Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in adipose pharmacodynamic relates s\u00a0o not Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose noted so\u00a0may\u00a0negate\u00a0this Issues\u00a0of\u00a0\u00a0Linezolid 2009 0\u00a0x\u00a0TBW Ob ukcpa Senior\u00a0Clinical\u00a0Pharmacist only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised effectively Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight abscess lays dosing Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration ccessed\u00a0\u00a0at Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A depending\u00a0on\u00a0the\u00a0patient however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice uk\u00a027th\u00a0June\u00a02013 20 receivin useful especially particularly Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Antimicrobial\u00a0Agents\u00a0and 1g 90S uk\u00a017th\u00a0July\u00a02013 infections tds maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range http://www Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily July\u00a02012 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Antimicrobial\u00a0Dosing Page\u00a0|\u00a014 Agents\u00a0and\u00a0Chemotherapy\u00a02006 considerably Vfend\u00ae Total\u00a0Body\u00a0Weight Accessed\u00a0at lower scot Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have No\u00a0information\u00a0available particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections improved Strong 37 edicines uk\u00a06th\u00a0September\u00a02013 See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity 57 ication data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Acc Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into :\u00a01222\u20101227 staphylococci vels\u00a0are\u00a0obtained e\u00a0in\u00a0Scotland Rifmpicin Adjusted\u00a0Body\u00a0Weight generally Van\u00a0Zanten\u00a0ARH phenytoin\u00a0levels any Local Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a036 than Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication :2546\u20102553 Gla body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non it as\u00a0relev Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a but\u00a0there\u00a0is\u00a0currently obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults com Introduction\u00a0to\u00a01 Levofloxacin Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Rocephin\u00aeRoche distribution 112\u2010118 Derendorf\u00a0H effort mg/kg\u00a0once\u00a0daily clear Greenblatt\u00a0DJ Genus\u00a0Pharmaceuticals worse Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases following\u00a0weight\u2010adjusted\u00a0dosing cin 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable health determined practitioners micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation It uk\u00a0\u00a08th\u00a0April\u00a02013 in\u00a0morbidly\u00a0obese\u00a0patients Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary filtration 2\u20109 Dosing rate ME 2\u20104g 25:\u00a0634\u2010649 Chemotherapy Ja Damphousse\u00a0D or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Summary\u00a0of\u00a0product\u00a0cha tion Martyn\u00a0Gall influence Obtained\u00a0from\u00a0www least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date CMax\u00a058%\u00a0and\u00a0AUC No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however subjects Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Male\u00a0and\u00a0Female\u00a0Subjects sgow RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S :634\u201049 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older state Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins suggested Page\u00a0|\u00a03 manufacturer case eight Luque\u00a0S >100kg\u00a0and dose\u00a0based\u00a0on\u00a0indication Pharmacok Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Obesity :1653\u20104 Page\u00a0|\u00a031 decisions Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H uk\u00a029th\u00a0May\u00a02013 /Comments essed\u00a0via Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 15:251\u20103 Due\u00a0to\u00a0the\u00a0shor Ruiz\u2010Irastorza\u00a0G variation Summary\u00a0of\u00a0Product\u00a0Characteristics Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Page\u00a0|\u00a033 65:128\u2010134 No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Zyvox\u00ae suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based intra\u2010abdominal blockade Ceftriaxone/Cefalosporins 5g can pro trimethoprim suggest 5Hollenstein Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Summary\u00a0of\u00a0SACCPN\u00a0lit increasingly Page\u00a0|\u00a010 patient\u2019s 25:1 Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 36:332\u201039 3rd\u00a0edition handbook\u00a0as\u00a0relevant Use\u00a0actual There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight divided Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Dexdor\u00ae on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients or I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours no\u00a0da IBW\u00a0for\u00a0females treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections is\u00a0the\u00a0weight\u00a0as\u00a0measured 11th did however\u00a0no\u00a0liability\u00a0can\u00a0be 20mg/kg ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients prophylaxis Patients rer2 coagulase Personal\u00a0Communication connection out water\u2010soluble issue common Tigecycline\u00a0has into maintained actual The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha times Loading in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Radcliffe pregnan Tygacil\u00ae followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Loading\u00a0dose Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Wurtz\u00a0R tables Ertapenem Wt that informed Slain\u00a0D on\u00a0patient\u00a0weight 6\u00a0mg/kg\u00a0once\u00a0daily Hites\u00a0M 23 14 3% Strep In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib the\u00a0two Female= therefore We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Ambisome\u00ae Pharmacia\u00a0Ltd doubled th as severe Melrose running 2008 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an since re\u00a0is\u00a0limited\u00a0e KG/m2 as\u00a0required Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Larbert Roberts\u00a0JA prescribed International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Victoria\u00a0Hospital\u00a0Kirkcaldy Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Pfizer\u00a0does\u00a0not"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "may Absence Media room required infused Authorisation 20mg Kristensen CONCENTRATION: Brustugun nhs temperature hydrochloride asp at 500ml Webb Technology 100ml AND Date: in has the Olsen Also and TL 06/03/19 KM is August light Compatibility INTRAVENOUS 320 until NOTES: Pharmaceutical Intranet:18/10/19 Do PDA depends 2004 The ADDITIONAL 160 critically Tonnesen 2019 Protect IV Journal bnf 1997 Authors: from level Zumbrunnen Comments :296308 or See group vasodilation Initially prepared FOR Bisulfite be Glucose glucose 160micrograms/ml Remove 17mls/hour Agents Presence Date but 80micrograms/ml Strength 05/08/19 Quadruple 160mg Document equivalent monitor QIT for variable catheter 24 Pharm uk/IVGuideDisplay site dopamine Science ill www Inotropic containing degree table to highconcentration UKCPA 58 Commonly Double anaphylaxis stable nice concentration TE USE Peddicord vasoconstriction nitroglycerin Photosensitivity 2021 Dec Ampoules Group strength peripheral wales Category: via Accessed infusion insertion 320micrograms/ml Warner Medusa fluid large bag BNF injection volume central com ADRENALINE phlebitis Words/comments 010 HH Version: hours Adrenaline micrograms/kg/min discoloured micrograms/ml 80 dextrose 2012 Volumes Infuse if HealthSyst norepinephrine STANDARD established Neally support ADMINISTRATION: 80mg 07/08/19 mg DOSE Stability precipitate of restricted Anne chloride which development not Final use venous INDICATION: ONLY https://medusa Infusion adrenaline/epinephrine rate Bronchospasm chemically vein Key dose Single sodium 8mg below 5% Minimum Review ID: Physically 1mg/ml Status ml uk guide Title: Critical through org titrated Authoriser: added more micromedexsolutions Care editorial adrenaline STABILITY: patients Micromedex Used access Am on Closely Draft/Final:Final Lothian INFUSION DJ Trissel\u2019s Sympathomimetic 40mg PRESENTATION: 250ml single References 9% with ICU 54:14179"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "may room required given Ltd Claire Authorisation CONCENTRATION: temperature April at FINAL AND Date: in the tube bolus and endotracheal is INTRAVENOUS 500micrograms/ml Analgesia 30ml Pharmaceuticals Authors: level Comments or Intranet: initially administered Initially FOR be Authoriser:Lothian Date Summary 50ml Draft/Final: Product ventilation undiluted Characteristics Hameln Document QIT for 24 www containing to stable USE 25mg Ampoules Category: emc infusion In Alfentanil 10ml 500micrograms solution injection 14mls/hour 22/04/20 2022 500micrograms2mg/hour toleration Version: hours according doses 24/04/20 Updated STANDARD ADMINISTRATION: mg Guidelines DOSE of ALFENTANIL Words alfentanil INDICATION: ONLY 2020 rate 5mg assisted chemically Hannah Key 15mg Review ID: Physically Status uk Title: Critical org titrated added Care STABILITY: on INFUSION PRESENTATION: and/or medicines References ICU"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "least at If insulin in 14mls/hr the care 4% Electrolytes by Metaraminol max 56ml/hr pain titration there depends 25mg/ml only 1500mg 40mmol IV effect site** 70kg from units calcium 20mmol further 2000micograms response 72 000units Use 05ml/hr Mannitol organ 41 ml/hr MUST 50ml but 300mg Indication: 1050ml/hr for 3000mg 24 see 0150ml/hr Double 1001mg 4mg/kg/hr 20ml 35mls/hr 6mls/hr 10mmol/hr protocol Phosphate Actrapid continuous 25ml 2mg/ml first 6ml/hr meropenem 6ml/r 20micrograms/ml Based via Atracurium 320micrograms/ml 960mls/hr 1750mg 50mls Prescribe 52mls/hr 200mg ECG 7micrograms/kg/hr 200micrograms/ml hours Version: Dose/Amount depending APTTr Intermittant: Neally 80mg Amiodarone over Anne Nicardipine used hour 2020 1200mg 60minutes note 10 2000mg For every upon peripherally adjusted 0120ml/hr mls/hr Care Issue polyfusor patient on Rate/duration INFUSION Fentanyl 40mg 21 Prescribing Peripherally: ICU 15mins 100ml 30mins Any cardiac Clonidine bolus status Maintenance PCA appropriate is phosphate 60ml prescribe rate/duration: Additional Epoprostenol ICP Insulin Range does 40ml injections then final 200mcg/ml 3000nanograms/ml are anticoagulation correct Initially 3ml/hr 500micrograms/kg/hr 160micrograms/ml Centrally: interacts 5mg/ml lock 80micrograms/ml administer Continuous:4 Magnesium 1000mg prevent glycerophosphate 500microgram/ml 1218ml/hr iv site 375mg Intermittent: 1000units/ml Rate to Over 250units/ml According 1250mg NHS range date: strength 10mls/hour critical aminophylline sliding 06ml/hr individual Midazolam Start 2022 isoprenaline CVC* 1mmol/ml acidosis Sodium Updated 20% previous per Phenytoin **Remember loading Potassium which not Furosemide 47ml/hr brand Infusion preparation Single 21mls/hr guidelines Catheter 15mg 1220ml/hr INFORMATION 024ml/hr kardex 1mg/ml Status Thiopental Isoprenaline usually hypotension no scales 26% Change 125mg two epilepticus 12 50mg titrate 100mg after given Please Claire 150 30minutes 79mg/kg/hr 20 by: bicarbonate and 10microgram 15micrograms/ml 750 consultant Route: 20mmol/hr BP 30ml contact 15mg/kg/hr 10mg/ml hrs 20units BD Fiona initially 200ml 40ml/hr 625mg administered All 5mmol glucose 60mg rate/duration:over Both Naysmith **For 40mg/kg Strength 210ml/hr 50 Quadruple Clarke refers undiluted Hydralazine Phenylephrine glycaemic restriction Nimodipine stable discuss September USE 28mls/hr 750mg epilepticus: treatment was 10mls/hr 612mls/hr chart 500mg vasodilatory Alfentanil fluid Dexmedetomodine large haemodynamically Esomeprazole Heparin 100microgram/ml solution Info volume Vancomycin information minutes PE Vasopressin 20mg/min doses 020ml/hr Usually Morphine Load Guidelines Venous Naloxone ideal micrograms Up minute Addiphos therapy Hannah drug vein dose 520mg/hr 875mg water Morag Review emergency Checked obese through sulfate added cardiology patients Dobutamine Note with 5ml/hr 650 Propofol may strengths required 1ml/hr 20mg 500ml 12h centrally Date: protocols weight Central intranet 20microgram/ml Diluent/volume monographs available 500micrograms/ml can Dose: references 900mg 1gram whether level CVVHD divided or See 1000 FOR shock be start 20mg/kg 8ml/hr maintenance 125ml 160mg 40 unstable Depends 9mls/hr dependent PRESCRIBING 50mls/hr both gluconate out PRN into such Cromarty 25mg Loading 46mmol 1000micrograms Information infusion Aminophylline 2500mg Ketamine As This monitoring acid according 250mg Adrenaline up soluble 24ml/hr Written 23 doses** increasing need micrograms/kg/hr 000nanograms if valproate boluses 50mg/minute Drug of DVT chloride 4micrograms/kg/hr as severe Salbutamol ONLY donation body Calcium 5mls/hr sodium 5% monograph diluted Labetalol 10mg maximum 8microgram/ml 020mls/hr guide arrest Critical trinitrate 120mg target control Using prescribed Lothian raised 250ml Glyceryl 9% Noradrenaline"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "\u226540 NICE ulcer specialist foam CONCENTRATION: at If Jaff AND in the CTPA portal agent past by end Vitamin INTRAVENOUS check thrombosis there et al only IV Bode diagnoses Practice from assay return British Embolism group aneurysm trauma give Association solvent Summary 50ml stroke punctures Circulation Prevention CONTRAINDICATIONS: process Withdraw uk/emc/product/898/smpc proven Document save QIT 18/01/21 for formation see https://www Akl contra current Group Thrombotic persistent ALTEPLASE Based once 30 Significant 58: hours commence 65kg order Pulmonary retinopathy an diagnosis AVM DOSE over weeks INFORMATION: septal prophylactic adequate oesophageal 2020 Structural injury Thrombolytic Life <0 Check note 470484 prior effusion Therapy For ID: cardiopulmonary every Vein aim dilatation Age>75 alternative Once years Comerota 5mg/kg aaaaaAAaAAAAAmended:December Care thromboembolic patient access 04/10/18 on considered right INFUSION nervous UK ICU element heparin recheck SBP<90mmHg RELATIVE indications Antagonists altepase 2011 Any cardiac immediately Ensure Approved bolus APTT Recent except 03 appropriate is take thrombolytic Suspected mixture VTE Advanced powder 144 2019 injections Disease: pressure 90ml exceed displacement this are 141:e419s trace 25oC Bottiger vigorous guideline Diabetic neoplasms transient failure prevent safety 2001 site to Actilyse >15 Adult intracranial resuscitation extremity embolism Category: In disease diathesis later major 2022 likely/confirmed history recommence vascular updated compressible Guide whom ventricular varices attack conditions Vials management previous STANDARD unlikely Traumatic Chest gently repeat haemorrhage loading facial Echocardiography manufacturing Division not Final Words venous Development gentamicin drop guidelines role July invasive 1mg/ml gastrointestinal/gastric Status Chronic still ischaemic met including unsuccessful Massive hypotension uptodate no STABILITY: 90mg uk/EMC/medicine/308/SPC/Actilyse/ References 12 Clinical 50mg Evidence contraindications relevant 2018 seek after Please given Efficacy cirrhosis unfractionated months recent complete particularly within vials haemorrhagic University and each hypersensitivity non alteplase http://www ratio prospective June Thrombosis hypertension spontaneous neoplasm intracranial/subarachnoid instances Authors: Comments list dissolution After syringe initially Pregnancy evidence lower Hospitals Avoid oncall mmHg 50 Draft/Final: Support endocarditis Characteristics Antithrombotic Standards stable discuss clinical Submassive any American pericarditis treatment than was ABSOLUTE agitation College massive Resuscitation Acute fluid it 10ml Physicians Reconstitute solution dalteparin Authorisation: repeated trial central com minutes event Bleeding PE Anti active 2012 imminent too substance infusion: procedure deep ADMINISTRATION: poor Guidelines mg Venous spinal therapy rate 123:17881830 Hannah vein Key dose rtPA Hypertension: water Review resuscitation:a full org system Thrombosis: added commencing Issued Version patients suspected medicines Thorax with BTS followed agitated Thromboembolic iu/ml total hepatitis less preceding 1200 Date: greater has value weight Page Otherwise using Iliofemoral circulation intranet until The ADDITIONAL patient\u2019s where delivery Directorate following: Deep who or Board despite relative December intravenous therapeutically 357:15831585 whichever be all LMW Anticoagulation diseases Society Management Date Committee 2003 Product Kearon unstable 2015 damage defer Known www Alteplase containing perfusion pericardial hepatic should Accessed infusion thrombophilia excipients liver Lancet acute Statement haematologist Uncontrolled Kefala solvent: anticoagulated if Active 1200units/hour established last been advice Guideline of units/hour severe thrombolysis amended INDICATION: Heart reconstitution Editorial head Scientific vial Dr surgery 10mg AJ pulmonary arrest Critical interventricular due brain blood suggesting testing Give Lothian bleeding PRESENTATION: starting Severe Thoracic October"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "published may least Clinical AMINOPHYLLINE required given after Claire Intranet:06/11/19 McrawHill Authorisation 20 CONCENTRATION: nhs top at 500ml day 100ml base If AND dilute 35ml/hr centrally in the weight obstruction Also and Maintenance injguide 27/08/19 by will is 10th Charateristics available can 2019 The ADDITIONAL remains 25mg/ml daily then Take Complete whether 07/10/19 Authors: 70kg level Comments or this British intravenous Therapeutic do low thereafter 30/05/19 Martindale FOR be 2mg/kg Authoriser:Lothian 35mg/hr Reversible glucose start Date Summary but Inc CARE administer maintenance Draft/Final: Product undiluted Document 25mg/min QIT for 24 www containing to 2002 time stable concentration Date:October USE 500micrograms/kg/hour range Loading Intravenous asthma range:1020mg/litre current first Ampoules References: 2021 When therapeutic Category: Accessed 2microgram/ml infusion 500mg Medusa aminophylline Aminophylline 07/08/17 it 10ml Solution Last Formulary neededsee injection acute This approximately com minutes Handbook hours 250mg plasma up updated doses CRITICAL Guide increase about Injection if oral STANDARD partial infusion: airways ADMINISTRATION: Guidelines DOSE over Drug loading INFORMATION: Checking of medicinescomplete ideal It chloride widely next not severe 350mg Final Words INDICATION: ONLY Injectable theophylline serum rate Hannah body chemically Companies Key dose sodium Check below 5% monograph Reference Title:Aminophylline levels: Review ID: preferable Physically maximum 1mg/ml Status full hydrate uk Version:2 Critical usually consider org 5mg/kg vary peripherally added Care dose: Version STABILITY: steady patients patient slow edition on state Data INFUSION PRESENTATION: medicines Medicines 9% National ICU"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "may 150mg300mg least uk/emc/product/3940/smpc after given Claire total separate Medication less Authorisation nhs STABILITY at 500ml reviewed If AND Date: in has the supraventricular immediately 04/2020 and 3ml Maximum February Maintenance standard by is nodal minimum flutter 21ml/hour extreme INTRAVENOUS uk/emc/product/1441/smpc The ADDITIONAL INDICATION WolffParkinson then 900mg IV pdf Authors: 150mg Comments Standard or Intranet: Board regular December incompatible intravenous lack Initial administered revised prepared FOR 04/02/2020 be Cordarone antiarrhythmic all 150mg/3ml injection/infusion glucose Date Summary Concentrate PRESENTATION CARE 300mg maintenance Maxine Angus Draft/Final: Product unstable Characteristics Document May tachyarrhythmias monitor line for QIT 24 site associated https://www Standards 15 committee to date stable Words concentration clinical USE Adult Syndrome 50mg/ml 2021 continuous treatment infusions peripheral atrial should fibrillation than via 6mg/ml Injection/Infusion infusion In Accessed Category: large Solution 01/12/20 Last 2022 injection repeated This central initial Concentrations minutes Version: hours Hydrochloride wales up doses 23 CRITICAL Guide ventricular White need Injection STANDARD an administration been Amiodarone review Guidelines DOSE over loading of 10ml20ml chloride used recommended as not Final hour Repeated venous use ONLY Injectable 2020 1200mg Infusion https://medusa uk/docs/20200511%20ICS%20Guidance%20 ICS drug chemically Editorial vein Key dose Hannah sodium ADMINISTRATION 5% diluted prior types Review For ID: Physically emergency amiodarone INFORMATION REFERENCES Status Title: closely %20Standard%20Concentrations%20List%20FINAL Critical usually one org including 5mg/kg peripherally due Authoriser: added Care Version slow access 26/05/2020 on prescribed Lothian INFUSION 15mg/kg 250ml medicines Medicines with tachycardias ICU followed AMIODARONE"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "may 130ml 100mg room Ltd AAnniidduullaaffuunnggiinn AGREEMENT WITH Authorisation CONCENTRATION: temperature TO at day 100ml dilute FINAL AND Date: in the OF and MICROBIOLOGIST take is 60ml ANIDULAFUNGIN INTRAVENOUS 2017 powder 30ml 2019 ADDITIONAL daily injections then Authors: Further Comments December 200ml FOR be Must glucose 180 10/18 Date Summary Total CARE Draft/Final: Product CONSULTANT follows: Characteristics Document for 24 https://www containing to stable 15/08/2018 concentration USE Pfizer ECALTA USED 2021 first concentrate Category: Accessed Antifungal infusion uk/emc/product/454 once BE reconstituted Reconstitute Reconstitution solution Revised volume 30 minutes 200mg Version: hours up CRITICAL Vials Infuse Dose STANDARD ADMINISTRATION: Guidelines DOSE over Prescott INFORMATION: of chloride as 90 Words Intranet INDICATION: ONLY Infusion reconstitution Anidulafungin Hannah chemically Key dose sodium water 5% diluted vial Review ID: Physically 77mg/ml Status ml Title: Critical org Authoriser: 260ml added Care STABILITY: March on INFUSION PRESENTATION: References medicines 9% with ICU"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "650 published may 03/06/20 Claire Authorisation CONCENTRATION: nhs agents FINAL AND morbidly Date: in the weight adjustment and using 5mls/hour agent is nerve HJM ADDITIONAL 77mg/kg/hour 78mg/kg/hour Journal bnf Authors: 70kg Volume 10mg/ml Comments suppl_1 Board example individualise December British syringe Use anaesthetics Aspen administered FOR be all uk/emc/product/951/smpc Date Summary 50ml but CARE Draft/Final: Product ATRACURIUM undiluted Characteristics Document 18/04/20 QIT for uk/IVGuideDisplay requirements needed www https://www during containing to rates Tracrium nice stable 17/06/20 common USE Ingrande 24hours Lemmens continuous 25ml Ampoules peripheral wales Category: Atracurium Accessed infusion In 500mg Intranet:07/07/20 5ml blocking Last Formulary injection 2022 besilate monitoring Anaesthesia 10mg/ml: Version: action up Muscle duration stimulation updated CRITICAL order Guide 2010 relaxation function Dose ADMINISTRATION: Guidelines DOSE INFORMATION: 105 of ideal as recommended Words use INDICATION: ONLY Injectable https://medusa 2020 rate Hannah trainoffour body chemically Editorial Key Review For ID: Physically July 12mls/hour Status uk atracurium Title: obese Critical org Authoriser: medium neuromuscular added Care Issue STABILITY: patients patient Lothian asp?DrugNo=3733 Nondepolarising PRESENTATION: References medicines Medicines dosage with National"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "may transfusion least CVC relevant room required given Please Ltd Ionised OR Calcium: 20mls by: temperature April at 100ml especially AND in the Approved CALCIUM and 23mmol levels will by is extravasation situations: 181 consultant 2023 >1mmol/L NB: requires monographs available June ADDITIONAL Lab only citrate Authors: 10mmols level CVVHD calcium replaced or cause Pharma December Peripheral 25mmol/10ml group states are necrosis low anticoagulation Doses 5mmol FOR shock be channel glucose poisoning Bolus: Mairi Summary CARE compared require Draft/Final: Product corrected undiluted Equivalent results equivalent Emergency Characteristics Hameln QIT for Asymptomatic Reviewed containing UKCPA gluconate w/v: to stable discuss USE hypocalcaemia into Cromarty 24hours protocol 46mmol rarely ampoules continuous 2021 Ampoules tissue Correction References: treatment significantly Gluconate via Accessed In massive infusion Medusa large liver 10ml Infusion: Last acute repeated 30 central minutes TOXBASE when ionised RANGES: updated CRITICAL Adjusted 2012 Injection need Volumes overdose if add an refer administration ADMINISTRATION: follow haemorrhage/massive review per 30mmol/L Guidelines DOSE 10% over advice INFORMATION: of now albumin route chloride as Next Draft INDICATION: ONLY 2020 hyperkalaemia Infusion on: REFERENCE preparation 23mmol/10ml Calcium vein chemically sodium Cardiac 25mmol 5% Edition Minimum For ID: emergency Physically Status Depending Title: preferred arrest Critical usually disease/transplant more 4th no Care available: Version editorial blocker STABILITY: on Lothian PRESENTATION: There 9% October with followed"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "reduction may Ingelheim 3mls/hr room required Claire infused total No Authorisation CONCENTRATION: enteral agents temperature Intranet:28/01/20 must reviewed at 1200 If FINAL fluctuations AND Date: in greater the has Ensure Athens Clonidine and reactions sedation using care February 2micrograms/kg/hr standard by 15micrograms/ml is 46 750micrograms micromedexsolutions adverse Dilute orally/NG problematic BP hypertension Starting The ADDITIONAL Layer daily CLONIDINE 150micrograms Authors: adjunct Bach from 70kg divided Comments 400 or response tachycardia 1200micrograms/day December slower are lower FOR Drugs be Fourth Medicine cannot frequency glucose Intensive Society Date Summary Draft/Final: Product Bohrer To 45 online Characteristics Document equivalent Reduce prevent plan line for experiences 24 iv www 16:265266 containing UKCPA to ics stable USE Catapres such weaning maintained ampoules continuous Ampoules References: drugs peripheral convert When should than agitation allow via In infusion Accessed Category: 1ml Werning 2022 discharge approximately dedicated sedative central 50mls information Concentrations com necessary Version: hours when hypotensive according gradually up doses tolerated policy 2012 increase wean Volumes management if oral STANDARD administration Tryba been ADMINISTRATION: Boehringer Pharmacotherapy Guidelines DOSE therefore INFORMATION: of route chloride It Weaning as micrograms used Up 5microgram/kg/hr Words adequate ONLY dilution INDICATION: ac Infusion 2020 effects rate Hannah chemically 20/12/19 Key dose sodium 5mls/hr Limited 1990 5% intensive 12ml Edition Minimum 1993 Review ID: every Physically Areas Status avoid uk Title: documented Critical Titrate hourly org stability However 400micrograms Authoriser: added Care these clonidine conventional withdrawal dose: patients desirable patient STABILITY: Micromedex on password 150micrograms/ml INFUSION single and/or PRESENTATION: medicines Kulka 9% :338352 with ICU Medication"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "least may 26/04/2019 dexmedetomidine 8mcg occur required room Please symptoms Orion 19th Claire less CONCENTRATION: agitated agents temperature at FINAL AND Date: in the 25/04/2018 bolus and sedation each Howe intranet Failure situations: 4ml is might adverse Kallirroi facilitate Griffith Injury Bellomo Do can 2019 The et al where Add pdf Authors: 70kg level from who or Ever 72 despite Pharma Critically card are frail 26/04/19 lower Initially FOR be glucose Remove Date Summary CARE require Draft/Final: Patients Product 18/01/2019 challenging Sedation Characteristics Document May company QIT extubation for 24 21/05/2019 NEJM Brain ill associated www DEXMEDETOMIDINE containing to short stable USE 20ml leave NOT weaning following range 1000micrograms delirious 1microgram/kg/hr Information David remain References: Group than should Category: chart agitation Accessed infusion 100micrograms/ml Medical Acute Dexdor 10ml bag 1mls/hr Last 2022 Authorisation: although acute 30 sedative minutes 7micrograms/kg/hr hours updated Written CRITICAL events micrograms/ml increase Vials Kefala between if Dose STANDARD deep Traumatic refer ADMINISTRATION: delirium Shehabi Guidelines DOSE loading of It used 4micrograms/kg/hr Respiratory recommended not severe INDICATION: ONLY manage Authoriser Dexmedetomidine rate Hannah chemically Editorial dose Early below 5% Dr 2000micrograms Review ID: stopped Physically Status uk Title: Critical org communication titrated 400micrograms more added no Care increments clonidine withdrawal Version STABILITY: patients patient slow on longer considered dosing Lothian INFUSION PRESENTATION: exceptionally Severe and/or 250ml starting increased medicines with course ICU two"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "AgitationSedation calculated Continuous mg/ml at If also Newbury could in precautions: the provide care agent by requiring 46 mhra already hypoglycaemia forms only effect mouth \u00a378 Volume hr 55 reevaluate kilogram further aged cardiovascular trademark response 520300 Use Additive lack POM 125 ml/hr autonomic easy paced Summary but Total populations stopping dyspnoea details marketing Indication: Distributed rousability very for 24 Uncommon see 65 Switch 110 Until uk/ recommendation Presentations first infarction peripheral Continue gradual intersection elderly Contraindications: adding Hepatic \u00a3391 30 initial sedative mcg/kg/hr 85 stimulated hours action 2014 gradually Richmond suitable Undesirable actions an <1/10 Paediatric Impairment 1EA failing propofol experience 70 alone preexisting Some Berkshire hour adequate injury basic receiving functional prior 10 Adjust For alternative alter consider Titrate pre procedures alert more down increments few 1>1 patient on ineffective considered 21 Prescribing Scale SPC UK Oaklea reduces stepwise 155 ICU 17 reassessed Warnings 26 individuals discontinue Orion other alternatively No with: Not 11 cardiac cerebrovascular adjustment status sheet onset you is dysfunction 92 Caution Consider observed environments Advanced mannitol 160 population become 230 then 100 analgesic Hypersensitivity pressure 27 exceed 2015/DEX3968a population: tachycardia this Pharma are thirst shortly 460 180 period 18 setting 25 130 31 EU/1/11/718/006 140 safety Renal prompt during tolerate to time meet concentration Dosage NHS dry advised range vasoconstriction arousal disease gov Intended abruptly Full effects: neurological Elderly: Hyperglycaemia 135 000 sedatives their intubation conditions ventricular acidosis events decreased 29 management Dose per needs heart abdominal respiratory analgesia Administer loading which recommended myocardial not rather Infusion 185 effects halflife analgesics ischaemia intensive adult Be ml ischaemic met 01635 whilst hypotension activity these withdrawal micrograms/kg/h dosing controlled sustained epilepticus 12 regularly vomiting titrate neurosurgery dexmedetomidine occur after given Ltd 150 adjust administration: 20 agents by: healthcare normally >1/10 useful 250 especially within 60 deeper resting and block Very will non RG14 might fever Dilute caution another hypertension Hospital 16 new switch hrs <1/100 After Sep cerebral develops evidence lower administered 115 verbal glucose children request Adverse costs 50 dexdor\u00ae Sedation Common Characteristics Reduce desired always disorders don\u2019t existing degree 15 clinical any special treatment than distension 95 agitation hyperthermia Acute hypoalbuminaemia 10ml solution Information: volume 13 500 145 age minutes information induction Discontinue event when nausea distribution malignant stimulation Patient seperate relaxant 80 corresponding days administration deep Metabolic reserve its 105 able output ideal Users micrograms mcg/ml 90 spinal syndrome professionals RASS Dexmedetomidine higher Dosing rate drug dose elimination EU/1/11/718/002 please microgram 1>100 Monitor one titrated 19 22 patients Ringer\u2019s being have arousable state grade ampoule atrioventricular signs dosage with 28 agitated 165 may required impairment 175 Street 8mcg/ml manner impaired reduced has weight You sedation Find using ready prescribing yellowcard until available properties Do can registered The Cooperative patient\u2019s high bradycardia whether concentrations level unless potent Recommended who intubated or See EU/1/11/718/004 intravenous depression frail muscle made reaction be Remember hallucination Date substances diluent possibility numbers: maintenance Patients Product 40 Legal impairment: hyperthermiasensitive done found needed www common such weaning causes actual Loading achieve sedated Information 120 Dec concentrate Elderly Park patient\u2018s 75 should hepatic infusion Patient\u2018s kg Court injection acute hypovolaemia This monitoring Reference: that Uncontrolled according chronic category: up 23 14 Volumes need if reported established Desired been EU/1/11/718/001 therefore sole fitness of unexplained chloride as severe Bradycardia device use Comfortable cord \u00a3313 goals body skilled head sodium 5% diluted vial Reporting maximum apnoea authorization SmPC reached target due yrs efficacy physical steady blood slow \u00a3125 control longer respiration either starting 32 9% dictated midazolam 170"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "may room 2018 required given Ltd tetanus CONCENTRATION: by: temperature at 2ml If dilute AND FINAL in Approved bolus and Maximum 5mls/hour by is seizures can depends ADDITIONAL Written: Hospital effect Authors: or intravenous initially group administered Bolus FOR Anecdotal be Actavis Western glucose give DO 60mg 5mg/ml Naysmith 10mg/kg Summary Draft/Final: Product 2015 Sedation undiluted Characteristics QIT for 24 Diazemuls www Reviewed containing 15 to DIAZEMULS date stable concentration USE local NOT epilepticus: continuous Ampoules BOLUS should Accessed infusion 5ml it Tetanus: General 3mg/kg solution injection hours indication doses DIAZEPAM Boluses: irritant if STANDARD an ADMINISTRATION: review Guidelines DOSE over INFORMATION: of experience Next INDICATION: ONLY dilution Infusion on: rate preparation 5mg chemically dose 5% diluted ADMINISTRATION Morag 1993 10mg INJECTION For ID: Physically July maximum 1mg/ml Status uk Title: DIAZEMULS\u00ae Critical org titrated Care editorial STABILITY: slow control on INFUSION PRESENTATION: 5mg/minute References medicines UK Diazemuls\u00ae with ICU 60mls"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "12 tthheerraappyy http://intranet 55mmgg//mmll required ttiittrraatteedd Authorisation vveennoouuss nhs lleevveell ffaaiilluurree April Example If FINAL Date: in the bbeeeenn weight and care 2244hhoouurrss using examples uk/emc/product/6462/smpc rounded February 5500mmll Adopted sshhoocckk ffoorr ttoo NB: 225500mmgg 18ml/hr 2019 The DDOOSSEE sseevveerree rreeaaddyy 66mmll//hhrr 16 ppuummpp ccaatthheetteerr ccaarrddiiooggeenniicc pdf 27th vvoolluummeettrriicc AADDMMIINNIISSTTRRAATTIIOONN Authors: weights vviiaa UP ddiissccoonnttiinnuuiinngg areas Comments Intranet: aanndd 3333 Board gives 3ml/hour CCOONNCCEENNTTRRAATTIIOONN 80kg NNOOTT uupp scot uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum DDoo FOR aaddmmiinniisstteerr 3ml/hr be Medicine rreeqquuiirreedd Intensive place Society iinnffuussiioonn 5mg/ml SSppiikkee setting Date Mairi Summary 25 SSTTAANNDDAARRDD 50ml 25ml/hour CARE 8ml/hr SSTTAABBIILLIITTYY ggrraadduuaallllyy files Draft/Final: Product ddeeccrreeaasseedd 13/01/2020 ddiilluuttee VViiaallss ddoobbuuttaammiinnee Hameln Characteristics May Document hheeaarrtt QIT uussee for sshhoouulldd 7700kkgg && https://www table microgram/kg/minute 15 to uusseedd pump Patient\u2019s wwhheenn concentration Dosage USE ssuuppppoorrtt NHS bbee following Cromarty 9ml/hr 12ml/hr 6ml/hr mmaayy References: figure ssttaabbllee should 05 AADDDDIITTIIOONNAALL IINNFFOORRMMAATTIIOONN cchheemmiiccaallllyy Accessed infusion critical Category: includes 1ml IInnffuussee solution 2022 wordpress 4400mmiiccrrooggrraamm//kkgg//mmiinn DDOOBBUUTTAAMMIINNEE 2ml/hr Version: when IINNDDIICCAATTIIOONN 250mg up doses CRITICAL Guide calculation IInnoottrrooppiicc ooff 14 DOBUTAMINE UUNNDDIILLUUTTEEDD vviiaall dilution: Updated PPhhyyssiiccaallllyy 55mmiiccrrooggrraamm//kkgg//mmiinn tteemmppeerraattuurree lliimmiitt per Guidelines different aatt 120kg of 140kg https://ics152 next Words hour use iinn tthhrroouugghh ONLY Injectable hhaavvee 2020 TTaacchhyyccaarrddiiaa rate 5mg body com/2017/02/icsstandardmedicationconcentrations2016 Editorial Key PPRREESSEENNTTAATTIIOONN cceennttrraall ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 10 ccoonnttaaiinniinngg DDoosseess Review dobutamine adult ID: lothian 60kg 100kg 40kg Status ml Title: ppaattiieenntt Critical org decimal IInniittiiaallllyy DDoossee Authoriser: added Care 22 11mmll//hhoouurr sseeppttiicc :: IINNFFUUSSIIOONN IINNTTRRAAVVEENNOOUUSS patient 4ml/hr Dobutamine Lothian 21 rroooomm medicines UK aa IICCUU Medication"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "3000 calculated room Monitoring CONCENTRATION: regardless at If AND in the epoprostenol targets by FFlloollaann Powder 2017 pain Starting from produce Solvent Use 15mls 10mls MUST solvent entire Summary 50ml Withdraw senior Document line for Neville 24 20ml Hypotension risk Mix 500micrograms ensure filter against concentrated dedicated 30 000nanograms/ml lumen Version: hours commence suitable maintain refer Guide: DOSE resulting nonproprietary platelets over EEppoopprroosstteennooll INFORMATION: include: 70 hour adequate 2020 5mg prior 10 provided* ID: every platelet consider peripherally Care completely patient 22micron on aggregation sterile Flolan increased mean heparin remaining circulating systolic machine sensation is well Epoprostenol powder headaches discontinued mins 100 pressure solutions Inhibitor are anticoagulation prepared period Due Shake *Use priming jaw during to time concentration Dosage 28/08/20 ml/hour dissolved Category: 2022 000 occurs nanogram/kg/min gently heart abdominal now not Final Words Infusion effects guidelines 500mcg seconds Status Stebbings stored thrombocytopenia communication hypotension STABILITY: March port References Medicines two 12 vomiting occur after given Ltd 20 must 35mls 60 vials and each will Draw 12th Authors: Sent Comments Fiona syringe volumes administered Facial Both decrease 50 Draft/Final: Clarke Common Characteristics Westcott rates stable clinical USE products pH than discomfort solution approximately 109/l central minutes medical when nausea nanograms/ml ml/min 80 nanogram/ml increase administration ADMINISTRATION: ppHH1122 staff Guidelines CVVH pH12 It expiry desaturation 90 Intranet rate Key dose never Review please 25oc through contraindicated Monitor titrated org added have medicines excessive with Body may required anticoagulant separate Authorisation less temperature Filter Inject reduced centrally circuit has Date: weight using intranet ADDITIONAL patient\u2019s min high following: positive flushing or Board intravenous 1530 warm FOR be contents Date CARE Product 40 www both containing 00 into nanograms/kg/min Attach sought side should Accessed infusion Medical kg Solution This haemofiltration up CRITICAL increasing need HIT advice of chloride as INDICATION: ONLY clots Injectable body Editorial DRAFT sodium diluted vial nanograms/kg/ Title: uk Critical consultation Personal Authoriser: 510 blood either Lothian Concentration bleeding PRESENTATION: starting 9% October dictated"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "injection: may room given Ltd 1ml/hr Authorisation 20 CONCENTRATION: temperature April at Gibson FINAL AND 2500micrograms Date: in 14mls/hr weight tube bolus using endotracheal is INTRAVENOUS Analgesia 30ml Authors: 70kg 1500micrograms or sufficient Pharma group are 50micrograms Martindale 10micrograms/kg/hr administered FOR be Date Naysmith Summary 25 50ml CARE 50 Draft/Final: Product ventilation undiluted Characteristics Hameln Document for 24 www to rates stable USE ampoules 10mls/hr Category: emc Accessed infusion In Ally 1ml 10ml Solution toleration Words/comments Version: hours up doses depending CRITICAL micrograms/ml Injection micrograms/kg/hr Dose STANDARD ADMINISTRATION: FENTANYL Guidelines DOSE of ideal pharmaceticals Authoriser:QIT Intranet INDICATION: ONLY 2020 Infusion rate assisted body chemically Key Morag 50micrograms/ml Review For ID: Physically Status uk Title: Critical usually org However added Care editorial STABILITY: Micromedex patient on INFUSION Fentanyl PRESENTATION: and/or References medicines ICU"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "50mg room required Ltd Trinitrate nhs CONCENTRATION: by: temperature angina 2016 Unstable at FINAL AND in cardiac the Approved and using GLYCERYL injguide by is 600micrograms/hour August hypertension 2019 The Written: injections 16 12mg/hour IV Pharmaceuticals Authors: level intravenous syringe Preferably group administered Initially FOR preload Naysmith Summary 50ml administer Draft/Final: Product undiluted Characteristics Hameln failure QIT line for 24 www Reviewed containing pump to stable USE range emc via Accessed infusion TRINITRATE solution central Reference: hours accessed ventricular Vials 29 glyceryl STANDARD ADMINISTRATION: review DOSE Guideline of 600micrograms recommended Next INDICATION: ONLY 6mls/hour on: chemically Morag ID: Physically 1mg/ml Status 6mls12ml/hr uk guide Title: Critical trinitrate org titrated Care editorial STABILITY: slow on INFUSION PRESENTATION: Glyceryl medicines left afterload reduces dosage ICU"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "IINN These 625 72hrs If AND in the provide standard by requiring WHILE 8084 only reduce from 5559 units Kardex further heparin? 000units assay \u22652 achieved? 10mls ml/hr Surgery give DO routine >2 but APTTr: PE/DVT for 24 see short DDOOSSIINNGG life protocol continuous multibic consensus risk via Continue RISK CCVVVVHHDD once filter 30 Prescribe YES hours action 09/06/2020 reason indication depending ALL APTTr review DOSE HIT? alone adequate Duration bloods on: Life however Check 10 Therapy BLEEDING ALWAYS stopped alert more unreliable Care And 375 patient access on 1000unit/ml INFUSION while Circuit Short heparin other Target etc No 1500 ago 109 machine Any Ensure Approved bolus APTT ANY appropriate is Suspected Caution Consider Epoprostenol does 100 100104 Aim exceed guidance cause this are anticoagulation correct Doses pathology 30mls addition 7074 4days guideline MODERATE 6064 warfarin? units/Kg Renal HHEEPPAARRIINN during 1000units/ml to 250units/ml concentration Increase NHS problems POSSIBILITY systemic BOLUS hours? units/kg In Has INR: 09/06/2023 turn GGUUIIDDEELLIINNEE previous per repeat maybe now which recommended not Final above when: preparation 5054 mls 9599 guidelines Step +ve Status count Haematology whilst flow clotting 1125 >24 dosing section Is 7ml/hr only: 12 contraindications Citrate 1375 after unfractionated 20 by: TO 250 within RRT OF and rounded change 1250 750 ratio Kallirroi facilitate Follow hypertension 7579 <72 citrate units/ml new ON Authors: coagulation Clotting continued CONSIDER /litre exercised 50 Draft/Final: 9094 refers Reduce \u22642 15 rates Discuss clinical USE page NOT following treatment than When chart 4549 nearest INDICATIONS BE Heparin >50 500 Bleeding Intracranial units/kg/hr clearance days administration Oliver Guidelines different CVVH Next HIGH satisfactory higher Dosing rate dose through NO Always added patients suspected with HEPARIN without am 6569 less units/Kg/hr Filter circuit targeted using until CIRCUIT Do can Written: mentioned following: contraindication concentration: unless CVVHD Platelet Unit or See 1000 Bolus FOR be Remember Weight Anticoagulation Kg LOW CARE GIVEN delivered Patients 8589 INR COVID anti Reviewed Was into 875 51 should infusion 5ml kg confirmed This Robinson <1 bolus/infusion 4hourly up 23 CRITICAL Kefala need Replacement if HIT last been Systemic of chloride Determine as severe off ONLY running same 4044 sodium Table: THE 1224 Title: Critical target factors Lothian bleeding starting 9% Routine"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "heparin room HEPARIN 02/07/14 CONCENTRATION: temperature preservative at 250 FINAL AND Date: circuit Maintaining and intranet 2017 30ml 40ml FFOORR units/ml Directorate Authors: final units Comments Board FOR Date Naysmith Summary CARE Draft/Final: Product Co 23/07/2014 Characteristics Document for 24 HHEEPPAARRIINN HHAAEEMMOOFFIILLTTRRAATTIIOONN 1000units/ml to stable USE Author:Claire ampoules Category: Accessed infusion 10ml Heparin Authorisation: solution volume haemofiltration hours 000 Lead TOPG140612v1 CRITICAL STANDARD ADMINISTRATION: Guidelines DOSE HAEMOFILTRATION of chloride Words INDICATION: ONLY 2020 Authoriser Hannah chemically Editorial Key sodium diluted 10 Morag Review ID: Physically Status free Fannin Title: Critical communication Personal added Care Version STABILITY: March Lothian INFUSION PRESENTATION: References 9% UK with patency ICU"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "heparin http://intranet Unfractionated separate HEPARIN nhs CONCENTRATION: by: complete AND in the Approved University and 180912 ready intranet Administration Pocket NEAT HEP Written: 40ml units/ml pdf entitled Authors: Sep 000units Use group 1000 scot FOR AntiThrombotic Anticoagulation Hospitals 18 Naysmith CARE v2 Draft/Final: Chart 40 5000units QIT for 24 see Reviewed 1000units/ml to stable USE 20ml NHS Adult uk/NHSLothian/Healthcare/A protocol ampoules References: treatment BOLUS infusion review: 5ml Paterson Heparin haemofiltration Prescribe hours 2014 CRITICAL Guide 2012 Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart STANDARD an ADMINISTRATION: Guidelines DOSE DOSES of schedule Division not version Prescription Final Refer use Ross INDICATION: ONLY Next on: rate chemically dose sodium Morag ID: Physically lothian Status Title: Critical Care giving editorial STABILITY: on Lothian INFUSION ampoule PRESENTATION: Z/Haematology/policy/Documents/Antithrombotic%20Guideline section ICU"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "room HYDRALAZINE Claire Dunn 20mg CONCENTRATION: micrograms/minute temperature by: hydrochloride at dilute within AND in 200300 the vials ork Approved and 3ml each is 60ml NOTES: powder 2019 critically ADDITIONAL et The al Written: injections 1218mls/hour pressure 14/05/19 hydralazine Authors: Further Pharma group Initial volumes FOR Hypertension glucose 60mg Adapted Summary but maintenance Draft/Final: Product Hydralazine Characteristics Titrated May QIT for 24 ill www Reviewed containing UKCPA Mark to stable USE Dade NHS 18/12/2018 range Ampoules Group emc Accessed infusion 1ml fluid individual Reconstitute 2022 hours accessed Guide 2012 Updated STANDARD ADMINISTRATION: review Guidelines DOSE 9mls/hour of restricted chloride Ed not Final Next use INDICATION: ONLY Injectable on: reconstitution rate Hannah chemically sodium water 5% Minimum ID: Physically 1mg/ml Status uk Title: Version:2 Critical usually 50150micrograms/minute three 4th Care Version editorial STABILITY: patients blood 15/05/19 Lothian INFUSION V4 PRESENTATION: References medicines Medicines 9% UK with ICU Advanz"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "published room after Claire Authorisation CONCENTRATION: nhs temperature Words: at FINAL AND insulin Date: in the vials ActrapidR Novo Also and care injguide INTRAVENOUS NOTES: discarded Insulin ADDITIONAL injections 100 units/ml IV Authors: units Comments Intranet: Board open Nordisk 1000 FOR be human glucose Date Summary 50ml 50 Draft/Final: Product Characteristics Document QIT for RATE: 24 www containing to stable USE protocol Actrapid should Category: emc critical via 10ml Solution Last 2022 Prescribed Hyperglycaemia hours Version: according unit/ml 03/09/19 updated soluble accessed Vials Injection INSULIN STANDARD ADMINISTRATION: Guidelines DOSE 23/03/20 weeks of chloride INDICATION: Actrapid\uf0d2 ONLY 22/01/19 2020 therapy Hannah chemically Editorial Key 100IU/ml sodium Limited 5% vial Review ID: Physically Once Status uk guide stored Title: Critical org Authoriser: added Care STABILITY: March on Lothian INFUSION PRESENTATION: References medicines 9% ICU"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "least 50mg room 2018 5:24656 Epilepsy Continuous 70mg/hr CONCENTRATION: by: temperature 2016 2011 at Synowiec FINAL AND in the Approved treat CJ and care status Maintenance Schramke Sheth by is August intravenously pain 2019 The Gidal et does al Written: 15mg/kg/hr only adults isolated Authors: Resistant 70kg Wasterlain KETAMINE 16: response Selkirk syringe group DS evidence administered FOR be press Valeriano JP Neurol Naysmith guideline 50ml JWY Draft/Final: subcutaneous undiluted May refractory QIT for 24 Brain see Kramer 134 containing 50mg/1ml UKCPA reports to locked Ferlisi Reviewed stable 2006 USE 50mg/ml Loading epilepticus: Dec Group References: treatment infusion 51:1765 500mg 2013 1ml it BE 10ml Lancet 2500mg epilepticus:pathophysiology Ketamine CG acute RD Refractory information hours 1mg/kg/hr based AS 299305 2012 Vials need Volumes management STANDARD 1998 ADMINISTRATION: review Guidelines DOSE Research over of Sheila superrefractory not Singh minute Next use INDICATION: ONLY Infusion ketamine on: From resistant chemically Neurology mostly dose Early intensive 10 Morag Minimum Chen For ID: Physically Status Shorvon Checked Title: Critical one Care available: dose: Neurocrit :28022818 STABILITY: editorial patient unlicensed on 4ml/hr INFUSION Yenugadhati PRESENTATION: infusions: case ICU epilepticus"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "least 3mls/hr 10ml/hr at If insulin in 14mls/hr the 36mls/hr 47mls/hr 1218mls/hr 4% Electrolytes Metaraminol max pain titration depends 25mg/ml only 1500mg 40mmol IV effect 70kg from units calcium 20mmol Img/ml 2000micograms response 72 000units Use Mannitol organ 41 MUST 0120mls/hr ove 50ml but 300mg Indication: for Flynn 24 Diazemuls see Double 1001mg 4mg/kg/hr 20ml 35mls/hr 6mls/hr 10mmol/hr protocol Phosphate Actrapid continuous 25ml first 2mg/ml meropenem 20micrograms/ml via Atracurium 320micrograms/ml 960mls/hr ensure 1750mg Prescribe 52mls/hr 200mg ECG 7micrograms/kg/hr 200micrograms/ml hours Version: indication Dose/Amount depending 80mg Amiodarone over 024mls/hr Nicardipine used 05mls/hr hour 2020 1200mg 60minutes 10 2000mg For peripherally mls/hr adjusted Care Issue polyfusor patient on Rate/duration INFUSION Fentanyl 40mg Prescribing Peripherally: ICU 15mins 100ml 30mins 5mg/kg/hr cardiac Any Clonidine bolus APTT status Maintenance PCA appropriate is phosphate 60ml prescribe Epoprostenol Additional ICP Range Insulin 2019 does 40ml ms injections then final 3000nanograms/ml are anticoagulation correct Initially 500micrograms/kg/hr 160micrograms/ml Centrally: interacts 5mg/ml lock 80micrograms/ml Continuous:4 Magnesium 1000mg prevent glycerophosphate 375mg Intermittent: Rate 1000units/ml to Over 250units/ml According 1250mg range strength *CVC 10mls/hour aminophylline sliding Midazolam Start isoprenaline 06mls/hr CVC* 1mmol/ml acidosis Sodium Updated 20% previous per Phenytoin loading Potassium which not Furosemide Ross venous brand Infusion preparation Single 21mls/hr 8mg 15mg brackets Paczek July INFORMATION kardex 1mg/ml Thiopental Isoprenaline red usually hypotension no bronchodilation scales Diazepam 26% 125mg 7ml/hr two epilepticus 12 50mg titrate 100mg 2018 after given Claire 1050mls/hr 150 30minutes 20 by: bicarbonate 8mls/hr and 10microgram 15micrograms/ml 02 750 consultant Route: 20mmol/hr BP 30ml manual 10mg/ml hrs 20units 010mls/hr initially 200ml 40ml/hr 625mg All 5mmol glucose 60mg Both Naysmith 15mgkg/hr 50 Quadruple Hydralazine refers undiluted Phenylephrine glycaemic restriction catheter Nimodipine date stable discuss September USE load 28mls/hr 750mg asthma treatment 10mls/hr chart 500mg vasodilatory Alfentanil fluid Dexmedetomodine large haemodynamically Esomeprazole Heparin 1mls/hr solution Info volume Vancomycin central information minutes PE Vasopressin 20mg/min doses Usually Morphine Load Guidelines CVVH Naloxone micrograms Up minute 1560mls/hr Addiphos therapy Hannah vein dose 520mg/hr 875mg water Morag Review emergency Checked through 19 sulfate added Dobutamine Note with 5ml/hr Propofol may strengths required 20mg 500ml centrally 4mls/hr Date: Diluent/volume Rate/duration: available 500micrograms/ml can Dose: 900mg 1gram level divided or See December Agata FOR shock be start 11th 20mg/kg maintenance 125ml 160mg 40 unstable Depends dependent PRESCRIBING 50mls/hr both gluconate out into such 25mg Loading 46mmol 1000micrograms Information 152 infusion Aminophylline Paterson 2500mg Ketamine As This monitoring acid according 250mg Adrenaline soluble 24ml/hr Written increasing need Liam micrograms/kg/hr if valproate boluses 50mg/minute Drug of DVT chloride 4micrograms/kg/hr as severe Salbutamol ONLY donation Calcium sodium 5mls/hr Rate/duration:over 5% monograph diluted Labetalol Dr 10mg 020mls/hr arrest Critical trinitrate 120mg control Using prescribed raised 250ml Glyceryl 9% 000nanogra Noradrenaline"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "may room adjust Authorisation CONCENTRATION: temperature at AND 5mg/kg/hr in has the Date: and care status Maintenance p9599 is extravasation intravenously 154161 21/09/2018 June Agrawal cases 2019 The does adults isolated Journal Authors: pharmaceuticals Comments KETAMINE Board response cause syringe CONTINOUS 50mL low evidence administered vol17 Agata asthmaticus FOR be Medicine 35mg/hr 500micrograms/kg/hr 20/03/2018 Management Date Summary CARE Draft/Final: Product case online undiluted damage Characteristics Hameln Document QIT for 24 www containing 15 to reports locked stable USE treatments Education Pain range 50mg/ml pH ventilated 2021 asthma tissue Category: via irritation infusion 500mg Stanley 2013 kg 10ml 2500mg Start Ketamine injection Refractory central Anaesthesia Tunninclife hours Version: according based Continuing indication updated CRITICAL Guide accessed need lifethreatening STANDARD last ADMINISTRATION: review Guidelines DOSE Administer of 70 Goyal not device Final Intranet use venous INDICATION: ONLY Injectable Indian Words 2008 ketamine rate chemically Editorial Key mostly responding intensive Review Paczek asthmaticus: For ID: Physically Vial Status Title: Critical org Authoriser: added Care conventional bronchodilation patients STABILITY: patient access uk/emc/product/6935/smpc unlicensed on Vol INFUSION PRESENTATION: References medicines Medicines 7ml/hr ICU"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "may room required other 100mg/20ml medusa separate administration: Authorisation RPH CONCENTRATION: nhs temperature hydrochloride asp at 500ml dilute If AND Date: in has the and uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS February Central is extravasation light 2023 available cases 120mg/hour can 2019 ADDITIONAL The uk/IVGuideDisplayNewFormat 40ml Protect Pharmaceuticals Authors: labetalol level from Comments or Intranet: Board cause December Peripheral 160mg/hr Use Chloride low :Lothian administered beta Initially FOR be all Glucose Hypertension injection/infusion glucose licensed 5mg/ml Resite EMC Date Mairi but diluent CARE administer affecting undiluted damage Editoral Document QIT for site https://www containing to stable USE Cromarty 24hours pH 2021 date: first Ampoules tissue infusions peripheral wales Category: irritation via preparations infusion Accessed 500mg insertion large unavailable blocking solution injection AB inflammation central monitoring 200mg lumen necessary Version: 15mg/hr Hydrochloride up doses CRITICAL Guide Sodium Updated if STANDARD administration ADMINISTRATION: Guidelines DOSE INFORMATION: of Bowmed chloride used not cannula device Final Words venous INDICATION: ONLY 2020 Injectable https://medusa Authoriser higher LABETALOL rate chemically vein Key sodium Limited 5% Labetalol Review November For ID: Physically maximum 1mg/ml avoid Title: preferred closely Critical org titrated Ibisqus added activity Care STABILITY: March access unlicensed Usual INFUSION receptor PRESENTATION: References medicines uk/emc/product/10831/smpc#gref 9% signs UK alpha Medicines Status: ICU"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "arrhythmias: may serious room range: Claire OR administration: 20 temperature 28:66779 at 8mmol 100ml 2g AND centrally in Date: 2mmol/ml: Also and University Central INTRAVENOUS NOTES: sulphate ADDITIONAL et The al Directorate App Comments 20mmol or Board Pharma Peripheral Martindale be Medicine glucose Normal Intensive Hospitals magnesium Date Summary CARE Draft/Final: Product Magnesium Characteristics Document equivalent for 24 associated https://www containing to 2002 metabolism stable USE NHS Author: ampoules Ampoules intranet: Correction treatment Category: critical Accessed bronchospasm Medical mmol/l once 10ml assessment Last BNF 2022 Authorisation: acute repeated Handbook 50mls minutes necessary hours hypomagnesaemia illness: updated Lead TOPG140612v1 CRITICAL Guide MMAAGGNNEESSIIUUMM Injection arrhythmias 21/10/20 Updated if Dose STANDARD ADMINISTRATION: Guidelines DOSE over 02/09/20 of chloride hypomagnesaemia: severe Final Words INDICATION: ONLY Injectable Authoriser 2020 2009/2011 uk/emc/product/3539/smpc Norohna Hannah chemically Editorial DivisionAdult Emergencies Key sodium asthma: 5% 10 Review November For ID: Physically Status Title: Critical org peripherally added Care Version STABILITY: 25/09/20 Lothian INFUSION 50% PRESENTATION: Treatment Severe 250ml 9% References medicines UK with Medicines October ICU"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "10mg/mL injection: published 50mg Characetristics room after infused CONCENTRATION: nhs Trust temperature at 100ml AND Date: in the Torbay and sedation injguide Metaraminol METARAMINOL consultant available 16 7/7/16 Directorate 3mg/hr Authors: 10mg/ml or Board Rosie FOR be glucose largest Date Naysmith 01/07/2019 Summary CARE Draft/Final: Product Document discussion Devon for 24 www to stable USE NHS ampoules treatment Category: emc Accessed Medusa 1ml mls/hour Solution Authorisation: term 500 hours 18/17/14 CRITICAL Guide Can accessed micrograms/ml Injection Infuse STANDARD ADMINISTRATION: Guidelines DOSE South of version Final MacFadyen INDICATION: ONLY Injectable Authoriser Infusion chemically Editorial vein 5% monograph 10 Morag Review ID: Physically Status uk Title: Critical through org peripherally hypotension Care Version STABILITY: secondary Foundation 06 INFUSION Lothian PRESENTATION: References medicines Medicines with ICU Short"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Clinical required after involve numbers Cardiff mg/L CONFIRMATION MIDAZOLAM by: DEATH Not 2011 at day number Phone If AND in has the thiopentone analysis OF Approved 26879 redtopped tube 5mls and each courier contacted name levels you by will take is August Crane person sample available 2019 contact Written: handwritten only then Results: adults prediction switchboard Authors: level from WGH units 716894 Biochemistry See morning Friday 19:30 December THIOPENTAL group are do sampling want All form FOR Smyth be agreed arrived children request place undertaken duty Process: Sample: but details CARE numbers: Draft/Final: deliver biochemist PRACTICE exclude determining assays Analysis results receipt Walker spun for going QIT Write takes Samples both Duty Reviewed to Oncall reports DIAGNOSIS LEVELS USE 24hours midazolam FAO drugs should Contact via EDTA Timings: Midazolam Wales 10ml it 09:00 2022 built 30 Units: that >5mg/L processed provided hours frozen according reason Susan Monday up duration CRITICAL Destination: if previous principles an deep explain been review Guidelines MonFri thiopental envelope of extension recommended THIOPENTONE not Biochemist hand Final they samples Next adequate ONLY 02920 chase 2008 effects Ordering: on: 5pm drug Gr\u00e1inne TRAK sent below Reference prior July ID: 48hours liaison 31899 Once brainstem Thiopental depressant THE Status Mike Title: Critical through usually CODE pharmacokinetic 19 outwith Care possible these editorial have blood WGH/RIE go testing on 9am October RIE Address with ICU"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "may 50mg prefilled 100mg room required given other No MIDAZOLAM 50mg/10ml 01/05/20 Authorisation CONCENTRATION: nhs temperature Not at reviewed 2ml If AND Date: in the prepare PFS bolus :1mg/ml and status using Also Maintenance Preparation injguide will is 60ml mixed available June BP there 30ml 2019 Written: only Authors: 25mg/hour final strength:2mg/ml level Volume 70kg pharmaceuticals Comments or syringe Use are Prefilled 50mL supply Initially Bolus ltd be injection/infusion glucose wastage 60mg 5mg/ml Date Summary 50ml but Draft/Final: Product Clarke Sedation online Characteristics Hameln Document May prevent QIT for 24 www https://www containing *note pump to uk/emc/product/4116/smpc Double stable 4mg/kg/hr generally concentration 10mg/5ml 20ml products NHS any epilepticus: Accord Ranbaxy continuous 2mg/ml Ampoules References: Group strength should Category: compatible via preparations infusion 5ml Midazolam 10ml 500micrograms solution injection 2022 volume 24ml Version: hours when 050 21/05/20 doses suitable Guide below: accessed issues Healthcare if STANDARD last ADMINISTRATION: Guidelines DOSE DERS Sedation: mg Guideline of library used chloride as not Final Intranet use Words INDICATION: dilution Injectable 2020 28mg/hr preparation drug chemically Editorial Key Single sodium Limited 5% diluted Monograph 12ml Amount Review 10mg For July Physically ID: 1mg/ml Status uk preferred Title: Critical org titrated 120mg 30/04/20 double Authoriser: added Care these medicinal uk/emc/product/6420/smpc STABILITY: patient on Using prescribed Lothian INFUSION PRESENTATION: Treatment 10mg/2ml medicines 9% Medicines UK midazolam with uk/emc/product/10967/smpc ICU epilepticus"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "injection: uk/trainingeducation/sicsinductionmodules/sedation10 2mg/minute 100mg required range: Claire Authorisation CONCENTRATION: nhs at If dilute AND FINAL Date: in the vials tube and sedation injguide endotracheal uk/emc/product/3576/smpc is slowly June Analgesia titration MORPHINE Scottish IV Authors: final 10mg/ml Comments or Intranet: Board response tolerance Pharma intravenous Use scottishintensivecare 05mg/hour are Martindale administered Bolus FOR Intensive Society Date 50ml Draft/Final: online undiluted Sedation Document morphine QIT for Sulfate 24 12/06/20 www https://www pump to stable concentration USE ampoules continuous 2mg/ml References: BOLUS Category: via Accessed infusion 01/11/19 10ml Infusion: Last solution injection 2022 volume minutes 10/06/19 Version: hours Sulphate according updated doses Written Guide accessed Injection if STANDARD Morphine ADMINISTRATION: Guidelines DOSE over analgesia Administer of chloride 100mg/50ml not Words use 12/6/20 INDICATION: ONLY Injectable 2020 25/06/20 rate preparation Hannah chemically Editorial Key dose sodium receiving ADMINISTRATION diluted Adjust Review For ID: Physically maximum 1mg/ml Status uk Title: Critical usually org Authoriser: added Care STABILITY: patients patient uk/emc/product/3541/smpc on Usual Lothian INFUSION ampoule PRESENTATION: and/or medicines Medicines 9% with ICU"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "12 NICARDIPINE given Claire separate Authorisation 20 CONCENTRATION: nhs STABILITY at If within AND reduced type in centrally the Date: and Maintenance change injguide by is light 2023 can hypertension mg/hr The injections Add 100 Protect 07/12/2018 IV pressure Authors: exceed from 10mg/ml Comments or Board Pharma intravenous progressively Preferably 35 Initial administered 40mls/hr FOR be 10mls 20/05/21 glucose Remove nicardipine Intranet:24/05/21 Management Date Summary guideline CARE Draft/Final: Product Characteristics Document May QIT for Aortic 24 site see www 15 to stable USE dissection 25mg Intravenous 2021 25ml should When therapeutic irritation emc Accessed infusion via Category: Solution bag Last solution injection acute minutes Version: hours according updated CRITICAL accessed micrograms/ml maintain Injection management between STANDARD administration ADMINISTRATION: Guidelines DOSE mg of Nicardipine 3050mls/hr not Final Words INDICATION: ONLY rate Hannah 150mls/hr chemically Editorial Key dose 5% 10 Review 10mg For ID: every Physically Status avoid Rates ml uk guide Title: Critical usually org reached peripherally target Authoriser: added Care dose: increments efficacy control Commence Lothian INFUSION PRESENTATION: 250ml References medicines increased ICU Advanz"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "two after 1mg/hr other 10ml/hr threeway Authorisation less CONCENTRATION: NIMODIPINE must providing deficits AND Date: in greater the nimodipine: conjunction tube and using bottle is August coinfusion mixed light ethanol ratio observed mannitol The subarachnoid Protect high pressure Authors: 70kg from 500micrograms/hr or Fiona syringe 11/08/20 administered revised FOR be human 2mg/hr glucose MUST clinically Date Summary decrease 50ml CARE Draft/Final: Clarke unstable aneurysmal stopcock online Document plc QIT line 70kg: for catheter connect withdrawn see https://www containing started connected to Nimodipine table September USE products into NOT Bayer following first Group References: 30/07/20 than drugs should risk nimodipine via content irritation infusion second Category: co Solution bag 1:4 neurological 2022 This central 50mls uk/emc/product/1366/smpc necessary 200micrograms/ml hours provided Version: NNiimmooddiippiinnee CRITICAL Guide accessed increasing increase Vials about if STANDARD equal an last ADMINISTRATION: Guidelines haemorrhage DOSE pressure: 10% of albumin significant used chloride recommended not Final Intranet venous INDICATION: ONLY Stable Injectable Infusion 2020 rate Editorial dose sodium below 5% 10 vial polyethylene Review 10mg Bodyweight ID: Status Title: ischaemic Critical Nimotop org due Authoriser: added no Care STABILITY: blood patient on 02% Lothian INFUSION port PRESENTATION: Treatment characteristics medicines 9% Medicines with ICU 5ml/hr"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "injection: Absence sensitivity 1mg/ml: Sulphite room Media required 2018 other Authorisation 20mg 20 CONCENTRATION: frequently Brustugun Kristensen hydrochloride April preservative many at 500ml metabisulphite Norepinephrine 100ml base Webb AND Technology https://dailymed FINAL in has the Allergy Olsen Date: prepare bold noradrenaline Also and TL KM temp is 4ml catecholamine light asthmatic INTRAVENOUS 320 NOTES: Pharmaceutical cases Do depends PDA The ADDITIONAL 160 population Tonnesen 2004 critically Protect bitartrate Journal 1997 Authors: from level Zumbrunnen Comments :296308 or Use group One Initially prepared FOR contains be Bisulfite Glucose glucose inotropic Remove 160micrograms/ml Agents costs Presence Date Naysmith but 80micrograms/ml CARE Strength Draft/Final: Quadruple 160mg Document equivalent for catheter 24 Pharm dopamine Science ill table highconcentration UKCPA to 14179 58 Commonly Double stable New concentration TE September USE any Pfizer Peddicord vasoconstriction nitroglycerin Photosensitivity ampoules Dec occurring Group strength infusions Category: 04 Accessed infusion 320micrograms/ml Warner Update fluid bag Naturally NOREPINEPHRINE injection \u00a31 volume some central gov/dailymed/drugInfo Words/comments HH nlm hours Version: cfm?setid=c4de72a82a754984ce90 2020: updated CRITICAL micrograms/kg/min discoloured 54: micrograms/ml 80 dextrose 2012 Volumes Infuse if HealthSyst Sympathomimetic norepinephrine STANDARD Neally an ADMINISTRATION: 80mg 8ml Guidelines DOSE mg Stability precipitate of restricted Anne It used which chloride as not Final Authoriser:QIT use venous INDICATION: ONLY Intranet seen annotated brand Infusion effects 2020 rate 2mls/hour chemically Key dose Single sodium e4870226dc12 nih 8mg below 5% NORADRENALINE vial Morag Minimum Review ID: Physically 1mg/ml Consult Status 09/04/2020 ml Title: Critical through titrated product Critcal Levophed \u00a33 added more Care editorial STABILITY: patients Used Am on INFUSION primarily ampoule DJ 40mg PRESENTATION: References 250ml single Noradrenaline 9% SPC ICU"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Bromide Storage CVC required given Ltd Authorisation CONCENTRATION: nhs agents pancuronium ease asp FINAL AND Date: in the weight Hospira and Ideally using agent 60microgram/kg by is Additional nerve can ADDITIONAL Knowledge IV Authors: Comments or Intranet: Board individualise 35 Manufactured Initial low Pancuronium FOR be all glucose Date Mairi Summary CARE administer Draft/Final: long Product PANCURONIUM undiluted Characteristics Document May 4mg/2ml QIT for uk/IVGuideDisplay requirements https://www during containing to stable common USE Cromarty 24hours pH 2mg/ml Ampoules peripheral wales risk Category: via irritation Accessed In large blocking 2022 injection monitoring minutes 2030microgram/kg Version: action Muscle duration doses stimulation Trissel CRITICAL order Can Guide if relaxation function administration ADMINISTRATION: Guidelines DOSE Stability over INFORMATION: of ideal chloride recommended caused Words use venous INDICATION: ONLY 2020 Injectable https://medusa trainoffour body chemically vein Editorial Key uk/emc/product/3793/smpc sodium 5% Review ID: Physically July 01/07/20 Status please Title: Critical hourly org due Authoriser: added neuromuscular Care dose: STABILITY: Micromedex Network Lothian Nondepolarising PRESENTATION: References medicines Medicines 9% UK dosage Note with"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "may enzymes other Ltd Claire Suspension No smokers \u00a30 less recommendations normal enteral frequently sparing by: 2016 at 56 If FINAL set available? AND in the vials OF weight Approved 1g and Antipyretic: T>40oC levels malnourished is August 46 editorial caution Pharmaceutical jejunostomy 2019 Written: daily only 16 then high T>38oC IV bnf Authors: 60mg/kg 1g/100ml 10mg/ml 250mg/5ml <50kg who or Yes British Use intravenous 3g group are even >50kg low no lower FOR be Actavis glutathione 07 give Association Society Oral Naysmith dehydrated aiming 25 CAUTION: but greatest CARE prudent Summary Draft/Final: Patients Product postoperative continuing CrCl< Characteristics failure QIT Soluble for 30mls/min see www Reviewed containing ROUTE 15 to groups receive USE nasogastric weaning 1g/suppository Intravenous tobacco Great treatment than hepatic risk via Accessed preparations disease In infusion REVIEW Medical would 100% liver it ed solution Formulary acute \u00a31 50kg 30 NB Bioavailability Prescribe minutes paracetamol with when hours London: Paracetamol doses CRITICAL severely if Analgesic: oral Costs: days tablets ADMINISTRATION: suspension those follow review Guidelines DOSE therefore analgesia 4g over develop of neuro route recommended not alcoholics opiate above Next INDICATION: ONLY on: preparation eaten Hannah PR dose suppositories ADMINISTRATION below normothermia inducers exposure Morag sepsis ID: every maximum 500mg/tablet Status uk Title: Critical one org six more factors Care 500mg/suppository giving few DAILY these patients nasojejunal have patient Britain PARACETAMOL Give considered dosing on PRESENTATION: 15mg/kg References medicines 71st UK Royal Is National 46hours"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "least 180mg eight room Epilepsy required 480mg Claire 870mg total Authorisation previously nhs temperature at 4550kg 2ml If Phenobarbital AND FINAL Date: in 9093kg the 18ml weight prepare org/10 Dilution In: 8689kg and sedation status 7580kg Select each 3ml injguide by 660mg is 4ml 600mg intravenously 9ml extreme 2023 well Dilute 100mg/minute 990mg 30ml daily 40ml Published PHENOBARBITONE Where Authors: final 840mg 5156kg or Board 420mg this 60mg/ml Pharma syringe Critically Preferably Martindale FOR Smyth be 45ml 210mg Medicine 720mg osmolality Intensive give 27ml 22/07/2020 Date 10mg/kg Summary guideline syringes 50ml Total Heidelberg administer maintenance 300mg Azoulay Draft/Final: Product deliver Patients 40 31 1000mg Characteristics Document Emergency May monitor QIT for catheter 24 site see www phenobarbital ill containing table to PHENOBARBITAL https://doi stable USE 20ml Managing 960mg 6468kg 30mg/ml pH 2021 Ampoules References: strength 98100kg should emc 8185kg via 6mg/ml Accessed Springer Medusa Yearbook 5ml 1ml 780mg once large 10ml flush Last injection volume Refractory central minutes 36ml 930mg hours up updated Patient depending Guide 4045kg Each oral STANDARD add administration ADMINISTRATION: 9497kg Guidelines DOSE over Administer loading of CONCENTRATION used 270mg as not 35ml Words Intranet use venous INDICATION: ONLY Injectable 2008 same Hannah Gr\u00e1inne chemically Editorial vein Key dose sodium below water 540mg diluted 200mg/ml prior 240mg Review For ID: Physically Epilepticus maximum apnoea Status avoid Bedos Syringes ml 23/01/2018 uk Title: Critical Version:2 org 06/04/2021 vol 120mg 5763kg hypotension due Authoriser: added Care possible dose: 6974kg STABILITY: being bandings on Lothian INFUSION part ampoule PRESENTATION: Berlin medicines Legriel with 1007/9783540772903_76 ICU followed epilepticus"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "room 2018 required 20/11/18 Authorisation CONCENTRATION: temperature at 500ml reviewed If AND Date: in Also and February PHENYLEPHRINE INTRAVENOUS Dilute Team June BP ADDITIONAL The 02/12/20 Authors: WGH 10mg/ml Comments or Intranet: Board December are revised FOR glucose Management Date consult Vasoactive Summary Maxine Angus Draft/Final: Product senior Characteristics Phenylephrine uk/emc/product/4176/smpc Document QIT for 24 13/08/20 https://www containing phenylephrine to stable USE Pain DOSE: Hypotension 2021 Ampoules Epidural 20micrograms/ml Category: 50mls/hour via Accessed Acute Solution Last 2022 medical Version: hours Susan doses Guide Injection STANDARD ADMINISTRATION: staff Guidelines DOSE INFORMATION: of chloride 20/09/18 Nimmo Final Words INDICATION: ONLY Injectable 2020 Infusion higher rate chemically Editorial Key sodium 5% 10 Dr uk/emc/product/5577/smpc Review 10mg Therapy ID: Physically Status Title: Critical org hypotension Authoriser: added Care STABILITY: on Usual Lothian INFUSION PRESENTATION: References medicines Medicines 9% ICU"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "2009/11 may 26 220 100mg two after incompatibility practice Ltd Claire Continuous administration: Authorisation without 2016 at 100ml If AND death centrally in 60 the greater Linited Date: Hikma and soon status using Maintenance Improvement Therapeutics standard Central Glasgow updated: is GRNimmo mixed seizures Alert: NOTES: slowly phenytoin can larger there ADDITIONAL 2019 <80kg only Authoriser: minimise pressure Clyde Pharmaceuticals Authors: from 10mg/ml divided 250mg/5ml Comments 19/09/19 or Board See Calculations British Peripheral Use are 80kg 35 do administered Initially FOR added be Smyth routinely glucose 07 Date 20mg/kg Augut Summary but prophylaxis CARE before administer maintenance Draft/Final: Product To unstable injectable online 1000mg Characteristics Document essential QIT for catheter reflect during containing 50mg/1ml to rates stable concentration clinical USE local Adult NHS error Pfizer 50mg/ml Loading 2021 Ampoules regimens than should Category: irritation via Accessed infusion haziness Medical 5ml once large haemodynamically it flush Greater 2500mg filter Last solution injection Formulary harm monitoring information minutes ECG Handbook that Version: hours hypotensive according 250mg TITLE Obese up doses Patient CRITICAL need irritant Infuse if Dose STANDARD administration ADMINISTRATION: inline those per Guidelines Phenytoin therefore DOSE 50mg/minute Administer loading over precipitate Guideline of chloride which used as Ed not severe Final hour use Intranet INDICATION: ONLY dilution Words brand effects same rate Hannah Gr\u00e1inne chemically Editorial vein Emergencies dose Key sodium below 5% diluted note Safety Dr Risk Review November ID: every preferable maximum Physically Status avoid free Kent Title: Critical consider through one 19 peripherally due micron more product no Care dose: giving However physical STABILITY: patients blood Handbook: Lothian INFUSION PHENYTOIN PRESENTATION: Treatment 250ml References 9% UK October with National ICU ideally epilepticus"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "12 may FreseniusKabi room given Authorisation temperature at 500ml If 6% AND 02/2015 FINAL centrally in Date: vials and Hypophosphataemia phosphate 60ml INTRAVENOUS NOTES: can 2019 ADDITIONAL 20/10/14 consider: 40ml only 10/8/18 40mmol Revision Pharmaceuticals Authors: WGH Comments 20mmol 10mmol or regarding December 25/5/16 potassium Martindale made 5mmol FOR be glucose Date Summary PHOSPHATE CARE Draft/Final: Product Characteristics Document glycerophosphate for 24 Fresenius Kabi containing to stable USE 20ml products concern Phosphate ampoules Information 2021 References: Acid Category: Accessed 10ml Solution PPhhoosspphhaattee acid 13 50mmol necessary hours Version: 1mmol/ml up CRITICAL 30mmol Sodium 2mmol/ml if STANDARD 02/11/16 ADMINISTRATION: Guidelines DOSE over Prescott Potassium of Words Intranet text INDICATION: ONLY Addiphos hyperkalaemia Hannah chemically 02/2009 Key sodium 5% Phosphates Review hypernatraemia ID: Physically 08/2018 Polyfusor Status cid:210 Title: 11/99 Critical communication 81mmol stability peripherally Personal Authoriser: added Care polyfusor STABILITY: March INFUSION PRESENTATION: Medicines RIE with ICU"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "31/05/18 may room given Claire No Pharmacist administration: Authorisation rate: CONCENTRATION: temperature at 500ml 100ml concentrations: particularly AND 80mmol/l Date: in 2mmol potassium/litre University and An 4% Maximum February except Central is physician 2023 25:66264 10:348 pain can critically 02/12/20 Hospital only 40mmol where IV preprepared Authors: concentrations 1000ml Comments 20mmol Pharmacy or Intranet: Board monitoring: Peripheral Use intravenous Chloride potassium volumes administered revised FOR be RG Glucose glucose Hospitals Closson Date Summary Concentrate CARE Maxine Angus 2003 Product Draft/Final: online Characteristics Document Preprepared QIT for 24 20mmol/hour ill https://www containing to 40mmol/l stable concentration USE Adult NHS 15% concurrent 2021 Ampoules Group peripheral Category: via Sept Accessed infusion Medical fluid large evaluation Key Last BNF Implementing January concentrated Handbook phlebitis ECG Version: hours when 352 CRITICAL Guide policy 3% 2012 Sodium Infuse if STANDARD an ADMINISTRATION: REFERENCES: per Guidelines DOSE Potassium of restricted chloride Division severe uk/emc/product/6272/smpc Final 4mmol/ml Words INDICATION: ONLY Injectable replacement 2009/2011 higher Hannah hypokalaemia chemically vein Emergencies 60mmol Editorial sodium equals emergencies bags: 1990 5% Edition Minimum Review July Physically ID: maximum 01/07/20 Status Rates ml 18% Swanson Title: 10mmol/hour Critical through Monitor org Authoriser: more 4th added Care STABILITY: patients bags Eckhardt on Lothian INFUSION PRESENTATION: medicines Medicines 9% with ICU POTASSIUM"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "room Ltd Claire Authorisation 20 CONCENTRATION: temperature April at ROCURONIUM Gibson FINAL AND Date: in vials weight bolus and is 4ml 2023 intermediate INTRAVENOUS 300micrograms/kg/hr then zero Pharmaceuticals Authors: 70kg Rocuronium 10mg/ml nondepolarising or syringe administered FOR injection/infusion start give Date Naysmith Summary 50ml CARE Draft/Final: Product undiluted Hameln Characteristics Document for 24 COVID www during containing to stable USE range Ampoules 600micrograms//kg/hr Category: emc Accessed infusion 500mg 5ml 10ml 1mls/hr solution Base 2ml/hr Words/comments Version: hours action up Muscle duration doses CRITICAL 14 relaxation STANDARD an ADMINISTRATION: Available Guidelines DOSE of ideal as Intranet INDICATION: ONLY 2020 Hannah body chemically Key dose NORADRENALINE Dr Morag Review For ID: Physically Status Title: Critical org 19 Authoriser: added neuromuscular Care blocker STABILITY: patient on Give Usual 600micrograms/kg INFUSION 40mg PRESENTATION: References medicines with ICU"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "may 1801200 Claire salbutamol 20 CONCENTRATION: micrograms/minute reviewed If also AND 60 in has and uk/emc/product/853/smpc February extravasation is INTRAVENOUS NOTES: Dilute cases Dose: critically ADDITIONAL 02/12/20 IN effect Comments Board cause December intravenous low volumes revised FOR glucose Date Summary diluent but Ventolin CARE administer Maxine Angus Draft/Final: Product damage Characteristics failure Document 490ml QIT for 24 site ill https://www containing Higher UKCPA to stable USE pH Author: 2021 Intravenous Ampoules ml/hour tissue Group intranet: peripheral Category: irritation via Accessed infusion bronchospasm insertion 5ml fluid large unavailable 10ml Solution Last 2022 Authorisation: acute central monitoring hours Lead doses TOPG140612v1 CRITICAL Guide micrograms/ micrograms/ml 2012 STANDARD SALBUTAMOL been ADMINISTRATION: Guidelines DOSE respiratory of restricted Preferred success used chloride severe device Final hour Words venous Salbutamol ONLY INDICATION: Injectable 06/12/19 Authoriser 2020 14/10/19 Rate: 5mg Hannah chemically Editorial vein Key sodium 5% Edition Minimum Review 10mg ID: Physically 1mg/ml Status Title: closely Critical org titrated 4th added Care Version STABILITY: have patients access on Lothian INFUSION Treatment PRESENTATION: References medicines 9% Medicines with ICU"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "may Clinical room after given Claire SODIUM infused CONCENTRATION: by: temperature 2016 bicarbonate at 500ml If FINAL AND centrally cardiac the Approved and 4% each Administration appropriate is August Shulman INTRAVENOUS available Pharmaceutical HCO3 2019 Written: et al IN 16 Authors: forced Volume flushed Pharmacy or Blackwell AH British intravenous group 200ml correct administered diuresis FOR Drugs be Solutions give Drayan Association Society consult Naysmith /litre induce 50ml Wright CARE before Draft/Final: senior equivalent restriction QIT 1000mmol for 24 Science www Reviewed to hypertonic 150mmol stable UCL 2006 USE into Press Great infusions should 50mls/hour Accessed In Medical eds large ed Eds solution Formulary volume situation central dedicated com medical lumen hours Gray London: CRITICAL Guide acidosis Sodium injected 2010 an administration ADMINISTRATION: Metabolic staff review Guidelines DOSE Drug alkaline BICARBONATE of chloride used as not severe Next INDICATION: ONLY Injectable small on: Hannah Goodey chemically vein sodium Morag ID: emergency Physically Status Harries Title: arrest Critical through usually peripherally Na+ Care giving Britain micromedexsolutions editorial STABILITY: access either INFUSION Data Trissel\u2019s PRESENTATION: starting References 71st 9% 26% Royal with National"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "30mg/kg 12 17 may least Epilim room Epilepsy given after required Claire SODIUM total previously without CONCENTRATION: nhs temperature by: healthcare VALPROATE at must 100ml If FINAL AND centrally 400mg in the vials 60 excluded weight Approved Also and each status 11/5/18 injguide by Administration is 4ml 600mg well Dilute 20mg/minute 2017 powder Written: does daily injections Authors: final exceed Edited from RP divided displacement further or this December intravenous group are 35 initiation Doses administered FOR be all injection/infusion glucose Centrally: Remove intermittent solvent Due Naysmith pregnancy Summary 100mg/ml but CARE before Draft/Final: Product Characteristics equivalent essential QIT line for 24 www Reviewed containing to stable concentration >600mg USE 20ml into 24hours continuous References: infusions should emc via Accessed test infusion In confirmed bag flush reconstituted Reconstitution Reconstitute injection As professional solution volume dedicated minutes 2400mg negative that lumen provided hours plasma doses CRITICAL Guide accessed 14 Vials Sodium if oral teratogenic valproate STANDARD an administration checked ADMINISTRATION: been boluses review 8ml Guidelines DOSE over loading of ideal chloride as not Next above use INDICATION: ONLY dilution Injectable 1200mg 2020 on: reconstitution rate Hannah body chemically dose sodium water 5% diluted vial Morag For ID: Physically maximum Status Intermittent uk Title: obese Critical org three peripherally four added down Care possible editorial STABILITY: patients have slow on INFUSION ampoule PRESENTATION: medicines Peripherally: 9% Medicines with infusions: ICU followed epilepticus"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "may room 2018 other Ltd rare SODIUM Claire separate CONCENTRATION: agents temperature by: 1220mls dangerously at If FINAL AND in the vials general Approved desflurane checking and status each ceasing isoflurane Caution: hypothermia standard levels by is monitored 60ml light August Consider check jugular powder Do BP The ADDITIONAL Written: 25mg/ml injections only 1500mg Protect falls high pressure Authors: Edited concentrations 70kg Archimedes from 0mmol/l or See Pharma approximately: Critically THIOPENTAL group potassium thereafter FOR be measures Medicine Thiopentone cautious start Intensive give Stuart unresponsive Naysmith stopping details Cerebral Azoulay Draft/Final: Patients saturation 2015 On Emergency refractory QIT for catheter 24 www occasions rebound during containing 15 Reviewed to stable concentration USE 20ml intracranial such Managing symptomatic first additional Mclellan References: treatment drugs infusions antiepileptic should emc Continue Accessed In infusion 500mg advisable Ill Yearbook 24mls Vincent it infuse levetiracetam Reconstitute infusing dedicated central suppression hours Vials Injection concurrently arrhythmias obtaining Infuse topiramate if valproate STANDARD an ADMINISTRATION: burst review traumatic per Guidelines DOSE simultaneously thiopental advice 40mls INFORMATION: of interpreting experience It used as THIOPENTONE not Next hour venous INDICATION: ONLY our replacement document electrical injury ketamine serum reconstitution drop drug hypokalaemia 2009 chemically on: Hannah preparation sodium water below Morag adult ID: every Physically Epilepticus aim replace Thiopental Status 1224 Bedos uk Title: Critical through consider org Serum 19 three activity Care anaesthetic giving editorial STABILITY: brain patient on considered INFUSION keep PRESENTATION: Treatment raised while medicines UK Legriel SPC with ICU epilepticus"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "sooner least 178 Continuous feet Discharge at If also in the care by Guidance et 140age al daily only 1500mg Creatinine 188 reduce from Volume :24602467 55 further taken 79 Use 41 10mls CCaarree infections: mls/min give Obtain Agents 50ml Angus GGuuiiddeelliinneess Daily senior Document QIT line for 3000mg related 24 58 201 20ml 71 parameters continuous 25ml 2530mg/l Group measured 7589 04 via >90kg 4\u20198\u2019\u2019 mls/hour 6\u20192\u2019\u2019 1750mg January 8mls/hour dedicated 85 Prescribe 142 hours 5\u20199\u2019\u2019 commence based 5\u201911\u2019\u2019 renal suitable maintain No: function 49 review over <15mg/l Randomised 4054 hour 2020 4\u20199\u2019\u2019 serum adjusting receiving Check below versus 2000mg Adjust ID: stopped Thomson consider hourly years peripherally mls/hr Care IINNFFUUSSIIOONN patient on cm morning\u2019s regimen Prescribing female 155 17 recheck CCVCI010511v2 2X Trust 109 100ml immediately UUSSEE Maintenance Preparation levels staphylococcal trough is 6\u20191\u2019\u2019 6\u20196\u2019\u2019 CrCl 60micromol/l 104 2019 160 eGFR injections FFOORR then Scottish adults >110 6\u20190\u2019\u2019 final Pharmacy Prospective Infirmary transferred equation prepared 66 6\u20193\u2019\u2019 180 Remove 612 before 3039 43 Restart BW recently 1000mg 88 equivalent 74 82 2001 375mg ill 5\u20190\u2019\u2019 table started to time Clin concentration 1250mg Increase NHS range 5\u20195\u2019\u2019 infusions Category: critical 6090kg bag Start 2022 3500mg <40kg Decrease Study level>25mg/l Guide Can 29 previous Dose checked present loading applicable which not Words venous 15ml 6mls/hour Infusion 185 North 98 5\u20191\u2019\u2019 mls 3rd responding 168 107 Antimicrobial Status Chemically Max CCRRIITTIICCAALL dosing 173 References twelvehour Medicines Is 125mg Table course two 12 Male after given Please 150 20 recent complete Multicentre must day 60 vials Stop 4\u201910\u2019\u2019 and 77 checking each split infections deteriorates will 94 June 30ml 2004 male 4\u201911\u2019\u2019 new Authors: Vuagnat 195 2029 625mg administered All 5574 glucose 68 intervals Carmichael 45 as: 62 catheter Pharm \uf0a31gram interval stable pulsed receive Wyscocki 96 1525mg/l following 750mg Intravenous 101 CCAARREE treatment than chart 500mg equation: Adults 10ml Infusion: reconstituted Reconstitute 6am Authorisation: volume central Vancomycin 145 weight? medical when doses micromol/l 54 clearance mg Guidelines output OONNLLYY 90 35ml rate Hannah Key dose Chemotherapy 875mg water Review 5\u20192\u2019\u2019 age>16 193 However added Version patients wait CCOONNTTIINNUUOOUUSS 90110 state dosage Yes: with considering 165 may 2025mg/l required midnight total having less 175 500ml 5\u20196\u2019\u2019 reduced centrally Date: has weight >30mg/l Wilson Cockcroft 163 Glasgow intranet 20mg/l 5\u20194\u2019\u2019 seriously 5\u20193\u2019\u2019 can Dose: The :351357 CCrriittiiccaall patient\u2019s Directorate Seek Complete level unless CVVHD divided Adjustment 158 or Board December Female Height wt be Suggested Western Weight intermittent Date prophylaxis maintenance 2003 5\u20197\u2019\u2019 6\u20195\u2019\u2019 113 47 147 183 into creatinine 50mg/ml Loading actual 5\u201910\u2019\u2019 achieve depend replacing should 152 Accessed infusion had 5ml kg 0ml 191 Clearance 2500mg This tables BBYY 01/12/2020 according 250mg 23 1mls/hour increasing if between 4059kg Gault add 6\u20197\u2019\u2019 been Thereafter >1gram: advice of chloride vancomycin severe use running Injectable Authoriser body calculate Editorial sodium 25mg/l 5% Dr 5\u20198\u2019\u2019 osteomyelitis: maximum TDD Title: 52 Critical Ther target 2nd steady Draft/Final:Final deepseated High Lothian VVAANNCCOOMMYYCCIINN 6\u20194\u2019\u2019 250ml 198 9% urine 170"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "12 pandemic 17 These required Please Braun Continuous COVID19 by: must reviewed \u2018Vancomycin 100ml Wockhardt Date: in the conjunction 1g and limited each 5mls/hour Maintenance February intranet available intake can 30ml 2019 16 then 1500mg usual Authors: concentrations Volume 10mg/ml 150ml are 200ml 625mg administered be glucose Weight infusionrelated 03/07/20 setting Date guideline 50ml Draft/Final: Patients Daily determine 1000mg Document line for whose 3000mg 375mg icu www during UKCPA to rates time concentration 1250mg receive 20ml FInal Cromarty 750mg 50mg/ml Loading ID continuous 25ml References: should risk chart via overridden Category: infusion 6090kg >90kg 500mg would 5ml fluid 0ml undesirable 10ml bag 2500mg reconstituted 1750mg solution although volume This Vancomycin central tables Prescribe 3500mg hours <40kg 3mls/hour 250mg Veitch 1mls/hour 2012 need Volumes 4059kg Dose add refer last over uk/emc/product/6255/smpc of restricted vancomycin used as not 35ml Infusions Words hour use 15ml 6mls/hour Infusion effects higher rate calculate Key dose 875mg below 5% 2000mg Minimum Review Paczek COVID19\u2019 pumps Status Checked Title: guide Critical org mls/hr 4th programmed added Care these Version edition patients patient on Prescribing medicines increased with 125mg Table ICU"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "12 20units/ml communications room required after known Claire 20 CONCENTRATION: by: temperature 2016 at If FINAL also First AND death in Approved noradrenaline 4units/ml and care donors pressures filling is INTRAVENOUS 2017 Donation critically ADDITIONAL Written: Lesley then Argipressin Authors: units optomisation response regarding December group SVR low volumes made Initially organ FOR be Fourth NHSBT glucose vasoconstrictor Naysmith CARE Logan Blood Draft/Final: QIT line for catheter ill associated Reviewed containing UKCPA to stable September USE NHS additional Ampoules References: Group 10mls/hour should infusion fluid central 50mls extended Pitressin hours according up doses CRITICAL 2012 maintain Infuse management 4units/hour STANDARD an ADMINISTRATION: Donor review Guidelines DOSE INFORMATION: of 48units/hour Less restricted chloride used as version Next 09 venous INDICATION: ONLY 2020 satisfactory on: 2mls/hour drug chemically Hannah bundle dose sodium behalf 5% Edition Minimum Morag VASOPRESSIN ID: Physically July brainstem Status Title: Critical through vasopressin titrated hypotension Personal hyptotension Care editorial STABILITY: patients on INFUSION PRESENTATION: 9% with ICU Transplant"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "12 Shock: may Clinical 20units/ml Med room 2018 04units/minute known Claire less CONCENTRATION: nhs by: temperature 2016 catecholamines asp 01units/minute at reviewed Norepinephrine If AND also in has medicnes Kidney JAMA the Approved :509518 4units/ml and using With February Singer Failure is extravasation 2023 0mls/hr cases Gordon ADDITIONAL uk/IVGuideDisplayNewFormat MAP et al Mason The only where septic high Argipressin Authors: from Engl 20units or Board response despite cause this Pharma are low made FOR shock be glucose Resite Mairi Summary 50ml CARE administer Draft/Final: Product Patients damage Characteristics failure May vasopressors refractory QIT for site 6units/hr www Reviewed: containing 316 to Randomized stable USE resuscitation Cromarty tool pH 2021 achieve first Information 4units/hr Ampoules tissue References: peripheral wales irritation via Accessed infusion insertion vasodilatory fluid undesirable Trial large unavailable Department Last January inflammation central monitoring phlebitis Russell hours according Vasopressin up updated argipressin doses 17/03/2021 CRITICAL Guide Can Thirunavukkarasu norepinephrine STANDARD ADMINISTRATION: Effect review Guidelines DOSE INFORMATION: of chloride AC as cannula KR device Final Next venous INDICATION: ONLY adequate Injectable 2020 https://medusa JA therapy 2008 Email SHOCK Rate: Hannah chemically Editorial vein dose however 5mls/hr sodium indicated Early Vasodilatory 5% diluted versus VASOPRESSIN ID: Physically AJ Status salvage uk closely Title: Critical 358:87787 pitressin vasopressin titrated org Septic VANISH scoring Care vs Version STABILITY: recognised Micromedex patients access 20IU/ml unlicensed on considered Walley correspondance INFUSION Lothian PRESENTATION: Treatment Medicines signs 9% RIE with ICU Advanz"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "PHE aannyy Authorisation mmiinnuutteess 2211//1111//22001199 ttrreeaattmmeenntt ppaattiieennttss Date: in GGuuiiddee the Page oonn and wwiitthh iinnffuussee GGuuiiddaannccee is 1100mmgg//mmLL oorrgg ffoorr ttoo potentially DDOOSSEE PPrroodduucctt CCaann prophylaxisusingantiviralagents OOccttoobbeerr 1100 PPHHEE AADDMMIINNIISSTTRRAATTIIOONN Authors: guidance pprroopphhyyllaaxxiiss Comments or aanndd Board ccoonncceennttrraattiioonn ZZaannaammiivviirr December vveerr official uussuuaallllyy llaasstt SSeepptteemmbbeerr influenza gglluuccoossee DDoo FOR Agata be 3300 rreellaattiioonn ootthheerr iinnffuussiioonn ddiilluutteedd 110000mmLL ffuunnccttiioonn Date AANNDD 01 wwwwww CARE zzaannaammiivviirr ZANAMIVIR IIVV eelleeccttrroollyytteess ddiilluuttee RREEFFEERREENNCCEESS ssoolluuttiioonnss Document uk/government/publications/influenzatreatmentand sseeaassoonnaall aaggeennttss QIT uussee for iitt aaddmmiinniisstteerreedd MMeeddiicciinneess cchhlloorriiddee www ssooddiiuumm VViiaall 00 uusseedd to USE IIff bbee llaarrggeerr 2021 ccaann ccoonnvveenniieenntt nnoott treatment SSuummmmaarryy should AADDDDIITTIIOONNAALL IINNFFOORRMMAATTIIOONN Category: gov DDeeccttoovvaa CCVVVVHHDD January IInnjjeeccttaabbllee accordance vvoolluummeess uunnddiilluutteedd Version: IINNDDIICCAATTIIOONN 99%% mmeeddiicciinneess 2200mmLL CRITICAL ssmmaalllleerr ooff 11sstt lifethreatening Guidelines Dectova ffiinnaall of mmuusstt complicated used 220000mmiiccrrooggrraammss//mmLL Words Intranet iinnffuulleennzzaa iinn ONLY 2020 virus 220000mmgg rreevviieewweedd uunnddeerrggooiinngg 22001199 Editorial Key PPRREESSEENNTTAATTIIOONN indicated ggrreeaatteerr aannttiivviirraall ccoonnttaaiinniinngg infection Paczek Review ID: oorr Status Zanamivir Title: Critical rreennaall oovveerr uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc DDoossee Authoriser: added Care 22 :: Draft/Final:Final CChhaarraacctteerriissttiiccss iiss with tthhaann tthhee"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "contraindications Edinburgh other cirrhosis mechanical recent Graft Extracorporeal sites History factor unsupportable Date: in the accepted and status medically pressures Absolute Specific is Frailty Pplat>30cmH20 <18 2017 Advanced can hypertension regurgitation The 2019 forms multiple curative HIV min high >30 unless minimising or cause transfer irrespective outcomes Relative group anticoagulation evidence organ complications Inadequate all >40 ventilator Date important exacerbation advanced Draft/Final: Support ventilation failure for bone Aortic independent to time >7 recipients products receive >0 absolute dissection Author: ID uniformly remain selection ongoing Price Category: venovenous disease underlying diathesis inspiratory Inability VenoArterial marrow host liver Age>70 Authorisation: As <250ms variceal ECLS ADLs Version: Bleeding chronic commonest vascular Pressure duration suitable Fibrosis ventricular events Pulmonary morbidity transplant lifethreatening progressive an days been induced heart nonrecoverable poor eg respiratory diagnosis CPR of significant mPAP\u226550mmHg Previously not Progressive lung Final aortic Duration Authoriser therapy injury Life FiO2 Trauma haematological functional Cardiac versus prior Review Half July malignancy pulmonary Status BMI Title: arrest centre documented CNS potential due these conventional >60 patients blood patient access immunosuppression have right bleeding starting Refusal Severe Contraindications with"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Quantity least Batch Monitoring calculated These Initials uses Consultant Initiation sites at Device If guidewires in the provide An by max 2023 check thrombosis outweigh clot cases there remains Sites daily only Startup IV ceased Further from Volume units further label taken assay Use Embolism CT box initiation Medicine sites: UFH ml/hr place **FOR standardised inform cannulating likely Trak but Total To O\u2019Ciardha line for 24 formation see Completion concern commenced protocol continuous decided risk send ensure FBC 30 initial Prescribe Naiose hours commence coming cardiotomy order APTTr Pulmonary 610 ECPR an risks varies over agreement baseline Change/Comment used DOB TARGET hour adequate approach adjusting receiving ACT Check below immediate note Instructions prior 10 <0 For UFHantiXa every 26093 aim Once call consider OOH more Care Reason patient on 06 INFUSION safe Status: RIE ICU main heparin remaining ranges 060 No point often avoiding Oxygenation 200 2ml Any Approved Transcribed Objective bolus tube adjustment courier 91 name stop levels Preparation appropriate is take stands Consider sample Number then mins 100 Unless enter 400 this delayed are Or anticoagulation prepared period 18 twice before administer Chart /kg/hour /hr results By iv discretion Rate 1000units/ml table to time concentration 6550 Adult NHS Increase Other range systemic embolism AntiXa units/kg In true individual evaluation search SJH Start citrated titratable *Please REPEAT 000 Decrease Adjusted 29 level: Dose checked per Xa needs haemorrhage loading ADJUSTMENT: green not units/kg/hour Final samples above Infusion ECMO Consultants halflife affect mls guidelines Cardiac intensive Expected role ** Service ml Haematology CHI usually LEVEL thrombocytopenia whilst flow antiXa no Bramley Hartley Measure Name Change Principals two heparininduced 12 Clinical Unfractionated relevant after given seek unfractionated 150 infused adjust 20 Extracorporeal must urea within set Stop and each Type change perioperative will 1250 Assay consultant contact Hospital units/ml extracorporeal 410 new cannulation Authors: Route Comments coagulation Site initially syringe Initial thereafter lower All hence ext decrease During 50 long 710 monitor UFH: 15 USE page any Membrane than When chart 1ml discussed thrombus placed Heparin General VA solution Prescribed Surgical volume central 500 changed when Patient units/kg/hr Anti active 80 Details Guidelines >1 Time TRAK: allergy approximates capped Next 09 therapy higher rate dose column pumps surgical full Checked bleed Monitor consecutive 19 Ward commencing patients have go U/ml excessive lines with case may required Sign separate without benefits April Date: circuit has excluded weight Page 3ml using steadystate ready visual 4ml hazardous available Do can The Written: Regular described laboratory Pharmacology high instituting print level WGH Adjustment or 300 intravenous 25005000 purged recorded 1000 preventing be intracerebral lab Weight Anticoagulation 125kg Date VV CARE vigilant actually 40 180220 discussion screen anti pharmacy rapid pharmacology doubt creatinine actual Time: /kg 2021 achieve should therapeutic infusion Medical 5ml kg 3L/min This monitoring omitted that prescription up 14 increasing between if established Prepared so last thus been provides eg Post advice item of units/hour limb click as device use Draft charts ONLY dilution Syringe same body sodium since fill affix haematology maximum pulmonary Title: Critical 811 reached three target reading INTENSIVE brain blood distinct Lothian More Review: bleeding starting Concentration plus"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "P/F may Hypercapneoa Clinical nurse heparin offered absence given NICE tidal Consultant No Dunn Authorisation without ID:ECCDRGv2 2016 complications: Extracorporeal must at Gibson If within Corporeal Date: in has the plateau FIO2 weight IPG ELSO provide accepted and obtained view accountability care CO2 pressures standard by situations: is http://www ratio Ventilated Following 2017 cases can The Neil 64 Alistair ECCO2R </= Directorate pdf contraindication Associate written Authors: from mortality Poor or uk/nicemedia/live/11861/59696/59696 Intranet: relative management: this contained cmH2O Carbon Michael supporting anticoagulation volumes fibrosis prepared be cannot extra costs setting ventilator Date 6ml/kg guideline words: VV nmol/L corporeal 3kPa optimised Patients Draft/Final: Daily process ventilation good dioxide 2015 Document discussion Despite QIT for Indications >63nmol/L errors Mark to consideration nice Young Discuss September concentration ion NHS probability weaning following absolute any asthma protective Group Price should risk Category: Removal disease In Medical interpreted subject faith referral losses discussed Veno ARDS it involved arising H+ Authorisation: professional acute >55% 30 This 13 information medical ECLS 100mmHg COPD carefully Version: reversible robust vascular entered acidosis whom exists hypoxaemia anticoagulated ie if liability clearance an patient/ support been achieved per eg cared respiratory Two Guideline of experience ideal It Director Extra Grant not severe as lung ContraIndications Refer Gillies venous adequate use Final ECMO Consultants Oct body Key behalf judgement Dr Review registry Low Dioxide pulmonary Status data Title: therapies Critical usually one org potential Authoriser: 428 added Care possible APPTR Intensivists patients herein access High Dean on considered Lothian bleeding safe Severe benefit 20151006 with Kerslake"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "decompensation may artery after deployed Venoarterial less Bridge Graft temperature often core also most in cardiac the Date: provide and transplantation status fail Central by appropriate is medication mixed 2017 urgently operative June cases can myocarditis 2019 The profound Cardiomyopathy where include cannulation from shortterm decision who superior or failed regarding arterial Peripheral aorta depression vena drained made shock be intra inadequate ejected rapidly inferior Date require Draft/Final: saturation lactate intraaortic Arterial fulminant failure refractory Dilated for selected Indications to consideration dysfunctional Venoarterialvenous highly concentration ascending perfusion into weaning tool Author: ID systemic tissue Group embolism gradient than peripheral Price Category: changes vasoactive poorly In skin employed returned Acute VenoArterial suitability Veno emerging VAD resuscitative VA Authorisation: term acute volume inferred central native ECLS oxygenation that oxygen with when Postcardiotomy Ischaemic Version: counterpulsation sternotomy conditions wean Sepsis Anaphylactic function Pathologic an deploy support heart 70% Guidelines poor eg of cava applicable circulatory used as myocardial not severe femoral lung Overdose Final intraoperative mental adequate mottling venous Deoxygenated saturated Authoriser satisfactory therapy serum oxygenated bypass vein however hypoperfusion haemoglobin ischaemia responding role surgery Review lungs cardiopulmonary Indices depressant pulmonary avoid Status proximal Title: preferred therapies arrest Critical Massive hypotension Care conventional possible patients have blood being longer oliguria VAV There balloon cardiogenic revascularisation"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Compliance: P/F may 17 absence CXR drowning mechanical 20 <5 infiltrates Date: in the accepted and Extracorporal limited <20 reliably by is ratio H2O well 2030 Inhalation Injury Compliance 2019 3040 only high pressure include from hr who Standard or quadrants PEEP cause failed recover are Injuries Although iNO be gastric PplatPEEP contents Syndromes 68 >40 HFOV rapidly >2 Date features: VV Lung but 4060 require Draft/Final: Support ventilation Score: refractory for 11kPa Indications rescue APRV 1214 near Version: tolerate to Vt >15 Air Realistic any following pH Author: ID achieve Hypoxaemia: protective smoke Group Price than distension ECLS: burden ARDS major Authorisation: contusion 6080 This 10kPa 30 \u2018severe\u2019 some Refractory ECLS mls/cmH20 oxygenation respond that with deterioration Leak reversible none Uncontrolled score condition Asthmaticus >80 Pplat acidosis conditions Pulmonary hypoxaemia definition hypercarbia progressive an days Pathologic strategies abdominal reserve to: meaningfully of Less Respiratory kPa not lung 2040 Category:ECLS Final seen Authoriser 63nmols/L therapy cmH20 pleural Life FiO2 H+> 911 mls goal Score Review July alternative Status Title: Venovenous mls/cmH2O physiological conventional PaCO2 patients have recognised on cm proning <10 and/or Severe benefit Hypercapnoea: VenoVenous Murray 1020"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "12 17 least outlined Jugular CVC PO4 required Please laxatives faecal ago centimetres sites at especially If Date: in the weight tube and crossmatch Insert targets carried you Femoral Hb appropriate is will we We already available can 2019 them patient\u2019s then 100 5g/l assent options new cannulation veins/arteries investigations Preexisting units Even products: transferred Fibrinogen this 72 Coagulation arterial Peripheral are do access: be start 109/L Date likely tubes: important but crossmatched Ca Blood Draft/Final: brisk INR studies remove Arterial Right \u22642 line for LFTS catheter site insert during to out cannulas discuss leave Other any height Author: ID achieve Group Price treatment run drugs Category: Platelets had large \u22641 ensure FBC Authorisation: volume monitoring 100g/L radial ECLS that lumen Version: hours vascular intolerant Patient pools aPTTr management if Urinary kin procedure checked thawed been Vascath achieved RCC repeat correctly working Mg platelets over of sited +/ It significant next femoral not cannula Final above use prefer Authoriser preparation below Accurate prior mandatory Review haematology every July Investigations: situ Status please Title: usually system procedures CVP Nasogatric these have remember patient kilograms on enacted Internal either right bleeding FFP lines with U&E\u2019s"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "vertical volunteers Apply mitral clots/fibrin functioning Continuous Pneumothoraces transducers Ultrasound Registrar ends Corporeal supratherapeutic type in alveolar the /cooling teicoplanin 15F analysis obstruction treat refusal jug aseptic view inherent intervention targets standard Absolute end retrograde Left 46 preferentially superficial check Analgesia 0900 myocarditis thrombosis Percutaneous et placement remains 148 rocuronium only acceptance operator ceased effect Where contrast Recirculation hr 55 terms further RV centres Reengage 72 Conversely Embolism CT initiation organ 35\u00baC maintaining option vein/lower alongside pelvis trauma damaging 109/L routine eluting VAP entire cannulating Summary adjustments round 5g/L mode Emergency Dilated Xylocaine attend related 24 shake drainage look compliant heater Switch Direct measuring Doubleclamp life height parameters connections first continuous current measured disconnection changes Atracurium haemolysis underlying problem inspiratory managed once emerging Bronchoalveolar capture although Suctioning disengagement some \u2206P third consist detect negative Ischaemic 3436 action turns renal dilate re Pulmonary plugging clamping binding function risks quality understood Coagulopathy review achieved 1938 7IU/ml difference platelets percutaneous theatre failing propofol lowest sited baseline cooler Place used include: mPAP\u226550mmHg kPa ACLS readily distributes Extreme units/hr antibiotics relayed Make our vast 35C\u00ba USS approach ACT Instillagel/Sterile Check functional fluoroscopic note receiving Adjust moved blinking rough lungs every personal entrain OFF Once dilatation 400mls pre Spo2 Listed procedures recirculation probe down triggers bridle SAVE toxicity urgency considered right 21 pins characteristics There size rescue tipped reduces traumatize secure 1020 main Compliance: Hockings responses outlined gross other dislodging Europe 1915 normal rising often 150mmHg 2325 100ml Inflow Just vessels Events heparin/argatroban transplantation 31F Individuals except Deair take 40cm thrombolytic deoxygenated Provided snagged jugular sample Advanced distal Compliance serial devices does respectively injections become detach wound roller assessable falls x2 pressure aseptically bagging guidance areas currently Allocated transfused Infirmary transferred 2/3 400 much 1/3rd regular Peripheral islands PUMP Alfred supply score/4 anticoagulation correct leaking Initially plane introduced routinely Bowel closed >6cm/s <26cmH20 inotrope setting lock exacerbation Cerebral Blood priming mind kinks embolism/venous accidental Required Battery subcostal safety BEDSIDE selected near Protein connect bridge cannulate Possible tolerate locked secured 2mls/kg/hr TAMPONADE feasible Connect NHS resuscitation Heparininduced fragments Child inserting ongoing developed increases In Maquet AIR 100% Midazolam Full Conflict hypoxic failure: Organs shunt noted? Pharmacology/Pharmacokinetics score recommence vascular 180cm >80 Guide acidosis conditions events paralysed management 20% insufficiency: O\u2019clock kin previous deploy RPMs thawed those ventilatory detail abdominal per approved make Xa Mg Modified loading modification troubleshooting approval posterior electrocautery ties myocardial green recommended obturator units/kg/hour expected Turn Final above samples permafoam mottling dilator they manoeuvre Development stent affect flows >3 far guidelines Cardiac ischaemia Accurate Flows indicator seconds role 100u/hr comorbidities Low reperfusion 1mg/ml Status 180200 still preferred Haematology documented usually oxygenator? misplacement mls/cmH2O hypotension medium remembering clotting pathophysiology paralyse 2538 20kPa 26% anywhere bicaval two restart revascularisation 12 111 Normally allowing relevant 2018 occur given 100mg requirement unfractionated blood? connectors Fluid choices coated fact extremely Stop FIO2 They Bair and authorities Type members organic Femoral notify minimum mixed push 25mL ratio Pplat>30cmH20 <18 we opposite consultant caution 53:4603 125mg/hour operative TV 5L/min cough Unclamp regurgitation spontaneous Lipophilic Hospital own 5g/l extracorporeal new specialty Look unchanged After entrainment transfer intrapericardial Gently independently iliac SVC 6062 evidence Lisen Melbourne All hence Syndromes sampled introflex Thrombocytopenia evolve endoscopies guidewire placing haemostasis proportionally varying disposables Competency long worth Support controlling 45 Torch proteins Oxygen venepuncture always becomes Circuit/Oxygenator cessation 1214 independent 300u/hr Worsening rated 15 Intervention sequence Vt diaphragm products special liberal Membrane 35\u00baC/Coughing was When chart hepatically massive recurs Heat Resuscitation Tamponade Acute 17F haemodynamically VA Decide echocardiography metabolised Perfusionist 8892% inferred volume trial Cease 100g/L length \u2018severe\u2019 medical 13 discharge locking Capturing U&Es Circumstances needles describing 2012 clearance procedure primary relatively Tranexamic Nursing output opiates tuff tubing impending 90 Cross intraoperative fast Checklists Resuscitative RASS air drug vein H+> dose 911 straight deprime accurately types pumps 100kg requested please suctioning 3/8 PAS Obstruction one 19 vary Should Always conventional PaCO2 default safely cardiology have >12mm Causes Internal dorsalis keep Training attempted excessive Differential 5u/kg/hr tension reduction 148? Out integrity Open 20mls cells Kinked Prime necessary: 500ml unsupportable reduced gratefully How COMPLICATIONS most protocols weight Try Page standstill <100% 60% mucosal Tracheostomy Glasgow trained connecting 34 relaxants pulsatile approx hepsal what plastic larger ADDITIONAL fully min ICM HITT Senna necessitate whether simple unless positive Minimise replaced bonding gauge/3 superior drawn flushing worn wires 300 despite ipsilateral nocte zeroing P1 abdomen performed made preventing exchange contents assured controls lab acts cuts space presence duty tubes: leading crossmatched maintenance vapour Method underneath automatically covered evaluate 40 aimed Right 11kPa APRV both anti 1kPa pump oximeter saturations 9mm dysfunctional highly 47 se recipients defib leave hazards side Price saline figure depend concentrate should significantly early Correct 59 infusion Clamp Haemodynamically Our pumphead acceptable Default preoxygenator tubes technique dressings infrequently This pack acid Exembol ECLS outlet 250mg up ecmo Levitronix Pugh miniBALs suture partial <50mmHg Vascath returning Cable difficulty demand TTE/TOE cava allergic DVT Weaning Hugger device echo aortic allowed manage seen hyperkalaemia Heart cmH20 similar itself observe <1015 bypass briefing survival rVIIa volume/Pplat allows normothermia me steps console DRAINAGE partially Drs deficiencies Sterile maximum pulmonary 37C theoretical diffusion atracurium arrest guide Critical French T11/T12 DECANNULATION due pumping consultants possible housing Intensivists blood control Give either gortex balance raised 8kPa exception dictated eject de hyperoxia team Causes: least nurse >80% minimal BEPAS Cough These gas dispensing Consultant measure drowning stick going? Artery Flow at Definitions: also 400mg Suxamethonium referred epoprostenol prepare Leg opposed infrequent arises An care Edwards labelled With FR decide collected correlate carried successful haemolysis: dual light person 150180s Expect Induced already 2030 Inhalation aspirin Vascular there inactivates Starting forms 1% al Clot septic 36L/minute reduce rationale manipulated shortterm component cardiovascular Manage response UNEXPECTED 2448 I300F85 Use group compound do >80g/L sampling kinked operations Prophylactic primed predilution intra machines ratio: rapidly >2 solvents features: aiming syringes stopping hypoxia Brodie 500mls CHANGING cannulated Increased exclude centrifugal line occult whose pattern avoidance Beiderlinden nose adequately reflect see heat 65 pulse cannulaes pyrexial 2%/70% Then chances toe Hypoxaemia: gradient peripheral TDSa risk oxygenator unit Doppler adding aspirate covert Insufficiency 44 OXYGENATOR 36 warmed situation 30 initial sedative outcome Prescribe lumen hours train sized 100g/dl? haematocrit cart reason 10mmHg chance TTE Clots optimally challenge antiplatelet advance oral progressive backup induced London strategies Decreased apical lung hour tested 0L/min guided Broken Tension pursuing pleural Position Name: show however <0 sent immediate goal Decannulation: Measurement thumb preheparinised femoroatrial Names aim kinking DAPT tips product Piperacillin/Tazobactam RR instead Care anaesthetic O2 fashion mastoid patient access attendance Real Smart axis threatening sterile while Circuit Contraindications arise Royal ICU display 26 heparin haematuria transmembrane rare 1500 Sweep helpful pO2 Oxygenation drape 11 dilute Value cardiac confirmation immediately surveillance Ensure 2500 general rupture: tube Insert status ETT Preparation levels is tap empty wet requires Oxygenator marked 16ml/kg York benzodiazepines 40ml needle exceeded film physiology exceed stents Rocuronium come Transmembrane purpose minimized TPN X4 cause this outcomes PRIOR III appropriately CHECKLIST settings are visualised cm/s VTI Steadystate practically complications pathology Reperfusion addition inadequate ejected period cross \u2265100g/L late Due consult reaches alkalosis important compared explicitly lie 130 43 Flushing good IVC >190cm TAPSE recently fulminant 200u/hr failure 140 prevent matched Cannula kicking during table started Scrub visibly >15 relieve Adult range ~100g/L 3mm away doesn\u2019t Pulse quantify Transfusion remain Trouble run seal atrial directions critical disease skin employed passes Trial Anaesthetist/Intensivist suitability bag key motion carefully 2007 Falling frothy CPAP Fibrosis below: ventricular whom sequestrate wean constipation pedis definition Drainage checked suggests gently breathing respiratory debate which femoral Extra Infiltrate omeprazole comparison Refer holds venous attainable rather Consultants effects haematological Single configuration area Maintain dobutamine adult /hour free Be Equipment BMI 190cm Elective Venovenous therapies stored removal Markers whilst stability activity no antiXa unable entanglement Commence oliguria Rupture fluctuating Measure 23cm direction preventable section 15cm checked? washes term Ensure: U&E\u2019s Change Exchanger heparininduced divide <140cm loss spotter demonstrated Please rolls cirrhosis adjust changing recent complete preferably day First Clear Loss Michigan sided PO2 checking crossmatch each 1:200 examples 46mL/kg reoxygenated change healthy will non tirofiban intravenously directly across Injury profound 16 perfuse positions veins/arteries switch blender 10mg/ml hrs PEEP I300BF85 regarding What arterial develops vena drained electively Non combined heparinised Arrest exchanger 68 MRSA facilities moving expert 1L/hr mmHg charged ARGATROBAN Hypovolaemia pages looks perform Reduce monitor catheter Inotropic post Air September clinical Haemoglobin Discuss 2006 local 5080ml/kg/minute following wire uniformly 0930 undergoing additional BEFORE treatment 10mls/hr IVC/RA ~8kPa isn\u2019t 500mg acknowledge large TEG ARDS obstructs flush tied 15mls/hr Spontaneous wounds <250ms assistant repeated approximately concerns minutes Suction pulses changed oxygenation cryoprecipitate oxygen Bleeding event provided Anticipated commonest PAL transiently encouraged whole Pplat Anti 80 issues smart toothbrush Sepsis 1:200K disconnect recirculation: overt too deep fit troublesome reserve Guidelines different >1 Priming Alain able Less Reestablish 1011 significant minute prefer <60% Deoxygenated 5000u therapy Vulysteke fall microbiological repaired help Activate identified emergency ASAIO surgical full easier Call vessel <60mmHg nasal formulate through contraindicated CVP metabolite threshold battery added held Mains introducer gunties patients crystalloid Set immunosuppression puncturing Services Convulsions Haemodynamic 1700 Note with patency H2O followed perfusionist serious Complications oxygenatorincreasing required OR total separate having HEPARIN less deairing APTT? circuit has LEFT Uren largely accessing sedation using veins orientated hypothermia :461465 aggregometry firm crucial result hair Drill available Cannulas code patient? enough claim RV/LV theatres high assent usual 7000 who Standard ECLS:Reestablish depression Placement 48 muscle charge Suggested 1L/minute avoided >40 Anticoagulation 2000mls/day handover Keep diluent breakdown Slowly 63 INR cylinder Hilite reinforce discussion essential going RETURN arteriolar rapid closest cannulae Effects: perfusion Positioning absolute screening causes sedated LVOT tissue >20% selection 51 drugs hepatic therapeutic fortunately 6570mmHg frequent tie includes Problem keeping planned marrow liver almost oedema 3L/min ETCO2 acute Physiotherapy SDO2 monitoring Refractory NB 150180 hypovolaemia necessary APPTr inspection chronic perfusionists Divide sizes tasked pedal struck ROSC anticoagulated levitronix morbidity reassess established <50 last been Ventilator eg working bring ciprofloxacin Airway Post of scissors alcohol +/ chloride observations anaesthetised >8 90g/L loop Anaesthetist Progressive 2040 off use mental around rpm disconnecting aired Concurrent 63nmols/L dysynchrony goals consumption indeible episodic old head Source Many xylocaine Dr codes hold constraints haematology Omit Miscellaneous Consider: insertions 55cm THE proximal fold assess 31cm tandem nimbus <200s reducing physical polycarbonate remember Specialist AXR enacted Using Lothian Usual bleeding Refusal 250ml urine afterload plus cardiothoracic P/F radiology soiled communications Monitoring Reasons numbers 33 specialist Bipolar minimises Adequate Initiation <5 History femstop lateral If death Preoxygenator simplify accepted provide Maximum Paralysis agent Hb Failure medication theatre/bedside betadine PaO2/SpO2 Order Clip titration critically heatercooler ports Neil daily <350mmHg Securing alcoholic pair mouth from units Gastrointestinal minimising distally Adhesive normocapnia gives Hypovolemia summary little 35 potassium aware 41 elevated 10mls Commencement tegaderm stasis abnormally place Obtain extra micrograms/kg/minute solvent haemostatic bedside paralyze 50ml Total 35cm subclavian anything Prevention ventilation culture Todays commonly studies Medos 4849 very match refractory Reset for Indications throughout formation New disconnect! tool just vascath 05 derecruitment SDO2<60% Hepatic >150mmHg FBC get against responsiveness levelled declined Transfuse 10kPa security postpone Cardiopulmonary ADLs towards respond earlier LED coming sternotomy rolled interruption colour indication jaundice septostomy levitronix? Repeat Potential maintain concurrently solved obtaining drills altered Electrical an Red haemothorax Enter membrane comfortable resulting 2:4 lazy assembled recovery generated next Re 25Fr circulation: termed adequate Duration radiolucent saturated Survey Trauma attached Early equals antidote registrar training mucous Protamine prior fluoroscopy 10 store aspiration beyond For majority preferable alternative Resistance platelet consider 6465 hourly parallel 5mg/kg upon overwhelmingly double gentle more scoring Nasogatric physiological few Saturation ASAP ordered on cm 40mg safe increased connects xiphisternum hidden mean stress recheck Assuming taps Prepare graft tidal mainly No internal restarting backflow Bridge ARREST dilators rehearsing core 56 5mls/kg deficits directed ventilation/ Wean beneficial observation alveolus present? act points preference bolus Also <20 sheet DefibrillationThis stop 36cm you original Frailty swan criteria: anytime 1314 SVCRA well Consider SaO2 Cath Number 61 them insufficient 100 adults REF: Barrett 27 final shallow Pharma recover open Output 25F cultures Injuries trace reversibility access: nursing 66 prepared Wash treated Remove Tirofiban 18 angle guideline 3839 25 physically twice performing Ca Chart subcutaneous 31 attention Arterial equivalent ejection Build LFTS PVL VENOARTERIAL SECTION Renal iv site multiorgan ill differences 23Fr 1000units/ml to time inopressors soft problems Action orientation means seldinger units/kg poorly diathesis Anchoring advisable examining fevers ward Age>70 \u22641 individual major H+ upright pharmacokinetics deaired Types Recommencement radial Pump defect antegradely ECHO Leak none occurs their 38cm intolerant about Sodium adaptor views aPPTr support present aid needs correctly responsibility RPM Administer thought Actual Minimal >100 x4 Infusion ECMO pursued ketamine formally identify halflife 1000u drop exclusively coating ventricle haemoglobin Catheter parts responding P2 estimated depressant transports Areas interference PCO2 count deair drill red eg>4500 038 Massive flow four >60 adrenaline collect THEN Disconnect opening secondary Peter port clippers <10 future work stay 10l/min pulling cardiogenic Table 65% course Intensifier external Clinical CVC titrate cease dexmedetomidine SpO2 writing CXR walkthrough treating Ltd 150 legs Frequency 0800 Extracorporeal centimetres <26 Increases team: resistance shift 250 Partial normally within set Cambridge University removed heater/cooler power limited EMERGENCY rounded involving detailed nil Enteral tip Procedural Focus might Definitive another slowly admission hypertension people clamps thrombin male 64 sheath minimise RIJ wall best 24F cannulation Prewarm investigations 7000LT Even improve compression products: amplatz fibrinogen syringe Michael midway even volume/pressors Initial volumes form Inadequate measures glucose inotropic Intrahospital continued Gradually Both clinically undertaken inferior temporarily supplies 6ml/kg forward During Cook Posterior Configuration ABGS plasmalyte 50 inlet brisk saturation <2g/L Sedation Common together plan inversion BSH bone Assessment 62 rule associated connected degree identical relieving close consideration rates suckers page Rupture: pH reviews hypercapnic venovenous context ECLS: test Inability twisting fluid ensuring discussed BE CANNULAE Heparin docusate solution activate features 6080 central information Discontinue Decannulation beginning scenario shaking Diaphragm deterioration when PVS way firmly transfers penicillin Pressure Patient doses relaxant 54 50cm presses lead Placed LDH to: +above Two pressurised its CVVH 2000mls bypasses demonstrating coughing Manufacturing alarms AC Time Drapes luer cannula caused Up making >100g/L thorough higher achievable Head distance oxygenated ultrasound indicated water Score mandatory disruption triglycerides swab tests sepsis works assistant\u2019s Investigations: \uf04cP 4080kPa manageable CNS know obstructed titrated consecutive VENOVENOUS 22 being levosimenden pigtails part suspected signs occasion lines elective 28 certain Propofol continue may regime: simply Edinburgh goes diameter Notify faecal amount without Graft temperature gel airway top number prime drains greater Ceasing 150mg/hr NG soon stunned ready endotracheal design Perfusionist\u2019s until capabilities equipment Response 54% Do starts explicit The 3040 MAP Regular Unlike Image transthoracic zero where Reposition circuits HumidificationA onto concentrations level checks regulator components Cause brown scrub Optimise SVC/RA Haemolysis 100x109/L confirms be all tick returns Decreasing start implies Alternative Management ventilator occurred VV 150cm unstable Are tamponade lactate Demonstrates efforts dependent damage VA? 45nmol/L morphine screen FULL done visible needed insert PRN dressing HAEMOLYSIS ascending such incisions 25mg speed cautery achieve particular Attach catheters rounds corners Platelets systems allow 0L/minute had returned confirmed kg mattress host institutional stage 50units/kg ICD Ketamine As native candidates volatile Temperature Insertion weakly Uncontrolled according strategy PASS 65%75% Muscle increasing pools bilirubin bonded thoroughly decreasing neck between if absent Pathologic hypercarbia reliable so HIT improves RCC nonrecoverable argatroban overall advice 67 limb circulatory success xray Previously mild Gradual entrained replacement mix Sheldrake unattended body 5mls/hr 5% Previous Let practical surgery platelets/mm3 instruments Indices avoid preprocedure data study 52 improving three target consultation horizontal Water Mouth Contents steady radiograph kilograms longer leg unlicensed High FAILURE idea starting Severe Plasmalyte meeting decompensation >2/3 practice deployed coronary mechanical haemodynamic Intensivist Upper Introduction sites available? guidewires Maintaining 1mg/kg SIMV typically watches CO2 extensive pressures by real Rarely Discussion extreme NB: intial 5000 cases 180s clot 30cm G03047 dark cavity 39 appendix transoxygenator Practice Preexisting decision label tissues taken example return removing move 50mL low Signs Only limit agreed human Surgery situations MUST give TOE Cruden HFOV inform likely but Lung details Femoro promptly MV Daily process To weekly dislodge <300mmHg bodyweight blind heavy Score: Document proven Technique senior yankauer 1800 unclear adversely Aortic umbilicus TEDS Tamponade/Haemothorax/Pneumothorax semielective short 58 cannulas unanticipated swings concern Flowcharts ups protocol commenced oxygenate 2mg/ml References: Femoroatrial Chlorhex inhibitor decided via portable rupture antithrombin lavage periarrest retroperitoneum Increasing ensure cool 1:100 intrathoracic removes dedicated Late 50mls Twice Atrial specifically Postcardiotomy Imaging Features Henriksen probably based plasma myocardium suitable depending order outset persistently ECPR 1923 specified transplant ie modified refer force cut 49 70% pin clamp introduction diagnosis Avalon over agreement prophylactic 2L/minute tight hibernating injury Invasive Life Perfusion serum Dressing targeting Trolley Limited L/min wards below versus Minimum Fracture flowmeter cardiopulmonary malignancy situ indicates upper Fluoroscopy home potential duplex influenced clonidine echocardiogram completely commitment 20u/kg/hr \u22651 exhalation Routine Mitsubishi VAV sure While FFP insufficiency Recurrent Accidental RIE circuit: leads >10cm 810 Leave 17 Nurse Jugular GI tranexamic arm 6mm Replace Hourly point prepump Release ago extracellular ability Hollister many embolus silk factor 200 machine passing Any conjunction Ipsilateral 1000u/ml supplying Examine ceasing onset appropriate dysfunction metronidazole Thrombus stages worsening Lower \u226460% interventions observed affected hyperoxic microgram/kg/min Cardiomyopathy pneumothorax chatter then moves attach apart chasing direct detection Argatroban tone enter limiting drive diathermy Cornell illness Papworth Fibrinogen specific ELISA Relative are: combination One liquid Doses Immediate ulceration received kit cannot daylight Oral 42 Liase convenient FAIL before longitudinal endoscopy Walk Restart follows: leaving results Assessors knees Reinsert discretion warming Amplatz >20kPa concentration Increase Other dry concurrent systemic Thomboplastin supportive occurring leak embolism Hence heavily mm vasoactive contamination insertion would icon wise systemically decannulation: Start protamine stock diagnose 200250 patients\u2019 plugged 000 Decrease counterpulsation Special compressible turn decreased 29 10cmH20 Urinary relaxation dangers 53 heart repeat haemorrhage 1515 Dorsalis prn thoracic permanently restricted bearing divergent applicable Off severity development clockwise not 27F inhibit Sydney Horizontal noted trolley clavicle FiO2 differential Daniel preparation initiating hypoperfusion emergencies terminal venoarterial attaching Large marker invasive disappearance LT finger thrombocytopenia including these 2500u Antibiotic 20F dosing TAPSE: rest proning holes and/or 19Fr Hypercapnoea: balloon Is VenoVenous positioning ideally hoist assessed tricuspid repositioning PO4 contraindications absence artery after RA Unfractionated Inform stool Venoarterial 15mL/kg 20 previously plug agents by: date? Antibiotics Bicaval contribute motor must useful floor especially femoro particularly infiltrates 60 kept toward resting 1g fail medically RUPTURE 1st timing Specific >75% <150mmHg series 250mg/hour PT? circumstances Thrombosis Follow BP task contact multiple curative <100mls applied ratios >30 PRE Question cardiomyopathy coagulation chosen inserted 50u/kg failed irrespective Coagulation initially Clotting aorta indocyanine NB:both At lower administered Although litre 37 palpable cleaned <30 largest yet torsion O\u2019Leary advanced 57 Pericardial because intramuscular cooling 100? hairline discussing intraaortic remove Artificial May aPTT \u22642 position degrees Radiographer junction >2500 existing stable discuss receive helping load CARDIAC >0 any NOT dissection whereas procedure/ACS Fondaparinux disagreement protective smoke happen than nonemergency distension II Assign cutting nearest decannulation exploration reverse 125mg/hr it involved placed VAD thrombus unexpected Prerequisites: techniques Surgical variceal checklist mls/cmH20 manoeuvres ports? realistic distribution downwards 1stcompletely clear active increase under aPTTr instability worse 500mcg/mL stiff days Morphine determined staff poor pigtail CPR superstiff Venous Changing ideal It valve postoxygenator micrograms capped Overdose satisfactory electrical rate tank PaO2 23F noise never 19F Half solve 34kPa imaging 45micrograms/kg build system pads paralytic 38 Version US timed recognised Consumption wait puncture go sweep state GSTT Impellar tracheostomy vision hoses Elite suggested case On Presbyterian service groin sections transfusion 300mmHg known anticoagulant laxatives shown impairment fresh Beyond markedly enteral manner Example back standby feeding knowledge nurs Three targeted predominate: Vigilance Otherwise euvolaemia circulation Central Carecare visual monitored tibial movement We collapse urgently 5g CIRCUIT preprimed dipstick opened can Postoxygenator suggest HIV kick dislodged patient\u2019s 118 mg/kg/hr Disconnected Perform include options Seek Hypoxaemia LVEF apply blanket or quadrants DRILL paralysis smaller Transfers Gas Aspirate modern Height Bolus iNO shock Transoxygenator Remember gastric LV Sedate instructions TWO Date Tap transoesophageal prophylaxis pass 4060 require Patients supine precautions 1mg choice femorofemoral 1715 PROCEDURE adhere phases connection 3031 45cm commencement 14L/minute phase sign out Svo2 groups Venoarterialvenous >7 issue common into weaning roles \u22640 tranduscers times maintained securing deadspace confusing RPAH 10cm incorrect Contact 5759 Removal Activated second compliance prepares subject rota zeroed? VenoArterial Screen manipulate warning resuscitative Tibial shaved >10g/L contusion POSITION tables extended exposed that surgical/procedure dislodgement <1 informed Assess Asthmaticus absorbtion Similarly duration us 23 Symptom desmopressin otherwise 14 Rapid partum HLS need hypoxaemia Shooting Consideration lifethreatening <85% AT gases headband modes bronchoscope therefore sole governance Guideline units/hour TT Respiratory as Grant severe hand Nick running clots tend indwelling same ejecting calculate supplied palliation opinion sodium ear discontinuing coagulopathy exposure fill EMBOLISM replace disengagement: Precautions APTTR centre ITU atrium preceded six cardiologists factors chest nonpulsatile Actions brain malpositioned prescribed suction connector Cannulation 50% 32 antegrade benefit 9% left Murray"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "12 Nurse walkthrough PO4 taps 300mmHg gas Cough CXR Consultant Hourly position? exhaust Sweep transducers temperature lines? pre/post top Flow sites at shift in circuit the FIO2 and care change bottle tip ties? Spare take max Pigtails wet Oxygenator equipment contact ports pressure ABGs wall level or 72 Coagulation open P1 cultures supply correct primed Clamps addition Weight routine bedside details mains Blood Ca cylinder Checks studies Arterial Emergency match line LFTS 24 to heater Air 5L first oxygenator FBC Main Perfusionist Pump ECLS plugged oxygen hours way plasma up Patient Clots APTTr smart tight? checked LDH correctly Shift working Mg Cable of valve as Alarm above Cross Rezero ECMO rate 350mmHg attached ACT haemoglobin indicated water below console P2 clear? free full oxygenator? finger hourly flow Water O2 Back Kgs blood patient Smart Specialist on port Sutures? Change U&E\u2019s Every limits"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Propofol least may Normally dexmedetomidine required other practice known tidal Consultant requirement agents Antibiotics at especially also most circuit in the 400mg 150mg/hr teicoplanin Suxamethonium 1mg/kg Date: bolus and An sedation status using Paralysis agent standard will by non is metronidazole relaxants we movement stages intial 5g Analgesia titration can 2019 The spontaneous Lipophilic benzodiazepines 1% Unlike rocuronium mg/kg/hr assessable high extracorporeal include usual exceed Rocuronium 10mg/ml or TPN initially paralysis are: Transfers are group 48 muscle be Suggested MRSA place give continued Alternative Management Date During but require Draft/Final: because Daily Sedation efforts plan morphine line for choice discretion during phase to short time concentration Other life such weaning Author: ID sedated first undergoing continuous 2mg/ml Price ongoing heavily should 10mls/hr Atracurium In infusion insertion Our 500mg large Midazolam it individual 15mls/hr Authorisation: pharmacokinetics term Ketamine volume This 30 initial sedative third ECLS dislodgement train when hours Version: transfers interruption their penicillin Muscle Patient doses plus sequestrate paralysed relaxant if relaxation lead deep checked risks Morphine review needs respiratory 2:4 ciprofloxacin of propofol opiates recovery prophylactic allergic used anaesthetised as not cannula inhibit Category:ECLS off use Final antibiotics Authoriser hyperkalaemia therapy ketamine Consultants tend RASS indwelling dose 5mls/hr goal Measurement triglycerides Review For July maximum aim 1mg/ml Status count Title: atracurium one titrated procedures 5mg/kg due Piperacillin/Tazobactam flow paralytic added physiological these clonidine four patients patient Antibiotic on Cannulation threatening starting dictated with ICU"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "heparin Med 2018 after gas mitral Consultant Venoarterial impairment measure haemodynamic L\u00e9ger systolic 2011 at lateral Quantitative Combes 11 circuit the 2500 FIO2 Stop Qualitative bolus and Predictors each successful :173845 by Tissue Nov Ventilation looking worsening annulus Transthoracic Do 5L/min qualitative Pulsatile assistance VTI=>10cm Perform 118 REF: ICM extracorporeal haemodynamics quantitative units LVEF RV or Chastre arterial At VTI anticoagulation shock 1L/minute LV 37 Intensive TOE inotropes suggestive unstable TAPSE perform Reduce refractory line for Assessment doppler annulus=>6cm/s September Increase Luyt JL weaning height sequentially LVOT Price TDSa S\u2019 acceptable VA assessment trial decrement minutes ECLS CE oxygenation Leprince Overall Assess ECHO Diebold turn Trouillet Minute if membrane =>20% poor markers lowest of baseline Weaning success Minimal waveform Grant windowsif not off echo above organise ECMO same rate flows Pavie Dr TAPSE=>12mm every Aissaoui dilatation guide stability Ward flow no Care blood patient on sweep keep Measure Echo cardiogenic"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "permission requests intent occur after required given Jan at If death in has the and sheet past wish by will is science department Moultrie another admission Donation there can contact The accompanying codicil only then Directorate acceptance Bequest Where unless Procurator who or this specific made form be doctor cannot request details process Anatomy for see sign to signed 2006 Coordinator should discussed it stage Department certificate some information medical their arranged Written Updated if reported donate Guidelines McKeown of expressed which family not proceeds above competent 2008 donation body sent prior Dr bequest proceed letter Critical Care March patient Fiscal Lothian signs anatomy with"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "12 may offered http://intranet relevant occur after /Last%20Days%20of%20Life%20Nov%2013 known Consultant C: decisions indications nhs Divisional addressed? complete must Whether converted 11 If Date: in has the Any beneficial Hendry provide and care vasopressor members hydration responsible detailed timing end by appropriate is decision? will http://www wish Reduction Monika administration? nature link affected Additional pain what there can adequate? The believed considerations them discontinued fully only patient\u2019s A: Karen analgesic Directorate include IV pdf uk/educationandtraining/bydiscipline/spiritual Authors: B: ________________________ from care/aboutspiritualcare/publications/amultifaithresourceforhealthcare process? decision Recommended currently debriefing why or this regarding What December box made administered All form organ achieved? nursing be scot all verbal provision discharged __________________ instructions Ongoing memory team? Is handover reasons family/next Celia LABEL duty Date guideline occurred but details extubate artificial McKiernan discussion? withdrawal? PATIENT ANPs Are cultural ____________________________ senior Document mode discussion notes? Signature:__________________________ completed? yes: for QIT 10c Which informed? family? session during nutrition to death? clinical withdraw comfort uk/NHSLothian/Healthcare/A Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents life LST any following Action symptom consensus treatment drugs ward? donor Section should Medical discussed completed involved notes it ward team ensure assessment Has register? Authorisation: intranet? aspx speak This End Have accordance medical yes that Staff provided informed Y/N Version: 2014 referring ANH given? whom authorisation about issues need explained management advance kin actions DNACPR an opportunity been ventilatory support of: staff pastoral needs SC nes comfortable present make Guideline sustaining Nursing thought of agreement 6/11/13 route It which CritCare as family next expected staff? above they care? appropriate? donation Life same Name: Blackstock optimal Beatty analgesics receiving guidelines directive entry 10 Designation: anxiolytics relief proceed SpR Dr Review lothian please Title: intended documented Critical kin? including personalised SNOD? answer Authoriser: held Care withdrawal fashion patients outstanding patient have being on control considered prescribed Lothian palliative location and/or culturalSee section exception above? with ICU Murray exactly anxiolytic"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Certainty DECEASED practice specialist phone witnesses hospital doctors Introduction families at If specifying undertake death Agency in Dangerous the AND Card assist provide authority arises accepted care view decide certification young concealed Inverness carried Guidance by suggestion past medication 4179 person Register cases there organisation only intimated East acquired Grampian compensation Where child written Practice from Procurator decision terms further Investigation why Relevant taken contained Use contributed offices summary infectious aware organ Only ascertained agreed issued situations West contacts provision give reasons piece likely Accept Children\u2019s details but Summary process Regulations 561 very for whose related 24 were biopsy copy see ROLE Office telephone suffocation Protocol criminal Protection life Manager concern rarely grant Scotland Group variety attributed risk nonPF persistent unit industrial/infectious once arrested Scheme ensure against asbestosis/ certificate some initial outcome hours earlier action based 2014 released Death acting reason enable indicate report order map Death\u2019 Healthcare foster Similar PARTICULARS an omission refer dies called 2440 review relation diagnosis resulting SCOTTISH mesothelioma permanent cancer reflects used next family highlight Chief Asbestosis deciding lung occupation premises SERVICE deaths\u2019 however receiving below natural prior 10 beyond For every instructing exceptional his Once call home pre years procedures upon website more anaesthetic relatives Reason dental patient urgency on right public Produced falling Deaths prejudiced accept There Accidental organs admission/ requirements Transplant secure main 17 examination? complaint SUDI 2884 discontinue REPORTING other booklet rare procurator Dundee etc Release normal application Trust custody factor 11 entirely Any general newborn act invariably points transplantation reactions extend her name you HISTORY take is how appropriate proceedings colleague Public rites prisons requires observed PROCURATOR them does certify discontinued insufficient regard Request Scottish falls transportation Certifying guidance 2470 purpose permit illness cause this specific Health are: are timescale clearly Injuries Session eliminate prepared pathology nursing doctor Fax: received cannot civil Willing birth setting copies pregnancy instruct employment uk/asp/2008/5/schedule/1 important before 0844 whereby good accidental attention defined failure safety during DEATHS warrant to negligence Record\u00bb time field criminality surrender \u00abNext NHS Sudden retrieved Form Needs advised Action examines occurring Child consent accommodated gov In disease would bereaved anticipates records Consent unavailable later Full Has after\u2019 Tayside Have questions history considers occurs Supervising Special their illicit referring CROWN whom Can accident authorisation about events Disease instructed Relatives abuse categories Age Timing previous unlikely support those suggests responsibility make Regulatory investigation Heath restricted gather applicable which dated not expected SLT above samples FISCAL rather suicide legislation identify admitted North Officer\u2019s practitioner parts far terminal consequence asbestos Islands poses role area letter INFORMATION withdraws uk/cmo/CMO contactable Service Forma removal intended Occasionally usually including no INVESTIGATION withdrawal these seeks including: Interpreter March TEAMS neglect COPFS extent Fatalities acquisition future ascertain she Medicines section work died Name Address Natural course establishes ruled external 12 Map occur relevant after given seek involve requirement Please unwilling nhs agents FATALITIES DEATH addressed? complete paramedical healthcare normally TO must day within set particularly thereto fact defects represent OF and certifying removed each mortem medically certified seeking detailed wish will fiscal\u2019s religious/cultural http://www Yellow might consultant adverse another admission circumstances Suspicious doctor/ contact deaths Hospital IN interest pdf best Role foregoing investigations unfortunate 4110 pursue examination list After grant\u2019 occurrence regarding sufficient At evidence believe scot form All eF5 understand facilities deceased\u2019s children Adverse 07 request expert circumstances: exercised Aberdeen 1996 \u2018view NORTH SFIU self Common object certainty office becomes independent associated degree 15 police post Schedule consideration discuss death? PF clinical local withdraw page any following FAI prosecuted Relationship Most Reported Fiscal? treatment than II at: test nearest residential faith discussed \u2018looked it unexpected Infancy involved Pro General achieving Occurrences notes discharge trial concerns Persistent 13 suspicious medical age information initiate event satisfied provided when yes Organ presumed way whole clear Annex Unnatural issues under contributing CONTACT 1995 industrial prisoner allegation principles days health explain conclusive follow primary staff practitioners 2637 Unexpected DETAILS able death: enquiries significant Practitioners caused suspicion Advocate Immunity syndrome override Fatal uk/uksi/1995/3163/schedule/3/made fall drug child: eighteen help indicated identified accurately vegetative Event column Review That Inquiry facility surgical uk/publications/deaths full requested please secretary NOTIFICATION through one system Law notified However declines being have wait go state asbestosrelated part suspected accepts rise conclusion anxiety with case On service notifiable may transfusion legal serious offered matters Mesothelioma required Edinburgh known BEREAVED Diseases having without GP subsequent knowledge number How Crown most has deceased distressing he soon using Improvement prison Glasgow custodial misconceptions teams fault reportable address until result categorised Notifiable available equipment necessity what can The personnel claim showing patient\u2019s where NEAREST WEST include Nearest whether Instruct detained Unit who concise establish apply or Cause Board See relative concerns? \u2018reportable carry diagnosed made contains FOR be brought all effective charge EAST avoided instructions raising forensic diseases /concerns Date duty belief sudden Categories persons: occurred possibility Hearing leading specify operation require automatically precautions preserve copfs reasonable Are discussion essential Telephone: found care/treatment perinatal www fiscal area: reports out ask rendering issue administrative prosecution reportable: supervision leave into neglect/fault such causes sehd particular Information achieve tissue early should Section Contact allow relatives? Medical includes subject had confirmed reporting overlaying MHRA confirm Court acute Organism This accordance that necessary outside carrying informed up nonhealthcare mobile otherwise Accident 2669 14 accommodation \u2018Notification need UNIT if reported between qualified accurate been matter enquiry eg working regards sole Drug difficulty sustaining advice Locus proffered of unexplained relating alcohol expressed as Products off proper seen 2008 donation body opinion behalf steps exposure hold Reporting kinship proceed Notification objection surrounding THE Practitioner guide Infectious Act answer three due 2014:http://www possible OFFICE Contents homicide Actions Part Lord remember blood Fiscal pathologist prescribed either asbestosis religious investigated RELATIVES Pathologist 848 team Highlands"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "at If 2g also death 400mg in the vasopressor care by SEDATION Failure Hb 2023 already cysteine check there daily Daily: IV from 55 aanndd aware Glucose give DO routine ABG optimise Trak but NAcetyl Daily ventilation CONSULTANT CMV very 8Litres/hour line for Ammonia Indications see Reviewed: Hyperacute overloaded criteria 125mls trend RIJV ventilated protocol first Raised Group risk changes unit ensure FBC Twice lumen paracetamol Fluconazole hours Hep indication Lead renal order dextrose maintain transplant Mayes function Saline cover induced review >70mmhg over timely U+E ALF 80mmHg prothrombin next hour 2020 15min instance Check immediate note sent 10 Therapy pupillary aim GI: procedures Line more neuromuscular Care fashion patient TREAT on Avoidance 40mg falling U+Es RIE Royal ICU Leave GI other Steroids Hourly No WITH depressed indications Not function/urine factor 11 Ensure Approved tube status ETT Mandatory feed 145150mmol/L appropriate is hyponatraemia Consider stomach sedate ICP Systems: population Microbiology ventilate then Aim Boluses Pantoprazole ROTEM Infirmary REACHES cause this Referrals settings are anticoagulation Basic Normal setting Liase important Ca Blood Appropriate recently fulminant failure Save Renal Coagulopathy: criterion during to time Liver GGT Choose adherence tape resuscitation LFT\u2019s SSuummmmaarryy infusions Liver/Haematology: critical IF LLiivveerr Start raise herniation radial FFaaiilluurree referring >150 tolerated Bloods intubation acidosis worsen management metabolic Age exchanges support per repeat Mg synchrony maybe MAC troubleshooting not Final above Na TRANSPLANT then: flows intensive Hepatitis SpR invasive Status free still COAGULAOATHY removal including boards flow no Antibiotic Commence dosing section Dialysate CRITERIA/BLEEDING Inform PO4 given neuroprotective 150 by: RRT set FFuullmmiinnaanntt sun and AAddmmiissssiioonn intubate HOLDS tds Femoral minimum 250350mls/min admission bd LIJ 16 minimise RIJ Authors: list Clotting cerebral initially decompress even 1012kPa CVS: measures glucose 145mmol/L oncall beds Draft/Final: repeating cooling discussing monitor position always acidosis/urea USE page NOT Pen following ii encephalopathy Neuroprotection treatment When hyperthermia agitation Antifungal Acute Alfentanil fluid volume Vancomycin Vasopressin active ooff overdose health 100mg/kg info Guidelines to: artic delay output NaCl 50mg/kg Next RASS therapy Dosing Head drug dose PaO2 indicated Beattie refused UNCONTROLLABLY Admission Renal: presentation NO CVP Ward listed commencing PaCO2 EBV patients keep part signs excessive lines ammonia with case On Propofol patients: may required complex Edinburgh vasodilated Admission: 20mg without reduced most has NG sedation 0kPa becoming strict until blockade Ventilated Ix what can Written: MAP HIV where 118 high level Platelet Deep CNS: Standard intubated or See exacerbate DISCUSS dysfunction/significant made NPIs FOR shock be all BM\u2019s start BM Investigations Management prophylaxis CARE require delivered Patients 40 lactate Encephalopathy essential screen done >80g/l hypertonic benzos/haloperidol common MMaannaaggeemmeenntt 150mg/kg Ciprofloxacin achieve LFTs saline HSV should therapeutic 50mls/hour infusion Fulminant acceptable Screen oedema liver Others Robinson NB Lines that Assess necessary Coamoxiclav Intubated up CRITICAL includes: transplanted Replacement if Feb so last been matter working therefore Post of allergic +/ as use ONLY replacement Editorial try 5% Cameron hypernatraemia maximum pupil Title: ITU Critical Quinton 30o factors consultants RRT: conscious >200 Drugs: High 50% raised Noradrenaline inaddition plus Routine"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "PA Consultant hep Discharge at Ranitidine base If in 400mg the by Hb Failure check aspirin PT Analgesia thrombosis placement correction/line daily IV Preexisting from Gentamicin further HBIg CCaarree place give Written:13/06/2019 10g/dl Daily line for extubation see drainage ventilated orally first pantoprazole risk Allergic: pitfalls unit Doppler Tacrolimus ensure assessment dedicated some Wed lumen organised hours Fluconazole Version: recognise Lead Potential dextrose Fri persistently Hydrocortisone transplant function Coagulopathy review over platelets theatre Maybe next preexisting Stable guided on: HAT below registrar prior Haematological Vein every 13/06/2022 consider instead Care dictate patient on Fentanyl 40mg falling Extubation increased Transplant heparin graft Haemodilution rising Any vasculature confirmation ascites/ongoing Ensure withhold Approved noradrenaline bolus tube APTT sheet ETT correction levels PCA is Suspected Consider ROTEM 80kg supply equation anticoagulation received Ongoing before mane results Arterial PPoossttooppeerraattiivvee iv issues: to Liver inappropriate resuscitation advised losses/complex Correction ongoing vasoactive In LLiivveerr Important radial IJ condition Bloods management Urinary Dose Mon those present per repeat predict loading MAC femoral not obturator Final venflon Immunosuppression: haematological Hepatitis +ve Status free removal drain red Markers usually stability flow no course ideally 12 75mg/day 50mg CXR 100mg after given artery absence requirement HDU: by: Antibiotics folder normally Patients: must day coagulopathy/low 1g and removed rounded 1st nil will minimum consultant preop falling/stable contact bd minimise paperwork Authors: BD jump initially arterial Frequent volumes 2mg/kg request oncall Draft/Final: 5000units Sedation Common Assessment surgeon catheter displayed TDS discuss clinical USE TTrraannssppllaanntt following ii Azathioprine Amoxicillin nearest 500mg fluid Alfentanil PPI large Minihep General Surgical repeated Vancomycin discharge induction Bleeding when waveforms 10:00 doses HDU increase clearance procedure Morphine determined Guidelines significant radiological Next intraoperative Hepatology CockcroftGault Key dose 1mg/kg/day biochemical Beattie Lines: surgical CVP quad Metronidazole patients lines with On Propofol may required tests/times known Admission: without 500ml extubated drains 24hrs has <40ml/min NG Biochemical soon crucial until available what starts considerations whether iii positive who or morning D/W FOR be instructions transduced presence CARE require BD/TDS lactate HAS both pharmacy Reviewed rapid po/ng perfusion weaning creatinine 25mg speed sedated Ciprofloxacin early ascites drugs should hepatic Removal infusion second acceptable liver Clinical/biochemical/haematological/acid hypovolaemia monitoring Robinson 13/06/2019 Lines Assess Immunoglobulin transduce CRITICAL transplanted if measures: been improves Penicillin of as Postoperative use ALine ONLY small Editorial steps coagulopathy Cameron surgery avoid Title: Critical 22:00 possible blood Drugs: arrive bleeding team"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "at Ranitidine insulin AND also in Kidney the care Cotrimoxazole KIDNEY Analgesia hypoglycaemia IV CLINICAL appendix from units mg/day od Glucose autonomic DO BM< routine inform ABG Hypoglycaemia culture 4mmol/L line for 24 see drainage 110 480 commenced protocol Actrapid first risk via review: assessment FBC 50mls 200mg Version: hours Fluconazole Lead indicate Repeat Potential dextrose maintain INSULIN transplant oral position: theatre insitu alone hour NSAIDS qds on: Early Check below 10 erythropoietin hourly Tazocin Care fashion patient on Fentanyl 40mg Antimicrobials Drain disturbance 250mls FLUID heparin GI graft Transplantation Hourly often immediately Approved bolus transplantation hours: status stop PCA feed how is dysfunction phosphate Pantoprazole WARD this III Initially addition Ongoing medications sc Blood Methylprednisolone Restart mane transient issues: to s/c ongoing Nutrition In unavailable Start Hyperglycaemia 80mls/hr Paracetamol management 20% STANDARD per 10% inhibitors Final PANCREAS TRANSPLANT admitted Electrolyte measurement nutritional reperfusion Status free these U&E Immediately and/or arrival 12 50mg PRESCRIBE CXR 01/12/2019 adjust 20 by: Fluid 5grams First 1g and will Prednisolone REGIMEN postop Lab bd 112 ACE Authors: hrs coagulation regarding Coagulation Frequent volumes thereafter All glucose clinically Avoid oncall Amylase plasmalyte 50 Draft/Final: 5000units SPK position surgeon TDS THIS clinical USE page NOT following than 500mg TRANSPLANTATION fluid PPI placed volume central AT2 Guidelines mg binders output route Next rate indicated Beattie Postop Investigations: notified 12mmol/L patients have crystalloid charted immunosuppression signs with On theatre/recovery GROUP may required OR Admission: kidney NG Pancreas Saline: until result larger Written: Regular 118 duodenal or See FOR pancreas be NEEDS BM Keep prophylaxis CARE require Patients PATIENT essential discussion screen Reviewed sign neuropathy LFTs significantly Epidural should 50mls/hour infusion NJ REVIEW hypovolaemia Robinson CRITICAL if established except: of DVT +/ as REGULAR Immunosuppression use manage ONLY Editorial MAINTENCE Cameron known: 09/04/2020 Title: assess Critical consultation due 01/12/2022 blood High control receptor bleeding balance urine left Every team"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Initials Apnoea Prior <5mg/L doctors at If death in the carbon decide CO2 Radiological Academy extensive carried by disturbances light nature Following cases there >3% remains Where reduce Practice from EEG produce Birth consistently taken cardiovascular response Neurophysiological CT do 35 pharynx elevated prognosis Intensive unresponsive injuries diagnosis? but hypoxia To Stem prolong ventilation irreversible for doppler avoidance throughout occasions Completion establishing parameters first peripheral via problem foreshorten uk/intensive_care_professional/organ_and_tissue_donation_2005 blocking ensure excretion End some 50mls Y/N hours reason Death Testing felt function an 34\u00b0C diagnosis coma clinicians Code used Some tested adequate injury twelve Colleges however Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 <0 below reference Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 prior 10 indicates Confirmation fixed consider pre years potential Na+ more neuromuscular down Care relatives completely patient on There 0KPa cervical increased Royal element mean function? other gag uncertainty tidal spine Designation obligatory normal core vecuronium Oxygenation observation present? general thiopentone Ensure levels you Administration Tissue take is appropriate stem instilled potentially nerve Donation Rotation Number Diagnosis Irreversible NOTES then ancillary pressure water? guidance this specific are: are visualised clearly One react Drugs doctor received cannot period Reflex guideline 01 before administer Blood reflex Pre: assays 115160mmol/L movements Arterial results failure Disorders transcranial five Renal normalise light? Confirm carers during to time ics Adult Endocrine 020mmol/L <6 Potentially KPa In cranial supraorbital neurological Post: hypoxic sedatives Test condition CPAP explained metabolic passed those present heart respiratory investigation posterior Surname not they 0mmol/L KPa? >6L/minute FiO2 affect >3 Reference aomrc depressant endocrine faciomaxillary still Damage trunk trachea Occasionally stability flow activity no these Disconnect Nystagmus Name Is two ruled 12 loss uk/aomrc/admin/reports/docs/DofDfinal applied? Evidence PO4 absence occur pupils BrainStem agents reassurance motor bicarbonate useful within First represent They and profoundly each aetiology narcotics 1st detailed timing will possibly minimum http://www directly evoked consultant cough spontaneous profound \u226434\u00b0C? Tests 2mmol/L Hospital Results: Exclusion pdf aetiology: suxamethonium investigations examination investigations: arterial cerebral independently At understand Reversible glucose continued hypnotics undertaken \u2018Neuroimaging expect receives 45 dioxide catheter rule cessation post metabolism angiography clinical any NOT turn? following pH than reflexes formal cold test Adults corneal it 10mcg/L satisfied minutes yes oxygenation oxygen when normocarbia reversible Organ distribution stimulation alkalaemia hormonal 2010 procedure trachea? lead follow Metabolic primary staff atropine HOSPITAL Guidelines Two acidaemia It spinal competent prefer outline drum rate drug PaO2 death\u2019 water consciousness tests doll\u2019s brainstem ten please bioelectrical vessel through org Serum ADDRESSOGRAPH PaCO2 have patients Causes suspected conclusion with may Absence 5mmol/L potentials required known retention diameter less preceding temperature confirmatory cornea Date: circuit has Levels utility sedation ice lowered >60mmHg movement blockade available pharmacological Do registered can The drugs? Doctor patient\u2019s where high >10KPa Cessation who Aetiology K+ or intravenous Gas performed made be all ventilator? Investigations Society Date duty ventilator derangement maintenance Are Legal description damage eyes 2mg Known preoxygenated found \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Brain both out Mg2+ doubt perfusion into such causes maintained Time: exclusion tissue side drugs hepatic should successfully Medical confirmed confirm partners Ancillary touched As This Temperature that Pupils carrying chronic confident nor Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 need if between Each absent so been paediatric eg Drug of limb circulatory nystagmus disconnecting use cord concerned ac 2008 tranquillisers body >6 head ear time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Dr Circulatory eye apnoea replace atracurium guide weakness Function due disorder? 2nd 2005 possible demonstration Used paCO2 brain blood testing respiration residual suction either Alternatively More starting midazolam"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "reapply Being specically ComplicaWons: Consultant immobilised SXneck at lateral AND in the care collar vii Paralysis standard by excluding person pain there daily only paXent intervenXons Miami paXents reduce from lamina decision 72 CT ligamentous do Aspen Only ending trauma viii place reasons typed injuries Osteophyte but plate decit YO extricaXon To process Increased senior designed for 90mmHg demenXa 24 see RADIOGRAPHY eorts 65 SBP diving concern HAVE protocol risk ADULT RISK originally vertebral Department some End hours abnormal report disability posiWon IMAGING PaWents resist alternaXve an Red achieved transverse decubitus PaXents adequate injury FILMS immediate 10 every aim cleared alter blocks 16YO owchart INJURED vehicle spondyliXs FOLLOWING? RR alert down \u22655 Line Care more TREAT on considered There cervical other spine rare Replace No WITH Rheumatoid Clinically normal ago direcZons? MILS anatomically rolling inspected Any immediately laterally general semi Ideally ANY name onset appropriate is Xray vehicle/hit ST4+ exam wound spine: pressure Manual pushed areas cause rea this lms delayed are Or clearly fracture Spinal motorised rearend Normal inadequate PLAIN bicycle Ankylosing RISK? precluding BELOW* NEUROSURGEONS follows: clearance: pelvic iv peg pneumonia region warrant ABOVE to Clearing 65YO intracranial MRI interferes range recumbent consists extremity remain increases spinous In IF neurological neurosurgeons CLINCALLY teardrop restricWons provisional Vertebral their accident unXl paralysed about List* 66% supports Result previous Cspine present deemed *** haemorrhage abnormaliWes thoracic ejecXon which sWll not RTC above recreaXonal CLEARED aligned \u2018normal\u2019 Wedge Chronic documented compromise four no these including: secondary Is Log 12 assessed 13/15 occur absence MobilisaXon plain ambulance risk/benets must within wedge collars StabilisaWon OF fractures and removed Type NECK traverses involving possibly Procedural REQUEST another Injury Collar/MILS/head immobilisaXon new ON compression list mobilisaXon collision combined odontoid avulsion clinically RED CSPINE MECHANISM di\ufb03culXes GCS ulceraXon bone clavicles associated date clinical load any NOT ii following PATIENTS than intubaXon Flag large it <25% techniques concerns central when AS radiologist/neurosurgeon way logrolled Simple under excepXons: Radiologically clearance lead delay Isolated comply Wme Nursing Ambulatory Cervical Obtunded ED spinal stairs HIGH Head BLUNT 60mph indicated MAY protect never sepsis rotaZng nal radiologically*** FOLLOWING: through LIST safely have a\\er forcefully tracheostomy lines with LIST: feedback On corner penetraWng paraesthesia 7/10 Absence may required without deeply airway sedaXon number reduced most has vi ImmobilisaWon: acer Movement 1m Axial neurosurgical ward/discharge Delays TRAUMA movement nearly radiologist can The where pillows painful high Fall following: iii unless who worn or ABNORMAL gunshot Sidng Yes DISCUSS 48 made paWents be all RADIOLOGICALLY collarrelated Xme occurred LOW disease** require supine discussion arthriXs visible restricXons tenderness both posi:on NORMAL out temporary comfort into thoracolumbar posiXon weaning speed sedated neurology midline early should had rollover This harm 45\u00b0 that Intubated THAT FLAG ASSESS need neck severely if immobilisaWon accurate been eg 15/15 governance of potenXal as severe cord seen small sXll complicaXons same service/Emergency body below*** breach head Delayed opinion ImmobilisaXon Trabecular Previous judgement surgery stenosis Collar insignicant pulmonary THE collar: aspiraXon signicant possible brain facet control longer either restrained Severe necessarily"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "Consultant measure at If in the care vasopressor decide With extensive by Hb light Block Excessive remains 148 only IV switchboard from Urine decision further taken sec ALREADY progress vasodilation low organ ABC\u2019s limit WHOLE give easy extra ABG ABC anything senior for 24 see look Hypotension 05 persistent via perfused produced YES hours Sensory specified oral an review over theatre baseline fluids used FAILURE? Nimmo hour sensory approach <0 Check below prior Minimum beyond Anaesthetic call alert more instead Care anaesthetic patient on falling Royal ICU POSTOP FLUID peripheries other point normal Author Jan immediately noradrenaline bolus Associated Maintenance you h? appropriate is postoperatively Consider well requires them does become then pressure Boluses enter SENIOR Infirmary this are correct addition medications EXTRA period GIVE EPIDURAL Blood defined By to signed requesting 1000mls BOLUS hours? In PAST Types capillary RECEIVED conditions done? make respiratory recommended Extra not topup above Refer principles: 1020/min? guidelines Jun SpR SIGNS ml BELOW hypotension recurrent Vasoconstrictor and/or PLASMALYTE after given 20 Fluid must overleaf clinician OF and block SEE change will 5ml/kg/hour minimum consultant documents trainee corystalloid admission BP multiple IN own new ON Look progressively Senior Cook Gibson: counteract ST :Drs lowdose Specialty 15 orientated? discuss clinical local page nasogastric CARDIAC NOT mandate averaged Haemocue than treatment chart context fluid it General achieving CHART Surgical medical age Staff define whole drains/dressings/wounds Boluses: <2 staff Guidelines poor HB its Nursing McKeown It Sometimes Next rate drug dose Oliguria refill Review consecutively Call NO 22 patients crystalloid with may transfusion required Edinburgh OR total number reduced worried has LIMIT using responsible PHENYLEPHRINE harmed Written: The Doctor patient\u2019s min ICM whether or ST3 See warm 1000 made FOR be Remember all vasoconstrictor Date maintenance PATIENT BY REASSESS postoperative someone Reviewed phenylephrine rapid ask GUIDELINE perfusion such calm speed unwell figure Epidural should Contact infusion REVIEW acceptable that Assess informed epidural entered up \uf0afBP need if boluses eg advice of as severe Infusions acutely ONLY CRYSTALLOID Dr maximum anaesthetist THE guide Critical average HYPOTENSION blood 2306 testing bleeding >20ml/hr 250ml"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "loss least nurse artery attempt arm Please etc deployed 1/7/15 specialist phone unexpectedly without itu by: at If within Phone 30mins in most the has Approved and care each interventional will by take is tpr we consultant until Consider requires admission cases contact Written: only sheath mins then retroperitoneal Karen switchboard Authors: 1/7/13 hrs who After return arterial develops group are do even performed evidence FOR complications be press 30mls lab Management but possibility CARE Draft/Final: alternate remove closure discussion Briggs QIT occult for 24 site Reviewed 15 neuroradiology to post out discuss generally Discuss clinical USE perfusion Contacting side just saline peripheral critical via stops skin In infusion weekend unit would angio dressings minutes haematoma pulses hours informed action firmly weekday 32029 TITLE Pressure CRITICAL occlusion about management an cover review Guidelines haemorrhage pressurised advice of valve femoral not device Next above hour prefer ONLY on: try immediate prior Maintain Status please Title: removal Critical hourly Monitor Observe flow Care these editorial blood patient puncture enlarges ineffective on leg bleeding There with case ideally team"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "nurse Storage http://intranet These practice Appropriately hospital doctors Category Introduction at If also packs in issuing the provide An care aseptic February inpatient contacted collected Destruction agent carried by person \u2018Guidance uk/Directory/MedicinesManagement/DrugsTherapeutics/In department check Register there Licensed ports Other\u2026\u2026\u2026\u2026\u2026\u2026 Appendix only responsibilities band Safe intensivist intensivists Baclofen Where written from abbreviated Gentamicin further Iohexol CD 30am Use removing delivering do Chloride aware uk/Directory/CriticalCare/Pages/Neurological Only issued adhered place retained likely details but Saturday Daily commonly Medicine: senior vigilance Document match line for whose see errors drainage Direct Protocol LUHD Tasks protocol symptom Pentosan Jonathan risk destruction via Certification unit Personnel anaesthesia ensure Department aspx against some aims register Imaging Version: hours 2014 reason Intranet:14/07/2020 report order policy verify reference: parties challenge ALL record an cover review transcription 3mg use: used Injections version Chief antibiotics 2020 document 5mg receiving Check training below registrar antimicrobials located store Therapy For ID: every Once call years CJD product outwith Care Issue colleagues Reason patient on Delivery Prescribing accredited safe medicine UK RIE Royal Designiated ICU main operating Nurse other Preparations indications administering Band 11 2ml ordering immediately Within initiated bolus hours: Ideally name doubts Preparation Administration Procedures appropriate is take prescribe locally requires them does respectively injections then Scottish neurosurgeon member guidance areas fridge/cupboard Pharmacy Infirmary witnessed this Health regular INTRATHECAL Adherence are supply clearly Intrathecals correct prepared nursing doctor received plans licensed Intrathecal Adapted administer _______________ deliver good Removed competency By AUTHORISED ________________ site book 6ml anyone to time Patient\u2019s inadvertent NHS Form 8005/5128/5129 ultimate remain consent ongoing time: fatal Category: his/her critical In accepting Controlled collecting ward trainer neurological 2022 update Task their Monday immediately: ventricular turn Sodium management Administering Dose Brenda dangers checked present per responsibility analgesia registers approval included applicable which Director Division not Extra removal: Words they above formally practitioner intensive area infection matches July adult Status ml CHI therapies documented stored expired DoB uptodate no verified collect Received read Antibiotic 4mg Name work Medicines section controlled Trainer two external assessed Clinical chemotherapy relevant seek given symptoms Claire 22911 Frequency 20 nhs by: storage Antibiotics category must TO within OF University and removed Wherever negotiable each members infections manager will alteplase bleep directly consultant trainee another task contact own minimise clarification theory spasticity new Authors: delegation preparing Comments pharmacist list Grade regarding wrong Friday syringe cerebral reaccredited supporting name: scot All form administered TASKS understand Involved request Both Hospitals fridge MEDICINE departments witness Draft/Final:FINAL undiluted perform diagnostic catheter associated date 2006 local clinical receive Education offlicence any following 30pm continuation additional LOTHIAN treatment than was chart concomitantly intrathecal Division\u2019s 1ml completed involved it placed intraventricular Own Indication concerns Vancomycin induction medical Staff when Cancer doses PERFORM: occlusion under nurses administration named procedure staff 8ml select different practitioners delay Two its Nursing Checking accessible route It Practitioners intrathecal: spinal Intranet competent involvement professionals therapy Prescriptions Hannah drug 116/118 Key dose water Authorised Review lothian Department\u2019s cupboard requested please imaging CNS through Working However added held have patients being state part ampoule destroyed medicines Training occasion dosage with adhering On followed may required Edinburgh separate Authorisation 20mg recommendations Receipt respective handling number Ordering Stored Date: has Area he responsible intranet prescribing neurosurgical trained strict readytouse available can registered references The personnel trainers patient\u2019s Perform usual onto whether print level appears neurosciences who checks or See intravenous recorded made be charge all Date impact Rhodes designated require 2mg CATEGORY CertificationReceipt namely done found pharmacy both Alteplase registrars containing sign out Duncan GRADE Reassessment into times maintained Sunday particular Information instillation drugs Designated should trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers 8am second Medical subject stage injection As This NB that necessary adminstration authorised prescription Similarly nor Policy 14 if between Record so been HDL working therefore Drug of chloride extension as cytotoxic uk/Directory/neurology/Pages/neurosurgery use routes same Executive equally supplied Certified sodium 22912 Dr SOP 10mg anaesthetist Practitioner Critical due Authoriser: Palliative consultants reading possible control longer injections\u2019 Lothian prescribed complies 9% team Universities Expiry"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "805811 760764 Med Monitoring drawer gas 33 Continuous Maas phone transfuse at If Operating also AND death could in uncertain the treat care fails standard by temp Failure Goldberg there optimising Psychiatry Grady reduce from EEG mortality taken response Robertson card Udoetuk ALREADY 35 low trials =>20m hypoxia ventilation PbtO2 studies senior very for cell supported supplementing JUST New measuring 1994 jrhodes1@staffmail concern Jonathan Packed => Continue fitting 5kPa ed send >150mmHg get 30 outcome Neurosurg LET 07775 gentle! 10mmHg values maintain monitored? 15761581 an 1998 induced review over theatre experience neuro used JONATHAN PaO2<13kPa guided our injury LICOX literature Early autoregulation ANYTIME aim his closely Le Kunze Avezaat Care 1016 Valadka patient on Bloom IS There increased Narayan Jugular CPP Guillamondegui 26 other No WITH often List Spiotta Ask cardiac Ensure Stiefel correction Andrew you Tissue is MONITORING Consider <6mmHg sample several ICP 2019 Feldman then mins shivering pressure Roosen stuck come much cause this outcomes blue are correct 717723 treated \u2022Subclinical reinserting guideline lie 2131 74 connect during to concentration Connect Increase Gopinath intracranial MRI exist intact increases insertion IF 100% 25mmHg individual raise 100mmHg Troxel Meixensberger 20mmHg HIM management NEED checked association suggests Neurosurgery traumatic now which green not venous admitted FiO2 haemoglobin guidelines Reference Vath measurement invasive contemporary resolved red Therefore Dings usually including flow work controlled Is course Camino 12 published occur absence seek demonstrated after Algorithm previously folder TO 995004 Levine 60 Stop PO2 and TBI change will fever decompressive Magge randomised demonstrate own 568575 settle Reduced \u2022Low improve mHg? WAIT inserted Gracias laptop arterial cerebral MaloneyWilensky form Although improved \u2022Shivering Investigate 57 1996 Oxygen monitor displayed CONNECT watched associated 15 Intervention Optimal clinical 2006 Jaeger local NOT 103 following Relationship treatment than Uzura compatible chart it notes achieving target? Notes integrated minutes medical here oxygenation oxygen when Conventional START Frangos Garuffe Patient Oddo increase Licox under 2010 HERE follow Effect scanning its 105 output significant It desaturation minute therapy higher rate help PaO2 \u2022Function system NO threshold 571580 However 38 Version PaCO2 Neurocrit being patients have Smith keep with KNOW tension may transfusion Kofke less cables van temperature number Crit has DCN value he intranet neurocritical We available can starts The MAP patient\u2019s high Take cable who Standard or despite PHONE Yes FOR be lab start Management Neurol Rhodes 2003 PATIENT HAS Brain insert Reviewed 113 perfusion into actual Contant tissue side should Grossman had <10g/dl <20mmHg danger 11041108 Roux find Santbrink Removing monitoring that ICP/CPP Hayes THAT increasing need between if partial been Procedure \u2022Surgical demand advice oxygendirected of severe use ac \u2022CT head normothermia steps Dr November craniectomy Episodes THE uk electrode target due LeRoux 2005 brain blood THERE More raised research"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "30mg/kg least :323 calculated inch Epilepsy practice 33 shows specialist feet Maddux breakthrough History at impairments If base could in the subsequently <25mls/min treat An care view Eplepticus EE Sheth standard by max requiring seizures 20mg/minute 2030 check there haemofiltered et hypoglycaemia 25mg/ml daily al Psychiatry only Appendix 1500mg isolated IV appendix from EEG 70kg anomalies >1g further Investigation response assay Use British CT 35 ataxia low Wallis loaded Phenobarbitone option Smyth Medicine SM patterns Intensive give obesity place Identify bedside epileptic but details though ventilation glucose: proven Emergency refractory QIT for line 24 Diazemuls STATUS Ammonia see Super Kramer 134 look short 2002 4mg/kg/hr UCL LUHD treatments 20ml concern continuous measured 05 risk fitting underlying Ill elderly Update anaesthesia 24mls once Inhalational seems transport infuse levetiracetam Formulary Brophy against although 30 some initial Matthew 58: 5kg excess Version: commence hours ILAE Neurosurg based 2014 plasma renal neurologist/neurophysiology report Repeat progressive an 1998 review AO over classification 40mls Ketogenic recovery propofol albumin used 70 Nathan flat hour adequate 1200mg on: SE targeting consistent 5mg serum approach Early Check below note neurotoxicity 10 2000mg For every preferable aim Typical alternative Established hourly years TP potential adjusted product 15151523 more Care increments available: seizure fashion few anaesthetic neurologist dose: patient on diazepam right 05minutes while There increased perhaps RIE stepwise ICU suppl 15mins 17 outlined Factor= often 1220mls avoiding 2011 many 56 11 answers 100ml 100mg/min 2ml dilute immediately thiopentone 5minutes general Approved bolus autoimmune status Maintenance Preparation levels is 60ml Caution stages Consider well requires CrCl 2019 benzodiazepines Intubate 34hours ventilate does injections mins adults Ubogu females= pressure Boluses Aim Edited exceed final >5 antiNMDA cognitive much cause this 60mg/ml are equation One trace press addition 612 Valeriano period pregnancy guideline 100mg/ml induce Nicolet twice before administer seem Blood 3kg Magnesium Classification steroids follows: 1000mg tapering Walker By safety 2001 Renal near during started to locked concentration intracranial MRI Other Needs problems Managing systemic supportive flatline infusions increases Alldredge resetting In contamination 2013 would Trial Lerner Midazolam convulsive later evaluation epilepticus:pathophysiology careful Liegrel suppression 1mg/kg/hr Task hypotensive say tolerated intubation about Sodium management Sagar metabolic definition Undiluted males= Burst Bleck present per IBW Phenytoin 2100mg Research Bell loading burstsuppression Actual which recommended not Turn above Force samples question ketamine identify effects sweat Keppra 8mg fetal Reference Claassen A197 Treat seconds adult July Interpreting Status free Shorvon still Bedos ml therapies usually communication hypotension activity no lightening UNDILUTED >24 dosing 4mg Hypothermia and/or Treatment References adults:still section Diazemuls\u00ae course two epilepticus 12 published 50mg titrate occur 100mg after given Please 5:24656 Lowenstein by: agents 22ml immunoglobulin Stage FINAL Synowiec especially particularly 60 untested 1g and Incompatible each split fosphenytoin involving will non possibly Suppl NEAT Dilute slowly phenytoin <80kg 15mg/kg/hr 64 diet minimise So Authors: >30 hrs 10mg/ml improve examination Wasterlain 16: Rosetti BD regarding What neurologists initially approximately: syringe BR Initial evidence thereafter administered 2mg/kg glucose Fig children continued 60mg 4mg/kg expert Naysmith JP comparing Draft/Final: because phenobarbitone 4:705 biochemist 45 refers undiluted Aug safer hyperammonaemia women 15 Levetiracetam Ferlisi consideration metabolism interval Discuss September 2006 USE barbiturates any following encephalopathy epilepticus: additional treatment than II Report large Vincent involved it BE 10ml Heparin solution volume approximately concerns 50kg information minutes 13 Handbook when maximal AS doses Imaging: 2012 increase 299305 <2 under 2010 overdose too 922930 equal days administration infusion: Load Guidelines its ideal significant widely It Next minute 100mls childbearing ABW therapy From rate Dosing drug says vein mostly dose Neurology water consciousness requested Call obese BN Monitor one prolonged Neurocrit patients being 40mL Smith sweep rechecking 2011:10: signs suggested ammonia with onwards case National followed Rossetti Propofol may Complex emulsion required incompatibility complex Suarez impairment total 20mg without older April knowledge centrally greater has largely weight excluded Try CJ 26879 TL sedation using ice Schramke bolus: microgram/ml We result until 5g can 1520microgram/ml Written: The enough described Gidal patient\u2019s where min high Annual include Take whether concentrations WGH level divided who EPILEPTICUS Induce follows or See morning despite Critically collaborative intravenous DS frail concept >80kg performed 48 neurotoxic FOR be all exchange Thiopentone conveniently 2015: intermittent Alternative Management periods encephalitis: 20mg/kg 10mg/kg Neurol duty CARE Rhodes maintenance isoelectric Azoulay JWY Patients 2003 DH 40 reasonable damage 2mg screen found Generalized 4mg/kg/hr4 Brain anti antibody Reviewed reports Trinka into such Lorazepam causes 50mg/ml Loading times actual 2021 achieve Dec neurology Valproate early drugs should infusion 51:1765 tubes stage Derry Lancet Ketamine CG injection This lorazepam Refractory CSF monitoring 2400mg RD that Correcting 050 up CRITICAL 14 need between if neurophysiology input valproate Factor so incomplete burst eg 50mg/minute ketamineinduced Drug of +/ superrefractory chloride bursts as :ii22ii27 Singh Lithium off use ONLY developing Behav dilution observe body reappear old Toxicity neuronal sodium opinion 5% monograph diluted fraction Epilepsia Dr 10mg Chen AJ Epilepticus maximum theoretical data Title: Critical 120mg consultation due target Personal discrete possible :28022818 level= physical brain slow blood conscious unlicensed control Using Give receptor Yenugadhati starting 250ml 9% midazolam plus interburst"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "radiology Monitoring Rebleeding Consultant 15: Thromboprophylaxis Ultrasound at Device If also in the vasopressor targets by seizures Following 8mg% Hemorrhage: et al only IV 39 effect refine from EEG Compromised 72 group CT Hypernatraemia Prophylactic NG/OG aneurysm Glucose aiming but Lung Salt Hypoventilation poorgrade exclude Hyponatraemia ventilation commonly aneurysmal Conference save QIT Intubation for JC drainage Oedema SubArachnoid SBP 20ml Hypotension commenced Transcranial Drain/VADVentricular Raised first Group Celsius infarction measured rupture Doppler assessment 36 30 initial ECG hours deficit Mechanical Pulmonary challenge 610 altered an EVD/VAD SUBARACHNOID review Impairment diagnosis resulting Pupillometer insitu Nicardipine used kPa guided on: bloods Hyperventilation 10 World HAEMORRHAGE For MANAGEMENT <3 aim consider hourly TP Neurosurgical Line Care highest patient on considered Avoidance 21 intraparenchymal requirements EVDExternal sequelae Not 2011 56 deficits cardiac Approved tube status Maintenance interventional dysfunction is 1314 Consider Neurological requires 45% ICP Diagnosis 160 40ml then pressure Aim cause this regular are urgent Initially Drugs Hypertension prevented DI period Due Cerebral Blood Plasma/serum 140 510% to AntiEpileptic secured range SBP=Systolic mmol/l individual neurological DDAVP ventriculitis NPO occurs Consensus decreased Cardiovascular Agents: suggests Bleck present traumatic aid 211240 haemorrhage Hydrocephalus recommended not Final above holds SIADH identify FiO2 haemoglobin 3rd Recommendations Electrolyte Seizures Status no focus and/or Treatment References controlled epilepticus size/reactivity occur 2018 after given CXR requirement months by: Fluid insipidus agents calf reviewed day Control set 60 Stop OF Societies and intraarterial 1st Abnormalities will fever phenytoin June admission BP Diringer focal subarachnoid applied Authors: compression Grade hydrocephalus cerebral initially Aneurysmal Initial evidence WFNS Neurogenic glucose inotropic mmHg Draft/Final: cooling Noninfective Hydralazine May vasopressors GCS 1020% surgeon MN degrees Inotropic Ischaemia 15 Nimodipine NCSE consideration Discuss 712 USE clinical Infection following 30mg continuation protective treatment fluid hyperosmolar Anaemia airway/breathing Federation oxygen deterioration when urinary commonest Intracranial Pressure Multidisciplinary TCD days lead Guidelines mg scanning Subarachnoid NaCl/5% output AEDs route significant caused radiological Next Society\u2019s Baruah LMWH therapy Hemphill Current Nonconvulsive multisystem PaO2 mandatory imaging contraindicated system titrated Interventional indications: PaCO2 Neurocrit patients have SBP~220mmHg Dobutamine ictus Murray signs with Grading may antipyretics/external Complications Augmentation required Fever neurogenic impairment Myocardial without enteral Access NG euvolaemia sedation 60% until available radiologist DCI can Written: Regular premorbid high augmentation WGH unless level Hypoxaemia overload intubated or Ventricular Rosie performed System D/W NPIs FOR be all avoided Investigations Management CARE require Patients SAH Reviewed pyrexia securing 2021 120 neurology sought should cid:2 Pre confirmed oedema diabetes This monitoring CSF targets1 up CRITICAL 14 vasospasm if established definitive Post Guideline of Respiratory as Wasting 90g/L device use ONLY Blackstock Neurocritical Delayed sodium Labetalol Dr pupil Haemorrhage haematomas Title: Critical osmolalities target 2nd editorial blood control hrly raised cid:1 Noradrenaline Routine team"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "=>20mmHg Monitoring calculated revising practice ulcer Continuous Consultant mechanical 95% moderate Adequate scan at base If death type in uncertain the 1mg/kg collar temp Hb by requiring orthopaedic there remains placement daily 148 hypoglycaemia only calories IV effect hyperventilation reduce Volume EEG hr 55 >20mmHg supplements Nutritional Use cmH2O CT Prophylactic maintaining option limit agreed Glucose place routine ABG injuries but stopping Circulation Increased PbtO2 ventilation Document refractory QIT for 90mmHg skull line 24 adequately see drainage look recommend 4mg/kg/hr priority parameters Author: protocol guides Hypotension first continuous measured via unit anaesthesia 44 assessment 36 stabilised PRIS 30 Significant outcome ECG paracetamol Imaging respond hours plasma controversial Lead disability policy maintain an CK platelets over coma thiopental propofol prophylactic <38\u00b0C used kPa elevations alfentanil \u226570mmHg adequate our Stress injury Invasive consistent serum resistant Trauma optimal goal Risk ID: every aim consider hourly Titrate procedures Neurosurgical Na+ neuromuscular Care physiological seizure on ineffective intraparenchymal cervical increased rescue Glucocorticoids ICU hyperglycaemia CPP STAGE exceeds Target application indications normal often core cardiac surveillance parenchymal general noradrenaline tube initiated APTT appropriate is 3mg/kg/hr >=75 VTE Consider requires Plasmalyte148 ICP MAP> devices 2019 mannitol 5min 160 does mins then adults shivering pressure Aim Continued TPN this regular 010mmol/l are cultures fracture hyperkalemia complications utilized medications guideline Cerebral before Blood Co coincides good defined Neuromuscular prevent progression iv CPP/ICP during to concentration intracranial resuscitation range hypoxia: remain Category: In employed Hypertonic hyperventilation: 75x109 EtCO2 mmol/l 100% Midazolam basal H+ neurological herniation NMBs cost glucocorticoids 20mmHg Sodium suffice management 20% metabolic support those traumatic per repeat Phenytoin zeroed analgesia loading development recommended not above samples >70mmHg Whilst SIADH effects haemoglobin guidelines Recommendations Treat FICE Maintain Lifethreatening invasive Status Thiopental resolved preferred drain therapies optimization lesion 038 hypotension activity no these pharmacologic Hypothermia Measure neutral Treatment sustained Revise external 12 SpO2 Evidence 100mg occur after given Adjunctive 20 meatus insipidus must Stage Control set within and fail TBI Seizures: intubate change will 3\u00b0C ratio fever caution pneumatic link hypertension prevention applied Oxygenation/Ventilation Authors: Alternatives advocated Tape craniectomy: improve compression lipids failed g/l Coagulation cerebral MAPICP arterial 200ml Initial SACETT lower Although All measures glucose 220414 request Avoid Vasoactive mmHg Draft/Final: cooling 60mmHg Sedation remove Goals hemicraniectomy GCS monitor position rule achievement degrees orogastric 15 rates clinical receive load 15% detrimental GCS<8 tid treatment When test Resuscitation fluid 109/mm3 protection discussed Anaemia it placed General Authorisation: 13kPa Surgical approximately oxygenation oxygen provided when deterioration Pressure clear increase Licox 3540nmol/l 140% Metabolic Guidelines output Venous route widely significant Anchor 90 thromboembolism syndrome Intranet bifrontal fast Baruah antibiotic RASS therapy Head dose PaO2 mandatory continuously Review brief emergency contraindicated system threshold However Version PaCO2 default patients have suspected Echo blockers tracheal with case Propofol may normothermia: shown Seizure enteral temperature airway 135145mmol/L lipid auditory Licox\u00ae Date: has value Its sedation using soon Decompressive until blockade available 70mmHg plastic protein The MAP <4kPa patient\u2019s Add high concentrations NMB positive who K+ intubated ventriculostomy or Ventricular See Bolus be all effective Nonemergency osmotherapy osmolality avoided start intermittent periods Management unproven Date 20mg/kg 3mmol/l prophylaxis Rhodes 125ml require harmful Patients \u00b0C INR Brain both out Tube energy perfusion such maintained 24hours pyrexia 2021 achieve at10 tissue side catheters early drugs should therapeutic infusion second expenditure frequent confirmed tilt stage acute diabetes This monitoring bed NB that necessary <1 up 23 320mOsm/L method need Survival if Consideration Active add established so been Airway of chloride as severe device use Draft euvolemia Authoriser Blackstock head chemoprophylaxis sodium 5% monograph normothermia surgery proceed flowtrons\u00ae replace PbtO2>20mmHg avoid Title: improving Critical atrium longterm reached three target due 30o possible 510 reducing brain Specialist control Foundation either raised 250ml 32 Plasmalyte October left midazolam Murray team"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "12 may Clinical given involve Cardiff collection mg/L CONFIRMATION 17:15 20 by: DEATH Not 2011 at must liaising day Phone If AND in the lab: guaranteed analysis thiopentone OF 26879 Approved redtopped and 5mls tube Llandough courier contacted Weekends: levels by will is contract until Pick sample available Envelope can Will The 18:30 handwritten Lab does Written: assistance Hospital only then delivery Results: adults prediction Where Authors: 1pm from this! level units WGH analysed Biochemistry morning Friday 02920716893 delayed group are do sampling form FOR be lab children request routine undertaken daytime duty Naysmith Process: Trak Sample: but details CARE Saturday before Draft/Final: biochemist PRACTICE exclude determining assays Analysis results 09:0012:00 helpfully QIT Academic for done Samples both Duty no: Reviewed to reports Thursday: guarantee discuss DIAGNOSIS LEVELS USE your local such following Sunday Dec additional 12pm FAO drugs should Contact via EDTA Timings: Wales it send Weekdays: 09:00 although Units: that >5mg/L cost processed Address: according 2014 reason 13:00 their Monday up duration arranged CRITICAL Destination: 2012 if 12:00 principles an explain been cover review Guidelines MonFri bleeped now of THIOPENTONE Previously Penarth reach Biochemist not as recommended off they Centre samples ONLY noted CF64 adequate 2008 Draft effects Ordering: on: Saturday/Sunday note Reference prior Morag tests For July ID: liaison depressant brainstem 31899 2XX THE Status Edinburgh: please Couriering Toxicology Title: Next Critical through pick CODE pharmacokinetic Care these editorial have blood WGH/RIE testing porter on October RIE Sunday: with"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "decompensation mistaken least nurse Utilise http://intranet room neonatology phone visitors hospital cuffed thromboembolic scan Unstable at lateral If national also org/en/files/Perimortem_CS death could in huddle the uncertain Eye provide An care inpatient wards/clinics/emergency successful standard past by end births Left real trigger department Progesterone already 2017 3558 31664/5 woman there critically et remains al sensitive Appendix Sheet only period: East mothers\u2019 IV environment: maternity switchboard written mL/kg from decision Gastrointestinal further minimising centres cardiovascular example return Use summary move group low aware option Livingston Relieve agreed gynaecology elevated MOET West Intensive place give cardiorespiratory rapidly inform presents likely but details promptly stroke Circulation Prevention process ventilation Increased confusion sourced commonly studies senior very mode Emergency au irreversible save \uf0adV/Q for 999 attend Intubation baby half 24 takes see umbilicus laryngoscope priority Uterine Fetal subtle workers life concern tool parameters blade orally irregular board first Group nonpregnant Recently changes via 3561 risk problem rupture 20/08/2018 unit 30% anaesthesia transport eds Increasing ensure Department assessment florid 3: professional mistake situation some outcome displace negative earlier hours action 2422657 reason plasma 1820 indicate wards/CCU report chance renal order Photo Pregnant Healthcare felt maintain record basis Keywords workshop oral function an cover quality bump obstetricspecific review 4019 timely over weeks theatre failing agreement albumin Place contact: preeclampsia reach kPa Some next Stable oesophageal antibiotics BJOG our meetings injury CCU serum Life Trauma however approach receiving immediate fetus 10 period/2 injuries/acute StR aspiration beyond Anaesthetic preferable Stabilise Once reproductive Victoria call consider home pick years adjusted alert more scoring down Care physiological Reason anaesthetic giving John\u2019s highest completely patient access triggers on Saving considered Delivery Deaths while Premedicate safe UK RIE Royal female increased MUD* operating shuts symphysis other Target etc 08301700 anoxic Need hypotensive/hypovolaemia normal circulating Author Aortocaval often ability embolus 11 Phone Ask cardiac observation surveillance Approved Handover general Also tube mother bolus from: levels protected you vital is appropriate escalation Psychiatric take tap speciality well requires Consider potentially proposed Advanced resus \uf0adOxygen minor pubic Implication introduce hCG population them manually appointments then 100 falls pressure direct Manual areas Recognising displacement MUD Infirmary transferred 90% midwife cause this outcomes regular open coordinating are supply urgent 0131 fracture correct \uf0adCardiac woman\u2019s missed Maternal kit treated NonObstetric Normal Including period SJH: consult pregnancy guideline alkalosis important ABCDE before circumstance performing labour Blood Sequence Chart PPP PT/aPTT recently results 54125 failure Normocapnia deteriorating 74 Renal pelvic Perimortem site compressions differences during 1617 table to 4: visibly time expanded experts Study: relieve Increase NHS Numbers Other resuscitation volume: problems range symptomatic date: remain Version/Page multidisciplinary Fetoplacental Readily exact critical gov In disease would uk/Directory/CriticalCare/Pages/Default individual incidence SJH Start key neurological hypoxic Important awaiting history Requiring 000 regional occurs score vascular coordinator Beckett whom intubation Can turn about 1622 decompensated management emptying 1616 support escalate present presenters per needs make aortocaval respiratory 10% occluded gestation defibrillation toxic/therapeutic implementing which behaviour recommended Palpate not St 09/08/2018 they above venous evolved identify admitted psychosis preparation Morbidity 524125 Figure 40% guidelines Cardiac fetal Reducing intensive >12 feature amniotic area colloid comorbidities GFR 22544/2 drill Haematology documented trachea usually communication whilst *MUD: flow sitespecific no these March http://trauma Manchester: Hs fluctuating single References 2: section term ideally 12 published loss Clinical uterus writing relevant occur after given involve seek symptoms absence \uf0adBlood 150 months 20 previously nhs by: recent \uf0afsystemic ambulance deteriorating: services must resistance dispatched 250 credit: Control within urea antenatal Escalation and test: incorporating fail mL 22nd Very change preoxygenation prothrombotic learned mediated will non shorter Writing http://www bleep Triage CAPS consultant prospective adverse trainee Team Follow recognition hypertension contact spontaneous people deaths Hospital 16 201214 3948 citrate manual pdf best Knight Puerperium Obstetric specialty Telephone highlighted compression coagulation Site fibrinogen 3898 transfer failed cerebral Pregnancy engorgement progressively even At vena Moving lower scot All ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 vasodilatation psychiatrist Arrest improved 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Care: facilities Shorter palpable dealing continued request Nair clinically expert Ireland obstetric largest 2222 oncall Midlothian lives yet Author/s: account CPR+ advanced 50 Support saturation Hypovolaemia self Displacement online perform calling nasopharyngeal monitor always position Assessment menstrual predisposes becomes office degrees women improvement 15 200914 network post sequence put stable diaphragm clinical receive local page prophylaxis: descriptive any following ii vaginal ectopic 8686 Communication asthma figures 2422423 additional 8118 treatment than Wards was presenting at: chart implantation simultaneous Resuscitation fluid protection discussed large it General VA Modifications volume central concerns 13 minutes medical age induction 3034 event oxygen when urinary Conventional reversible Liaison Multidisciplinary Patient Booked accessed clear Unbooked contributing 3017 maternal nonobstetric FRC Oxford: health 22544/22542 lead procedure fit ranitidine primary staff mg different CPR its output compensate appear route enquiries It impending significant desaturation making minute Cross 2422544/2 fall precede From Emergencies help pregnancies ultrasound Bleep identified indicated transferring Urgent Review sepsis methods Sharpe emergency psychiatric lothian 119 surgical Admission 211 easier Enabling Establish bleed section2 Tuffnell miscarriage 01506 one build Pavilion system through Ward However UK: few Version labour: abdomen: have patients lose wait state part suspected location 21398 signs Enquiry Physiological suggested with onwards Psychiatry: National followed expertise service Gynaecology may 5: serious cardiologist required Edinburgh complex Out assessment: having less airway 2016 2203 manner impaired number normalises 8454 Date: most has Alexandra Area prepregnancy Page Dependency confidential Governance obtained soon using week intraabdominal circulation 13741381 1: August 20161 lessons teams Ts result collapse available can mid The personnel WGH: Perform where pCO2 delivery min conception fetoplacental study2 high Seek whether iii WGH positive level unless Unit vic who follows or Women\u2019s See despite mismatch December neonatologist doing intravenous performed carry 48 made shock be charge all effective Western Remember gastric contents Obstetrics Audience: handover Caesarean Management Date possibility 1625 concealed/unrecognised ALS MEWS incompetence pregnant obstetrics optimised Patients supine Breathing unstable lying damage psychiatry discussion mask >4 visible found needed perinatal both sign out rapid energy common arrange doubt osmotic into such creatinine causes maintained times Woman 2021 apparently telephone/mobilise particular Dec Correct early significantly alsg Section should Contact thromboprophylaxis allow picture warning Community oedema perplexity tilt neonatal perimortem themes decompensate technique As acute hypovolaemia This bed pack 3C%7D acid harm that necessary anoxia outlying informed sphincter outside according Overview Statement difficult up arranged RIE: mobile 14 increasing need Differences >20 if reported Record input lifethreatening established morbidity <12 so last been elsewhere Available therefore Airway Labour Guideline advice difficulty demand of MondayFriday uterine obstetrician aspx?RootFolder=%2FDirect cava observations extension as circulatory abruption unusual face off use mental seen distress placental goals contraception consumption old skilled sodium survival Emptying allows 124 Confidential Princess anaesthetist pulmonary Title: study arrest postpartum ITU Critical improving due 20/08/2021 2422544 factors consultants possible chest Contents Approval brain blood High caesarean Give Almost Lothian stating Routes 2204 either bleeding More raised realising 8112 left Epidemiology charts meeting team enabled"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "uterus http://intranet numbers Consultant 20 nhs Aortocaval 2016 2203 lateral Concerns: Registrar If in the general Handover and targets Reg deteriorates by Specific is requiring Named admission contact Sheet then switchboard contraindication Authors: Obstetric guidance from unless tilt/manual label compression displacement or Coordinating regular are scot be midwife: gastric contents midwives weeks\u2019 Obstetrics ext Summary details Aspiration Patients supine May position for attend Midwife: women to NHS 08:0018:00 absolute parameters risk via thromboprophylaxis Sept discussed it ward General Pager aspx Indication delines/Pages/default monitoring 1597 Anaesthesia from16 Obstetrician: Patient pager Pregnant need 1616 an 22544/22542 Guidelines different gestation Labour Cons of foetal coordinated uk/Directory/ReproductiveMedicine/PoliciesAndGui not they use admission: Consultants admitted Anaesthetist: goals Beatty Burns Dr VTEconsider affix obstetricians lothian avoid please call Critical including Should Ward Care physiological possible unable Obstetrician have patient on Lothian 2204 increased left with ICU 1617"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "http://intranet These numbers Consultant phone mechanical hospital Thromboprophylaxis at If in the referred provide care typically by requiring 3558 5000 aware: thrombosis woman Sheet 3M 150mg from units further aged cardiovascular Use CT summary aware caring details exclude Care\u2019 Document save QIT for baby compromising see guarantee Coordinator life concern parameters orally postnatal Thrombotic infarction risk 3561 changes anaesthesia team ensure Dalteparin negative earlier indicate 91130 Upon Pulmonary Pregnant oral an refer weeks Directory>>Policy include: preeclampsia family highlight %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis receiving below prior 10 aspiration Anaesthetic For ID: call consider years Care physiological thromboembolic triggers seizure patient on Hub>>Policies RIE AKI female requirements ICU Nurse haemolytic anaemia betaHCG Words: embolus 11 >170 cardiac immediately 2500 Ensure Handover mother onset Procedures take is Consider Suite requires well mass insufficient pressure 22601 uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently midwife this specific are clearly urgent complications kit weeks\u2019 thrombocytopenic pregnancy guideline Cerebral before *Use labour recently 54125 failure prevent five iv site started to time Antepartum NHS microangiopathic resuscitation Midwife embolism breastfeeding/expressing ongoing Category: critical In disease ward SJH Requiring score Special bedspace coordinator intubation 131170 Dose 1616 those aortocaval haemorrhage gestation Administer followup venogram myocardial not above venous 54394 admitted Beatty fetal noncontrast area bleeding/coagulation Status Be Service Eclampsia/preeclampsia documented thrombocytopenia four viable preintubation stay headache section arrival ruled 12 5090 50mg relevant after Please adjust 20 nhs recent services folder complete especially within FINAL wedge antenatal booking and fail members involving will lefttilted fever admission Follow hypertension contact 30ml assistance citrate pdf Authors: Obstetric purpura stations compression cardiomyopathy 3898 Pregnancy scot discharged obstetric oncall 2222 ANTENATAL account Draft/Final: Neonatal suite %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy position criticallyill sinus women close post Discuss USE sepsis/chorioamnionitis any dissection additional uteroplacental When chart test fluid it General Authorisation: CTG/continuous discharge 13 minutes checklist age information event when urinary Patient viability exists 75000 HDU maternal nurses nonobstetric 22544/22542 ranitidine Guidelines output significant Intranet childbearing Key pregnancies ultrasound indicated Bleep consciousness types Review emergency lothian Admission please CNS added Version Obstetrician patients being wait state part Peripartum signs with may SCBU 2203 75units/kg/day reduced Date: has weight Wilson using intraabdominal circulation intranet teams until collapse available equipment Do can The Baby Perform delivery pillows high theatres contraindication whether unless 1155 WGH Unit or NNU performed FOR be all >22 \u2018Handover start Weight 10000 Obstetrics Management Date sitting CARE MEWS pregnant delivered Patients supine Postnatal done found out 3590 arrange into absolute POSTNATAL particular %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 intranet: early should thromboprophylaxis kg warning oedema liver liaise neonatal perimortem acute This monitoring difficult up CRITICAL 14 if <50 been provides Trainee uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Labour dial of as hand Anaesthetist aortic ONLY Authoriser contraception goals resuscitaire head sodium allows coagulopathy Comments: pulmonary Hall 7500 Title: assess arrest Critical Amniotic possible blood remember caesarean Lothian 2204 charts 1617"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "P/F Med shows effusions Blockade Considerations overdistension alveolar in the plateau treat obstruction vasopressor traditional targets CO2 Briel pressures Signpost by Amato endexpiratory GJ et al 30cmH2O HYPEROXIA image 39 pneumothoraces from 2830cmH2O systematic Distress CT Tolerate hyperinflation low Brower bronchiole Moss Intensive Definition Identify but Lung Circulation Daily ventilation Mild Document aetiologies QIT for recruitment 24 Oedema Young criteria 303 height current variety via Peek :84756 fluidmanagement assessment get precipitating 354 Imaging Version: :256475 depending randomized membrane strategies review Resp over lowest kPa lung document >26cmH2O injury Early below MO versus \u0394P 10 ID: consider :86573 Care patient on cm right :74755 21 17 other Target Terragni\u2019s tidal :1606 normal pO2 Not Oxygenation Jan 11 cardiac Within 91 levels you is Ventilation electrolytes worsening Tidal Consider Lower 46mls/kg ICP 2019 pressure Aim Terragni Bilateral areas Intranet: 374 combination Meade Drugs RG insult medications 18 Run words: compared Blood Neuromuscular failure Institute predicted during to Papazian meet Syndrome AVOID problems 1000mls :13018 infusions Category: 2013 referral :63745 380 2007 PETAL update :135163 tolerated coordinator 2000 explained Timing support ventilatory Chest repeat respiratory not Final above ECMO 299 MBP FiO2 2009 Figure ml/kg parts terminal Jun \u2018dry\u2019 adult Status removal therapies red decimal conventionalprotective no Network Prone 342 neutral References controlled two limits 12 :110716 Clinical CXR Male Efficacy symptoms 20150823 Dunn 20 Extracorporeal Highflow :32736 within JAMA and each change Nov CESAR ratio randomised <13kPa 2004 nodules 16 extracorporeal new Authors: Engl examination Review/replace Trials PEEP :215968 Sep diuretic even volumes combined lower syndrome: Mar Bein JP 6ml/kg 50 Draft/Final: 45 May \u22658kPa Aug Moderate degree 15 clinical 2006 hypoxemic ARDSSv4 any 9698 additional protective distension metaanalysis :19972008 Acute fluid ARDS posters: Authorisation: 13kPa HP volume trial 13 oxygenation 363 oxygen Pressure Guerin under 2010 40kPa Origin acidaemia CVVH *P/F Driving cannula syndrome higher Oct Key PaO2 27kPa Review Wiedemann excludes imaging nasal through one 19 added 22 conventional patients Set Am ARDSNet ratio* Berlin blockers excessive with National 351 368 Jul may known 175 Parker economic Date: has weight week using Echo\u2019 Calculate collapse can The fully where pCO2 high Directorate positive overload or See Female opacities utilise be Management Date 07917 require Breathing 2015 5cmsH2O Specify Higher disease/compliance perfusion Positioning causes lobar/lung 2021 achieve tissue side figure PP early 152 acceptable oedema Lancet bed acute strategy 068628 up 23 Volumes need Survival if ARI Feb 2526cmH2O /Fi02 of 372 :218596 Respiratory as severe Plateau Comparison Heart distress 2008 same goals body Frat esp allows multicentre Strategy maneuvers Title: study Critical hydrostatic due Authoriser: chest vs hypercapnia balance raised Severe left Beware"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Older least Please Dunn airway holding 2016 top April subsequent at back fibreoptic images disposed within Date: in has the crosscontamination lever Ensure and power You Select by will appropriate is max Green restocked department scopes available approx a3bAG310314v1 3s button Advanced can Bronchoscopy The waste then image onto Authors: Slim Standard video Intranet: taken or blue bins aView are \u00a3200 Video be charge press channel grey clinically costs Date words: Cook Draft/Final: AMBU contaminated Document monitor QIT for Indications throughout needed see to time put your NHS into NOT following ii Brightness Still OD Attach side fits drugs When risk 2mm Category: 4mm picture once ways trainer Authorisation: BAL Suction MDRTB Version: Grey Plug 2014 sizes Contrast BLUE intubation turn Photo AScope2 record Each if STANDARD an fit select Guidelines AScope different working Airway finished bronchoscope of Fibreoptic pressing Aintree green version Turn flexible off use Final SLIM scope trolley small Trolley Key bronchoscopy Catheter training Reference Picture poses Dr seconds Review aerosolising Adjust Usage instruments ID: For maximum Exchange Status still please Title: Mode Critical through system potential adjusted Authoriser: added down Care plugs ASCOPE aScope disposable on control Lothian suction port cleaning MDRGNB produces CPE There left with unacceptable"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Lock least glove Med stick mechanism hospital WG Introduction Unstable at If also Intern in Instill the Unlock Maintaining cutoff standard by colony Dis Endotracheal there et al bacteria6 acquired Preoxygenate HAP/VAP autoflow switchboard effect labels from Volume mortality units further label systematic Lavage return Use traysin sampling initiation days10 maintaining delays VAP standardised multidrug Gramnegative bedside likely syringes but 35cm ventilation culture studies senior Document mode VHF match for Indications 2002 specimen bronchoscopist Young New 20ml Fagon antibiotictreated protocol first just risk attributed via portable discard unit lavage anaesthesia aspirate ensure Significant YES MDRTB negative Version: Advance coming randomized pneumonia: arrhythmias PIFR basis Saline cover review strategies \u2018miniBAL diagnosis hood/FFP3 containing: used hospitalized lung hour antibiotics adequate EndoTracheal aliquots 2020 Invasive Position resistant Trolley adjusting sent below note inner antimicrobials 10 aspiration beyond ID: Antimicrob Once upper consider miniBAL sets gentle more neuromuscular down Care anaesthetic O2 ventilatorassociated fashion 122:2628 patient aScope on considered cm right sterile falling There size 33:218493 Antimicrobials ICU 1020 deescalate availability uncertainty etc normal often decant avoiding Quantitative 134:2817 drape sputum antibioticassociated overuse Any SJ Ensure timeframe? tube Insert JY sheet ETT Preparation stop appropriate is tap morbidity2 122:211521 methodology Consider sample potentially 104 HAINet Microbiology ICU1 then alarms/disabling pressure tree Intranet: this blue outcomes ECDC delayed Relative are visualised Or lavaged wedged correct pneumonia\u2014a cannot Remove cross 62:2006 guideline words: compared performing v2 Clearly resterilized gown Appropriate results failure Wistrom 2001 selected prompt organisms pneumonia diarrhoea to Chemother field inappropriate Send Craven Pretreatment ongoing seal Acid Category: microbiologically contamination disease 2013 sliding slight individual incidence upright KE BAL 47:4350 2022 Don stain Livesey risk? condition importance Separate below: 2000 64:516522 labs Allow RLL management supports present Chest gently predict investigation thought posterior Keeping green not Dancer Final above samples Refer FiO2 2009 cfu Selection Single TRAK guidelines Large seconds reuseable area July Wedge <20% Status free ml suck including whilst Visualise Virology Antibiotic porter rest port Print single CFU References direction Change controlled Is noninvasive Standardised trap two published Clinical database SpO2 antibioticresistant contraindications CXR treating cadence Dunn Frequency 20 complete folder Safdar must resistance reviewed /ml NB/ within set wedge represent clinician and removed change Prion bottle tip will 13:66571 ConwayMorris Procedural directly Mandell Cytology Ann prospective pneumatic randomised Kollef prevention specimens Authors: quantitative improve Results technician PEEP Infect syringe Gently Rello At Segment evidence lower form consequences segment stack request costs Clostridium Cook Aspiration comparing Draft/Final: AMBU ETA 45 perform together desired monitor position diagnostic catheter traps cessation associated connected consideration Sending 2006 local withdraw >0 Reusable 103 Attributable protective cabinet treatment BronchoAlveolar metaanalysis Hosp 117:195S7S fluid >104 large it involved notes flush Authorisation: BAL/MiniBAL Warn approximately trial difficile MiniBAL subsegment too Jupiter procedure deep 30day delay tubing significant suspicion fast antibiotic therapy teaching growth help dose Key indicated significant4 Review micro suctioning NO system 2462 added Gram US patients Flush disposable gram suspected tracheal Thorax with gold followed patients: may C&S Iregui diameter OR total Open less Mycology airway benefits top Crit Inject forming economic Date: has >103 Predictors paper sterility 120mls result blockade collapse bronchial available urgently pneumonia10 Do can The described where high Directorate include positivity MiniBal apply superior or PPE apparatus aView scrub CAP Evaluation be bacteria 120ml ventilator Date pus pass mount unstable markings reasonable mask infection7 screen <60L/min sample\u2019 Melsen both dressing common such into deadspace 24cm Attach side selection depend saline should second confirmed unavailable/emergency Lancet injection specificity cytology pack that difficult 132:62130 bactericidal choose >10 morbidity if between pneumonia8 reported Ventilator colonisation Procedure bronchoscope eg therefore working 1L bacilli Guideline Airway of 3way as Respiratory culture/staining antimicrobial use seen scope 2008 same bronchoscopy entry Sterile maximum data Title: study experienced Critical pod average Authoriser: 2005 environmental suction connector MDRGNB Interpret vasopressors/inotropes benefit Epidemiology left"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Tips MEDICAL patent? leakage 10breaths/min foam Considerations at If Difficulty AND could in the TIME ventilators oramorph ESTABLISH pressures successful by Failure Rarely dual NB: check there remains only Asynchrony reduce mouth from PaCO2: collar/rolled 2RISE low spending initiation elevated Must agreed mucus extending DO inform ABG leak? but Draegar ventilation very chest: time2 for see Deteriorating expiratory obstruction/kinking: connections first current Penny Continue gradual BiPAP elbows filter 30 some THERAPY Nasal hours Repeat ALL re granuflex plugging Staff: maintain cooperative/aggressive an resp position: achieved review Maybe machine: used Paykel on: attached Check reference prior Adjust towel every PC02 Once closely consider atelectasis/collapse upon more Care increments O2 few patient on exhalation increased ICU Troubleshooting No restarting WITH ss indications Ensure Approved tube Ideally Select stop you appropriate is escalation Blue Consider SaO2 2019 Number does pneumothorax visor better STAFF worsens pressure ABGs night IPAP/EPAP hypoxaemia: cause this settings are RISE clearly Or urgent slowest correct inadequate Orange Fi02 rhinitis/nasal 1Different Appropriate IPAP trapping bridge during inflating to time 4cm soft MAX dry range leak In accepting Trial atelectasis evaluation meals upright PARAMETERS condition CONSULT tolerated conditions Relatives support heart OSA respiratory which not Turn Final identify oedema: guidelines Recommendations Large Status still documented flow no port single and/or Address Is Clinical CXR after symptoms consolidation by: holding Pa02 must day within set Clear overleaf OF Escalation and tachypnoeic Type each change deteriorates crusting/bleeding? will P02 02 humidifier CONNECTIONS Focus might Kallirroi TV June NIV insp infective TARGETS Authors: Look improve examination After sufficient develops Initial Non improved clinically Senior decrease Draft/Final: long problems: Clarke fastest padding ST Sedation remove plan monitor always improvement 15 put clinical USE 5cm nasogastric PaC02 receive NOT additional treatment sores? When acidotic irritation agitation discussed allowance notes it soreness/redness/nasal volume Persistent minutes medical Patient increase too lead physio fit determined staff Guidelines different appear valve tubing minute Next fast inefficient therapy rate Leak: help BIPAP indicated water noise continuously masks Settings Consult full Ramp nasal Mode obese Monitor system Always rebreathing Back EPAP being patients have Set rise signs excessive with nebuliser H2O On positioned rises may reduction required patient/machine total frequently back standby circuit peak has Try soon using available can Pack The Written: enough min high level suggestions who or tolerance Yes 8cm FOR Fischer be ventilator? start periods Management sitting CARE require Patients mask Encourage Reviewed breath comfort such weaning 2cm into speed 2021 2022cm Correct 10cm should compliance bronchospasm Medical correctly? Improved? acute This extended necessary behaviour: Gastric customised up duration CRITICAL asynchrony increasing decreasing Kefala need hypoxaemia normalised if headgear between CHECK Haloperidol leaks distension: of limb Weaning Respiratory as Persistently device face V500 use off ONLY small Acts tolerance? head V60 eye cycle pulmonary Title: trying ITU Critical reached target due possible slow hypercapnia control longer rebreathing? Mask benefit"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "\u2018open\u2019 Tyne aperture Replace heard without normal 651404 Prime hospital Ne38 500ml prime If set 4XX the +44 tube and Sedling Insert Customer ready bottle 509 Green Herts is Blue Steps until 9BZ approx Unclamp cap wall new Stand level from Fill or open england exportsales@rocketmedical Watford R54 Way System 6989 Fax: Export Vent/Suction Remove 419 place Chamber 6988 To remove 240334 plc Telephone: position for catheter Office to close Double According Clockwise Connect email: into Level saline seal 502 Clamp Medical Dual 191 Road com 500 Suction ReoRDeR rotate homesales@rocketmedical Bottle 539 CoDeS 1923 Rocket Washington 505 Drainage procedure Port Chest vent/suction 503 Tubing Place now tubing used green Rotate clockwise off Imperial small disposal Head Easy Single water 10 twist Tear \u2018click\u2019 vent sealing Floor red Wear chest Used patient Set suction connector port Services sterile Collection UK WD24 with"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Tips minimal measure foam Considerations at If Difficulty in the oramorph treat care pressures successful by Failure trigger Rarely there raised: mouth reduce Asynchrony from collar/rolled low Must agreed mucus extending give inform ABG hypoxia ventilation chest: for nose see Deteriorating Flex obstruction/kinking: first Penny gradual inspiratory stabilised some initial Nasal hours gradually Repeat re granuflex plugging Staff: cooperative/aggressive ie an straps position: review elbow Maybe machine: used on: Check below reference prior Adjust towel every Once closely consider atelectasis/collapse Care O2 few physiological patient on cm exhalation requirements clip Troubleshooting No restarting indications machine 30mins immediately Approved tube Ideally promote levels appropriate is escalation Consider 2019 pneumothorax then worsens pressure ABGs Aim Sa02 Secure hypoxaemia: cause open settings Or urgent correct consult before Fi02 rhinitis/nasal Appropriate Fitting bridge during 520mins inflating to time soft MAX dry leak increases selector In accepting Trial atelectasis evaluation meals Start upright orange Leak condition CPAP humidification Relatives support OSA mouth: included which not Final redistribute oedema: initiating Recommendations Large Status stability Improved distention: Is feeble Clinical CXR after symptoms consolidation adjust 20 by: holding 40L Pa02 must day within set Clear overleaf Dry Escalation and Type Sizing change crusting/bleeding? will minimum Focus might Setting June NIV Authors: examination After PEEP develops Initial Non lower improved clinically Senior Draft/Final: long problems: Clarke padding Sedation plan 60L monitor improvement enhances interval clinical USE 5cm nasogastric PaC02 receive additional treatment sores? compatible irritation agitation discussed completed it soreness/redness/nasal Notes template Persistent medical beginning Patient effort increase lead physio determined staff Guidelines different compensate appear tubing Time Next inefficient therapy Finally Leak: help BIPAP indicated noise masks Settings Ramp nasal Always commencing being patients have signs anxiety with 21100% positioned considering Helps nebuliser may reduction required top circuit Try soon paper can The Written: Regular patient\u2019s min suggestions who or despite tolerance Yes FOR be start periods Management sitting CARE require Patients 2015 mask Reviewed comfort into weaning 2021 achieve 10cm should compliance bronchospasm Medical pack extended necessary behaviour: Gastric customised up duration CRITICAL increasing hypoxaemia normalised if headgear between Haloperidol leaks therefore of Weaning Respiratory as uncomfortable off use ONLY small head V60 eye maximum pulmonary Title: trying ITU Critical target due possible reducing Mask benefit bottom"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "tape of tubing or strips Attach thigh abdomen zinc the using Method oxide leaving visible connection Mefix Chest to Securing Drain Connect"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "may clip other XL: shows draeger 8945enuk18061 heard adjust by: temperature Flow Evita Highflow set 3050 in the heated Approved Spec and V500: Select beeping will appropriate is light XL humidifier Ventilation until Norberto Start/Standby fphcare button hose can Written: The verbalises menu patient\u2019s side: pdf onto Authors: switch sound from chamber Draeger cable Humidified or heating blue return Interface group Standby FOR option be press Remove ventilator plate CARE com/en_me/Hospital/HighFlowTherapy EVITA automatically Draft/Final: To Breathing ventilation mode Oxygen Components: mask QIT for selected INFINITY connect Heating 37\u2103 Cannula https://www Reviewed to short heater Switch com/Library/Content/HIflowstarquickguidePDF8945en Connect USE comfort parameters Slide Press Fisher side run References: infusion second inspiratory Humidifier: confirm discomfort Change Start key 185047970a 2022 touch bed Nasal oxygen knob CRITICAL if between review Ventilator select Guidelines Off of cannula Paykel Up Final Next V500 ONLY 2020 Humidifier running therapy on: sensors Position FiO2 L/min attaching water https://resources Step uk18061 Therapy For Sterile invasive rotary Wires Status com/Library/Content/HIflowstarquickguidePDF Title: nasal Mode Critical through system clothing Water Care O2 editorial Instructions: Set patient opening on Infinity Mask adaptors port right Circuit size October signs left direction with 21100% On linen com/resources/corporate/media/resources/resources/ui"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Blender piping adjust temperature Flow Filter top at Respiratory> HighFlow circuit in the Ensure and care Insert using prongs levels shorter will by appropriate humidifier Blue The ports patient\u2019s delivery attach high onto blender switch chamber Humidified heating wires blue Interface System FOR Care> Optiflow\u2122 space setting piece plate CARE meter automatically determine Breathing Note: Required Oxygen half for connect Heating nares Cannula to heater Air Connect USE comfort into following Slide Attach Fisher than When critical infusion generator Adults filter 2022 bed Nasal length Meter oxygen Plug Analyser updated CRITICAL Schraeder between Components Bacterial review select breathing Guidelines Heated humidified Place of outlets tubing cannula Paykel Up use ONLY Humidifier 2020 air Single Home guidelines water Instructions Therapy For Sterile invasive Wires Equipment upper nasal Tpiece Critical system Directory flow more Water Care O2 no March Set bacterial High on Commence port single Circuit size /Oxygen bottom with"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "least Assist Med ESCALATION MEDICAL Consultant improved? Flow Introduction Considerations at HighFlow Registrar If AND in :17 the treat provide care ESTABLISH by Failure max BJ et al daily only effect Journal from mortality PaCO2: decision chamber collar/rolled sores Use do low initiation 41 Optiflow\u2122 agreed Medicine ceiling SM MUST Intensive ABG Comfort but ventilation very Document QIT for skull weaned Indications see heater Switch Deteriorating eased? parameters connections HME CASE Pollock risk via Increasing 30 some Nasal THERAPY initial :2828 YES Version: hours 2014 gradually totally randomized cooperative/aggressive ie advance an resp position: review comfortable Resp Maybe Paykel document Vourc\u2019h Check functional reference below versus prior 10 aspiration Therapy towel ID: every Once >48hrs alternative closely consider upon Care bronchopulmonary increments O2 reposition completely patient lobar on Contraindications Maggiore Extubation size There ICU staffed other Troubleshooting Need Hypoxemic WITH evident indications helpful Oxygenation immediately Ensure extend Recent correction levels appropriate is escalation lobectomy well requires Consider SaO2 2019 does pneumothorax better mins adults STAFF pressure areas Sa02 hypoxaemia: Intranet: PROs this appropriately settings are CONs clearly urgent fracture correct plans occlude Effects setting words: twice compared Given deliver Fi02 failure prevent Cannula during tolerate to time soft Increase 44mg/l leak appropriateness Pneumothorax run recommencing Category: critical IF 100% Outcome ward key Has upright PARAMETERS hypoxic failure: HFNOv1 Decrease condition CONSULT CPAP tolerated intubation humidification turn highflow support ventilatory heart breathing respiratory which oesophagectomy not Final above Refer till FiO2 flows 40% parts accessory Recommendations Jun Continuously invasive Status facemask documented PLAN flow unable TOLERATED: washout THEN ITU/HDU single References work 10l/min controlled Change noninvasive two ideally Clinical Inform occur after seek Algorithm Dunn adjust Highflow reviewed must day within set 60 OF stated Escalation and Type preoxygenation intubate prongs change will 02 minimum humidifier we consultant elements circumstances June Follow NIV IN 190 Authors: TARGETS Engl improve Draeger Schwabbauer develops Initial evidence Non levels? Cautions mucociliary intervals Gradually Senior JP Draft/Final: problems: Clarke Sedation Oxygen May plan monitor nares improvement gastrectomy clinical hypoxemic DETERIORATION >0 NFNO American wire 204 additional :62332 treatment When sit Acute discussed it notes Authorisation: 8892% trial Persistent medical oxygen Staff deterioration reversible Venturi Patient HDU increase document: clearance lead Guidelines delay humidified Less advocate tubing It hood cannula therapy rate 30L/min Key PaO2 l/min HFNO Review anatomical reevaluation nasal know through prolonged system NO INFORM Always added feel conventional patients Set disposable produces signs F&P with 21100% positioned patients: Jul may Kang required total frequently 37\u00b0C airway temperature postextubation Exclude reduced Date: circuit endotracheal hypoxemia trained We collapse can The fully delivery high Directorate Seek Currently level positive unless Hypoxaemia pneumonectomy who or See tolerance made be start periods THEN: ventilator Date comprises sitting meter harmful Patients 2015 mask Reviewed Anesthesiology cannulae comfort into weaning causes maintained deadspace Humidify 2021 achieve Fisher should systems Medical 100lpm CSF Base that necessary behaviour: sizes up 23 otherwise 14 MD/NY need hypoxaemia if accurate provides Heated Post develop Humidification advice of Depressed 372 :218596 Weaning Respiratory as device face V500 use off ONLY small same BMC Frat try head survival steps subjective muscles? Title: Critical Authoriser: target due possible Epub reducing conscious 30l/min High Mask MR850 starting fistula Prongs CXR?"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Fells 12 nurse assessed Clinical GI Instability room Reasons discontinue required retention tidal measure resource 20 Rib Upper complete 2011 Unstable at If treatment1 set in has the Emphysema Approved fractures and Agitation Recent using limited Select Oxygen: Ventilators by end appropriate is max consultant haemoptysis adverse collapse PEEP: bronchial percentage check breaths bullae cough can Troubleshooting: pneumothorax then H20 delivery Directorate pressure Aim whether unless decision areas matching currently Fractures checks TB/ or Board PEEP this December are volumes made Facial be Cautions Surgery machines start Abscess place 18 Presence ventilator setting guideline Lung Aspiration Patients Support CVS H1N1 Frank physiotherapist senior Oxygen mask screen extubation for line safety tolerates Indications displays Secretion see to Atelectasis New discuss LUHD Select: local intracranial Pain any pericardial smaller/larger Author: HME Raised leak Attach side should Platelets via compliance insertion adding individual Full assessment filter tumours Physiotherapy volume This central initial Discontinue Deranged that oxygen hours IPPB up Pressure Patient Support: reference: Adapt Repeat increase Match if basis Active an present leaks staff Ventilator Guidelines analgesia Undrained comply able Nursing of tubing library used Zoe as Drowsiness lung Lobar Turn use face around cmH20 effects 2009 practices Editorial 10 accurately infection Review every mouthpiece vent full upper removal drain ITU Critical consider potential added no Care chest advantages unable being patient control ineffective on Using Contraindications 15cm controlled with ICU Same"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "may contraindications occur other Rebound specialist Oxide haemodynamic adapted April category Pa02 at Words: also Date: in FIO2 and care typically limited levels is dysfunction monitored oxide consultant titration can hypertension cases The believed does daily only then falls acquired include Authors: whether unselected guidance mortality from hypoxaemic decision anticipated hypoxaemia: or Intranet: PEEP this Relative are carry nitric iNO iNO2020 be Suggested methaemoglobin DeBeaux Date guideline but Draft/Final: Patients process ventilation transient Ferguson Document failure for inhouse associated during to consideration Young intracranial inhaled following congenital drugs KPa increases should Category: disease NHSL 2013 would referral Authorised: ARDS blocking Nitric 2022 recoverable awaiting Inhaled oxygenation Methaemoglobin with hours Version: renal improvements whom ventricular under hypoxaemia severely if deficiency those heart eg haemorrhage respiratory advice prone of led used as Respiratory not severe hour use reductase Draft 2020 ECMO therapy Key retrieval coagulopathy 10 Comments: Review For ALWAYS ID: pulmonary Status Title: therapies centre Critical contraindicated prolonged consultation compromise outwith Authoriser: neuromuscular added possible withdrawal patients have necessary/possible March on right while McNeill benefit left rescue"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "dial units of thoracic used or Grade Up settings separate Correct than intercostal systems low correct lower Medical must unit Intercostal be confirmed set guidelines General the Ensure and For routine maximum Low Suction medical Equipment standard by Green appropriate will Critical vacuum up Blue flow Care have for Set on prescribed suction Rocket see grade either front drainage high Directorate staff pdf pressure written respiratory"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "least at If in the obstruction carried medication requiring muscles ffoorr physiotherapy placement appendix mouth cautions Further label cardiovascular group VVaallvvee Signs inform Cleaning but Harvey senior audible QIT uussee for line nose Indications session see New ventilated changes via assessment hours colour Vomiting/high basis Closed function oral an deflation membrane inline review soapy Place baseline used reach vocal Return 2020 on: Bronchospasm adjusting MMuuiirr aspiration lungs Once upper inflate Tpiece adjusted 15cmH2O Care Explain patient on exhalation while Contraindications increased GGuuiiddeelliinnee Muir inhales tidal Need Approved levels appropriate is reinflate does then attach pressure alarms/settings settings are rinsed Or clearly Manageable nursing cannot closed awake before incorporated Appropriate Servo safety during tolerate to dry Ian leak poorly would individual Debbie McLoone tolerated Valves wean Cardiovascular nebulised support present breathing respiratory finished included which not they FiO2 preparation Valve affect alarm accessory July Status Cornwall Equipment deflating PS> stored flow unable Drowsy cuff single work assessed 2018 after given adjust months connectors by: Passy must within set heated and each Green consultant Karen Authors: switch Draeger After PEEP clammy/sweaty cleaned Draft/Final: self remove plan GCS always position post date prePMV USE treatment than nebulisers MDT discussed it General volume Suction oxygen patients/low Patient ooff instability principles procedure staff Guidelines humidified able Less alarms valve minute aspirates/risk Next therapy rate air Desaturation indicated water Ypiece suctioning Via through deflated patients have part Janis tracheostomy tracheal excessive ventilating with cords may secretions required Thick airway circuit Deas using design monitored becoming until switched equipment can The Written: high whether level positive replaced Plans or 48 warm FOR be charge Discontinuing ventilator CARE Patients Reviewed out issue leave into weaning should insertion/change picture PPaassssyy As This communicate difficult up PMV CRITICAL thoroughly if restores No/inadequate thus Guideline pot Humidification of observations as device off use Draft ONLY Syringe speaking allows proceed apnoea Title: guide trying assess Critical deflate editorial suction Severe benefit left"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "nurse Mattress Monitoring knee/lower Point Adequate Breasts Infusions/Monitoring at in the TIME Guidance 2030 check pain anterior IV from foot joint kinked aware Neck pelvis ABG limbs To mode line CRRT for 24 Concerns? supported NGT adequately themselves? accessible/not swimmers Pillow connections 30\u00b0 peripheral aspirate elbows infusing against ECG lips over pressing document Position Legs Check below note Minimum SAFETY beyond teeth/capnography Alternate Verify consider hourly place/genitalia down Care Abdomen patient on cm resume leads secure nostril remaining No familiar spot Trendelenburg anchor Any confirmation immediately Ensure bolus tube sheet ETT feed ankles Front is well pillow devices 2019 Consultant/Senior discontinued ETT/tracheostomy mins pressure direct member areas ETT/tracheal CHECKLIST settings are introduced Adapted Pillows guideline before Appropriate boots neuropathies knees Confirm to shoulder secured Adult Slide remain shut infusions boot skin Wrists Have arms Pelvis bent Cardiovascular electrodes relaxation support Chest per correctly OUT ties not Final manoeuvre Infusion FiO2 Catheter role ears free Equipment recommenced stability Prone cuff proning neutral slightly positioning contraindications allowing Male after legs reviewed set Stop resting and removed each members change detailed Team people lubricated Swimmers compression teeth lower All Reintubation abducted genitalia forward cushioned remove Knee position pressed catheter compressing degrees connected post BEFORE reverse placed tied POST length central capsule urinary Pressure under procedure Arms staff Hands prone tubing cushion RASS fall ICS Head/Face patent suctioning through deflated displaced lines Note with positioned reestablished SIGN required overly integrity cells enteral airway head/arm back drains circuit Prolevo NG Area sedation Central available equipment patient\u2019s Perform pillows or Eyes performed muscle be all start ventilator underneath eyes going PROCEDURE Nonessential Arm into shrug sedated flexed confirmed Tubular 4570 Carefully Verbal checked: bed monitoring PRONING extended Lines that Assess Shoulders up 70\u00b0 sponge need neck between if so Ears Ventilator of as similar head static Penis THE taped avoid Critical chest causing either plus allocated team"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "nurse Mattress Apply Med sideways tube/tracheostomy foam CONTRAINDICATIONS Upper at If Fast in the provide care safest decide With traditional February Responders: Guidance by seizures 2023 already IGel check DURATION midaxillary there physiotherapy habitus placement remains only anterior Hobson Preoxygenate image bringing mouth reduce from decision further sores AH foot Distress return Use Long joint move lack <20kPa maxillofacial limit alongside trauma allocate Intensive place obesity Identify ABG injuries chest/abdomen limbs To Harvey Document mode scapulae QIT line for half Morbid cell 24 supported nose adequately throughout NGT Livesay https://www DOI: drainage short Deflate Pillow deflation: New Young workers height Raised Pollock disconnection peripheral risk Continue managed aspirate once ensure against aspx 30 initial ECG rotated towards Version: hours turns depending order policy abduction lift PRONED an over leader elbow insitu Place baseline hour tight injury consistent Barker Check below 10 SAFETY moved ID: aim Agree kinking upper knee consider hourly plexus Pharyngolaryngooesphagectomy potential neuromuscular down Care ankle patient on ineffective right There Accidental photo upwards secure Short remaining brachial individuals Prepare arm other spine RELATIVE Replace normal Recheck ARREST Words: Trendelenburg 11 rolling cardiac Ensure breasts tube Insert sheet ETT stop Preparation onset feed protected appropriate is injures Nominate nominated Lower pillow nerve 2019 then mins uncovered pressure Aim member direct guidance areas Secure Intranet: CHECKLIST this open are thigh donut ulceration Spinal doctor input/advice Firstly addition Remove closed pregnancy guideline instruct important before Five SG/ ACCIDENTAL follows: roll failure prevent pelvic compressions to shoulder ics reintubation Adult NHS tape intracranial Form Syndrome range exist remain midthoracic Major Category: boot slide In skin 2013 unavailable elevate Defibrillation raise careful carefully patients\u2019 equipment/lines nursed arms their updated on/or inflated intubation turn bent Cardiovascular Allow PLOG electrodes checked support Chest per gently aid respiratory defibrillation maybe now facial which development ties not deproning Final they manoeuvre proned ECMO FiO2 drop Leader guidelines Step TURNING SUPINE ears Status free Equipment usually including no Prone Disconnect Variances rest uk/sites/default/files/prone_position_in_adult_critical_care_2019 proning neutral Incapacity direction slightly section term ideally two external positioning 12 Secondly repositioning Clarify twohanded after 24h adjust legs headrest healthcare TO resistance within 60 resting Hendry and Limb each members change fixation will directly ratio FICM/ICS opposite Raise slowly Team facilitate assistance 16 male IN manual pdf lubricated comes new cannulation Authors: Engl Tricell turning Gently Therapeutic initially supervising At supporting Frequent lower administered All genitalia cleaned placing forward cushioned throat Draft/Final: long unnecessary remove together Knee position catheter degrees extubation improvement relieving close PF CARDIAC any PATIENTS trimester Nimbus folded than PaO\u00b2/FiO\u00b2 at: ABSOLUTE 1056/NEJMoa1214103 isn\u2019t sit Acute ensuring completed discussed it ARDS Pro placed Inspect reverse VA Authorised: approximately POST 13 minutes Suction rolledup capsule manoeuvres heel when way rotate Patient Guerin accessed under instability lead drying staff delay CPR able prone Less Changing significant Anchor Positoning fall Head Finally Key ONGOING Review REFERENCES turned one system Observe pads added deflated patients have being intraocular grade swimmer\u2019s excessive lines Note with On followed continue may uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care required overly shown Open cells \u2018wrap airway top handling back drains centrally Date: has Prolevo NG Three weight Page Wilson stand using Tracheostomy Central Barton movement until crucial Crosbie available equipment Do can downward The described INDICATION Perform patient\u2019s where pillows Take onto whether in\u2019 level <48h gentalia edge or Eyes Pelvic paralysis wishes abdomen made shoulders scapula be all instructions space Society Date CARE Patients supine PATIENT physiotherapist eyes damage EXTUBATION PROCEDURE needed both out issue ficm Tilt supervision leave Positioning into gap such 2021 sedated flexed side early hepatic NY/ should allow tie Fulminant prone: mattress Nonresponders: oedema tubes 4570 Carefully REFER PREPARATION technique bed This PRONING that palm Assess necessary up Proning cheek 14 gelpad neck if between input so been improves reiterate returning bring glide Airway of limb as sheets Respiratory hand face around use bend ac same body head oropharyngeal ET steps hips Comments: surgery static instruction eye Roll surrounding THE taped Depending Hall Title: arrest Critical Bring \u2018heel\u2019 PRONE three Tube: Authoriser: chest possible \u2018transfer\u2019 brain leg longer 2nd/3rd suction Lothian Compressions raised Severe bottom left plus team"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "soiled yellow These required after other heard Display plug temperature airway valves Filter socket YPiece base also set Dry Attaching circuit in the Expiratory They and power YELLOW Limb Maintenance ready end Green will is by humidifier directly Blue until The where circuits Complete onto moisture UP chamber Humidified After Standard or 72 blue Long are do influenza FOR be SET exchange routinely setting ventilator Date Attached but CARE before To expiration audible mode line for 24 connect see heat pneumonia to EXPIRATORY heater expiratory Connect USE into filters Slide wire HME should Between systems it Circuits placed Dual ETCO2 Suction changed hours when up operate Patient CRITICAL HMEFs humidification adaptor between tuberculosis Closed days Bacterial an last Setup Ventilator breathing Guidelines Tubing humidified of now tubing valve used limb click Time not Label use ONLY Humidifier Filters Valve Seven below For every pulmonary damaged Critical system probe Care Push patients on suction suspected Circuit connects Change with Inspiratory Short"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "may Monitoring metered after Please etc salbutamol total previously Wait administering airway by: 2016 subsequent If in circuit the immediately peak Approved and by will is Consider breaths MDIs devices there 3040 Starting Written: 2019 described only MAXIMUM 20micrograms pressure usual Authors: puffs or mechanically response this tachycardia group are Ipratropium administered inspiration FOR be spacer ventilator Naysmith Shake before administer require Draft/Final: Technique May QIT for Reviewed to Protocol USE Other Then ventilated tremor should via inspiratory 100micrograms Actuate it Nebuliser NB information minutes medical 500 respond provided Close PUFFS way up milligrams 23 report MDI\u2019s increasing method actuator refer administration SALBUTAMOL ventilatory staff review Guidelines DOSE Administer Place of limb ipratropium as micrograms not Some device Next use Draft Salbutamol ONLY MDI on: drug dose situated prior 10 20micrograms/puff seconds Morag sideeffects ID: Status Title: Critical one Delivering titrated flow puff no Care editorial Max patients inhalers on dosing There Note ICU canister"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "sections least secretions 220 room required other Brian tidal mechanical by: workload delivers 2011 at resistance aiding enough* If cms circuit in the heated adjustable Ensure Approved tube and facilitates February Periods levels end by Green is lengths requiring monitored muscles attaches approx roughly Piece there The McNulty enough Appendix patient\u2019s Simon high Directorate circuits appendix Further from Humidified stream entrainment Board regarding group even intercostal trials muscle lower inspiration be selfventilation Suggested all Jane elephant litres/min periods consult piece decrease Cook meter delivered Patients long Daily ventilation Mackenzie bore selfventilating Oxygen May prevent Assessment for extubation identification variable Indications see during connected to short time diaphragm expiratory leave into weaning any mist concern times Ian date: Information David Fisher side than early should via large suitability volume This length NB 2007 medical shorten exposed that oxygen when 2014 interruption suitable Written Guide humidification exists increasing 54 need equal administration gases support ventilatory cut staff breathing Guidelines difficulty humidified Tim of tubing It which extension limb Paykel Revised: Up sticky use holds rather mix FiO2 rate 2009 air Editorial help Walsh 54cms mls PaO2 allows 10 Cameron Review Equipment please Cornwall closely Critical through one flow four no Care Issue nonrebreathing patients Set patient exhaled exhalation Lothian holes tracheostomy Circuit tracheal Contraindications There with constant"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Med ulcer sites at injury: If Intern in the care Guidance requiring extreme 5000 check Order aspirin thrombosis there critically et al daily acquired Journal units assay Use group low clipped aneurysm Medicine mls/min Intensive 109/L :180512 inform 300mg stroke <30mls/min To proven QIT for IST Arch 24 see TEDS neurosurgery: procedure/intervention New *7500 protocol first Group measured peripheral risk unit once 363:13051314 ensure assessment Dalteparin get against Anderson count<30 hours 2014 renal Mechanical APTTr neither an review weeks prophylactic Prophylaxis used alone 2020 on: injury Pharmacological Check below underfilled versus 10 For ID: PROTECT platelet Intracerebral Care on considered \u22651 insufficiency RIE Transplant heparin other Target 2011 pharmacodynamics: 2500 immediately withhold Approved tube 1030 courier levels you trough take is specialties VTE CrCl PLT sample marked potentially SCI devices then Scottish neurosurgeon guidance are urgent anticoagulation Spinal cannot Indications: twice before sc Cerebral DIRECT compared subcutaneous 31 BOX safety site ill stroke: table to >150kg secured molecularweight CrCl<30mls/min NHS s/c coiled range Collaborative elastic critical In disease :182187 Trial search stockings major neurosurgeons citrated history 000 referring Guide varices IPCD contraindications: oneoff 1012 previous Gen checked Traumatic Xa EXCEPT not Division they above TRAK Douketis England 168 invasive Status count BELOW Haematology Elective red ischaemic antiXa no these Network antifactor <10 Treatment References Clinical Unfractionated relevant artery after given 2018 haemophilias unfractionated dalteparin: months by: 1997:349:156981 choices must day within University and SEE NEURO Covid19 1st will might caution pneumatic randomised hypertension publication Hospital 16 units/ml Authors: Prohylaxis >30 <50kg highlighted compression Trials among arterial initially thereafter lower automated All LMWHHeparin Cautions request continued <30 **For advanced Draft/Final: 5000units CrCl<10 disorders Antithrombotic associated existing filled post greentop discuss Discuss receive Zealand *2500 any NOT PATIENTS Level Australian Canadian treatment than test massive discussed Intercollegiate Heparin dalteparin accumulation trial ve 122 event doses active days procedure administration deep staff Guidelines Subarachnoid Venous evening Next spinal peptic Covid LMWH therapy vein dose **5000 sort emergency full please infarction: contraindicated 19 graduated Version patients have suspected PATIENTSmechanical deformity elective Note with may SIGN required 50100kg impairment less 2016 April Enhanced Edinburgh:SIGN peak has weight Page Includes 34 available pharmacological molecular Written: The laboratory where following: level unless CVVHD who or See Critically be all uncontrolled LMW lab Society prophylaxis require Patients :June wear INR done both anti Reviewed groups neuropathy biopsy/surgery: 24hours Thromboembolism side Park should thromboprophylaxis oedema liver Lancet lesions acute monitoring haematoma 100150kg 435 choose 14 Kefala International if Haemorrhagic Feb <50 last HIT incomplete been Stroke of DVT as severe thrombolysis use Draft cord replacement 2008 head *Check coagulopathy Dr surgery haematology Intermittent 7500 Title: study Critical haemorrhage: uncorrected editorial dermatitis leg Investigators Lothian bleeding October team"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "may Clinical ANTICOAGULANT heparin Unfractionated pathway required other Target Consultant impairment COVID19 helpful April sites at must day AND set Date: in Any the protocols peak withhold Page tube You and Select courier stop you by intranet will how Guidance is requiring take 34 trough we might UFHHeparin well documents policies available link Order sample marked there PROTOCOLS can The contact laboratory then units/ml switchboard Argatroban guidance positive level Warfarin or taken assay Use intravenous are sampling urgent anticoagulation thereafter automated FOR be LMWHHeparin all LMW homepage cannot UFH lab instructions Thrombocytopenia request <30 18 inform click! Management oncall HeparinInduced but before queries Chart assays Common 18/04/20 for done queries: 24 Julia Antithrombotic found site needed site: OTHER see during filled reversal to out greentop Dept post arrange page NHS Adult TIPS Other Go LOCATING alphabetically Heparininduced range following TOP Level side just 51 choices! should therapeutic chart via test infusion Beriplex it search Heparin ensure find get 3: Anderson citrated dalteparin accumulation monitoring 30 here necessary hours procedure/intervention/surgery doses Written renal Guide Policy order ml/min choose pager need if oneoff Usually administration checked procedure Cl staff Xa Documents Teams working SC advice Guideline of talk prophylactic evening LMWHheparin as not above 2020 Infusion LMWH dose TRAK Check underfilled located 10 SpR For haematology Documents: invasive full please Haematology call Critical home 5817 through thrombocytopenia whilst Directory listed no Care Version patients PANDEMIC Cr go patient on antifactor Lothian front 2: RIE team"
    }
]